Quarterlytics / Consumer Cyclical / Packaged Foods / SunOpta

SunOpta

soy · TSX Consumer Cyclical
Claim this profile
Ticker soy
Exchange TSX
Sector Consumer Cyclical
Industry Packaged Foods
Employees 1001-5000
← All annual reports
FY2017 Annual Report · SunOpta
Sign in to download
Loading PDF…
Bringing well-being to life

Organic and Healthy Foods Company 
with Global Reach

2017 ANNUAL REPORT

2017 Annual ReportOUR MISSION
To responsibly bring healthy 
food from field to table.

OUR VISION
To be the most innovative, 
vertically integrated provider of 
organic ingredients and healthy 
food solutions.

FINANCIAL HIGHLIGHTS
All dollar amounts in U.S. $ millions, except per share amounts, and in accordance with U.S. GAAP

2017

2016

2015

1,279.6 1,346.7

1,145.1

145.1

11.3%

0.8

126.0

9.4%

14.7

110.4

9.6%

21.3

(3.0)

Revenue

Gross profit

Gross profit percentage

Operating income (1)

Loss from continuing operations attributable to SunOpta Inc.

(135.3)

(50.6)

Loss per share from continuing operations attributable to SunOpta Inc.

$(1.66) $(0.61)

$(0.04)

Adjusted earnings (loss) (2)

Adjusted earnings (loss) per diluted share (2)

Adjusted EBITDA (3)

Adjusted EBITDA, excluding flexible resealable pouch and nutrition bar (3)

Total assets

Total debt

Working capital (4)

Net cash flows from operating activities – continuing operations

(12.3)

5.8

$(0.14)

$0.07

66.8

72.6

81.7

82.9

19.0

$0.26

62.2

62.7

982.2

1,129.6

1,219.2

462.1

351.6

31.5

432.6

360.0

0.7

482.8

364.8

26.4

Net cash flows from investing activities – continuing operations

(40.1)

(21.6)

(521.6)

(1)

(2)

(3)

(4)

Operating income is defined as “earnings (loss) from continuing operations before the following” excluding the 
impact of “other income/expense items” and goodwill impairments.
Refer to pages 46, 47, 56 and 57 of the 2017 Form 10-K for a tabular reconciliation of Adjusted earnings (loss) 
and Adjusted earnings (loss) per diluted share to the most directly comparable GAAP measure.
Refer to pages 48 and 58 of the 2017 Form 10-K for a tabular reconciliation of Adjusted EBITDA and Adjusted 
EBITDA, excluding flexible resealable pouch and nutrition bar to the most directly comparable GAAP measure.
Working capital is defined as current assets less current liabilities, excluding cash and cash equivalents, bank 
indebtedness, current portion of long-term debt and current assets/liabilities held for sale.

2017 Annual ReportTO OUR SHAREHOLDERS

It has been just over a year since I joined SunOpta as CEO, and 
I am very encouraged by the progress we have made against 
the objectives we set for the year. At the end of 2016, we 
launched our Value Creation Plan, which was designed to deliver 
sustainable, long-term shareholder value. We said we would 
invest in our people, our assets and our capabilities while finding 
ways to streamline our portfolio where it made sense in order to 
focus on our core business. 

During 2017, our efforts under the Value Creation Plan have 
yielded an improved business mix and a more efficient, reliable 
and higher-quality production network. We also reinvested 
savings generated from our productivity initiatives into building 
the talent and infrastructure necessary to drive future growth. 
Although there is still a lot of work to be done, I am confident 
that we are entering 2018 with a solid foundation to drive long-
term profitable growth. 

Our mission remains unchanged:  “To responsibly bring healthy 
food from field to table”.  In the pursuit of this mission, the 
organization has operated with the following four Core Values:

1.  Quality and Safety

Food and worker safety are paramount, and in addition to 
quality, are the responsibility of every employee at SunOpta.

2. Customer Centricity

We exist to serve and delight our customers.

3. Innovation

We create remarkable healthy food products that solve a 
need for consumers and our customers.

4. Continuous Improvement

We are unrelenting in our pursuit of perfection.

Our vision is to be the most innovative, vertically integrated 
provider of organic ingredients and healthy food solutions. 
To achieve this, our strategy is to invest in and grow efficient 
integrated supply chains and to innovate in growing healthy 
food and beverage categories, all with an unrelenting focus on 
food safety, quality and best-in-class operational performance. 

As I have previously stated, we are in the midst of a turnaround 
at SunOpta.  The turnaround involves three phases, “Clean it 
up”, “Tune it up” and “Turn it up”. Significant progress has been 
achieved during the past year in phase one of the turnaround.  
The first phase of the turnaround is the most challenging 
requiring difficult decisions that are necessary to establish the 
foundation upon which we will deliver long term sustainable 
growth.  We developed the Value Creation Plan as the 
mechanism to unlock the unrealized potential of our company, 
an update on our progress is provided on the pages that follow.

2017 Annual Report 
THE VALUE CREATION PLAN

The Value Creation Plan is a broad-based initiative focused on increasing shareholder value through 
strategic investments made in the people and assets of the company to deliver sustained profitable 
growth. It is built on four pillars which provide the framework for all our efforts to improve operational 
performance and drive long-term sustainable growth and shareholder value.

Pillar One: Portfolio Optimization

The focus of the portfolio optimization pillar is to simplify the business, investing where structural 
advantages exist, while exiting businesses or product lines where we are not effectively positioned.  
Highlights include:

• Expansion project to add incremental freezing capacity, storage, and retail bagging capabilities 
to our Mexican frozen fruit facility (which we now wholly-own, following our acquistion of the 
remaining non-controlling interests in July 2017).  This project will also allow us to take advantage 
of diversification of fruit varieties sourced from Mexico and is expected to provide the highest 
quality and lowest cost frozen fruit solutions to our customers.

• Expansion project to add a second roasting and processing line at our organic cocoa facility in The 
Netherlands.  This expansion is expected to double processing capacity in addition to adding new 
capabilities, all in support of increased demand and future growth opportunities in cocoa.

• Addition of a new sunflower oil processing line at our Bulgarian sunflower facility, which is 
expected to drive incremental margin through volume growth and production efficiency.

• Investment into our roasted snacks capabilities at our Crookston, Minnesota facility, which also 
involves the planned closure of our Wahpeton, North Dakota roasting facility.  This expansion is 
expected to be operational in the third quarter of 2018, which will support further growth of a 
variety of roasted grains, seeds and other plant based snacks.  

• Discontinuation of flexible resealable pouch and nutrition bar product lines and operations in the 
fourth quarter of 2017, and related closure of our Carson City, Nevada nutrition bar processing 
facility.

• Consolidation of certain soy and specialty grain volume and closure of a grain-handling facility 
in Moorhead, Minnesota in the third quarter of 2017 to enhance facility utilization and reduce 
operating costs. 

Since the initiation of the Value Creation Plan, we have implemented portfolio changes that are expected 
to yield approximately $7.9 million of annualized adjusted EBITDA benefits. 

2017 Annual ReportPillar Two: Operational Excellence

The focus of the operational excellence pillar is to ensure food quality and safety, coupled with improved 
operational performance and efficiency.  We expect these efforts to generate productivity improvements 
and cost savings in manufacturing, procurement and logistics.  Highlights include:

• Advances in food safety and quality efforts across the entire manufacturing footprint. 

• Rollout of a new continuous improvement methodology (“SunOpta 360”) across our network of 

aseptic beverage facilities, which is helping to drive an expected 20% improvement in output from 
existing aseptic lines in 2018, in addition to enhanced production capabilities that will add new 
value-added non-dairy alternatives.

• Actions taken to right-size the incoming 2018 fruit crop, in connection with the implementation of 
new sales and operations planning (“S&OP”) tools within Consumer Products, which is expected 
to reduce storage costs, lower working capital, and operationally better prepare our frozen fruit 
operations for the start of the upcoming fruit season.

• Continued identification and implementation of productivity initiatives focusing on manufacturing 

efficiencies, purchasing synergies and effective supply chain management.

• Working capital optimization efforts leading to a significant year-over-year improvement in 

operating cash flows.

Since the initiation of the Value Creation Plan, we have implemented process improvements and cost 
savings that are expected to yield approximately $6.9 million of annualized adjusted EBITDA benefits.

Pillar Three: Go-to-Market Effectiveness

The focus of the go-to-market effectiveness pillar is to optimize customer and product mix in existing 
sales channels, and identify and penetrate new high-potential sales channels.  We expect efforts under 
this pillar to improve revenue growth and profitability over time.  Highlights include:

• Developed significant pipeline of 

commercial opportunities across all 
consumer product platforms, with 
opportunities across categories and 
channels where we are currently under-
represented.

• Filling of the new position of Chief 

Customer Officer for Consumer Products, as 
well as hiring a new head of marketing.

• Addition of new commercial talent in the 
areas of sales, marketing, and research 
and development, which has furthered the 
development of control branded products 
that are expected to enhance access to the 
foodservice channel.

• Creation of a new foodservice distribution 
network, leveraging third parties, which 
will support our plan to grow and diversify 
penetration into the foodservice channel. 

In 2017, we have implemented go-to-market improvements through strategic pricing actions expected to 
yield approximately $1.2 million of annualized adjusted EBITDA benefits.  In 2018, efforts under the go-to-
market pillar are focused on driving incremental sales volume. 

2017 Annual ReportPillar Four: Process Sustainability

The focus of the process sustainability pillar is to ensure we have the infrastructure, systems and skills 
to sustain the business improvements and value captured from the Value Creation Plan.  Broadening the 
skillset and experience of our leadership team is a critical component to the process sustainability pillar 
of the Value Creation Plan.  Highlights included: 

•  Filling the positions of Chief Executive Officer, Chief Human Resources Officer, Chief Information 
Officer, Chief Quality Officer, Senior Vice President of Operations and Senior Vice President of 
Supply Chain, as well as the appointment of new General Managers to lead our Healthy Beverage 
and Healthy Fruit platforms.

•  Additional hiring of other management-level positions in the areas of sales, marketing, customer 

service, engineering, operations, quality and other functional support services.

•  Progress on an enterprise resource planning implementation project at the Mexican frozen fruit 

facility, with expectation that the new system will be operational during the second quarter of 
2018.  Restructuring of the Sales & Operations Planning (S&OP) process and tools in the frozen 
fruit operations, which is expected to drive greater discipline and accuracy in the fruit pack plan, 
ensuring grower commitments are aligned with commercial demand.

•  Addition of experienced directors of quality for each of our product platforms and plant and 

quality assurance managers in several facilities. 

•  Continued focus on customer service and working capital levels as S&OP processes and support 

systems are refined.

•  Under new leadership, shifting the focus of the internal audit function towards value-

added business process improvements that are designed to support and ensure we sustain 
improvements made as part of the Value Creation Plan. 

2017 Annual ReportThree Phases of the Value Creation Plan

During the first phase of the Value Creation Plan we are targeting the implementation of $30 million of 
productivity driven annualized EBITDA enhancements over 2017 and 2018. To date, we are pleased to 
report that we have implemented over $16 million of annualized productivity savings, and remain on-
track to deliver the balance in 2018.

For 2017, these EBITDA enhancements were offset by expenses associated with the Value Creation 
Plan, including structural investments made in the areas of quality, sales, marketing, operations and 
engineering resources, as well as non-structural third-party consulting support, severance and recruiting 
costs. This was consistent with our plan and these investments have helped to establish the people, 
processes and systems that we need to be successful as we transition to the second phase of our Value 
Creation Plan. 

THE YEAR AHEAD: FOCUSED ON TOP-LINE GROWTH

Looking ahead to 2018, as we transition to the second phase of our Value Creation Plan, we expect to 
drive revenue growth through our go-to-market effectiveness efforts and continue to realize benefits 
from our productivity initiatives.

One year in, I am pleased with the impact the Value Creation Plan has had on our business performance.  
We saw increased gross margins across all of our businesses, with the exception of frozen fruit, during 
the fourth quarter of 2017 reflecting our portfolio optimization and operational excellence efforts.  We 
have also generated and started to convert a significant sales opportunity pipeline across all of our 
product lines and within multiple sales channels with both existing and new customers.  There is still 
work to be done to get all of our businesses back to growth and to their targeted margin profiles; 
however, I feel good about the progress we have made to date.  

Unfortunately, much of this progress was masked by the underperformance of frozen fruit, and our 
organization is taking action to address this under-performance.  

2017 Annual ReportIn 2018, we are focused on lowering costs by leveraging procurement and processing capabilities at our 
recently expanded Mexican frozen fruit facility, while operating our Californian facilities in a more cost 
effective manner. We are also right sizing our inventories to current demand with a focus on improving 
overall fruit quality while reducing storage costs and working capital. As we enter 2018, we have been 
focused on building a pipeline of sales opportunities, rebuilding relationships with key customers 
and developing opportunities with new customers, all while establishing the correct assortment, 
merchandising, pricing and innovation strategies. We believe the combination of these efforts will allow 
us to stabilize and return this business to growth over time. 

A year ago, I joined SunOpta based on its significant growth potential as a result of its positioning in 
organic and non-GMO ingredients, as well as its consumer packaged capabilities that are squarely aimed 
at the fast growing healthy and better-for-you segment of the food industry.  Today, I remain enthusiastic 
about the significant opportunities that exist for SunOpta and I am equally committed to delivering on 
the promise of value creation for our shareholders.  Let me reiterate what we will do:

We will focus on food safety, quality and execution;
We will remain focused and decisive as we execute our strategic plan;
We will focus on long-term value creation; and
We will make decisions with a long-term focus, even if those decision do not maximize near-term 
earnings.

Thank you for your investment in SunOpta and for your confidence and support of me and my team.

DAVID J. COLO
President & Chief Executive Officer

2017 Annual ReportUNITED STATES 
SECURITIES AND EXCHANGE COMMISSION 
Washington, D.C. 20549 

FORM 10-K/A 
Amendment No. 1 

   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the fiscal year ended December 30, 2017 

   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the transition period from          to            

Commission File No. 001-34198 

SUNOPTA INC. 
 (Exact Name of Registrant as Specified in Its Charter) 

CANADA 
(Jurisdiction of Incorporation) 

Not Applicable 
(I.R.S. Employer Identification No.) 

2233 Argentia Drive, Suite 401 
Mississauga, Ontario L5N 2X7, Canada 
(Address of Principal Executive Offices) 
(905) 821-9669 
(Registrant's telephone number, including area code) 

Securities registered pursuant to Section 12(b) of the Act: 

Title of each class 

Name of each exchange on which registered 

Common Shares, no par value                                        

The NASDAQ Stock Market, Toronto Stock Exchange 

Securities registered pursuant Section to 12(g) of the Act:  None 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes  

    No  

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes  

     No  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange 
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has 
been subject to such filing requirements for the past 90 days.  Yes  

   No  

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive 
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter 
period that the registrant was required to submit and post such files).  Yes 

    No  

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be 
contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of 
this Form 10-K or any amendment to this Form 10-K.  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting 
company, or emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and 
“emerging growth company” in Rule 12b-2 of the Exchange Act.  (Check one): 

Large accelerated filer 
Smaller reporting company 

 Emerging growth company 

  Accelerated filer 

   Non-accelerated filer 

  (Do not check if a smaller reporting company)  

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for 
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes 

      No 

Aggregate market value of the common equity held by non-affiliates of the registrant, computed using the closing price as reported on the 
NASDAQ Global Select Market for the registrant’s common shares on July 1, 2017, the last business day of the registrant’s most recently 
completed second fiscal quarter, was approximately $765 million.  The registrant’s common shares trade on the NASDAQ Global Select 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Market under the symbol STKL and on the Toronto Stock Exchange under the symbol SOY. 

The number of shares of the registrant’s common stock outstanding as of February 23, 2018 was 86,805,091. 

Documents Incorporated by Reference:  Portions of the SunOpta Inc. Definitive Proxy Statement for the 2018 Annual Meeting of 
Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K. 

EXPLANATORY NOTE 

SunOpta Inc. (the “Company”) filed its Annual Report on Form 10-K for the fiscal year ended December 30, 2017 (the “Original Filing”) 
with the U.S. Securities and Exchange Commission (the “SEC”) on March 1, 2018.  The Company is filing this Amendment No. 1 (the 
“Amendment”)  to  its  Original  Filing  solely  to  revise  the  following  typographical  error  in  the  Report  of  Independent  Registered  Public 
Accounting Firm related to their Opinion on the Financial Statements included in Item 8 of Part II of the Original Filing: 

(cid:120)  Under the Basis for Opinion, the first sentence has been corrected to state: “These financial statements are the responsibility of the 
Company’s management.”  In the Original Filing, this sentence stated: “The Company's management is responsible for maintaining 
effective  internal  control  over  financial  reporting  and  for  its  assessment  of  the  effectiveness  of  internal  control  over  financial 
reporting, included in the accompanying Management's Annual report on Internal Control Over Financial Reporting.” 

In addition, pursuant to the rules of the SEC, the exhibit list included in Item 15 of Part IV of the Original Filing has been amended to contain 
currently-dated certifications from the Company’s Chief Executive Officer and Chief Financial Officer, as required by Sections 302 and 906 
of the Sarbanes-Oxley Act of 2002.  The certifications of the Company’s Chief Executive Officer and Chief Financial Officer are attached 
as exhibits to this Amendment. 

Except as described above, this Amendment does not amend or update any other information contained in the Original Filing.  The Original 
Filing continues to speak as of the date of the Original Filing, and other than expressly indicated in this Amendment, the Company has not 
updated the disclosures contained therein to reflect any events which occurred at a date subsequent to the filing of the Original Filing and 
does not modify or update in any  way disclosures made in the original Form 10-K.  The Company has included a complete copy of the 
Original Filing, as amended per above, in this filing.

 
 
 
 
 
 
 
 
 
 
SUNOPTA INC. 
FORM 10-K 
For the year ended December 30, 2017 
TABLE OF CONTENTS 

Basis of Presentation 
Forward-Looking Statements 

PART I 

Item 1 
Item 1A 
Item 1B 
Item 2 
Item 3 
Item 4 

PART II 

Item 5 

Item 6 
Item 7 
Item 7A 
Item 8 
Item 9 
Item 9A 
Item 9B 

PART III 

Business 
Risk Factors 
Unresolved Staff Comments 
Properties 
Legal Proceedings 
Mine Safety Disclosures  

Market  for  Registrant’s  Common  Equity,  Related  Stockholder  Matters  and  Issuer  Purchases  of 
Equity Securities 
Selected Financial Data 
Management’s Discussion and Analysis of Financial Condition and Results of Operations 
Quantitative and Qualitative Disclosures About Market Risk 
Financial Statements and Supplementary Data 
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 
Controls and Procedures 
Other Information 

Item 10 
Item 11 
Item 12 

Item 13 
Item 14 

Directors, Executive Officers and Corporate Governance 
Executive Compensation 
Security  Ownership  of  Certain  Beneficial  Owners  and  Management  and  Related  Stockholder 
Matters 
Certain Relationships and Related Transactions, and Director Independence 
Principal Accounting Fees and Services 

PART IV 

Item 15 
Item 16 

Exhibits, Financial Statement Schedules 
Form 10-K Summary 

2 
2 

5 
17 
31 
32 
33 
33 

34 
37 
38 
67 
68 
68 
69 
70 

72 
72 

72 
72 
72 

72 
80 

SUNOPTA INC. 

1 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basis of Presentation 

Except  where  the  context  otherwise  requires,  all  references  in  this  Annual  Report  on  Form  10-K  for  the  fiscal  year  ended 
December  30,  2017  (“Form  10-K”)  to  “SunOpta”,  the  “Company”,  “we”,  “us”,  “our”  or  similar  words  and  phrases  are  to 
SunOpta Inc. and its subsidiaries, taken together. 

In this report, all currency amounts presented are expressed in thousands of United States (“U.S.”) dollars (“$”), except per 
share amounts, unless otherwise stated.  Other amounts may be presented in thousands of Canadian dollars (“C$”), euros (“€”) 
and Mexican pesos (“M$”), as well as British pounds (“£”).  The following table sets forth, for the periods indicated, the rate 
of exchange for the Canadian dollar, euro, and Mexican peso, expressed in U.S. dollars, based on Bank of Canada exchange 
rates.  These rates are provided solely for convenience, and do not necessarily reflect the rates used by us in the preparation of 
our financial statements. 

Canadian Dollar 

Euro 

Mexican Peso 

Year 
2017 
2016 
2015 

  Closing 
0.7971 
0.7448 
0.7225 

  Average 
0.7708 
0.7548 
0.7820 

  Closing 
1.1998 
1.0553 
1.0859 

  Average 
1.1281 
1.1066 
1.1091 

  Closing 
0.0509 
0.0485 
0.0582 

  Average 
0.0530 
0.0537 
0.0631 

Forward-Looking Statements 

This Form 10-K contains forward-looking statements which are based on our current expectations and assumptions and involve 
a number of risks and uncertainties. Generally, forward-looking statements do not relate strictly to historical or current facts 
and are typically accompanied by words such as “anticipate”, “estimate”, “target”, “intend”, “project”, “potential”, “continue”, 
“believe”, “expect”, “could”, “would”, “should”, “might”, “plan”, “will”, “may”, “predict”, the negatives of such terms, and 
words and phrases of similar impact and include, but are not limited to references to future financial and operating results, 
plans, objectives, expectations and intentions; our ability to implement the four pillars and achieve the objectives of our strategic 
Value Creation Plan, including realizing our targeted  adjusted earnings before income  taxes, depreciation and amortization 
(“EBITDA”),  expected  benefits  from  adjusted  EBITDA  enhancements  implemented  to-date,  and  targeted  working  capital 
efficiencies; estimated losses and related insurance recoveries associated with the recall of certain roasted sunflower kernel 
products; anticipated timing for completion of the expansion of our Mexican frozen fruit facility; anticipated timing of the 
consolidation  of  our  roasted  snack  operations  and  related  closure  of  our  Wahpeton,  North  Dakota,  facility;  other  possible 
operational  consolidations;  rationalization  of  assets  and  operations;  business  strategies;  plant  and  production  capacities; 
revenue generation potential; anticipated construction costs; competitive strengths; goals; capital expenditure plans; business 
and  operational  growth  and  expansion  plans;  anticipated  operating  margins  and  operating  income  targets;  gains  or  losses 
associated  with  business  transactions;  cost  reductions;  rationalization  and  improved  efficiency  initiatives;  proposed  new 
product offerings; future growth of our business and global markets for our products; and other statements that are not historical 
facts.  These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation 
Reform  Act  of  1995,  including  Section  27A  of  the  Securities  Act  of  1933,  as  amended,  and  Section  21E of  the  Securities 
Exchange Act of 1934, as amended.  These forward-looking statements are based on certain assumptions, expectations and 
analyses we make in light of our experience and our interpretation of current conditions, historical trends and expected future 
developments, as well as other factors that we believe are appropriate in the circumstances.  

Whether actual results and developments will be consistent with and meet our expectations and predictions is subject to many 
risks and uncertainties.  Accordingly, there are important factors that could cause our actual results to differ materially from 
our expectations and predictions.  We believe these factors include, but are not limited to, the following:  

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

failure or inability to implement our value creation strategies to achieve anticipated benefits; 

conflicts of interest between our significant investors and our other stakeholders; 

disruptions to our business caused by shareholder activism; 

product liability suits, recalls and threatened market withdrawals that may arise or be brought against us;  

food safety concerns and instances of food-borne illnesses that could harm our business; 

litigation and regulatory enforcement concerning marketing and labeling of food products; 

SUNOPTA INC. 

2 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

significant food and health regulations to which we are subject;  

ability to obtain additional capital as required to maintain current growth rates; 

the potential for impairment charges in goodwill or other intangible assets;   

the highly competitive industry in which we operate; 

that our customers may choose not to buy products from us;   

the potential loss of one or more key customers;   

changes and difficulty in predicting consumer preferences for natural and organic food products;   

our ability to effectively manage our supply chain;   

volatility in the prices of raw materials and energy;   

the availability of organic and non-genetically modified ingredients; 

unfavorable growing and operating conditions due to adverse weather conditions;    

an interruption at one or more of our manufacturing facilities;   

technology failures that could disrupt our operations and negatively impact our business; 

the potential for data breaches and the need to comply with data privacy and protection laws and regulations; 

the loss of service of our key management;   

labor shortages or increased labor costs;   

technological innovation by our competitors;   

ability to protect our intellectual property and proprietary rights;   

changes in laws or regulations governing foreign trade or taxation; 

agricultural policies that influence our operations;   

substantial environmental regulation and policies to which we are subject; 

the enactment of climate change laws;   

fluctuations in exchange rates, interest rates and the prices of certain commodities;   

exposure to our international operations;   

increased vulnerability to economic downturns and adverse industry conditions due to our level of indebtedness; 

restrictions under the terms of our debt and equity instruments on how we may operate our business; 

our ability to renew our revolving asset-based credit facility (the “Global Credit Facility”) when it becomes due on 
February 10, 2021; 

(cid:120) 

ability to meet the financial covenants under the Global Credit Facility or to obtain necessary waivers from our lenders;   

SUNOPTA INC. 

3 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

our ability to effectively manage our growth and integrate acquired companies; 

our ability to achieve the estimated benefits or synergies to be realized from business acquisitions; 

exposure to unknown liabilities arising from business acquisitions; 

unexpected disruptions in our business, including disruptions resulting from business acquisitions; 

our ability to successfully consummate possible future divestitures of businesses; 

volatility of our operating results and share price; 

that we do not currently intend to, and are restricted in our ability to, pay any cash dividends on our common shares 
in the foreseeable future;  

dilution in the value of our common shares through the exchange of convertible preferred stock, exercise of stock 
options, participation in our employee stock purchase plan and issuance of additional securities; and 

(cid:120) 

impact of the publication of industry analyst research or reports about our business on the value of our common shares.   

All  forward-looking  statements  made  herein  are  qualified  by  these  cautionary  statements,  and  our  actual  results  or  the 
developments  we anticipate  may  not be realized.  Our forward-looking statements are  based only on information currently 
available to us and speak only as of the date on which they are made. We do not undertake any obligation to publicly update 
our forward-looking statements, whether written or oral, after the date of this report for any reason, even if new information 
becomes available or other events occur in the future, except as may be required under applicable securities laws.  The foregoing 
factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are 
included in this report. For a more detailed discussion of the principal factors that could cause actual results to be materially 
different, you should read our risk factors in Item 1A, Risk Factors, included elsewhere in this report. 

SUNOPTA INC. 

4 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
Item 1. Business 

INTRODUCTION 

PART I 

SunOpta, a corporation organized under the laws of Canada in 1973, is a leading global company operating businesses focused 
on a healthy products portfolio that promotes sustainable well-being.  We are focused on sourcing non-genetically modified 
(“non-GMO”) and organic ingredients and manufacturing healthy food and beverage products. We operate an integrated “field-
to-table”  business  model  leveraging  our  global  ingredient  sourcing  platform  to  process  and  market  non-GMO  and  organic 
ingredients for retailers, food manufacturers and foodservice operators. We also manufacture packaged products focused on 
the high growth healthy beverages, healthy fruit and healthy snacks categories for our retail, foodservice and branded food 
customers. We believe we are a North American market leader in non-dairy organic aseptic beverages, premium refrigerated 
private label orange juice, individually quick frozen (“IQF”) organic fruit, healthy premium fruit snacks, and the global sourcing 
and supply of non-GMO and organic raw materials and ingredients. Our scalable global sourcing platform makes us one of the 
leading suppliers of non-GMO and organic raw materials and ingredients in the food industry, and provides us leading insights 
into emerging food and beverage trends. Our product portfolio is strategically aligned with the fast-growing consumer demand 
for high quality, healthy non-GMO and organic food and beverage products.  

Our  vertically  integrated  business  model  makes  us  a  preferred  partner  to  our  retail  (e.g.,  grocery,  mass,  club,  natural  and 
specialty chains), foodservice and branded food customers. We deliver a diverse, innovative portfolio of high quality, food and 
beverage  products  supported  by  our  global  sourcing  platform,  scalable  operating  footprint,  manufacturing  expertise  and 
commitment to innovation. This platform enables us to consistently supply our customers with a broad range of non-GMO and 
organic ingredients as well as high quality healthy food and beverage products that cater to the evolving demands of today’s 
consumers.  As  a  leading  supplier  of  non-GMO  and  organic  ingredients  to  the  food  industry,  we  leverage  our  insights  into 
emerging consumer tastes and preferences to develop innovative new food and beverage products. 

Our Product Portfolio  

Our diverse consumer products portfolio utilizes non-GMO and organic raw materials and ingredients that are sourced primarily 
by our vertically integrated global ingredients capabilities, and consists of three main commercial platforms:  

(cid:120)  Healthy Beverages – We offer a full line of aseptic beverages, including non-dairy beverages (including almond, soy, 
coconut,  rice  and others),  broths, teas and nutritional beverages. We  also offer refrigerated premium juices,  shelf-
stable juices and  functional  waters. We believe  we  are the  leading North  American provider of non-dairy organic 
aseptic beverages and premium refrigerated private label organic orange juice.  

(cid:120)  Healthy Fruit – We offer IQF fruit for retail (e.g., strawberries, blueberries, mango, pineapple, blends and other berries 
and  fruit),  IQF  and  bulk  frozen  fruit  for  foodservice  (e.g.,  purées,  fruit  cups  and  smoothies),  and  custom  fruit 
preparations for industrial use. We believe we are the leading North American provider of private label non-GMO and 
organic IQF fruit.  

(cid:120)  Healthy Snacks – We offer fruit snacks (including bars, twists, ropes and bite-sized varieties) and roasted grain and 
seed snacks.  We believe we are a leading North American provider of premium healthy fruit snacks.  During 2017, 
we exited our flexible resealable pouch and nutrition bar product lines and operations, which were formerly part of 
the Healthy Snacks platform.  

Our global ingredients platform is focused on the procurement and sale of non-GMO and organic grains and seeds (including 
ancient grains and seeds), fruits, vegetables, sweeteners, coffees, nuts and other products as ingredients in both raw material 
and processed ingredient forms. In addition to supplying ingredients for our own healthy food and beverage product portfolio, 
we are a leading supplier of raw materials and processed ingredients to a number of global food manufacturers and foodservice 
operators. Our vertically integrated model allows us to leverage our scalable and diverse supply of high quality non-GMO and 
organic ingredients, adding value to a product at multiple stages of the supply chain and delivering comprehensive non-GMO 
and organic food ingredients and packaged goods solutions to our customers’ evolving demands.  This model allows us to 
generate  additional  revenue  from  our  global  ingredients  customers  by  providing  them  with  high  quality  healthy  food  and 
beverage products.  

Using our vertically integrated business model, we process non-GMO and organic food ingredients into consumer-packaged 
products. Our food ingredients are converted from raw materials, and our raw materials are sourced from approximately 5,000 

SUNOPTA INC. 

5 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
suppliers  encompassing  approximately  10,000  growers  in  over  65  countries.  Our  employees  and  assets,  which  include  22 
processing and packaging facilities, are principally located in North America and Europe with smaller sourcing and processing 
operations in Africa and China. Our operations and capabilities provide the flexibility to modify our product portfolio to adapt 
to the changing consumer needs for non-GMO and organic food and beverage products. As a general principle, we do not own 
or operate our own farms, retail stores, or extensively market our own consumer brands. 

Our commitment and proactive approach to new product development and innovation drives our ability to introduce new higher 
margin  food  and  beverage  products  to  the  market.    The  resources  of  our  advanced  innovation  center  in  Edina,  Minnesota, 
support our product development activities, with a dedicated team of food scientists, engineers and technicians, who proactively 
engage customers in creating and developing new products. Our innovation platform supports our leadership position in non-
GMO and organic food and strengthens our relationships with our retail, foodservice and contract manufacturing customers. 

Value Creation Plan 

On October 7, 2016, we entered into a strategic partnership with Oaktree Capital Management L.P., a private equity investor 
(together  with  its  affiliates,  “Oaktree”).    On  October  7,  2016,  Oaktree  invested  $85.0  million  through  the  purchase  of 
cumulative, non-participating Series A Preferred Stock (the “Preferred Stock”) of our wholly-owned subsidiary, SunOpta Foods 
Inc. (“SunOpta Foods”).   

Following  the  strategic  partnership,  with  the  assistance  of  Oaktree,  we  conducted  a  thorough  review  of  our  operations, 
management and governance, with the objective of maximizing our ability to deliver long-term value to our shareholders.  As 
a product of this review our management and the Board of Directors developed a Value Creation Plan built on four pillars: 
portfolio optimization, operational excellence, go-to-market effectiveness and process sustainability.  The Value Creation Plan 
is a broad-based initiative focused on increasing shareholder value through strategic investments made in the people and assets 
of the Company to deliver sustained profitable growth.  We expect the Value Creation Plan to be implemented in phases, and 
span several years. 

As part of the first phase of the Value Creation Plan, we are targeting implementation of $30 million of productivity-driven 
annualized enhancements of adjusted EBITDA, in the first phase of the plan, to be implemented over 2017 and 2018.  During 
fiscal  2017,  these  adjusted  EBITDA  benefits  were  offset  by  expenses  associated  with  the  Value  Creation  Plan,  including 
structural investments made in the areas of quality, sales, marketing, operations and engineering resources, as  well as non-
structural third-party consulting support, severance, and recruiting costs.  The plan also calls for increased investment in capital 
upgrades  at  several  manufacturing  facilities  to  enhance  food  safety  and  manufacturing  efficiencies.    Over  time,  these 
investments are expected to yield additional improvement in adjusted EBITDA beyond the $30 million of initial productivity-
driven savings.  During 2017, we progressed against each of the four pillars of the Value Creation Plan and we believe we are 
on track to achieve  targeted  productivity enhancements,  while continuing to  make  the  necessary structural investments  we 
believe will accelerate growth and drive long-term value.  Progress on each of the four pillars of the Value Creation Plan is 
highlighted below: 

Portfolio Optimization 

The focus of the portfolio optimization pillar is to simplify the business, investing where  structural advantages exist,  while 
exiting businesses or product lines where we are not effectively positioned.  Highlights include: 

(cid:120)  Expansion project to add incremental freezing capacity, storage, and retail bagging capabilities to our Mexican frozen 
fruit  facility  (which  we  now  wholly-own,  following  our  acquistion  of  remaining  non-controlling  interests  in  July 
2017).  This project should enable diversification of the fruit varieties sourced from Mexico, and is expected to drive 
incremental cost savings, in addition to enhanced profitability from retail bagging capabilities. 

(cid:120)  Expansion project to add a second roasting and processing line at the our organic cocoa facility in the Netherlands.  
This expansion is expected to approximately double processing capacity in addition to adding new capabilities, all in 
support of increased demand and future growth opportunities in cocoa. 

(cid:120)  Addition  of  a  new  oil  processing  line  at  our  Bulgarian  sunflower  facility,  which  is  expected  to  drive  incremental 

margins through growth and production efficiency. 

(cid:120) 

Investment into our roasted snacks capabilities at our Crookston, Minnesota, facility, which also involves the planned 
closure of our Wahpeton, North Dakota, roasting facility.  This expansion is expected to be operational in the third 
quarter of 2018, which will support further growth of a variety of roasted grains and seeds.   

SUNOPTA INC. 

6 

December 30, 2017 10-K 

 
  
 
 
 
 
 
(cid:120)  Discontinuation of flexible resealable pouch and nutrition bar product lines and operations in the fourth quarter of 

2017, and related closure of our Carson City, Nevada, nutrition bar processing facility. 

(cid:120)  Consolidation  of  certain  soy  and  specialty  grain  volume  and  closure  of  a  grain-handling  facility  in  Moorhead, 

Minnesota, in the third quarter of 2017, to enhance facility utilization and reduce operating costs.  

(cid:120)  Closure of our San Bernardino, California, juice facility in the fourth quarter of 2016. 

(cid:120)  Consolidation of our ingredients processing operations in the fourth quarter of 2016, and the related closure of a soy 

extraction facility located in Heuvelton, New York.  

Since the initiation of the Value Creation Plan, we have implemented portfolio changes that are expected to yield approximately 
$7.9 million of annualized adjusted EBITDA benefits.  

Operational Excellence 

The  focus  of  the  operational  excellence  pillar  is  to  ensure  food  quality  and  safety,  coupled  with  improved  operational 
performance and efficiency.  We expect these efforts to generate productivity improvements and cost savings in manufacturing, 
procurement and logistics.  Highlights include: 

(cid:120)  Advances in food safety and quality efforts across the entire manufacturing footprint.  

(cid:120)  Rollout  of  a  new  continuous  improvement  methodology  (“SunOpta  360”)  across  our  network  of  aseptic  beverage 
facilities, which is helping to drive an expected 20% improvement in output from existing aseptic lines in 2018, in 
addition to enhanced production capabilities that will add new value-added non-dairy alternatives. 

(cid:120)  Actions taken to right-size  the incoming 2018 fruit crop, in connection  with the  implementation of new  sales and 
operations planning (“S&OP”) tools within Consumer Products, which is expected to reduce storage costs and lower 
working capital, and operationally better prepare our frozen fruit operations for the start of the upcoming fruit season. 

(cid:120) 

Incremental  counter-seasonal  harvest  opportunities  enabled  by  the  expansion  of  the  Mexican  fruit  processing 
operations, allowing procurement to leverage lower cost sourcing alternatives.  

(cid:120)  Continued  identification  and  implementation  of  productivity  initiatives  focusing  on  manufacturing  efficiencies, 

purchasing synergies and effective supply chain management. 

(cid:120)  Working capital optimization efforts leading to a significant year-over-year improvement in operating cash flows. 

Since the initiation of the Value Creation Plan, we have implemented process improvements and cost savings that are expected 
to yield approximately $6.9 million of annualized adjusted EBITDA benefits. 

Go-To-Market Effectiveness 

The focus of  the go-to-market effectiveness pillar is to optimize  customer and product  mix in existing  sales channels, and 
identify and penetrate new high-potential sales channels.  We expect efforts under this pillar to improve revenue growth and 
profitability over time.  Highlights include: 

(cid:120)  Continued growth of the pipeline of commercial opportunities across all consumer product platforms, with a growing 

diversity of opportunities across categories and channels where we are currently under-represented. 

(cid:120)  Filling  of  the  new  position  of  Chief  Customer  Officer  for  Consumer  Products,  as  well  as  hiring  a  new  head  of 

marketing. 

(cid:120)  Addition of new commercial talent in the areas of sales, marketing, and research and development, which has furthered 

the development of control branded products that are expected to enhance access to the foodservice channel. 

(cid:120)  Creation of a new foodservice distribution network, leveraging third parties, which will support our plan to grow and 

diversify penetration into the foodservice channel.  

SUNOPTA INC. 

7 

December 30, 2017 10-K 

 
In 2017, we have implemented go-to-market improvements through strategic pricing actions expected to yield approximately 
$1.2 million of annualized adjusted EBITDA benefits.  In 2018, efforts under the go-to-market pillar are focused on driving 
incremental sales volume.  

Process Sustainability 

The focus of the process sustainability pillar is to ensure we have the infrastructure, systems and skills to sustain the business 
improvements and value captured from the Value Creation Plan.  Broadening the skillset and experience of our leadership team 
is a critical component to the process sustainability pillar of the Value Creation Plan.  Highlights include:  

(cid:120)  Filling the positions of Chief Executive Officer, Chief Human Resources Officer, Chief Information Officer, Chief 
Quality Officer, Senior Vice President of Operations and Engineering, and Senior Vice President of Supply Chain, as 
well as the appointment of a new General Manager to lead our Healthy Fruit platform. 

(cid:120)  Additional hiring of other management-level positions in the areas of sales, marketing, customer service, engineering, 

operations, quality, and other functional support services. 

(cid:120)  Progress  on  an  enterprise  resource  planning  implementation  project  at  the  Mexican  frozen  fruit  facility,  with 

expectation that the new system to be operational during the second quarter of 2018. 

(cid:120)  Restructuring of S&OP process and tools in the frozen fruit operations, which is expected to drive greater discipline 

and accuracy into the fruit pack plan, ensuring grower commitments are aligned with commercial demand. 

(cid:120)  Addition of experienced plant and quality assurance managers in several facilities.  

(cid:120)  Continued focus on customer service and working capital levels as S&OP processes and support systems are refined. 

(cid:120)  Under  new  leadership,  shifting  the  focus  of  the  internal  audit  function  towards  value-added  business  process 
improvements that are designed to support and ensure we sustain improvements made as part of the Value Creation 
Plan.  

In 2018, it is expected that the majority of future adjusted EBITDA benefits achieved under the Value Creation Plan will be 
focused on the operational excellence and go-to-market effectiveness pillars. 

The statements we make in this Form 10-K about the expected results of the Value Creation Plan, including the timing for 
completion  of  measures  undertaken,  expected  improvements  in  earnings,  adjusted  EBITDA,  working  capital  efficiencies, 
expected cash flows, and expected costs, are forward-looking statements.  Forward-looking statements contained in this Form 
10-K are based on certain factors and assumptions regarding expected growth, results of operations, performance, and business 
prospects and opportunities.  While we consider these assumptions to be reasonable, based on information currently available, 
they may prove to be incorrect.  Forward-looking statements are also subject to certain factors, including risks and uncertainties 
that could cause actual results to differ materially from what we currently expect.  These factors are more fully described in the 
“Risk Factors” section at Item 1A of this Form 10-K.  Adjusted EBITDA is a non-GAAP measures that management uses when 
assessing the performance of our operations.  See footnote (3) to the “Consolidated Results of Operations for Fiscal Years 2017 
and 2016” table in management’s discussion and analysis of financial condition and results of operations at Item 7 of this Form 
10-K  for a discussion on  the  use of this  non-GAAP  measure  and  for a  reconciliation of  adjusted EBITDA  from loss  from 
continuing operations, which we consider to be the most directly comparable U.S. GAAP financial measure. 

SUNOPTA INC. 

8 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
Governance and Management Transitions 

Board of Directors 

On November 6, 2017, Derek Briffett was appointed to the Company’s Board of Directors, increasing the size of the Board to 
nine  directors.    Mr.  Briffett  also  serves  on  the  Company’s  Audit  Committee.    Mr.  Briffett  most  recently  served  as  Chief 
Operating Officer from 2013 to 2015 for Associated Brands,  which  was acquired by Treehouse Foods, leading operations, 
supply chain and co-manufacturing sales in addition to finance, information technology and customer service.  

Management 

Effective January 31, 2018, Colin Smith no longer serves as Chief Operating Officer (“COO”) of Consumer Products, due to 
his acceptance of a new role at Oaktree.  Mr. Smith is a Managing Director and member of the Portfolio Transformation Team 
at Oaktree, and was appointed COO of Consumer Products in February 2017, following Oaktree’s investment in, and strategic 
partnership with, SunOpta in October 2016.  Mr. Smith’s position with Consumer Products will be eliminated following his 
departure.  Mr. Smith will continue to act as an advisor to the Company for matters related to the Value Creation Plan. 

ACQUISITION HISTORY 

SunOpta has been built through business acquisitions and significant internal growth.  The following is a summary listing of 
business  operations  that  we  have  acquired  and  retained  since  the  inception  of  SunOpta.    This  summary  does  not  include 
acquisitions that were subsequently divested. 

Date of Acquisition  Business Operations Acquired 
August 3, 1999 
August 15, 2000 
September 18, 2000  Northern Food and Dairy, Inc.  

Sunrich Inc.  
Certain assets of Hoffman Aseptic 

March 14, 2001 
May 8, 2003 
November 1, 2003 
December 1, 2003 
September 13, 2004 

First Light Foods Inc. 
Kettle Valley Dried Fruit Ltd. 
SIGCO Sun Products, Inc. 
Sonne Labs, Inc.  
51% of the outstanding shares of Organic Ingredients, Inc. (remaining 
49% of the outstanding shares were acquired on April 5, 2005)  
Earthwise Processors, LLC  
Pacific Fruit Processors, Inc.  
Hess Food Group LLC 
The Organic Corporation  
Dahlgren & Company, Inc.  

June 2, 2005 
July 13, 2005 
November 7, 2006 
April 2, 2008 
November 8, 2010 
December 31, 2012  Organic Land Corporation OOD 
March 2, 2015 
August 11, 2015 
October 9, 2015 

Citrusource, LLC 
Assets of Niagara Natural Fruit Snack Company Inc. 
Sunrise Holdings (Delaware), Inc. 

Reportable Segment 
Global Ingredients 
Consumer Products 
Consumer Products/  
Global Ingredients 
Consumer Products 
Consumer Products 
Global Ingredients 
Global Ingredients 
Consumer Products  

Global Ingredients 
Consumer Products  
Consumer Products  
Global Ingredients 
Global Ingredients 
Global Ingredients 
Consumer Products 
Consumer Products 
Consumer Products 

SEGMENT INFORMATION 

The composition of our reportable segments is as follows:  

(cid:120)  Global Ingredients aggregates our North American-based Raw Material Sourcing and Supply and European-based 
International Sourcing and Supply operating segments focused on the procurement and sale of specialty and organic 
grains and seeds, raw material ingredients, value-added grain- and cocoa-based ingredients, and organic commodities. 

(cid:120)  Consumer  Products  consists  of  three  main  commercial  platforms:  Healthy  Beverages,  Healthy  Fruit  and  Healthy 
Snacks.    Healthy  Beverages  includes  aseptic  packaged  products  including  non-dairy  beverages,  broths  and  teas; 
refrigerated premium juices; and shelf-stable juices and functional waters.  Healthy Fruit includes IQF fruits for retail; 
IQF and bulk frozen fruit for foodservice; and custom fruit preparations for industrial use.  Healthy Snacks is focused 
on fruit snack offerings, and formerly included our flexible resealable pouch and nutrition bar product lines, which we 
exited in 2017. 

SUNOPTA INC. 

9 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
In  addition,  Corporate  Services  provides  a  variety  of  management,  financial,  legal,  information  technology,  treasury  and 
administration services to each of our operating segments from our headquarters in Mississauga, Ontario and our administrative 
office in Edina, Minnesota. 

Financial information for each reportable segment describing revenues from external customers, a measure of profit or loss, 
and total assets for the last three fiscal years, as well as financial information about geographic areas for  the last three fiscal 
years, is presented in note 24 of the Consolidated Financial Statements. 

Global Ingredients 

Operations and Product offerings—Global Ingredients 

Global  Ingredients  aggregates  our  North  American  and  international  raw  material  sourcing  and  supply  operating  segments 
focused  on  the  procurement,  processing  and  sale  of  specialty  and  organic  grains,  seeds,  fruits,  grain-  and  cocoa-based 
ingredients, and other commodities, which are used primarily in applications serving the natural and organic food industry.  Its 
operations are centered in Amsterdam, the Netherlands; Edina, Minnesota; and Scotts Valley, California. 

Global Ingredients sources raw materials, ingredients and certain grain-based food products from approximately 65 countries 
around the world, which include: 

(cid:120)  Organic  fruit- and vegetable-based raw  materials and ingredients, sweeteners, cocoa, coffees, ancient  grains, nuts, 

seeds and pulses and other organic food products. 

(cid:120) 

Identity  preserved  (“IP”),  non-GMO  and  organic  seeds  and  grains including soy,  corn  and  sunflower  for  food 
applications, with control maintained at every stage of production, from seed selection and growing through storage, 
processing and transportation. 

(cid:120)  Seed- and grain-based animal feed and pet food products that originate from select organic and non-GMO soy, corn, 

sunflower and other commodities.  

Global Ingredients also engages in processing and contract manufacturing services that include: 

(cid:120)  Seed and grain conditioning services for soy, corn and sunflower.   

(cid:120)  Grain milling for corn, with various granulations and batch sizing. 

(cid:120)  Coffee and sesame seed processing.   

(cid:120)  Dry and oil roasting and packaging, including in-shell sunflower and sunflower kernels, corn, soy- and legume-based 

snacks.  

(cid:120)  Liquid (concentrates and oil) and dried format seed, grain and cocoa based ingredients utilizing non-GMO and organic 

soy, corn, sunflower, rice, and cocoa. 

(cid:120)  Specialty  and  organic  functional  ingredients,  including  maltodextrins,  tack  blends,  flavor  enhancing  products, 

including snack coatings, cheese powders and flavor systems. 

Competition—Global Ingredients 

Food ingredients are considered niche items often sourced, developed or processed for specific customers or industry segments.  
Global Ingredients competes with large seed, grain, raw material and specialty ingredient suppliers for customers and competes 
with other companies active in the international commercial seed, grain and raw material procurement market for supply.  Its non-
GMO and organic specialty products compete in the smaller niche commercial non-GMO and organic seed, grain and raw material 
markets. Key to competing in these markets is access to transportation, supply and relationships  with producers. Competitors 
include major food companies with food ingredient divisions, other food ingredient and sourcing companies, and consumer food 
companies  that  also  engage  in  the  development  and  sale  of  food  ingredients.  Many  of  these  competitors  have  financial  and 
technical resources, as well as production and marketing capabilities that are greater than our own. 

SUNOPTA INC. 

10 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The international organic food industry is very competitive due primarily to the limited worldwide supply of organic raw materials.  
Global Ingredients competes with worldwide brokers, traders and food processors for the limited supply of organic raw material 
ingredients.  In many cases, it will enter into exclusive arrangements with growers and/or processors of key strategic commodities 
to control the reliability of its supply chain. 

Distribution, Marketing, and Sales—Global Ingredients  

As a leading provider of IP, non-GMO and organic, grains, seeds, grain- and cocoa-based ingredients, and other raw materials, 
Global Ingredients has well established sales and marketing capabilities, including technically oriented sales teams strategically 
located  close  to  specific  geographic  sourcing  and/or  sales  regions.    Its  specialty  grains,  seeds  and  other  raw  materials  and 
ingredients are sold to food manufacturers and producers worldwide, including some of the largest U.S. consumer-packaged 
food companies. In addition, in our estimation, it maintains one of the largest organic raw material ingredient sourcing and 
supply  networks  in  the  world,  working  closely  to  develop  and  manage  global  organic  supply  and  link  these  supplies  with 
diverse customer needs.  It also provides procurement and ingredient processing support to the Consumer Products operating 
segment.   

No customers accounted for more than 10% of revenues from our Global Ingredients segment in 2017.   

Suppliers—Global Ingredients 

Global Ingredients has an extensive established IP, organic soy, corn and sunflower grower network in North America, with 
many relationships existing for over 25 years.  It also has a network of growers in Europe, South America, Africa and Asia.  
Because weather conditions and other factors can limit the availability of raw materials in a specific geography, it continues to 
focus  on  expanding  production  and  sourcing  capabilities  to  other  parts  of  the  world  to  ensure  supply  in  years  when  local 
production is below normal levels.  By diversifying supply, it also has the ability to divert available product based on market 
demand and customer requirements in order to maximize return.   

Organic  raw  material  ingredient  suppliers  include  growers,  processors  and  traders  of  organic  fruit-  and  vegetable-based 
ingredients,  sweeteners  and  other  food  products.    The  diversity  of  our  supplier  base  helps  to  ensure  continual  supply  by 
providing contra-seasonal solutions to mitigate crop and quality risks. Organic food suppliers are required to meet stringent 
organic  certification  requirements  equivalent  to  the  U.S.  Department  of Agriculture  (“USDA”)  National  Organic  Program, 
European Union (“EU”) standards, or others. 

Consumer Products 

Operations and Product Offerings—Consumer Products 

Consumer Products provides healthy and organic food products that are primarily consumer-packaged to retailers, foodservice 
distributors and major global food manufacturers with a variety of branded and private label products.  Consumer Products’ 
packaged food products are categorized into the following three main commercial platforms: 

(cid:120)  Healthy Beverages  

(cid:120)  Aseptic beverages including almond, soy, coconut, rice and other non-dairy beverages, as well as adjacent 
categories such as broths, teas and nutritional beverages.  Specializing in aseptic product offerings, Consumer 
Products produces a variety of pack sizes,  including  multi-serve  and single-serve formats, all shelf stable 
with long shelf lives.  

(cid:120)  Organic  and  conventional  beverage  products,  including  shelf  stable  and  refrigerated  juices,  specialty 
beverages, and functional waters.  Consumer Products partners with third-party fillers to provide extended 
shelf life refrigerated packaging formats to its customers. 

SUNOPTA INC. 

11 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(cid:120)  Our  Healthy  Beverage  platform  operates  from  an  east  to  west  network  of  three  facilities,  as  well  as  co-
manufacturing  relationships  that  allow  us  to  minimize  distribution  costs  for  our  customers,  maintain 
redundant back-up plans, and offer reliable, year-round programs. 

(cid:120)  Healthy Fruit 

(cid:120) 

IQF natural and organic frozen fruits and vegetables, including strawberries, blueberries, raspberries, mango, 
peppers, broccoli, blends and many other items. Consumer Products produces a variety of packaging formats, 
including  tubs,  stand-up  pouches,  cups  and  polybags  to  address  the  needs  of  its  retail  and  foodservice 
customers.   

(cid:120)  Specialty fruit toppings and bases, which are custom formulated to provide unique flavor and texture profiles 
for a wide range of specialized applications.  Applications include fruit bases for yogurts, ice creams, cheeses, 
smoothies, shakes, frozen desserts, bakery fillings, health bars, various beverages, dressings, marinades, dips 
and sauces, and fruit toppings for foodservice applications.   

(cid:120)  Our frozen fruit operations consist of five facilities that extend from central Mexico to California, as well as 
a  production  facility  in  Kansas.    Strategically  our  north  to  south  footprint  on  the  west  coast  allows  us  to 
maximize access to supply of fruit over the course of the  full growing  season, while our operation in the 
Midwest  serves  as  a  lower-cost  launching  pad  to  deliver  product  to  the  east  coast.    Our  fruit  ingredient 
operations are located in California. 

(cid:120)  Healthy Snacks 

(cid:120)  Natural and organic fruit-based snacks in bar, twist, rope and bite size shapes, with the ability to add a variety 

of ingredients.   

(cid:120)  Our healthy snack platform maintains bi-coastal production which helps to minimize delivery costs to our 

customers. 

Competition—Consumer Products 

Consumer Products’ healthy beverage and healthy snack offerings compete with major food manufacturing companies, as well 
as a number of other regional manufacturers.  Its healthy fruit offerings face competition from both branded and private label 
fruit  providers.    It  faces  competition  when  securing  fruit  and  vegetable  raw  materials;  however,  due  to  the  location  of  its 
processing  facilities,  it  is  able  to  source  these  raw  materials  from  a  number  of  growing  regions  and  suppliers.    Integrated 
sourcing through Global Ingredients, which supplies a number of core raw materials, combined with in-house processing and 
packaging capabilities, provides Consumer Products with a low-cost advantage over many of its competitors. 

Distribution, Marketing and Sales—Consumer Products 

Consumer Products supplies the private-label retail market, including large retailers and club stores, branded food companies, 
food manufacturers, foodservice distributors, quick service and casual dining restaurants located principally in North America.  
In  addition,  it  markets  branded  food  products  under  SunOpta-controlled  brands,  including  Sunrich®  Naturals  and  Pure 
Nature™.    Consumer  Products  generally  conducts  its  business  with  customers  on  the  basis  of  purchase  orders  and  price 
quotations, without other formal agreements related to minimum or maximum supplies or pricing. 

In  2017,  Costco  Wholesale,  Starbucks  Corporation  and  Walmart  Inc.  accounted  for  approximately  17%,  15%  and  11%, 
respectively,  of  revenues  from  our  Consumer  Products  operating  segment  and  approximately  10%,  9%  and  6%,  of  our 
consolidated  revenues,  respectively.    No  other  customers  accounted  for  more  than  10%  of  revenues  from  our  Consumer 
Products operating segment in 2017.   

Suppliers—Consumer Products 

Consumer Products’ raw materials are subject to the availability of fruit and vegetable supply, which is based on conditions 
that  are  beyond  our  control.    Fresh  and  frozen  fruits,  berries,  and  vegetables  are  sourced  directly  from  a  large  number  of 
suppliers throughout the U.S., Mexico and globally, or through Global Ingredients.  We believe our scale and location close to 
growing areas makes Consumer Products’ an attractive customer for fruit growers.     

SUNOPTA INC. 

12 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consumer Products also relies on its packaging suppliers to ensure delivery of often unique, portable, and convenient consumer 
packaging formats.  In our aseptic packaging facilities, we specialize in the use of Tetra Pak equipment in a variety of pack 
sizes and also offer a variety of opening types and extended shelf life (“ESL”) options.  Consumer Products also partners with 
third party fillers to provide ESL and refrigerated packaging formats to its customers. 

Corporate Services 

Our  corporate  headquarters  is  located  in  Mississauga,  Ontario.    In  addition,  centralized  information  technology,  human 
resources, operations, research and development, legal and financial shared services groups are located in Edina, Minnesota.  
Employees  of  Corporate  Services  provide  support  services  across  the  organization  including  management,  finance,  legal, 
operations,  business  development,  information  technology,  research  and  development,  human  resources  and  administrative 
functions.  

REGULATION 

We are subject to a wide range of governmental regulations and policies in various countries and regions where we operate, including 
the U.S., Canada, Mexico, the Netherlands, throughout the rest of the EU, China and Ethiopia. Outside of the U.S., regulations 
concerning the sale or characterization of food ingredients vary substantially from country to country, and we take appropriate steps 
to comply with such regulations.  These laws, regulations and policies are implemented, as applicable in each jurisdiction, on the 
national, federal, state, provincial and local levels.  For example, we are affected by laws and regulations related to: seed, fertilizer 
and pesticides; the purchasing, harvesting, transportation and warehousing of grain and other products; the processing, packaging 
and sale of food, including wholesale operations; and product labeling and marketing, food safety and food defense.  We are also 
affected by government-sponsored price supports, acreage set aside programs and a number of environmental regulations.   

U.S. Regulations 

Our activities in the U.S. are subject to regulation by various government agencies, including the Food and Drug Administration 
(“FDA”), the Federal Trade Commission (“FTC”), the Environmental Protection Agency (“EPA”), the USDA, Occupational Safety 
and  Health Administration  (“OSHA”),  and  the  Departments  of  Commerce  and  Labor,  as  well as  voluntary  regulation by  other 
bodies.  Various state and local agencies also regulate our activities. 

USDA National Organic Program and Similar Regulations 

We currently manufacture and distribute a number of organic products that are subject to the standards set forth in the  Organic 
Foods Production Act and the regulations adopted thereunder by the National Organic Standards Board. In addition, our organic 
products may be subject to various state regulations. We believe that we are in material compliance with the organic regulations 
applicable  to  our  business,  and  we  maintain  an  organic  testing  and  verification  process.    Generally,  organic  food  products  are 
produced using: 

(cid:120) 

(cid:120) 

(cid:120) 

agricultural management practices intended to promote and enhance ecosystem health; 

no genetically engineered seeds or crops, sewage sludge, long-lasting pesticides, herbicides or fungicides; and 

food processing practices intended to protect the integrity of the organic product and disallow irradiation, genetically 
modified organisms or synthetic preservatives. 

After  becoming  certified,  organic  operations  must  retain  records  concerning  the  production,  harvesting,  and  handling  of 
agricultural products that are to be sold as organic for a period of five years.  Any organic operation found to be in violation of 
the  USDA  organic  regulations  is  subject  to  enforcement  actions,  which  can  include  financial  penalties  or  suspension  or 
revocation of their organic certificate.  

SUNOPTA INC. 

13 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Food Safety, Labeling and Packaging Regulations 

As a  manufacturer and distributor of food products,  we  are subject to  the  Federal Food, Drug and Cosmetic Act, the Fair 
Packaging and Labeling Act and regulations promulgated thereunder by the FDA and the FTC. This regulatory framework 
governs the manufacture (including composition and ingredients), labeling, packaging and safety of food in the U.S.  

State and local statutes and regulations may impose additional food safety, labeling, and packaging requirements. For instance, 
the California Safe Drinking Water and Toxic Enforcement Act of 1986 (commonly referred to as “Proposition 65”) requires, 
with a few exceptions, that a specific warning appear on any consumer product sold in California that contains a substance, 
above certain levels, listed by that state as having been found to cause cancer or birth defects. We believe we are in material 
compliance with state and local statutes and regulations as they apply to our business. 

Environmental Regulations 

We are also subject to various U.S. federal, state and local environmental regulations.  Some of the key environmental regulations 
in the U.S. include, but are not limited to, the following: 

(cid:120)  Air  quality  regulations  –  air  quality  is  regulated  by  the  EPA  and  certain  city/state  air  pollution  control  groups.  

Emission reports are filed annually. 

(cid:120)  Waste treatment/disposal regulations – solid waste is either disposed of by a third-party or, in some cases, we have a 
permit to haul and apply the sludge to land.  Agreements exist with local city sewer districts to treat waste at specified 
levels of Biological Oxygen Demand (“BOD”), Total Suspended Solids (“TSS”) and other constituents.  This can 
require weekly/monthly reporting as well as annual inspection.   

(cid:120)  Sewer regulations – we have agreements with the local city sewer districts to treat waste at specified limits of BOD 

and TSS.  This requires weekly/monthly reporting as well as annual inspection.  

(cid:120)  Hazardous  chemicals  regulations  –  Various  reports  are  filed  with  local  city/state  emergency  response  agencies  to 

identify potential hazardous chemicals being used in our facilities. 

(cid:120)  Storm water – all facilities are inspected annually and must comply with an approved storm water plan to protect water 

supplies. 

Employee Safety Regulations 

We are subject to certain safety regulations, including OSHA regulations. These regulations require us to comply with certain 
manufacturing safety standards to protect our employees from accidents. We believe that we are in material compliance with 
all employee safety regulations applicable to our business. 

Canadian and Other Non-U.S. Regulations 

Outside of the U.S., regulations concerning the sale or characterization of food ingredients vary substantially from country to 
country, and we take appropriate steps to comply with such regulations.   

In Canada, the sale of food is currently regulated under various federal and provincial laws, principally the federal Food and Drugs 
Act (“FADA”), Canada Agricultural Products Act (“CAPA”), and the Canadian Environmental Protection Act, 1999 (“CEPA”), 
along  with  their  supporting  regulations.    Some  of  the  key  Canadian  regulatory  instruments  include  but  are  not  limited  to  the 
following: 

(cid:120)  Food and Drug Regulations (under the FADA) – food and drugs are subject to specific regulatory requirements, including 
composition (such as food additives, fortification, and food standards), packaging, labeling, advertising and marketing, 
and licensing requirements. New requirements regarding nutrition and ingredient labeling and food color were introduced 
on December 14, 2016.  To the extent the new labeling requirements apply to products manufactured and sold by the 
Company, we will have a five-year transitional period to adopt them. Amendments dealing with food colour specifications 
and the removal of synthetic colour certification requirements came into effect immediately. 

(cid:120)  Organic Products Regulations, 2009 (“OPR”) (under the CAPA) – the OPR require mandatory certification to the revised 
national organic standard for agricultural products that are to be represented as organic in international and inter-provincial 

SUNOPTA INC. 

14 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
trade, or that bear the federal organic agricultural product legend (or federal logo).  Except for certain exceptions and 
conditions, a U.S.-Canada Organic Equivalence Arrangement is currently in place whereby agricultural products produced 
and processed in conformity with the USDA National Organic Program are considered to be equivalent to the requirements 
of the OPR. 

(cid:120)  Canada  Consumer  Product  Safety  Act  (“CCPSA”)  –  the  CCPSA  provides  oversight  and  regulation  of  consumer 
products with respect to manufacturers, importers, and retailers.  It includes, without limitation, the ability to require 
product recalls, mandatory incident reporting, document retention requirements, increased fines and penalties, and 
packaging and labeling requirements. While the CCPSA does not apply to food, it does apply to its packaging with 
respect to safety. It is possible that there will be amendments introduced to the FADA, to capture the essence of the 
regulatory oversight found in the CCPSA. We have no way of anticipating if and when that may occur. 

(cid:120)  Consumer Packaging and Labeling Act (“CPLA”) – the CPLA and its supporting regulations outline requirements for 
packaging and labeling of products, including food products. The CPLA sets out labeling requirements relating to the 
description  of  the  product,  net  quantity  and  dealer  information,  as  well  as  packaging  standards.  The  CPLA  also 
includes a prohibition against false or misleading labeling. 

(cid:120)  Canada Food Inspection Agency Act (“CFIAA”) – the CFIAA grants power to the Canadian Food Inspection Agency 
(the “CFIA”), which is tasked with the administration and enforcement of certain Canadian food legislation. By virtue 
of  the  CFIAA  and  CAPA,  the  CFIA  has  the  power  to  inspect  and,  if  deemed  necessary,  recall  certain  products, 
including fresh fruit and vegetables, processed foods and organic foods, if the Minister believes that such products 
pose a risk to the public, animal or plant health. 

(cid:120)  Processed Products Regulations (“PPR”) (under the CAPA) – the PPR regulates the grading, packing and marking of 
processed products that are produced in Canada for inter-provincial or export trade or imported into Canada. Under 
the PPR, processed food products are those that are prepared to assure preservation of the food product in transport, 
distribution  and  storage.  The  PPR  establishes  requirements  with  respect  to  the  content,  preparation,  packing  and 
marking of processed food products. 

In January, 2017, the Government of Canada published the second version of its proposed Safe Food for Canadians Regulations 
(“SFCR”) under the authority of the Safe Food for Canadians Act (“SFCA”).  Publication of the SFCR was accompanied by a 
90-day public consultation period that ended on April 21, 2017. In January, 2018, the CFIA published a report summarizing 
submissions received pursuant to the proposed SFCR.  The final regulations are expected to be published in the spring of 2018. 
If and when they become effective, the SFCR will consolidate 13 existing Canadian regulations and the food labeling provisions 
of  the  CPLA,  and  thereby  establish  a  comprehensive  set  of  regulations  which  govern  all  food  sectors  subject  to  CFIAA 
oversight, including federally registered sectors and food that is destined for import, export or interprovincial trade. Principal 
elements  of  the  SCFR  which  are  likely  to  impact  the  Company  include  licensing  requirements  for  the  import,  export  and 
interprovincial trade of food, traceability requirements, reporting requirements and timelines, preventative controls, an export 
certificate request process, prescribed container sizes and weights for certain products, labeling regulations and standards  of 
identity and expansion of organic certification to service providers and additional products.  The licensing requirements will 
be immediate for sectors such as meat, eggs and other previously federally registered sectors and up to three years for other 
sectors. 

We are subject to Dutch and European Commission (“EC”) regulations and policies.  Our European subsidiary, The Organic 
Corporation (“TOC”), is involved in the sourcing, supplying, processing, marketing, selling and distribution of organic food 
products  and,  as  such,  is  subject  to  standards  for  production,  labeling  and  inspection  of  organic  products  contained  in  EC 
Regulation 2092/91 (and its subsequent amendments).  TOC is certified by Skal, the inspection body for the production (trading 
and selling) of organic products in the Netherlands.  Products certified as organic by an EU-recognized inspection body, such 
as Skal, can be marketed within the entire EU.  In addition, under the terms of an equivalency arrangement between the U.S. 
and the EU, organic operations certified to the USDA organic or EU organic standards may be labeled and sold as organic in 
both the U.S. and EU. 

TOC is also affected by general food legislation both at EU and Dutch level relating to product safety and hygiene, among 
others. TOC is BRC Agents and Brokers certified in the Netherlands and manages a fully computerized system that manages 
the  traceability  of  each  product.    In  addition,  TOC  also  considers  and  abides  by  EU  and  local  legislation  with  regard  to 
packaging and packaging waste.  TOC is also subject to the regulations and policies of the countries outside of the EU in which 
it operates, including China and Ethiopia. 

SUNOPTA INC. 

15 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
Our frozen fruit processing facility in Mexico is subject to Mexican regulations, including regulations regarding processing, 
packaging and sales of food products, labor relations and profit-sharing with employees. 

RESEARCH AND DEVELOPMENT 

Research  and  development  and  new  product,  process  and  packaging  innovation  are  key  priorities  of  our  Company  and 
initiatives  are  focused  on  continuous  improvement  of  our  existing  product  portfolios  and  continuing  efforts  to  improve 
production process to reduce costs and improve efficiencies, as well as the development of innovative new products.  Innovation 
is a key pillar for us and a necessity in the natural and organic foods categories.  We believe our commitment and proactive 
approach to new product development and innovation  is important to our ability  to introduce new  higher-margin  food and 
beverage products to the market. 

Our innovation center located in Edina, Minnesota, supports our product development team of highly trained and experienced 
food  scientists  and  technologists  that  are  dedicated  to  the  research  and  development  of  new  product  offerings,  as  well  as 
addressing product development opportunities for our customers.  These opportunities include new and custom formulations, 
innovations in packaging formats, and new production processes and applications.  Applications and technical support provided 
to  our  customers  include  all  aspects  of  product  development  from  concept  to  commercial  launch,  as  well  as  ongoing 
manufacturing and processing support.   

We continue to develop new products to maximize the capabilities of our aseptic packaging facilities, including the development 
of  non-dairy-based  beverages  that  address  the  growing  consumer  demand  for  beverages  that  satisfy  allergy  concerns  and 
provide a unique nutritional profile, as well as broths, teas and nutritional beverages.  In addition, we continue to develop new 
fruit-based beverages, and fruit- and grain-based snacks, as well as innovative fruit ingredient systems for the dairy, foodservice 
and beverage industries.  We are also continually looking to develop new value-added products for our customers that leverage 
our global sourcing platform.   

INTELLECTUAL PROPERTY 

The nature of a number of our products and processes requires that we create and maintain patents, trade secrets and trademarks.  
Our policy is to protect our technology, brands and trade names by, among other things, filing patent applications for technology 
relating to the development of our business in the U.S. and in selected foreign jurisdictions, registering trademarks in the U.S., 
Canada and selected foreign jurisdictions where we sell products, and maintenance of confidentiality agreements with outside 
parties and employees. 

Our success will depend, in part, on our ability to protect our products, trade names and technology under U.S. and international 
patent laws and other intellectual property laws.  We believe that we own or have sufficient rights to use all of the proprietary 
technology, information and trademarks necessary to manufacture and market our products; however, there is always a risk 
that patent applications relating to our products or technologies will not result in patents being issued, or, if issued, will be later 
challenged by a third party, or that current or additional patents  will not afford protection against competitors  with similar 
technology.   

We also rely on trade secrets and proprietary know-how and confidentiality agreements to protect certain technologies and 
processes.  Even with these steps taken, our outside partners and contract manufacturers could gain access to our proprietary 
technology  and  confidential  information.    All  employees  are  required  to  adhere  to  internal  policies,  which  are  intended  to 
further protect our technologies, processes and trade secrets. 

PROPERTIES 

We operate 22 processing facilities in seven U.S. states, as well as Canada, Mexico, the Netherlands, Bulgaria, and Ethiopia.  
In addition, we also own and lease a number of office and distribution locations in the U.S., Canada, Mexico, Europe, Ethiopia 
and China, and lease and utilize public warehouses to satisfy our storage needs.  We also lease farmland that  we sublease to 
fruit growers.  For more details see Item 2. Properties, included elsewhere in this report. 

ENVIRONMENTAL HAZARDS 

We believe that, with respect to both our operations and real property, we are in material compliance with environmental laws 
at all of our locations.  

SUNOPTA INC. 

16 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
EMPLOYEES 

As at December 30, 2017, we had a total of approximately 1,800 full-time employees (December 31, 2016 – 2,000).  We also 
employ up to 1,700 seasonal employees in the U.S. and Mexico during peak fruit seasons each year.  We consider our relations 
with our employees to be good and have not experienced any work stoppages, slowdowns or other serious labor problems that 
have materially impeded our business operations. 

AVAILABLE INFORMATION 

Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those 
reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”), are 
available free of charge on our website at www.sunopta.com as soon as reasonably practicable after we file such information 
electronically  with,  or  furnish  it  to,  the  U.S.  Securities  and  Exchange  Commission  (the  “SEC”)  and  applicable  Canadian 
Securities Administrators (the “CSA”).   

Item 1A.  Risk Factors 

Our business, operations and financial condition are subject to various risks and uncertainties, including those described below 
and elsewhere in this report.  We believe the most significant of these risks and uncertainties are described below, any of which 
could  adversely  affect  our  business,  financial  condition  and  results  of  operations  and  could  cause  actual  results  to  differ 
materially from the results contemplated by the forward-looking statements contained in this report.  In such case, the trading 
price of our common stock could decline, and our shareholders may lose all or part of their investment.  There may be additional 
risks  and  uncertainties  not  presently  known  to  us  or  that  we  currently  consider  immaterial.    Consequently,  you  should  not 
consider the following to be a complete discussion of all possible risks or uncertainties applicable to our business.  These risk 
factors should be read in conjunction with the other information in this report and in the other documents that we file from time 
to time with the SEC and the CSA.   

Risks Related to Our Value Creation Plan, Significant Investors and Shareholder Activism 

The implementation of our Value Creation Plan could pose a number of risks that could have an adverse impact on our 
business, financial condition and results of operations 

Following  our  strategic  partnership  with  Oaktree,  we  conducted  a  thorough  review  of  our  operations,  management  and 
governance, with the objective of maximizing our ability to deliver long-term value to our shareholders.  As a product of this 
review,  our  management  and  the  Board  developed  a  Value  Creation  Plan  built  on  four  pillars:    portfolio  optimization, 
operational  excellence,  go-to-market  effectiveness  and  process  sustainability.    The  Value  Creation  Plan  is  a  broad-based 
initiative focused on increasing shareholder value through strategic investments made to the people and assets of the Company 
to deliver sustained profitable growth. We expect the Value Creation Plan to be implemented in phases, and span several years.  
In connection with the Value Creation Plan, we are implementing a number of operational actions to improve our profitability 
and streamline our operations for long-term success.  These actions may include rationalization or consolidation of certain of 
our operations or facilities, reinvestment in certain of our operations or facilities, investments in personnel, processes and tools, 
as well as other cost saving initiatives. These actions could consume capital resources and could also give rise to impairment 
and other restructuring charges that would be both cash and non-cash in nature, and these charges could be material.  

The  implementation  of  the  Value  Creation  Plan  could  have  a  material  impact  on  our  operations,  strategy,  governance, 
management and future prospects.  For example, in 2016, we announced the closures of our San Bernardino, California, juice 
facility  and  Heuvelton,  New  York,  soy  extraction  facility,  resulting  in  impairment  charges  amounting  to  $13.2  million. 
Similarly, in 2017, we announced the exits from flexible resealable  pouch and nutrition bar product lines and operations, as 
well as the consolidation of our roasted snack operations, resulting in impairment charges of $18.2 million relating to these 
assets.  Certain actions that we take may lead to additional write-downs of assets and/or charges in future periods.  In addition, 
we cannot predict whether the actions we take will achieve our goals of improving our profitability and financial performance 
and delivering long-term value to our shareholders.  The ongoing implementation of our Value Creation Plan could expose us 
to a number of other risks, including the following:  

(cid:120) 

(cid:120) 

distraction of management; 

difficulties in hiring, retaining and motivating key personnel as a result of uncertainty generated by the review and the 
implementation of any resulting recommendations; 

SUNOPTA INC. 

17 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
(cid:120) 

(cid:120) 

difficulties in maintaining relationships or arrangements with customers, suppliers and other third parties; and  

increases  in  general  and  administrative  expenses  associated  with  the  need  to  retain  and  compensate  business  and 
recruiting consultants and other advisors. 

The occurrence of any one or more of the above risks could have an adverse impact on our business, financial results, liquidity 
and financial condition.  

Our significant investors may have interests that conflict with those of our debtholders and other stakeholders 

As at December 30, 2017, Oaktree held a 19.8% voting interest in the Company through its holdings of 11,333,333 special 
voting shares and 8,092,699 common shares of the Company.  Oaktree has also nominated two members of the Board and is 
entitled to designate two nominees for election to the Board so long as it beneficially owns or controls at least 11.1% of SunOpta 
Inc.’s common stock on an as-exchanged basis.  If Oaktree beneficially owns or controls less than 11.1% but more than 5% of 
SunOpta Inc.’s common stock on an as-exchanged basis, it will be entitled to designate one nominee.   In addition, Engaged 
Capital has nominated one member of our Board.  

Oaktree is assisting us  with our efforts to improve our operations,  management and governance.  Oaktree’s objectives and 
perspectives  as  an  equity  investor  in  SunOpta  may  not  always  be  aligned  with  those  of  other  stakeholders,  including  our 
debtholders and smaller shareholders. 

The interests of Oaktree and Engaged Capital, as well as their affiliates, may differ from the interests of our other stakeholders 
in material respects. For example, our large investors and their affiliates may have an interest in directly or indirectly pursuing 
acquisitions, divestitures, financings or other transactions that, in their judgment, could enhance their other equity investments, 
even  though  such transactions  might involve  risks to  us, including risks  to our liquidity and  financial  condition. Our  large 
investors and their affiliates are in the business of making or advising on investments in companies, including businesses that 
may directly or indirectly compete with certain portions of our business. They may also pursue acquisition opportunities that 
may be complementary to our business, and, as a result, those acquisition opportunities may not be available to us. 

A concentration of ownership within our large investors could potentially be disadvantageous to, or conflict with, interests of 
our debtholders or smaller shareholders. In addition, if any significant shareholder were to sell or otherwise transfer all or a 
large  percentage  of  its  holdings,  we  could  find  it  difficult  to  raise  capital,  if  needed,  through  the  sale  of  additional  equity 
securities. 

Our business could be negatively impacted as a result of shareholder activism or an unsolicited takeover proposal or a proxy 
contest 

In recent years, proxy contests and other forms of shareholder activism have been directed against numerous public companies. 
If a proxy contest or an unsolicited takeover proposal was made with respect to us, we could incur significant costs in defending 
the Company, which would have an adverse effect on our financial results.  Shareholder activists may also seek to involve 
themselves in the governance, strategic direction and operations of the Company.  Such proposals may disrupt our business 
and divert the attention of our management and employees, and any perceived uncertainties as to our future direction resulting 
from such a situation could result in the loss of potential business opportunities, be exploited by our competitors, cause concern 
to our current or potential customers, and make it more difficult to attract and retain qualified personnel and business partners, 
all of which could adversely affect our business.  In addition, actions of activist shareholders may cause significant fluctuations 
in our stock price  based on temporary or speculative  market perceptions or other factors that do not necessarily reflect the 
underlying fundamentals and prospects of our business. 

Risks Related to Our Business  

Product liability suits, recalls and threatened market withdrawals, could have a material adverse effect on our business  

Many of our products are susceptible to harmful bacteria, and the sale of food products for human consumption involves the 
risk of injury or illness to consumers. Such injuries may result from inadvertent mislabeling, tampering by unauthorized third 
parties, faulty packaging materials, product contamination, or spoilage.  Under certain circumstances, we or our customers may 
be required to recall or withdraw products, which may lead to a material and adverse effect on our business, financial condition 
or result of operations. Our customers may also voluntarily recall or withdraw a product we manufactured or packaged, even 
without  consulting  us,  which  could  increase  our  potential  liability  and  costs  and  result  in  lost  sales.    A  product  recall  or 
withdrawal could result in significant losses due to the costs of the recall, the destruction of product inventory, and lost sales 

SUNOPTA INC. 

18 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
due to the unavailability of product for a period of time.  In addition, a recall or withdrawal may cause us to lose future revenues 
from,  or  relationships  with,  one  or  more  material  customers,  and  the  impact  of  the  recall  or  withdrawal  could  affect  our 
customers’ willingness to continue to purchase related or unrelated products from us, or could otherwise hinder our ability to 
grow our business with those customers.  We could also be forced to temporarily close one or more production facilities.  

For example, on May 3, 2016, we announced a voluntary recall of certain sunflower kernel products that have the potential to 
be contaminated with Listeria monocytogenes bacteria, and a number of our customers initiated recalls of their products that 
contain  the  affected  sunflower  kernels  as  an  ingredient  or component.    Additionally,  we  ceased  production  at  our  roasting 
facilities for the period from April 21, 2016 until on or about May 15, 2016, while we put in place corrective and preventive 
actions.  While we have recognized estimated losses of $47.5 million related to this recall, we may need to revise our estimates 
to be materially larger as we continue to work with our customers to substantiate the claims received to date and any additional 
claims that may be received.  Consequently, we may not be able to determine the full extent of the losses related to the recall 
for some time and certain factors impacting these losses, such as our customers’ processes for developing their claims, the 
timing of submission of any such claims, and the terms of our customers’ insurance policies and related coverage, which are 
beyond our control. Revisions of our estimated losses and costs may occur at any time as we continue this process. 

We have general liability and product recall insurance policies with aggregate limits of $47.0 million under which we expect 
to recover the sunflower kernel recall-related costs, less applicable deductibles.  As at December 30, 2017, we had recognized 
recoveries up to the limit of the coverage available under our insurance policies.  Consequently, to the extent any losses are 
excluded under the insurance policies or additional losses are recognized related to existing or new claims, these excluded or 
excess losses will be recognized as a charge to future earnings.  

Even if a situation does not necessitate a recall or market withdrawal, product liability claims might be asserted against us.  If 
a product recall or withdrawal were to lead to a decline in sales of a similar or related product sold by a customer or other third 
party, that party could also initiate litigation against us. While we are subject to governmental inspection and regulations and 
believe our facilities and those of our co-packers comply in all material respects with all applicable laws and regulations, if the 
consumption of any of our products causes, or is alleged to have caused, a health-related illness in the future, we may become 
subject to claims or lawsuits relating to such matters.  Even if a product liability claim is unsuccessful or is not fully pursued, 
the negative publicity surrounding any assertion that our products caused illness or physical harm could adversely affect our 
reputation with existing and potential customers and consumers and our corporate and brand image. 

Moreover,  future  claims  or  liabilities  of  this  sort  might  not  be  covered  by  our  insurance  or  by  any  rights  of  indemnity  or 
contribution that we may have against others.  Further, we may incur claims or liabilities for which we are not insured or that 
exceed the amount of our insurance coverage.  A product liability judgment against us or a further product recall could have a 
material and adverse effect on our business, financial condition and results of operations. 

Food safety concerns and instances of food-borne illnesses caused by third parties could harm our business  

Our internal processes and training may not be fully effective in preventing contamination of food products that could lead to 
food-borne illnesses.  We rely on third-party suppliers and distributors, which increases the risk that food-borne illness incidents 
(such as e. coli, salmonella or listeria) could occur outside of our control and at multiple locations.  If consumers lose confidence 
in the safety and quality of our products or organic products generally, even in the absence of a recall or a product liability 
case, our business, financial condition and results of operations could be materially and adversely affected. Instances of food-
borne illnesses, whether real or perceived, and whether or not traceable to our operations or a result of our actions or omissions, 
could cause negative publicity about us or the products we serve, which could adversely affect sales.  Food safety concerns and 
instances of food-borne illnesses and injuries caused by contaminated products sold by third parties could cause customers to 
shift their preferences, even if no food-borne illnesses or injuries are traced to our products.  As a result, our sales may decline. 
Loss of customers as a result of these health concerns or negative publicity could harm our business.  

Litigation  and  regulatory  enforcement  concerning  marketing  and  labeling  of  food  products  could  adversely  affect  our 
business and reputation  

The marketing and labeling of any food product in recent years has brought increased risk that consumers will bring class action 
lawsuits  and  that  the  FTC  and/or  state  attorneys  general  will  bring  legal  action  concerning  the  truth  and  accuracy  of  the 
marketing and labeling of the product.  Examples of causes of action that may be asserted in a consumer class action lawsuit 
include fraud, unfair trade practices, and breach of state consumer protection statutes (such as Proposition 65 in California).  
The  FTC  and/or  state  attorneys  general  may  bring  legal  action  that  seeks  removal  of  a  product  from  the  marketplace,  and 
impose fines and penalties.  Even when not merited, class claims, action by the FTC or state attorneys general enforcement 
actions can be expensive to defend and adversely affect our reputation with existing and potential customers and consumers 

SUNOPTA INC. 

19 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
and our corporate and brand image, which could have a material and adverse effect on our business, financial  condition and 
results of operations.  

We are subject to significant food and health regulations  

We are affected by a wide range of governmental regulations in Canada, the U.S., Mexico and several countries in Europe, 
among others.  These laws and regulations are implemented at the national level (including, among others, federal laws and 
regulation in Canada and the U.S.) and by local subdivisions (including, among others, state laws in the U.S. and provincial 
laws in Canada).  We are also subject to regulations of the EU and the regulatory authority of regulatory agencies in several 
different countries.  Examples of regulatory agencies influencing our operations include: the USDA, the FDA, the DHS, the 
EPA, the CFIA, and Skal, among others.  

Examples of laws and regulations that affect us include laws and regulations applicable to:  

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

the use of seed, fertilizer and pesticides;  

the purchasing, harvesting, transportation and warehousing of seeds, grain and other products;  

the processing and sale of food, including wholesale operations; and  

the product labeling and marketing of food and food products, food safety and food defense.  

These laws and regulations affect various aspects of our business.  For example, certain food ingredient products manufactured 
by SunOpta may require pre-market approval by the FDA that the ingredient is generally recognized as safe, or “GRAS.”  We 
believe that most food ingredients for which we have commercial rights are GRAS.  However, this status cannot be determined 
until actual formulations and uses are finalized.  As a result, we may be adversely impacted if the FDA determines that our 
food ingredient products do not meet the criteria for GRAS.  

In addition, certain USDA regulations set forth the minimum standards producers must meet in order to have their products 
labeled as “certified organic”, and we currently manufacture a number of organic products that are covered by these regulations. 
While we believe our products and our supply chain are in compliance with these regulations, changes to food regulations may 
increase our costs to remain in compliance.  We could lose our “organic” certification if a facility becomes contaminated with 
non-organic materials or if we do not use raw materials that are certified organic.  The loss of our “organic” certifications could 
materially and adversely affect our business, financial condition and results of operations.  

Our business is subject to the Perishable Agricultural Commodities Act (“PACA”).  PACA regulates fair trade standards in the 
fresh produce industry and governs our purchases of fresh produce and sales of frozen produce.  We source fresh produce under 
licenses issued by the USDA, as required by PACA.  Our failure to comply with the PACA requirements could, among other 
things,  result  in  civil  penalties,  suspension  or  revocation  of  our  licenses  to  sell  produce  and  in  certain  cases,  criminal 
prosecution, which could have a material and adverse effect on our business, financial condition and results of operations. 

Changes in any government laws and regulations applicable to our operations could increase our compliance costs, negatively 
affect our ability to sell certain products or otherwise adversely affect our results of operations.  In addition, while we believe 
we are in material compliance with all laws and regulations applicable to our operations, we cannot assure you that we have 
been, or will at all times be, in compliance with all food production and health requirements, or that we will not incur material 
costs or liabilities in connection with these requirements.  Our failure to comply with any laws, regulations or policies applicable 
to our business could result in fines, lawsuits, enforcement actions, penalties or loss in the ability to sell certain products, any 
of which could materially and adversely affect our business, financial condition and results of operations.  

We may require additional capital, which may not be available on favorable terms or at all  

We have grown via a combination of internal growth and acquisitions requiring available financial resources.  Our ability to 
raise capital, through equity or debt financing, is directly related to our ability to both continue to grow and improve returns 
from our operations.  Debt or equity financing may not be available to us on favorable terms or at all.  In addition, any future 
equity financing would dilute our current shareholders and may result in a decrease in our share price if we are unable to realize 
adequate returns.  We will not be able to continue to fund internal growth and/or acquire complementary businesses within the 
natural and organic food industries without continued access to capital resources. 

SUNOPTA INC. 

20 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Impairment charges in goodwill or other intangible assets could adversely impact our financial condition and results of 
operations 

As a result of business acquisitions, a significant portion of our total assets is comprised of intangible assets and goodwill.  We 
are required to perform impairment tests of our goodwill and other intangible assets annually, or at any time when events occur 
that could affect the value of these assets.  We may engage in additional acquisitions, which could result in our recognition of 
additional  intangible  assets  and  goodwill.    If  the  financial  performance  of  the  acquired  businesses  is  not  as  strong  as  we 
anticipate, we could be required to record significant impairments to intangible assets and/or goodwill, which could materially 
and adversely impact our business, financial condition and results of operations.  

For example, in 2017, we recognized a goodwill impairment charge of $115.0 million related to the Healthy Fruit reporting 
unit of the Consumer Products operating segment, and, in 2016, we recognized a goodwill impairment charge of $17.5 million 
related to the Sunflower reporting unit of the Raw Material Sourcing and Supply operating segment.  

We operate in a highly competitive industry  

We operate businesses in highly competitive product and geographic markets in the U.S., Canada, Europe and various other 
international  markets.    We  compete  with  various  U.S.  and  international  commercial  grain  procurement  marketers,  major 
companies with food ingredient divisions, other food ingredient companies, trading companies, and consumer-packaged food 
companies that also engage in the development and sale of food ingredients and other food companies involved in natural and 
organic foods.  These competitors may have financial resources and staff larger than ours and may be able to benefit from 
economies of scale, pricing advantages and greater resources to launch new products that compete with our offerings.  We have 
little  control  over  and  cannot  otherwise  affect  these  competitive  factors.    If  we  are  unable  to  effectively  respond  to  these 
competitive factors or if the competition in any of our product markets results in price reductions or decreased demand for our 
products, our business, financial condition and results of operations may be materially and adversely affected.  

Our customers generally are not obligated to continue purchasing products from us  

Many  of  our  customers  buy  from  us  under  purchase  orders,  and  we  generally  do  not  have  long-term  agreements  with  or 
commitments from these customers for the purchase of products.  We cannot provide assurance that our customers will maintain 
or increase their sales volumes or orders for the products supplied by us or that we will be able to maintain or add to our existing 
customer base.  Decreases in our customers’ sales volumes or orders for products supplied by us may have a material adverse 
effect on our business, financial condition and results of operations.  

Loss of a key customer could materially reduce revenues and earnings  

Our relationships with our key customers are critical to the success of our business and our results of operations.  Our three 
largest customers accounted for approximately 24% of revenues for the year ended December 30, 2017.  The loss, decrease or 
cancellation of business with any of our large customers could materially and adversely affect our business, financial condition 
and results of operations. 

Consumer preferences for natural and organic food products are difficult to predict and may change  

Our success depends, in part, on our ability and our customers’ ability to offer products that anticipate the tastes and dietary 
habits of consumers and appeal to their preferences on a timely and affordable basis.  A significant shift in consumer demand 
away  from  our  products  or  products  that  utilize  our  integrated  foods  platform,  or  a  failure  to  maintain  our  current  market 
position,  could reduce our sales and harm our business.  Consumer trends change  based on a number of  factors, including 
nutritional values, a change in consumer preferences or general economic conditions.  Additionally, there is a growing focus 
among some consumers to buy local food products in an attempt to reduce the carbon footprint associated with transporting 
food products from longer distances, which could result in a decrease in the demand for food products and ingredients that we 
import from other countries or transport from remote processing locations or growing regions.  Further, failures by us or our 
competitors to deliver quality products could erode consumer trust in the organic certification of foods.  These changes could 
lead  to,  among  other  things,  reduced  demand  and  price  decreases,  which  could  have  a  material  and  adverse  effect  on  our 
business, financial condition and results of operations.  

SUNOPTA INC. 

21 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
If we do not manage our supply chain effectively, our operating results may be adversely affected  

Our supply chain is complex.  We rely on suppliers for our raw materials and for the manufacturing, processing, packaging and 
distribution of many of our products.  The inability of any of these suppliers to deliver or perform for us in a timely or cost-
effective manner could cause our operating costs to rise and our margins to fall.  Many of our products are perishable and 
require timely processing and transportation to our customers.  Additionally, many of our products can only be stored for a 
limited amount of time before they spoil and cannot be sold.  We must continuously monitor our inventory and product mix 
against forecasted demand or risk having inadequate supplies to meet consumer demand as well as having too much inventory 
that may reach its expiration date.  If we are unable to manage our supply chain efficiently and ensure that our products are 
available to meet consumer demand, our operating costs could increase and our margins could fall, which could have a material 
and adverse effect on our business, financial condition and results of operations. 

Some of our operations are subject to seasonal supply fluctuations. For example, we purchase strawberries and other fruit from 
farmers during the peak California growing season, which occurs during the first two quarters of the year. As a result, our costs 
may be higher during these periods. We may not be successful in counteracting or smoothing out the effects of seasonality, and 
we expect that certain parts of our operations will continue to remain subject to significant seasonality.  

Part of our supply source also depends in part on a seasonal temporary workforce comprised primarily of migrant workers. 
Changes  in  immigration  laws  or  policies  that  discourage  migration  to  the  U.S.  and  political  or  other  events  (such  as  war, 
terrorism or health emergencies) that make it more difficult for individuals to immigrate to or migrate  throughout the U.S. 
could adversely affect the migrant worker population and reduce the workforce available for farms and production facilities in 
the U.S. Additionally, increased competition from other industries for migrant workers could increase our costs and adversely 
affect our business, financial condition and results of operations. 

Volatility in the prices of raw materials and energy could increase our cost of sales and reduce our gross margins  

Raw materials represent a significant portion of our cost of sales.  Our cost to purchase services and materials, such as grains, 
fruits and other commodities, processing aids, and natural gas, can fluctuate depending on many factors, including weather 
patterns, economic and political conditions and pricing volatility.  In addition, we must compete for limited supplies of these 
raw materials and services with competitors having greater resources than us.  If our cost of materials and services increases 
due to any of the above factors, we may not be able to pass along the increased costs to our customers.  

We enter into a number of exchange-traded commodity futures and options contracts to partially hedge our exposure to price 
fluctuations on transactions to the extent considered practicable for minimizing risk from market price fluctuations.  Futures 
contracts  used  for  hedging  purposes  are  purchased  and  sold  through  regulated  commodity  exchanges.    Our  inventories, 
however, may not be completely hedged, due in part to our assessment of exposure from expected price fluctuations and an 
inability to hedge a number of raw materials.  

Exchange  purchase  and  sales  contracts  may  expose  us  to  risks  that  a  counterparty  to  a  transaction  is  unable  to  fulfill  its 
contractual obligation.  We may be unable to hedge 100% of the price risk of each transaction due to timing and availability of 
hedge contracts and third-party credit risk.  In addition, we have a risk of loss from hedge activity if a grower does not deliver 
the commodity as scheduled.  We also monitor the prices of natural gas and from time to time lock in a percentage of our 
natural gas needs based on current prices and expected trends.  

An increase in our cost of sales resulting from an increase in the price of raw materials and energy could have a material and 
adverse effect on our business, financial condition and results of operations. 

Our future results of operations may be adversely affected by the availability of organic and non-GMO ingredients 

Our ability to ensure a continuing supply of organic and non-GMO ingredients at competitive prices depends on many factors 
beyond our control, such as the number and size of farms that grow organic and non-GMO crops, climate conditions, changes 
in national and world economic conditions, currency fluctuations and forecasting adequate need of seasonal ingredients. 

The  organic  and  non-GMO  ingredients  that  we  use  in  the  production  of  our  products  (including,  among  others,  fruits, 
vegetables, nuts and grains) are vulnerable to adverse weather conditions and natural disasters, such as floods, droughts, water 
scarcity, temperature extremes, frosts, earthquakes and pestilences. Natural disasters and adverse weather conditions (including 
the potential effects of climate change) can lower crop yields and reduce crop size and crop quality, which in turn could reduce 
our supplies of organic or non-GMO ingredients or increase the prices of organic or non-GMO ingredients. If our supplies of 
organic or non-GMO ingredients are reduced, we may not be able to find enough supplemental supply sources on favorable 

SUNOPTA INC. 

22 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
terms, if at all, which could impact our ability to supply product to our customers and adversely affect our business, financial 
condition and results of operations. 

Adverse weather conditions and natural disasters could impose costs on our business  

Our various food products, from seeds and grains to ingredients, fruits, vegetables and other inputs, are vulnerable to adverse 
weather conditions and natural disasters, including windstorms, hurricanes, floods, droughts, fires, temperature extremes and 
earthquakes,  some  of  which  are  common  but  difficult  to  predict,  as  well  as  crop  disease  and  infestation.    Severe  weather 
conditions  may  occur  with  higher  frequency  or  may  be  less  predictable  in  the  future  due  to  the  effects  of  climate  change.  
Unfavorable growing conditions could reduce both crop size and crop quality.  In extreme cases, entire harvests may be lost in 
some geographic areas.  Adverse weather conditions or natural disasters may adversely affect our supply of one or more food 
products or prevent or impair our ability to ship products  as planned.  These factors can increase costs, decrease our sales 
volumes and revenues and lead to additional charges to earnings, which may have a material adverse effect on our business, 
financial condition and results of operations.  

A significant portion of our fruit supply is sourced from California, which experienced severe drought conditions between fall 
2011 and fall 2015 due to extremely low levels of rainfall.  Such conditions resulted in lost crops as well as increased water 
costs for growers in California.  In particular, we depend on growers in California for strawberries. In January 2014, a drought 
state  of  emergency  was  declared  in  California  and,  among  other  actions,  legislation  was  passed  requiring  monitoring  of 
groundwater pumping, which limits the amount of groundwater for which farmers can drill. Strawberry growers are largely 
dependent on well water, and diminishing groundwater resources could lead to a reduced strawberry supply. In April 2015, 
statewide  mandatory  water  conservation  measures  were  imposed  in  California,  including  increased  water  use  reporting  by 
agricultural water users, enhancing the state’s ability to enforce against diversions and unreasonable use of water in an effort 
to curtail wasteful water practices in agricultural fields.  Precipitation returned to more normal levels in 2016 and early 2017, 
and  the  drought  emergency  was  lifted  in  April  2017.  However,  drought  conditions  are  a  recurring  feature  of  California’s 
climate, and existing and future water conservation laws could negatively impact the agricultural industry in California and 
have a material adverse effect on our business, financial condition and results of operations. 

An  interruption  at  one  or  more  of  our  manufacturing  facilities  could  negatively  affect  our  business,  and  our  business 
continuity plan may prove inadequate  

We own or lease, manage and operate a number of manufacturing, processing, packaging, storage and office facilities.  We 
may be unable to accept and fulfill customer orders as a result of disasters, epidemics, business interruptions or other similar 
events.  Some of our inventory and manufacturing facilities are located in areas that are susceptible to harsh weather, and the 
production of certain of our products is concentrated in a few geographic areas.  In addition, we store chemicals used in the 
equipment  for  quick  freezing  of  fruit  or  used  for  cooling  processes  during  ingredient  processing,  and  our  storage  of  these 
chemicals could lead to risk of leaks, explosions or other events.  Although we  have a business continuity plan, we cannot 
provide assurance that our business continuity plan will address all of the issues we may encounter in the event of a disaster or 
other unanticipated issue.  Our business interruption insurance may not adequately compensate us for losses that may occur 
from any of the foregoing.  In the event that a natural disaster, or other catastrophic event were to destroy any part of any of 
our facilities or interrupt our operations for any extended period of time, or if harsh weather or epidemics prevent us from 
delivering products in a timely  manner, our business, financial  condition and results of  operations could be  materially and 
adversely affected. In addition, if we fail to maintain our labor force at one or more of our facilities, we could experience delays 
in production or delivery of our products, which could also have a material adverse effect on our business, financial condition 
and results of operations.  

Technology failures could disrupt our operations and negatively impact our business 

In  the  normal  course  of  business,  we  rely  on  information  technology  systems  to  process,  transmit,  and  store  electronic 
information.  For example, our production and distribution facilities and inventory management utilize information technology 
to  increase  efficiencies  and  limit  costs.  Information  technology  systems  are  also  integral  to  the  reporting  of  our  results  of 
operations.  Furthermore, a significant portion of the communications between, and storage of personal data of, our personnel, 
customers,  consumers  and  suppliers  depends  on  information  technology.  Our  information  technology  systems  may  be 
vulnerable to a variety of interruptions, as a result of updating our enterprise platform or due to events beyond our control, 
including, but not limited to, natural disasters, terrorist attacks, telecommunications failures, computer viruses, hackers,  and 
other  security  issues.    These  events  could  compromise  our  confidential  information,  impede  or  interrupt  our  business 
operations,  and  may  result  in  other  negative  consequences,  including  remediation  costs,  loss  of  revenue,  litigation  and 
reputational damage. 

SUNOPTA INC. 

23 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
Our reputation and our relationships with customers, consumers and suppliers would be harmed if our systems are accessed 
by unauthorized persons 

We maintain certain personal data, including personal data regarding our personnel, customers, consumers and suppliers. This 
data is maintained on our own systems as well as that of third parties we use in our operations. If a breach or other breakdown 
results in disclosure of confidential or personal information, we  may suffer reputational, competitive and/or business harm.    
While we have implemented administrative and technical controls and taken other preventive actions to reduce the risk of cyber 
incidents and protect our information technology, they may be insufficient to prevent physical and electronic break-ins, cyber-
attacks or other security breaches to our computer systems.  The costs relating to any data breach could be material, and we 
currently do not carry insurance against the risk of a data breach. Any data breach or other access of our systems by unauthorized 
persons could have a material adverse effect on our business, financial condition and results of operations. 

Changes in laws and regulations of privacy and protection of user data could adversely affect our business 

We are subject to data privacy and protection laws and regulations that apply to the collection, transmission, storage and use 
of  proprietary  information  and  personally-identifying  information.  The  regulatory  environment  surrounding  information 
security and data privacy varies from jurisdiction to jurisdiction and is constantly evolving and increasingly demanding. The 
restrictions imposed by such laws continue to develop and may require us to incur substantial costs, adopt additional compliance 
measures, such as notification requirements and corrective actions in the event of a security breach, and/or change our current 
or planned business models. We are already subject to strict data privacy laws in the European Union and other jurisdictions 
governing the collection, transmission, storage and use of employee data and personally-identifying information. The General 
Data  Protection  Regulation  (“GDPR”),  coming  into  effect  in  Europe  in  May  2018,  creates  a  range  of  new  compliance 
obligations and increases financial penalties for non-compliance and extends the scope of the European Union data protection 
law to all companies processing data of European Union residents, regardless of the company’s location. The GDPR and other 
privacy and data protection laws may be interpreted and applied differently from country to country and may create inconsistent 
or conflicting requirements. Such regulations increase our compliance and administrative burden significantly. While we have 
developed and are executing comprehensive plans to meet these requirements and do not currently foresee significant obstacles 
that  would  prevent  timely  compliance,  these  plans  are  subject  to  many  variables  that  could  delay  or  otherwise  affect 
implementation. 

If our current security measures and data protection policies and controls are found to be non-compliant with relevant laws or 
regulations in any jurisdiction where we conduct business, we may be subject to penalties and fines, and may need to expend 
significant resources to implement additional data protection measures. In addition, we may be required to modify the features 
and functionality of our system offerings in a way that is less attractive to customers. 

If we lose the services of our key management, our business could suffer  

Our prospects depend to a significant extent on the continued service of our key executives, and our continued growth depends 
on our ability to identify, recruit and retain key management personnel. We are also dependent on our ability to continue to 
attract, retain and motivate our personnel.  We do not typically carry key person life insurance on our executive officers.  If we 
lose the services of our key management or fail to identify, recruit and retain key personnel, our business, financial condition 
and results of operations may be materially and adversely impacted.  

If we face labor shortages or increased labor costs, our results of operations and our growth could be adversely affected  

Labor is a significant component of the cost of operating our business.  Our ability to meet our labor needs while controlling 
labor costs is subject to external factors, such as employment levels, prevailing wage rates, minimum wage legislation, changing 
demographics,  health  and  other  insurance  costs  and  governmental  labor  and  employment  requirements.    In  the  event  of 
increasing  wage  rates,  if  we  fail  to  increase  our  wages  competitively,  the  quality  of  our  workforce  could  decline,  while 
increasing our  wages could cause our earnings to decrease.  If we  face  labor shortages  or increased labor costs because of 
increased competition for employees from our competitors and other industries, higher employee-turnover rates, unionization 
of farm workers or increases in the federal- or state-mandated minimum wage, change in exempt and non-exempt status, or 
other employee benefits costs (including costs associated with health insurance coverage or workers’ compensation insurance), 
our operating expenses could increase and our business, financial condition and results of operations could be materially and 
adversely affected. 

SUNOPTA INC. 

24 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
Technological innovation by our competitors could make our food products less competitive  

Our competitors include major food ingredient and consumer-packaged food companies that also engage in the development 
and sale of food and food ingredients.  Many of these companies are engaged in the development of food ingredients and other 
packaged  food  products  and  frequently  introduce  new  products  into  the  market.    Existing  products  or  products  under 
development by our competitors could prove to be more effective or less costly than our products, which could have a material 
adverse effect on the competitiveness of our products and our business. 

We rely on protection of our intellectual property and proprietary rights  

Our success depends in part on our ability to protect our intellectual property rights.  We rely primarily on patent, copyright, 
trademark and trade secret laws to protect our proprietary technologies.  Our policy is to protect our technology by, among 
other things, filing patent applications for technology relating to the development of our business in the U.S. and in selected 
foreign jurisdictions.  

Our trademarks and brand names are registered in the U.S., Canada and other jurisdictions.   We intend to keep these filings 
current and seek protection for new trademarks to the extent consistent with business needs.  We also rely on trade secrets and 
proprietary know-how and confidentiality agreements to protect certain of the technologies and processes that we use.  

The failure of any patents, trademarks, trade secrets or other intellectual property rights to provide protection to our technologies 
would make it easier for our competitors to offer similar products, which could result in lower sales or gross margins. 

Changes in laws or regulations governing foreign trade or taxation could adversely affect our business 

Changes in governmental laws or regulations affecting foreign trade or taxation, or the introduction of new laws or regulations, 
may have a direct or indirect effect on our business or those of our customers or suppliers.  Such changes could increase the 
costs of doing business for the Company, our customers, or suppliers, or restrict our actions, causing our results of operations 
to be adversely affected. 

The current President of the United States has expressed an intention to change existing trade agreements, such as the North 
American Free Trade Agreement (“NAFTA”).  Any changes to NAFTA could impact our Mexican and Canadian operations.  
Changes  in  U.S.  political,  regulatory  and  economic  conditions  or  laws  and  policies  governing  foreign  trade  with  countries 
where we or our customers operate, in particular Canada, Mexico and Europe, could adversely affect our operating results and 
our business. 

Tax laws are dynamic and subject to change as new laws are passed and new interpretations of the law are issued or applied. 
The U.S. recently enacted significant tax reform, and certain provisions of the new law may adversely affect us. In addition, 
governmental  tax  authorities  are  increasingly  scrutinizing  the  tax  positions  of  companies.  Many  countries  in  the  European 
Union,  as  well  as  a  number  of  other  countries  and  organizations  such  as  the  Organization  for  Economic  Cooperation  and 
Development,  are  actively  considering  changes  to  existing  tax  laws  that,  if  enacted,  could  increase  our  tax  obligations  in 
countries where we do business. If U.S. or other foreign tax authorities change applicable tax laws, our overall taxes could 
increase, and our business, financial condition and results of operations may be adversely impacted. 

Our operations are influenced by agricultural policies  

We are affected by governmental agricultural policies such as price supports and acreage set aside programs and these types of 
policies may affect our business.  The production levels, markets and prices of the grains and other raw products that we use 
in our business are materially affected by government programs, which include acreage control and price support programs of 
the USDA.  Revisions in these and other comparable programs, in the U.S. and elsewhere, could have a material and adverse 
effect on our business, financial condition and results of our operations. 

We are subject to substantial environmental regulation and policies  

We are, and expect to continue to be, subject to substantial federal, state, provincial and local environmental regulation. Some 
of the key environmental regulations to which we are subject include air quality regulations of the EPA and certain city, state 
and provincial air pollution control groups, waste treatment/disposal regulations, sewer regulations under agreements with local 
city sewer districts, regulations governing hazardous substances, storm water regulations and bioterrorism regulations.  For a 
more  detailed  summary  of  the  environmental  regulations  and  policies  to  which  we  are  subject,  see  “Item  1.  Business—
Regulation” of this report.  Our business also requires that we have certain permits from various state, provincial and local 

SUNOPTA INC. 

25 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
authorities related to air quality, storm water discharge, solid waste, land spreading and hazardous waste.  

In the event that our safety procedures for handling and disposing of potentially hazardous materials in certain of our businesses 
were to fail, we could be held liable for any damages that result, and any such liability could exceed our resources.  We may 
be required to incur significant costs to comply with environmental laws and regulations in the future.  In addition, changes to 
environmental regulations may require us to modify our existing plant and processing facilities and could significantly increase 
the cost of those operations.  

The foregoing environmental regulations, as well as others common to the industries in which we participate, can present delays 
and costs that can adversely affect business development and growth.  If we fail to comply with applicable laws and regulations, 
we may be subject to civil remedies, including fines, injunctions, recalls or seizures, as well as potential criminal sanctions, 
which could have a material adverse effect on our business, financial condition and results of operations.  In addition, any 
changes to current regulations may impact the development, manufacturing and marketing of our products, and may have a 
negative impact on our future results. 

Climate change laws could have an impact on our financial condition and results of operations  

Legislative  and  regulatory  authorities  in  the  U.S.,  Canada  and  internationally  will  likely  continue  to  consider  numerous 
measures related to climate change and greenhouse gas emissions. In order to produce, manufacture and distribute our products, 
we  and  our  suppliers  use  fuels,  electricity  and  various  other  inputs  that  result  in  the  release  of  greenhouse  gas  emissions.  
Concerns about the environmental impacts of greenhouse gas emissions and global climate change may result in environmental 
taxes, charges, regulatory schemes, assessments or penalties, which could restrict or negatively impact our operations, as well 
as those of our suppliers, who would likely pass all or a portion of their costs along to us.  We may not be able to pass any 
resulting cost increases along to our customers.  Any laws or regulations regarding greenhouse gas emissions or other climate 
change laws enacted by the U.S., Canada or any other international jurisdiction where we conduct business could materially 
and adversely affect our business, financial condition and results of operations.  

Fluctuations in exchange rates, interest rates and commodity prices could adversely affect our business, financial condition, 
results of operations or liquidity  

We are exposed to foreign exchange rate  fluctuations as our non-U.S.-based operations  are  translated into U.S.  dollars for 
financial  reporting  purposes  and  we  also  sell  product  in  currencies  that  are  different  from  the  currency  used  to  purchase 
materials, or process finished goods.  We are exposed to changes in interest rates as a significant portion of our debt bears 
interest at variable rates.  We are exposed to price fluctuations on a number of commodities as we hold inventory and enter into 
transactions to buy and sell products in a number of markets.  Additional qualitative and quantitative disclosures about these 
risks can be found in “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” of this report.  As a result of 
these exposures, fluctuations  in exchange rates, interest rates and certain commodities could adversely  affect our business, 
financial condition, results of operations or liquidity.  

Our international operations expose us to additional risks  

We source our products from numerous suppliers and growers from around the world.  Outside of the U.S. and Canada,  we 
have processing, packaging and warehousing facilities in Mexico, Europe, Africa and Asia.  Our international operations and 
customers expose us to certain risks inherent in doing business abroad, including:  

(cid:120) 

exposure  to  local  economic  conditions,  expropriation  and  nationalization,  foreign  exchange  rate  fluctuations  and 
currency controls;  

(cid:120)  withholding and other taxes on remittances and other payments by subsidiaries;  

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

investment restrictions or requirements;  

export and import restrictions;  

compliance with anti-corruption and anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;  

compliance with export controls and economic sanctions laws;  

increases in working capital requirements related to long supply chains; and  

SUNOPTA INC. 

26 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(cid:120) 

disruptions in our supply chain from  unforeseen events, such as natural disasters, terrorism and political and civil 
unrest.  

For example, we have significant operations in Mexico, including a facility in the State of Michoacán, near areas where there 
have been incidents of unrest, which may heighten the risks of our international operations described above.  

As we continue to expand our business globally, we may have difficulty anticipating and effectively managing these and other 
risks that our international operations may face, which may adversely impact our business, financial condition and results of 
operations.  In addition, any acquisition of businesses with operations outside of the U.S. and Canada may exacerbate this risk.  

A significant portion of our assets and certain of our executive officers and directors are located outside of the U.S.; it may 
be  difficult  to  effect  service  of  process  and  enforce  legal  judgments  upon  us  and  certain  of  our  executive  officers  and 
directors  

A significant portion of our assets and certain of our executive officers and directors are located outside of the U.S. As a result, 
it may be difficult to effect service of process within the U.S. and enforce judgment of a U.S. court obtained against us or our 
executive officers and directors.  Particularly, our stakeholders may not be able to:  

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

effect service of process within the U.S. on us or certain of our executive officers and directors;  

enforce judgments obtained in U.S. courts against us or certain of our executive officers and directors based upon 
the civil liability provisions of the U.S. federal securities laws;  

enforce, in a court outside of the U.S., judgments of U.S. courts based on the civil liability provisions of the U.S. 
federal securities laws; or  

bring an original action in a court outside of the U.S. to enforce liabilities against us or any of our executive officers 
and directors based upon the U.S. federal securities laws.  

Risks Related to Our Indebtedness  

Our level of indebtedness could adversely affect our financial condition and prevent us from fulfilling our debt obligations 

Our level of indebtedness could adversely affect our business, financial condition and results of operations, including, without 
limitation,  impairing  our  ability  to  obtain  additional  financing  for  working  capital,  capital  expenditures,  debt  service 
requirements or other general corporate purposes.  In addition, we will have to use a substantial portion of our cash flow to pay 
principal, premium (if any) and interest on our indebtedness, which will reduce the funds available to us for other purposes.  If 
we do not generate sufficient cash flows to satisfy our debt service obligations, we may have to undertake alternative financing 
plans, such as refinancing or restructuring our debt, selling assets, reducing or delaying capital investments or seeking to raise 
additional capital.  Our level of indebtedness will also make us more vulnerable to economic downturns and adverse industry 
conditions, and may compromise our ability to capitalize on business opportunities and to react to competitive pressures as 
compared to our competitors. 

Our debt and equity agreements restrict how we may operate our business, and our business may be materially and adversely 
affected if these restrictions prevent us from implementing our business plan  

The agreements governing our debt and preferred equity instruments contain restrictive covenants that limit the discretion of 
our management with respect to certain business matters.  These covenants place restrictions on, among other things, our ability 
to obtain additional debt financing, to create other liens, to complete a merger, amalgamation or consolidation, to make certain 
distributions or make certain payments, investments and guarantees and to sell or otherwise dispose of certain assets.  These 
restrictions may hinder our ability to execute on our growth strategy or prevent us from implementing parts of our business 
plan.  

SUNOPTA INC. 

27 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our business may be materially and adversely affected if we are unable to renew the Global Credit Facility and/or refinance 
our senior secured second lien notes 

The Global Credit Facility matures on February 10, 2021.  We may not be able to renew this facility to the same level or size, 
or on terms as favorable as at present.  A reduced facility may impact our ability to finance our business, requiring us to scale 
back our operations and our use of working capital.  Alternatively, obtaining credit on less favorable terms would have a direct 
impact on our profitability and operating flexibility.  Our senior secured second lien notes mature on October 9, 2022.  Our 
ability to refinance these notes upon maturity will depend on the capital markets and our financial condition at such time.  As 
a result, we may not be able to obtain refinancing at commercially reasonable terms, which could have a material and adverse 
impact on our business,  financial condition and results of  operations.  Alternatively,  we  may  have to undertake  alternative 
financing plans, such as restructuring our debt,  selling assets, reducing or delaying capital investments, or seeking to raise 
additional capital. 

Our business could be materially and adversely affected if we are unable to meet the financial covenants of the Global 
Credit Facility 

Our ability to comply with the financial covenants under the Global Credit Facility agreement will depend on the success of 
our businesses, our operating results, and our ability to achieve our financial forecasts.  Various risks uncertainties and events 
beyond our control could affect our ability  to comply  with the financial  covenants and terms of the  Global Credit  Facility 
agreement.    Failure  to  comply  with  our  financial  covenants  and  other  terms  could  result  in  an  event  of  default  and  the 
acceleration of amounts owing under this agreement, unless we are able to negotiate a waiver.  The lenders could condition any 
such waiver on an amendment to the agreement on terms (including, but not limited to, the payment of consent fees) that may 
be  unfavorable  to  us.    If  we  are  unable  to  negotiate  a  covenant  waiver  or  replace  or  refinance  the  Global  Credit  Facility 
agreement  on  favorable  terms,  our  business,  financial  condition  and  results  of  operations  will  be  materially  and  adversely 
impacted. 

Risks Related to Business Acquisitions and Divestures 

We may not be able to effectively manage our growth and integrate acquired companies  

From time to time we may pursue acquisition opportunities that are consistent with our overall growth strategy. In October 
2015, for example, we completed the acquisition of Sunrise Holdings (Delaware), Inc., which was the largest acquisition in the 
history of our company. Our ability to effectively integrate past or future business acquisitions, including our ability to realize 
potentially available marketing opportunities and cost savings in a timely and efficient manner will have a direct impact on our 
future results. We may encounter problems in connection with the integration of any new businesses, such as challenges relating 
to the following:  

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

integration of an acquired company’s products into our product mix;  

the amount of cost savings that may be realized as a result of integrating an acquired product or business;  

unanticipated quality and production issues with acquired products;  

adverse effects on business relationships with suppliers and customers;  

diversion of management attention;  

integrating acquired operations that have management teams and company cultures that differ from our own;  

difficulty with personnel and loss of key employees;  

implementation of an integrated enterprise-wide accounting and information system and consolidation of back office 
accounting;  

compatibility of financial control and information systems;  

exchange rate risk with respect to acquisitions outside the U.S.;  

SUNOPTA INC. 

28 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(cid:120) 

(cid:120) 

(cid:120) 

potential for patent and trademark claims or other litigation against or involving the acquired company;  

integration of businesses that operate in new geographic areas, including difficulties in identifying and gaining access 
to customers in new markets; and  

in  the  case  of  foreign  acquisitions,  uncertainty  regarding  foreign  laws  and  regulations  and  difficulty  integrating 
operations and systems as a result of cultural, systems and operational differences. 

If we experience any of these problems in the integration of acquisitions, they could have a material and adverse effect on our 
business, financial condition and results of operations.  

We may not have accurately estimated the benefits or synergies to be realized from business acquisitions  

Our expected benefits and synergies from acquired businesses may not be realized if our cash flow estimates associated with 
the  assets  of  those  businesses  are  materially  inaccurate  or  if  we  fail  to  identify  operating  problems  or  liabilities  prior  to 
acquisition.  We perform inspections of the assets to be acquired, which we believe to be generally consistent with industry 
practices.  However, the accuracy of our assessments of the assets and our estimates are inherently uncertain.  There could also 
be environmental or other problems that were not discovered in the course of our due diligence and inspections. If problems or 
risks are identified after the closing of an acquisition, there may be limited recourse against the former owners.  

Business acquisitions may expose us to unknown liabilities  

When  we acquire a business,  we often assume or otherwise  become subject to liabilities of acquired businesses, including 
contingent liabilities that may depend on the outcome of legal and administrative proceedings or other events. As a result, we 
may become subject to liabilities that are unknown to us or that cannot be  quantified at the  time  of the  acquisition.  If  we 
become  subject  to  significant  liabilities  or  other  obligations as  a  result  of  an  acquisition,  our  business  could  be  materially 
affected.  Moreover, to the extent we have contractual rights to indemnification against losses and liabilities of businesses we 
acquire, the amount of indemnification available could be limited and may not be sufficient to cover the actual losses we suffer.  

Business acquisitions could result in unexpected disruptions of our business  

In response  to an acquisition, the customers  may cease or reduce their business  with the  combined company,  which  could 
negatively affect our business.  Similarly, current or prospective employees may experience uncertainty about their future roles 
with  the  combined  company.    This  may  adversely  affect  our  ability  to  attract  and  retain  key  management,  marketing  and 
technical personnel.  In addition, the diversion of the attention of our respective management teams away from day-to-day 
operations during the pendency of the business acquisition could have an adverse effect on our financial condition and operating 
results. 

The possible future divestiture of businesses could impact our profitability  

We may, from time to time, divest businesses that are no longer a strategic fit or no longer meet our growth or profitability 
targets.  Our profitability may be impacted by gains or losses on the sales of such businesses, or lost operating income or cash 
flows from such businesses.  Additionally, we may be required to record asset impairment or restructuring charges related to 
divested businesses, or indemnify buyers for liabilities, which may reduce our profitability and cash flows.  For example, in 
2017  and  2016,  we  recognized  asset  impairment  and  facility  closure  costs  of  $33.3  million,  as  well  as  related  employee 
termination costs of $8.4 million, in connection with portfolio optimization measures taken under the Value  Creation Plan, 
including the exits from flexible resealable pouch and nutrition bar product lines and operations.  We may also not be able to 
negotiate such divestitures on terms acceptable to us. Such potential divestitures will require management resources and may 
divert  management’s  attention  from  our  day-to-day  operations.    If  we  are  not  successful  in  divesting  such  businesses,  our 
business could be harmed. 

Risks Related to Ownership of our Common Shares  

Our operating results and share price are subject to significant volatility 

Our net sales and operating results may vary significantly from period to period due to:  

(cid:120) 

changes in our customers and/or their demand;  

SUNOPTA INC. 

29 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
(cid:120) 

changes in our operating expenses;  

(cid:120)  management’s ability to execute our business strategies focused on improved operating earnings;  

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

organizational and personnel changes;  

interruption in operations at our facilities;  

product recalls or market withdrawals;  

legal  and  administrative  cases  (whether  civil,  such  as  environmental  or  product  related,  or  criminal),  settlements, 
judgments and investigations;  

foreign currency fluctuations;  

supply shortages or commodity price fluctuations; and  

general economic conditions.  

In addition, our share price may be highly volatile compared to larger public companies. Certain announcements could have a 
significant effect on our share price, including announcements regarding:  

(cid:120) 

fluctuations in financial performance from period to period;  

(cid:120)  mergers, acquisitions and/or divestitures, either by us or key competitors;  

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

changes in key personnel;  

strategic partnerships or arrangements;  

litigation and governmental inquiries;  

changes in governmental regulation and policy;  

patents or proprietary rights;  

changes in consumer preferences and demand;  

new financings; and  

general market conditions.  

Higher  volatility  increases  the  chance  of  larger  than  normal  price  swings  which  reduces  predictability  in  the  price  of  our 
common shares and could impair investment decisions.  In addition, price and volume trading volatility in the stock markets 
can have a substantial effect on our share price, frequently for reasons other than our operating performance.  These broad 
market fluctuations could adversely affect the market price of our common shares.   

Periods of volatility in the overall market and the market price of a company’s securities, is often followed by securities class 
action  litigation  alleging  material  misstatements  or  omissions  in  disclosures  provided  to  shareholders.    Such  litigation,  if 
instituted against us, could result in substantial costs and a diversion of our management’s attention and resources.  

Our debt instruments restrict, and our future debt instruments may restrict, our ability to pay dividends to our shareholders, 
and we do not currently intend to pay any cash dividends on our common shares in the foreseeable future; therefore, our 
shareholders may not be able to receive a return on their common shares until their shares are sold  

We have never paid or declared any cash dividends on our common shares.  We do not anticipate paying any cash dividends 
on our common shares in the foreseeable future because, among other reasons, we currently intend to retain any future earnings 
to finance the growth of our business.  In addition, the covenants included in our debt instruments, and the  covenants to be 

SUNOPTA INC. 

30 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
included in our future debt instruments may restrict our ability to receive cash from our subsidiaries and pay dividends on our 
common shares.  The future payment of dividends will be dependent on factors such as these covenant restrictions, cash on 
hand, or achieving and maintaining profitability, the financial requirements to fund growth, our general financial condition and 
other factors the Board may consider appropriate in the circumstances.  Until we pay dividends, which we may never do, our 
shareholders will not receive a return on their common shares until their shares are sold.  

The future issuance of additional common shares in connection with the exchange of convertible preferred stock, exercise 
of stock options, participation in our employee stock purchase plan and issuance of additional securities could dilute the 
value of our common shares 

We have unlimited common shares authorized but unissued.  Our articles of amalgamation authorize us to issue these common 
shares, and we may also issue options, rights, warrants and appreciation rights relating to common shares for consideration and 
on terms and conditions established by the Board in its sole discretion.   

The exchange of outstanding convertible preferred stock, exercise of stock-based awards, participation in our employee stock 
purchase plan, and issuance of additional securities in connection with acquisitions or otherwise could result in dilution in the 
value of our common shares and the voting power represented thereby.  Furthermore, to the extent common shares are issued 
pursuant  to  the  exchange  of  outstanding  convertible  preferred  stock,  exercise  of  stock-based  awards,  participation  in  our 
employee stock purchase plan and issuance of additional securities, our share price may decrease due to the additional amount 
of common shares available in the market.  The subsequent sales of these shares could encourage short sales by our shareholders 
and others, which could place further downward pressure on our share price.  Moreover, the holders of our stock options may 
hedge their positions in our common shares by short selling our common shares, which could further adversely affect our stock 
price.  

If securities or industry research analysts do not publish or cease publishing research or reports about our business or if 
they issue unfavorable commentary or downgrade our common shares, our share price and trading volume could decline  

The trading market for our common shares relies in part on the research and reports that securities and industry research analysts 
publish about us, our industry, our competitors and our business.  We do not have any control over these analysts.  Our share 
price and trading volumes could decline if one or more securities or industry analysts downgrade our common shares, issue 
unfavorable commentary about us, our industry or our business, cease to cover our Company or fail to regularly publish reports 
about us, our industry or our business. 

Item 1B.  Unresolved Staff Comments  

None. 

SUNOPTA INC. 

31 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
Item 2. Properties 

The following table lists the location, description, ownership and segment of our principal properties: 

Location 
Mississauga, Ontario(1) 
Edina, Minnesota(1) 

Hope, Minnesota(2) 

Facility Description 
Corporate head office  
Corporate administrative office and Consumer Products 
head office 
Grain processing and Raw Material Sourcing and Supply 
head office 
Grain processing and distribution 
Vacant 
Sales office 
Grain processing, warehouse and distribution 
Warehouse 
Grain processing, warehouse and distribution 
Roasted snack processing, warehouse and distribution 
Grain storage 
Grain storage 
Sales and administrative office 
Sales and International Sourcing and Supply head office 

Breckenridge, Minnesota(2) 
Moorhead, Minnesota(2)(4) 
Moorhead, Minnesota(2) 
Crookston, Minnesota(2) 
Crookston, Minnesota(2) 
Grace City, North Dakota(2) 
Wahpeton, North Dakota(2) 
Blooming Prairie, Minnesota(2) 
Ellendale, Minnesota(2) 
Scotts Valley, California(2)(3) 
Amsterdam, The Netherlands(2) 
Middenmeer, The Netherlands(2)  Cocoa processing 
Cavaillon, France(2) 
Skye, Germany(2) 
Dalian, China(2) 
Dalian, China(2) 
Addis Ababa, Ethiopia(2) 
Humera, Ethiopia(2) 
Silistra, Bulgaria(2) 
Varna, Bulgaria(2) 
Kenema, Sierra Leone(2) 
Heuvelton, New York(2)(5) 
Cresco, Iowa(2) 
South Gate, California(3) 
Alexandria, Minnesota(3) 
Alexandria, Minnesota(3) 
Alexandria, Minnesota(3) 
Modesto, California(3) 
Modesto, California(3) 
Allentown, Pennsylvania(3) 
Allentown, Pennsylvania(3) 
Omak, Washington(3) 
Carson City, Nevada(3)(6) 
Rogers, Arkansas(3) 
St. David’s, Ontario(3) 
Edwardsville, Kansas(3) 
Oxnard, California(3) 
Oxnard, California(3) 
Santa Maria, California(3) 
Placentia, California(3) 
Jacona, Mexico(3) 

Sales office 
Sales office 
Storage 
Sales office  
Coffee processing, warehouse and staff housing 
Grain processing, warehouse, storage and office 
Grain processing 
Sales and administrative office 
Cocoa storage 
Vacant 
Grain milling  
Fruit ingredient processing, warehouse and distribution 
Aseptic beverage processing and packaging  
Ingredient processing 
Warehouse 
Aseptic beverage processing and packaging  
Warehouse 
Aseptic beverage processing and packaging  
Warehouse 
Fruit snack processing, warehouse and distribution 
Vacant 
Sales office 
Fruit snack processing, warehouse and distribution 
Frozen fruit processing, warehouse and distribution 
Frozen fruit processing, warehouse and distribution 
Frozen fruit processing, warehouse and distribution 
Frozen fruit processing, warehouse and distribution 
Sales and administration office 
Frozen fruit processing, warehouse and distribution 

Owned/ 
Leased 
Leased 
Leased 

Lease Expiry 
Date 
June 2021 
November 2022 

Owned 

August 2020 

November 2019 

February 2021 
October 2022 
December 2022 
July 2022 
November 2020 
November 2024 
December 2024 

Owned 
Owned 
Leased 
Owned 
Leased 
Owned 
Owned 
Owned 
Owned 
Leased 
Leased 
Leased 
Leased 
Leased 
Leased 
Leased 
Leased  March 2018 
Leased  May 2018 
Owned 
Leased 
Leased 
Owned 
Owned 
Leased 
Owned 
Owned 
Owned 
Leased  May 2019 
Leased  May 2024 
April 2027 
Leased 
Leased 
November 2025 
Leased  May 2027 
Leased 
Leased 
Leased 
Owned 
Owned 
Leased 
Leased 
Leased 
Owned 

December 2020 
July 2019 
December 2020 

December 2018 
December 2018 
January 2019 

July 2019 
August 2019 

June 2020 

Included in Corporate Services. 
Included in Global Ingredients. 
Included in Consumer Products. 

(1) 
(2) 
(3) 
(4)  Moorhead, Minnesota, grain handling facility was closed on August 31, 2017. 

SUNOPTA INC. 

32 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(5)  Heuvelton, New York, ingredient processing facility closed in January 2017. 
(6)  Carson City, Nevada, nutritional bar processing facility ceased production in December 2017. 

Executive Offices 

Our executive head office is located at 2233 Argentia Drive, Suite 401, Mississauga, Ontario.   

Item 3.  Legal Proceedings  

Employment Matter 

On April 19, 2013, a class-action complaint, in the case titled De Jesus, et al. v. Frozsun, Inc. d/b/a Frozsun Foods, was filed 
against Sunrise Growers, Inc. (then named Frozsun, Inc.) in California Superior Court, Santa Barbara County seeking damages, 
equitable relief and reasonable attorneys’ fees for alleged wage and hour violations.  This case includes claims for failure to 
pay all hours worked, failure to pay overtime wages, meal and rest period violations, waiting-time penalties, improper wage 
statements and unfair business practices. The putative class includes approximately 10,000 non-exempt hourly employees from 
Sunrise’s production facilities in Santa Maria and Oxnard, California. The parties attended mediation on October 12, 2017 and 
reached a general agreement to resolve the matter on a class-wide basis.  The parties are negotiating the remaining details of 
the  settlement  which  is  subject  to  court  approval.    It  is  anticipated  that  the  parties  will  seek  preliminary  approval  of  the 
settlement  from  the  court  in  March  2018.    The  Company  expects  to  recover  the  full  amount  payable  under  the  settlement 
through  insurance  coverage  and  an  escrow  account  established  in  connection  with  the  Company’s  acquisition  of  Sunrise 
Holdings (Delaware), Inc. in October 2015.  

Product Recall 

On November 20, 2017, Treehouse Foods, Inc., several of its related entities, and its insurer filed a lawsuit against the Company 
in  the  Circuit  Court  of  Cook  County,  Illinois  titled  Treehouse  Foods,  Inc.  et  al.  v.  SunOpta  Grains  and  Food,  Inc.      The 
Company was served with the Summons and Complaint on January 24, 2018.   The plaintiffs allege economic damages resulting 
from  the  Company’s  2016  voluntary  recall  of  certain  roasted  sunflower  kernel  products  due  to  the  potential  for  Listeria 
monocytogenes contamination.  The case includes claims for breach of express and implied warranty, negligence, strict liability, 
and  indemnity  seeking  $16.2  million  in  damages.    There  are  no  allegations  of  personal  injury.      The  Company  intends  to 
vigorously defend itself against these claims.  The Company cannot reasonably predict the outcome of this claim, nor can it 
estimate the amount of loss, or range of loss, if any, that may result from this claim. 

In addition to the above mentioned matters, from time to time, we are involved in litigation incident to the ordinary conduct of 
our business.  For a discussion of certain legal proceedings, see note 23 of the consolidated financial statements included at Item 
15 of this Form 10-K.  

Item 4.  Mine Safety Disclosures 

Not Applicable. 

SUNOPTA INC. 

33 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
PART II 

Item 5.     Market  for  Registrant’s  Common  Equity,  Related  Stockholder  Matters  and  Issuer  Purchases  Equity 

Securities 

Our common shares trade in U.S. dollars on The NASDAQ Global Select Market under the symbol “STKL”, and in Canadian 
dollars on the TSX under the symbol “SOY”.   

The following table indicates the high and low sales prices for our common shares for each quarterly period during the past 
two fiscal years on the NASDAQ and TSX.  The prices shown are representative inter-dealer prices, do not include retail mark-
ups, markdowns or commissions and do not necessarily reflect actual transactions. 

Fiscal 2017 
First quarter 
Second quarter 
Third quarter 
Fourth quarter 

Fiscal 2016 
First quarter 
Second quarter 
Third quarter 
Fourth quarter 

NASDAQ 

TSX 

High 
$ 

Low 
$ 

High 
C$ 

Low 
C$ 

7.60   
10.20   
10.20   
9.65   

6.77   
5.69   
7.17   
7.70   

6.00   
6.30   
8.00   
6.95   

4.12   
3.16   
4.22   
5.73   

10.08   
13.53   
13.23   
12.37   

9.88   
7.18   
9.39   
10.09   

8.05 
8.53 
9.94 
8.88 

5.38 
4.14 
5.47 
7.58 

As  at  December  30,  2017,  we  had  approximately  420  shareholders  of  record.    We  have  never  paid  cash  dividends  on  our 
common stock and do not anticipate paying dividends in the foreseeable future.  Our future dividend policy will depend on our 
earnings, capital requirements and financial condition, requirements of the financial agreements to which we are then a party 
and other factors considered relevant by our board of directors.  Additionally, the terms of our existing debt instruments include 
covenants that restrict our ability to pay dividends to shareholders. The receipt of cash dividends by U.S. shareholders from a 
Canadian corporation, such as we are, may be subject to Canadian withholding tax. 

SUNOPTA INC. 

34 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity Compensation Plan Information  

The following table provides information as at December 30, 2017 with respect to our common shares that may be issued under 
the Company’s stock incentive and employee share purchase plans:   

Number of 
Securities to be 
Issued Upon 
Exercise of 
Outstanding 
Options, Warrants, 
and Rights  
(a) 

Weighted-Average 
Exercise Price of 
Outstanding 
Options, Warrants 
and Rights  
(b) 

Number of Securities 
Remaining Available 
for Future Issuance 
Under Equity 
Compensation Plans 
(Excluding Securities 
Reflected in Column 
(a))  
(c) 

5,601,836   
-   

851,720   
6,453,556   

 $7.51(3)  
-   

 $7.00(3)  

$7.44   

3,674,298 
1,112,073 

- 
4,786,371 

Plan Category  

Equity compensation plans approved by 

securities holders: 

2013 Stock Incentive Plan(1) 
  Employee Share Purchase Plan 

Equity compensation plans not approved by 

securities holders: 
  CEO Plan(2) 

Total 

(1)  Represents  common  shares  of  the  Company  issuable  in  respect  of  3,306,728  stock  options,  775,356  restricted  stock  units  (“RSUs”)  and  1,519,752 

performance share units (“PSUs”) granted to selected employees and directors of the Company. 

(2)  Represents common shares of the Company issuable in respect of 473,940 performance-based stock options, 100,000 RSUs and 277,780 PSUs granted 

to the Chief Executive Officer of the Company. 

(3)  Vested RSUs and PSUs entitle the holder to receive one common share per unit without payment of additional consideration.  Accordingly, these units 

are disregarded for purposes of computing the weighted-average exercise price.  

SUNOPTA INC. 

35 

December 30, 2017 10-K 

 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Shareholder Return Performance Graph  

This  performance  graph  shall  not  be  deemed  “filed”  for  purposes  of  Section 18  of  the  Exchange  Act  or  incorporated  by 
reference into any filing of SunOpta under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be 
expressly set forth by specific reference in such filing.  

The following graph compares the five-year cumulative shareholder return on our common shares to the cumulative total return 
of the S&P/TSX Composite and the NASDAQ Industrial Indices for the period which commenced December 29, 2012.  

 250.00

 200.00

 150.00

 100.00

 50.00

 -

SunOpta Inc.

NASDAQ Industrial

S&P/TSX Composite

2012

2013

2014

2015

2016

2017

SunOpta Inc. 

Nasdaq Industrial Index 

S&P/TSX Composite Index 

2012 

2013 

2014 

2015 

2016 

100.00   

100.00   

100.00   

177.80   

143.14   

109.56   

210.48   

145.99   

117.69   

121.49   

158.02   

104.64   

125.22   

171.26   

122.95   

2017 

137.66 

212.45 

130.37 

Assumes that $100.00 was invested in our common shares and in each index on December 29, 2012.  

SUNOPTA INC. 

36 

December 30, 2017 10-K 

 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 6. Selected Financial Data 

The  following  information  has  been  derived  from  financial  statements  prepared  in  accordance  with  accounting  principles 
generally accepted in the United States of America (“U.S. GAAP”). The information set forth below is not necessarily indicative 
of results of future operations, and should be read in conjunction with the consolidated financial statements and related notes 
thereto  prepared  in  accordance  with  U.S.  GAAP  contained  in  Item  8  of  this  report,  as  well  as  the  discussion  in  Item  7, 
“Management’s Discussion and Analysis of Financial Condition and Results of Operations”. 

Revenues 
Earnings (loss) from continuing 
operations attributable to 

  SunOpta Inc. 
Basic earnings (loss) per share 
from continuing operations 
Diluted earnings (loss) per share 

from continuing operations 

Total assets 
Bank indebtedness 
Long-term debt (including current 

 portion) 

Long-term liabilities (including 

current portion) 

2017 
$ 

2016 
$ 

2015(1) 
$ 

2014 
$ 

2013(2) 
$ 

1,279,593   

1,346,731   

1,145,134   

1,102,745   

998,660 

 (135,320)(3)  

 (50,618)(4)  

(2,996)  

 19,295 (5)  

 (8,396)(6) 

(1.66)  

(0.61)  

(0.04)  

0.29   

(0.13) 

(1.66)  

982,173   
234,090   

(0.61)  

(0.04)  

1,129,558   
201,494   

1,219,203   
159,773   

0.28   

640,950   
78,454   

228,033   

231,087   

322,995   

4,581   

13,652   

20,854   

23,052   

1,086   

(0.13) 

705,935 
126,274 

6,139 

3,205 

(1)    Includes the results of operations of Sunrise Holdings (Delaware), Inc. (acquired October 9, 2015), Niagara Natural Fruit Snack Company Inc. (assets 

acquired August 11, 2015) and Citrusource, LLC (acquired March 2, 2015) from the respective dates of acquisition. 

(2)    Includes the results of operations of Organic Land Corporation OOD (acquired December 31, 2012) from the date of acquisition. 

(3) 

(4) 

Includes a goodwill impairment charge of $115.0 million related to the Healthy Fruit reporting unit of the Consumer Products operating segment, as well 
as a charge of $18.2 million for the impairment of long-lived assets associated with the exit from flexible resealable pouch and nutrition bar product lines 
and operations, and consolidation of roasted snack operations, as well as the closure of a juice processing facility located in San Bernardino, California. 

Includes a goodwill impairment charge of $17.5 million related to the Sunflower reporting unit of the Raw Material Sourcing and Supply operating 
segment, as well as a charge of $13.3 million for the impairment of long-lived assets associated with the closure of the San Bernardino juice facility and 
a soy extraction facility located in Heuvelton, New York. 

(5) 

Includes a charge for the impairment of investment of $8.4 million, as well as a gain on disposal on assets of $1.3 million. 

(6) 

Includes a charge for the impairment of investment of $21.5 million. 

SUNOPTA INC. 

37 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
 
 
 
  
  
  
 
 
 
  
  
  
 
 
 
  
  
  
 
 
 
 
 Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 

Forward-Looking Financial Information  

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) section provides 
analysis of our operations and financial position for the fiscal year ended December 30, 2017 and includes information available 
to February 28, 2018, unless otherwise indicated herein.  It is supplementary information and should be read in conjunction 
with the consolidated financial statements included elsewhere in this report.  

Certain  statements  contained  in  this  MD&A  may  constitute  forward-looking  statements  as  defined  under  securities  laws.  
Forward-looking  statements  may  relate  to  our  future  outlook  and  anticipated  events  or  results  and  may  include  statements 
regarding our future financial position, business strategy, budgets, litigation, projected costs, capital expenditures, financial 
results, taxes, plans and objectives.  In some cases, forward-looking statements can be identified by terms such as “anticipate”, 
“estimate”, “target”, “intend”, “project”, “potential”, “continue”, “believe”, “expect”, “could”, “would”, “should”, “might”, 
“plan”, “will”, “may”, “predict”, or other similar expressions concerning matters that are not historical facts. To the extent any 
forward-looking  statements  contain  future-oriented  financial  information  or  financial  outlooks,  such  information  is  being 
provided  to  enable  a  reader  to  assess  our  financial  condition,  material  changes  in  our  financial  condition,  our  results  of 
operations, and our liquidity and capital resources.  Readers are cautioned that this information may not be appropriate for any 
other purpose, including investment decisions.   

Forward-looking statements contained in this MD&A are based on certain factors and assumptions regarding expected growth, 
results  of  operations,  performance,  and  business  prospects  and  opportunities.    While  we  consider  these  assumptions  to  be 
reasonable, based on information currently available, they may prove to be incorrect.  Forward-looking statements are also 
subject to certain factors, including risks and uncertainties that could cause actual results to differ materially from what we 
currently expect.  These factors are more fully described in the “Risk Factors” section at Item 1A of this Form 10-K. 

Forward-looking statements contained in this commentary are based on our current estimates, expectations and projections, 
which we believe are reasonable as of the current date.  You should not place undue importance on forward-looking statements 
and should not rely upon this information as of any other date.  Other than as required under securities laws, we do not undertake 
to update any forward-looking information at any particular time. 

Unless otherwise noted herein, all currency amounts in this MD&A are expressed in U.S. dollars.  All tabular dollar amounts 
are expressed in thousands of U.S. dollars, except per share amounts. 

Overview 

The composition of our reportable segments is as follows:  

(cid:120)  Global Ingredients aggregates our North American-based Raw Material Sourcing and Supply and  European-based 
International Sourcing and Supply operating segments focused on the procurement and sale of specialty and organic 
grains and seeds, raw material ingredients, value-added grain- and cocoa-based ingredients, and organic commodities. 

(cid:120)  Consumer  Products  consists  of  three  main  commercial  platforms:  Healthy  Beverages,  Healthy  Fruit  and  Healthy 
Snacks.    Healthy  Beverages  includes  aseptic  packaged  products  including  non-dairy  beverages,  broths  and  teas; 
refrigerated premium juices; and shelf-stable juices and functional waters.  Healthy Fruit includes individually quick 
frozen (“IQF”) fruits for retail; IQF and bulk frozen fruit for foodservice; and custom fruit preparations for industrial 
use.  Healthy Snacks is focused on fruit snack offerings, and  formerly included our flexible resealable pouch and 
nutrition bar product lines, which we exited in 2017. 

For a more detailed description of our operating groups and their businesses, please see the “Business” section at Item 1 of this 
Form 10-K. 

Fiscal Year 

We operate on a fiscal calendar that results in a given fiscal year consisting of a 52- or 53-week period ending on the Saturday 
closest to December 31.  Fiscal years 2017, 2016 and 2015 were each 52-week periods ending on December 30, 2017, December 
31, 2016, and January 2, 2016, respectively.        

SUNOPTA INC. 

38 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value Creation Plan 

On October 7, 2016, we entered into a strategic partnership with Oaktree Capital Management L.P., a private equity investor 
(together  with  its  affiliates,  “Oaktree”).    On  October  7,  2016,  Oaktree  invested  $85.0  million  through  the  purchase  of 
cumulative, non-participating Series A Preferred Stock (the “Preferred Stock”) of our wholly-owned subsidiary, SunOpta Foods 
Inc. (“SunOpta Foods”).   

Following  the  strategic  partnership,  with  the  assistance  of  Oaktree,  we  conducted  a  thorough  review  of  our  operations, 
management and governance, with the objective of maximizing our ability to deliver long-term value to our shareholders.  As 
a product of this review our management and the Board of Directors developed a Value Creation Plan built on four pillars: 
portfolio optimization, operational excellence, go-to-market effectiveness and process sustainability.  The Value Creation Plan 
is a broad-based initiative focused on increasing shareholder value through strategic investments made to the people and assets 
of the Company to deliver sustained profitable growth.  We expect the Value Creation Plan to be implemented in phases, and 
span several years. 

During 2017 and 2016, costs incurred in connection with measures taken under the Value Creation Plan included inventory 
and long-lived asset impairment charges and  facility closure  costs primarily related to the  closures of our San Bernardino, 
California, juice and Heuvelton, New York, soy extraction facilities; the exits from flexible resealable pouch and nutrition bar 
product lines and operations; and consolidations of our grain handling and roasted snack operations.  In addition, we incurred 
employee recruitment,  relocation, retention and severance  costs related to exit activities and organizational changes  within 
management and executive teams, and recruiting efforts in the areas of quality, sales, marketing, operations and engineering.  
We also incurred third-party legal advisory, consulting and temporary labor costs in support of the Value Creation Plan. 

The following table summarizes costs incurred since the inception of the Value Creation Plan to December 30, 2017: 

Fiscal 2016 
Costs incurred and charged to expense 
Cash payments 
Non-cash adjustments 
  Balance payable, December 31, 2016 

Fiscal 2017 
Costs incurred and charged to expense 
Cash payments, net of proceeds on disposal of assets 
Non-cash adjustments 
  Balance payable (receivable), December 30, 2017(1) 

Asset 
impairments 
and facility 
closure costs 
$ 

Employee  
recruitment, 
retention and 
termination 
costs 
$ 

11,522 
- 
(11,522) 
 - 

21,766 
(10,746) 
(11,720) 
 (700) 

2,763 
(694) 
(266) 
1,803 

11,618 
(9,683) 
689 
4,427 

Consulting 
fees and 
temporary 
labor costs 
$ 

4,041 
(2,384) 
- 
1,657 

16,528 
(18,185) 
- 
- 

Total 
$ 

18,326 
(3,078) 
(11,788) 
3,460 

49,912 
(38,614) 
(11,031) 
3,727 

(1)  Balance receivable under asset impairments and facility closure costs represents remaining proceeds on the sale of nutrition bar equipment received 

at closing on January 3, 2018.  Total proceeds were $0.9 million. 

In addition to the costs reflected in the preceding table, we made capital investments at several of our manufacturing facilities 
to enhance food safety and production efficiency.   

SUNOPTA INC. 

39 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Costs incurred and charged to expense for the years ended December 30, 2017 and December 31, 2016 were recorded in the 
consolidated statement of operations as follows: 

Cost of goods sold(1) 
Selling, general and administrative expenses(2) 
Other expense(3) 

December 30, 
2017 
$ 
3,189 
22,894 
23,829 
49,912 

December 31, 
2016 
$ 
- 
4,041 
14,285 
18,326 

(1)  Inventory write-downs and facility closure costs recorded in cost of goods sold were allocated to the Consumer Products operating segment. 
(2)  Consulting fees and temporary labor costs, and employee recruitment, relocation and retention costs recorded in selling, general and administrative 

expenses were allocated to Corporate Services. 

(3)  For the year ended December 30, 2017, asset impairment and employee termination costs recorded in other expense were allocated as follows:  Raw 
Material Sourcing and Supply operating segment - $2.1 million; Consumer Products operating segment - $20.6 million; and Corporate Services - 
$1.1 million.  For the year ended December 31, 2016, asset impairment and employee termination costs recorded in other expense were allocated as 
follows:  Raw Material Sourcing and Supply operating segment - $1.6 million; Consumer Products operating segment - $10.6 million; and Corporate 
Services - $2.1 million. 

We  do not expect to incur and expense significant additional direct costs related to the Value Creation Plan beyond  2017; 
however, we will continue to incur annual lease costs of approximately $0.5 million related to our nutrition bar processing 
facility, until such time that we can locate an interested party to assume the lease.  This lease extends until December 2020.  
Our expectation for additional costs related to the Value Creation Plan does not include currently unforeseen asset impairment 
charges or employee-related costs that may arise from future actions taken under the plan.   

For more information regarding the Value Creation Plan, see note 4 to the consolidated financial statements at Item 15 of this 
Form 10-K. 

Recall of Certain Roasted Sunflower Kernel Products 

During  the  second  quarter  of  2016,  we  announced  a  voluntary  recall  of  certain  roasted  sunflower  kernel  products  due  to 
potential contamination with Listeria monocytogenes bacteria.  Estimated losses related to the recall totaled $47.5 million as at 
December 30, 2017, compared with $40.0 million as at December 31, 2016, comprised of estimates for customer losses and 
direct incremental costs that we incurred.  Our estimates for customer losses are provisional and were determined based on an 
assessment  of  the  information  available  up  to  the  date  of  filing  of  this  Form  10-K,  including  a  review  of  customer  claims 
received as of that date and consideration of the extent of potential additional claims that have yet to be received.  We have 
general liability and product recall insurance policies with aggregate limits of $47.0 million under which we expect to recover 
recall-related costs.  As at December 30, 2017, we had recognized recoveries up to the limit of the coverage available under 
our insurance policies.  Consequently, to the extent any losses or out-of-pocket costs are excluded under the insurance policies 
or additional losses are recognized related to existing or new claims, these excluded or excess losses or costs will be recognized 
as a charge to future earnings.  As at December 30, 2017, we had settled customer claims and direct costs in the amount of 
$40.5 million, which settlements were fully funded under our general liability and product recall insurance policies. 

For more information regarding the recall, see note 6 to the consolidated financial statements at Item 15 of this Form 10-K. 

Business Development 

Our significant business development activities include: 

(cid:120)  On  April  6,  2016,  we  completed  the  sale  of  our  66%  holding  of  common  shares  of  Opta  Minerals  Inc.  (“Opta 
Minerals”).  The sale of Opta Minerals was consistent with our objective of divesting our non-core assets in order to 
become a pure-play organic and healthy foods company.  We have no continuing involvement with Opta Minerals.   

For more information regarding the sale of Opta Minerals, see note 5 to the consolidated financial statements at Item 15 of this 
Form 10-K. 

(cid:120)  On October 9, 2015, we acquired 100% of the issued and outstanding common shares of Sunrise Holding (Delaware), 
Inc. (“Sunrise”), for total consideration of $472.7 million in cash (the “Sunrise Acquisition”).  Sunrise is a processor 

SUNOPTA INC. 

40 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
 
 
 
 
 
 
 
 
of conventional and organic frozen fruit in the U.S. and Mexico.  The acquisition of Sunrise was aligned with our 
strategic focus on organic and healthy foods.   

(cid:120)  On August 11, 2015, we acquired the net operating assets of Niagara Natural Fruit Snack Company Inc. (“Niagara 
Natural”), for a cash purchase price of $6.5 million, plus contingent consideration of $2.3 million.  Niagara Natural is 
a manufacturer of all-natural fruit snacks, and is located in the Niagara Region of Ontario. 

(cid:120)  On  March  2,  2015,  we  acquired  Citrusource,  LLC  (“Citrusource”),  a  producer  of  premium  not-from-concentrate 
private label organic and conventional orange juice and citrus products in the U.S., for $13.3 million in cash, plus 
contingent consideration of $18.4 million.  

Sunrise,  Niagara  Natural  and  Citrusource  have  been  included  in  the  Consumer  Products  operating  segment  since  their 
respective  dates  of  acquisition.  For  more  information  regarding  these  acquisitions,  see  note  2  to  the  consolidated  financial 
statements at Item 15 of this Form 10-K.    

Critical Accounting Estimates 

The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and 
assumptions that affect the reported amounts of assets and liabilities, related revenues and expenses, and disclosure of gain and 
loss  contingencies  at  the  date  of  the  financial  statements.    The  estimates  and  assumptions  made  require  us  to  exercise  our 
judgment  and  are  based  on  historical  experience  and  various  other  factors  that  we  believe  to  be  reasonable  under  the 
circumstances.  We continually evaluate the information that forms the basis of our estimates and assumptions as our business 
and the business environment generally changes.  The use of estimates is pervasive throughout our financial statements.  The 
following are the accounting estimates which we believe to be most significant to our business. 

Revenue Recognition  

We recognize revenue at the time of delivery of the product and when all of the following have occurred:  a sales agreement is 
in place; the price is fixed or determinable; and collection is reasonably assured.  Consideration given to customers such as 
value incentives, rebates, early payment discounts and other discounts are recorded as reductions to revenues at the time of 
sale. 

Accounts Receivable  

Our accounts receivable primarily includes amounts due from our customers.  The carrying value of each account is carefully 
monitored  with a view to assessing the likelihood of collection.  An allowance for doubtful accounts is provided for as an 
estimate of losses that could result from customers defaulting on their obligation to us.  In assessing the amount of reserve 
required, a number of factors are considered including the age of the account, the credit-worthiness of the customer, payment 
terms, the customer’s historical payment history and general economic conditions.  Because the amount of the reserve is an 
estimate, the actual amount collected could differ from the carrying value of the amount receivable.  Note 8 of the consolidated 
financial statements at Item 15 of this Form 10-K provides an analysis of the changes in the allowance for doubtful accounts.   

Inventory  

Inventory is our largest current asset and consists primarily of raw materials and finished goods held for sale.  Inventories are 
valued at the lower of cost and estimated net realizable value except for certain grain inventories that are carried at market 
value.  In order to determine the value of inventory at the balance sheet date, we evaluate a number of factors to determine the 
adequacy of provisions for inventory.  These factors include the age of inventory, the amount of inventory held by type, future 
demand for products, and the expected future selling price we expect to realize by selling the inventory.  Our estimates are 
judgmental in nature and are made at a point in time, using available information, expected business plans, and expected market 
conditions.  As a result, the actual amount received on sale could differ from our estimated value of inventory.  We perform a 
review of our inventory by operation and product line on a quarterly basis.  Note 9 of the consolidated financial statements at 
Item 15 of this Form 10-K provides an analysis of the movements in the inventory reserve.  

Intangible Assets 

We  evaluate  amortizable  intangible  assets  acquired  through  business  combinations  for  impairment  if  events  or  changes  in 
circumstances  indicate  that  the  carrying  amounts  of  these  assets  may  not  be  recoverable.  Our  evaluation  is  based  on  an 
assessment of potential indicators of impairment, such as an adverse change in the business climate that could affect the value 

SUNOPTA INC. 

41 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
of an asset, such as the loss of a significant customer; current or forecasted operating or cash flow losses that demonstrate 
continuing losses associated with the use of an asset, such as the introduction of a competing product that results in a significant 
loss of market share; and a current expectation that, more likely than not, an intangible asset will be disposed of before the end 
of its previously estimated useful life, such as a plan to exit a product line or business in the near term.  

Impairment exists when the carrying amount of an amortizable intangible asset is not recoverable through undiscounted future 
cash flows and its carrying value exceeds its estimated fair value. A discounted cash flow analysis is typically used to determine 
fair  value  using  estimates  and  assumptions  that  market  participants  would  apply.  Some  of  the  estimates  and  assumptions 
inherent in a discounted cash flow model include the amount and timing of the projected future cash flows, and the discount 
rate used to reflect the risks inherent in the future cash flows. A change in any of these estimates and assumptions could produce 
a different fair value, which could have a material impact on our results of operations. In addition, an intangible asset's expected 
useful life can increase estimation risk, as longer-lived assets necessarily require longer-term cash flow forecasts, which for 
some of our long-lived assets can be in excess of 20 years. In connection with an impairment evaluation, we also reassess the 
remaining useful life of the intangible asset and modify it, as appropriate. 

Goodwill 

Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable 
net assets acquired.  Goodwill is not amortized but is instead tested for impairment at least annually, or whenever events or 
circumstances  change  between  the  annual  impairment  tests  that  would  indicate  the  carrying  amount  of  goodwill  may  be 
impaired.  We perform the annual test for goodwill impairment in the fourth quarter of each fiscal year.  Prior to fiscal 2017, 
we  performed  a  quantitative  test  for  goodwill  impairment  by  comparing  the  carrying  amount  of  each  reporting  unit  to  its 
estimated fair value (Step 1).  If the carrying amount exceeded the reporting unit’s fair value, there was a potential impairment 
of goodwill.  Any impairment of goodwill was measured by comparing the implied fair value of goodwill with its carrying 
amount (Step 2).  The implied fair value of goodwill was determined by deducting the fair value of all the assets and liabilities 
of the reporting unit from the reporting unit’s fair value as determined in Step 1.   

Effective with the fiscal 2017 annual impairment test, we elected the early adoption of Accounting Standards Update 2017-04, 
“Simplifying the Test for Goodwill Impairment”, which simplifies the accounting for goodwill impairment by eliminating the 
requirement to calculate the implied fair value of goodwill as contemplated by Step 2 of the prior goodwill impairment model.  
Instead, impairment charges are recognized based on the excess of a reporting unit’s carrying amount over its fair value as 
contemplated by Step 1 of the prior goodwill impairment test model.   

Goodwill is tested for impairment at the reporting unit level, which is defined as an operating segment or one level below.  Our 
Raw  Material  Sourcing  and  Supply  operating  segment  comprises  two  reporting  units,  namely  Grains  and  Sunflower.    Our 
International Sourcing and Supply operating segment consists of one reporting unit.  Our Consumer Products operating segment 
comprises three reporting units based on commercial platforms, namely Healthy Beverages, Healthy Fruit and Healthy Snacks. 

The fair values of our reporting units are determined using an income approach (discounted cash flow method).  We believe an 
income approach provides the most reliable indication of fair value as it reflects forecasted revenues and earnings based on 
business  and  market  conditions  that  are  unique  to  each  individual  reporting  unit,  which  a  market  approach  may  not  fully 
incorporate.  Because the business is assumed to continue in perpetuity, the discounted cash flows include a terminal value.  
Cash flows to perpetuity are forecasted based on projected revenue growth and our planned business strategies in future periods.  
Examples of planned strategies would include a plant or line expansion at an existing facility; a reduction of working capital at 
a specific location; and price increases or cost reductions within a reporting unit.  The discount rate is based on a reporting 
unit’s targeted weighted-average cost of capital, which is not necessarily the same as our weighted-average cost of capital.  
These assumptions are subject to change and are impacted by our ability to achieve our forecasts and by economic conditions 
that may impact future results and result in projections not being attained.  Each year we re-evaluate the assumptions used to 
reflect changes in the business environment.  

Based on the results of the annual impairment test performed for the years ended December 30, 2017 and December 31, 2016, 
we recognized goodwill impairment charges of $115.0 million and $17.5 million, respectively, related to our Healthy Fruit 
reporting unit in 2017 and our Sunflower reporting unit in 2016.  None of the goodwill balances of our other reporting units 
were considered to be at risk of impairment, as the fair value of those reporting units substantially exceeded their carrying 
values – that is, a hypothetical 10% decrease in the fair value of any of our other reporting units would not have triggered a 
goodwill impairment.  The results of our annual impairment tests for goodwill are described in note 11 of the consolidated 
financial statements at Item 15 of this Form 10-K. 

SUNOPTA INC. 

42 

December 30, 2017 10-K 

 
 
 
 
 
 
 
  
 
 
Acquisitions 

Business acquisitions are accounted for by the acquisition method of accounting.  Under this method, the purchase price is 
allocated to the assets acquired and the liabilities assumed based on the fair value at the time of the acquisition.  Any excess 
purchase price over the fair value of identifiable assets acquired and liabilities assumed is recorded as goodwill.  We believe 
the fair values assigned to the assets acquired and liabilities assumed are based on reasonable assumptions; however, these 
assumptions may be incomplete or inaccurate, and unanticipated events and circumstances may occur.   

The assumptions and estimates with respect to determining the fair value of customer relationship intangible assets acquired 
are  among  the  most  significant  in  our  acquisition  accounting  and  generally  require  the  most  judgment.    Key  variables  in 
determining the fair value of customer relationships are the estimated customer attrition rate and the percentage of revenue 
growth attributable to existing customers.  Changes to either or both of these variables could have a significant impact on the 
customer relationships intangible assets’ values, and changes to the estimated customer attrition rate could have a significant 
impact on the estimated useful lives of these assets.  The expected customer attrition rate assumed in the estimate of fair value 
for  the  customer  relationships  intangible  assets  is  generally  supported  by  an  analysis  of  historical  attrition  of  the  acquired 
business’s customers and consideration of its amortization policy of previously acquired customer relationships, amortization 
policies  adopted  for  acquired  customer  relationships  by  other  companies  in  similar  transactions,  and  the  contractual  terms 
between the acquired business and its customers.  The percentage of revenue growth attributable to existing customers assumed 
in the estimate of fair value for the customer relationships intangible assets is typically supported by an analysis of the acquired 
business’s historical and forecasted revenue growth rates by customer.  Changes in any of the assumptions or estimates used 
in determining the fair value  of the customer relationship intangible assets could have a significant impact on the amounts 
assigned to goodwill in the purchase price allocation.  Future net earnings can be affected by changes in these estimates resulting 
in  an  increase  or  decrease  in  amortization  expense,  or  impairment  of  the  intangible  assets  and/or  goodwill.    Note  2  of  the 
consolidated financial statements at Item 15 of this Form 10-K provide information with respect to businesses acquired, and 
note 11 outlines annual amortization expense relating to these intangibles.  

Some acquisitions involve contingent consideration to be potentially paid based on the achievement of specified future financial 
targets by the acquired business.  Acquisition-related contingent consideration is initially recognized as a liability at estimated 
fair  value  and  re-measured  each  reporting  period  with  changes  in  the  estimated  fair  value  recognized  in  earnings.    These 
estimates of fair value involve uncertainties as they include assumptions about the likelihood of achieving the specified financial 
targets, projections of future financial performance, and assumed discount rates.  A change in any of these assumptions could 
produce a different fair value, which could impact the amounts assigned to assets and liabilities in the purchase price allocation, 
or  the  amounts  recognized  in  earnings  to  reflect  subsequent  changes  in  the  carrying  value  of  the  liability.      Note  7  of  the 
consolidated  financial  statements  at  Item  15  of  this  Form  10-K  includes  disclosures  regarding  the  estimated  fair  value  of 
contingent consideration. 

Contingencies  

We make estimates for payments that are contingent on the outcome of uncertain future events.  These contingencies include 
accrued but unpaid bonuses; tax-related matters; and claims or litigation.  In establishing our estimates, we consider historical 
experience with similar contingencies and the progress of each contingency, as well as the recommendations of internal and 
external advisors and legal counsel.  We re-evaluate all contingencies as additional information becomes available; however, 
given the inherent uncertainties, the ultimate amount paid could differ from our estimates.   

In particular, as discussed above under “Recall of Certain Roasted Sunflower Kernel Products”, we had recognized estimated 
losses of $47.5 million related to this recall as at December 30, 2017.  These estimates are provisional and were determined 
based on an assessment of the information available up to the date of filing of this report, including a review of customer claims 
received as of that date and consideration of the extent of potential additional claims that have yet to be received.  We may 
need to revise these estimates to be materially larger as  we continue to work with our customers to substantiate the claims 
received to date and any additional claims that may be received.  

Income Taxes  

We are liable for income taxes in the U.S., Canada, and other jurisdictions where we operate.  Our effective tax rate differs 
from the statutory tax rate and will vary from year to year primarily as a result of numerous permanent differences, investment 
and other tax credits, the provision for income taxes at different rates in foreign and other provincial jurisdictions, enacted 
statutory tax rate increases or reductions in the year, the benefit of cross-jurisdictional financing structures, changes due to 
foreign exchange, changes in valuation allowance based on our recoverability assessments of deferred tax assets, and favorable 
or unfavorable resolution of various tax examinations. 

SUNOPTA INC. 

43 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
In making an estimate of our income tax liability, we first assess which items of income and expense are taxable in a particular 
jurisdiction.  This process involves a determination of the amount of taxes currently payable as well as the assessment of the 
effect  of  temporary  timing  differences  resulting  from  different  treatment  of  items  for  accounting  and  tax  purposes.    These 
differences in the timing of the recognition of income or the deductibility of expenses result in deferred income tax balances 
that are recorded as assets or liabilities as the case may be on our balance sheet.  We also estimate the amount of valuation 
allowance to maintain relating to loss carry forwards and other balances that can be used to reduce future taxes payable.  This 
judgment is based on forecasted results in the jurisdiction and certain tax planning strategies and as a result actual results may 
differ from forecasts.  We assess the likelihood of the ultimate realization of these tax assets by looking at the relative size of 
the tax assets in relation to the profitability of the businesses and the jurisdiction to which they can be applied, the number of 
years  based  on  management’s  estimate  it  will  take  to  use  the  tax  assets  and  any  other  special  circumstances.    If  different 
judgments had been used, our income tax liability could have been different from the amount recorded.  In addition, the taxing 
authorities  of  those  jurisdictions  upon  audit  may  not  agree  with  our  assessment.    Note  19  of  the  consolidated  financial 
statements at Item 15 of this Form 10-K provides an analysis of the changes in the valuation allowance and the components of 
our deferred tax assets. 

While we believe we have adequately provided for all tax positions, amounts asserted by taxing authorities could differ from 
our accrued position.  Accordingly, additional provisions on federal, provincial, state and foreign tax-related matters could be 
recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved. 

Consolidated Results of Operations for Fiscal Years 2017 and 2016 

Revenues 
  Global Ingredients 
  Consumer Products 
Total revenues 

Gross Profit 
  Global Ingredients 
  Consumer Products 
Total gross profit 

Segment operating income (loss)(1) 
  Global Ingredients 
  Consumer Products 
  Corporate Services 
Total segment operating income 

Other expense, net 
Goodwill impairment 
Loss from continuing operations before the following 
Interest expense, net 
Recovery of income taxes 
Loss from continuing operations(2),(3) 
Earnings attributable to non-controlling interests 
Loss from discontinued operations attributable to 
  SunOpta Inc. 

December 30, 
2017 
$ 

December 31, 
2016 
$ 

550,527 
729,066 
1,279,593 

574,295 
772,436 
1,346,731 

67,682 
77,405 
145,087 

64,374 
61,578 
125,952 

21,951 
9,905 
(31,089) 
767 

23,660 
115,000 
(137,893) 
32,504 
(35,829) 
(134,568) 
752 

26,787 
1,206 
(13,247) 
14,746 

28,292 
17,540 
(31,086) 
43,275 
(23,797) 
(50,564) 
54 

Change 
$ 

(23,768) 
(43,370) 
(67,138) 

3,308 
15,827 
19,135 

(4,836) 
8,699 
(17,842) 
(13,979) 

(4,632) 
97,460 
(106,807) 
(10,771) 
(12,032) 
(84,004) 
698 

Change 
% 

-4.1% 
-5.6% 
-5.0% 

5.1% 
25.7% 
15.2% 

-18.1% 
721.3% 
-134.7% 
-94.8% 

-16.4% 
655.6% 
-343.6% 
-24.9% 
-50.6% 
-166.1% 
1292.6% 

- 

(570) 

570 

100.0% 

Loss attributable to SunOpta Inc.(4) 

(135,320) 

(51,188) 

(84,132) 

-164.4% 

(1)  When assessing the financial performance of our operating segments, we use an internal measure of operating income that excludes other income/expense 
items and goodwill impairments determined in accordance with U.S. GAAP.   This measure is the basis on which management, including the Chief 
Executive Officer (“CEO”), assesses the underlying performance of our operating segments.  

SUNOPTA INC. 

44 

December 30, 2017 10-K 

 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We believe that disclosing this non-GAAP measure assists investors in comparing financial performance across reporting periods on a consistent basis 
by excluding items that are not indicative of our operating performance.  However, the non-GAAP measure of operating income should not be considered 
in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP.  The following table presents a reconciliation of 
segment operating income/loss to loss from continuing operations before the following, which we consider to be the most directly comparable U.S. 
GAAP financial measure. 

December 30, 2017 
Segment operating income (loss) 
Other expense, net 
Goodwill impairment 
Earnings (loss) from continuing operations before the following 

December 31, 2016 
Segment operating income (loss) 
Other expense, net 
Goodwill impairment 
Earnings (loss) from continuing operations before the following 

Global 
Ingredients 
$ 

21,951 
(2,311) 
- 
19,640 

26,787 
(1,753) 
(17,540) 
7,494 

Consumer 
Products 
$ 

9,905 
(21,093) 
(115,000) 
(126,188) 

1,206 
(25,705) 
- 
(24,499) 

Corporate 
Services 
$ 

(31,089) 
(256) 
- 
(31,345) 

(13,247) 
(834) 
- 
(14,081) 

Consolidated 
$ 

767 
(23,660) 
(115,000) 
(137,893) 

14,746 
(28,292) 
(17,540) 
(31,086) 

We  believe  that  investors’  understanding  of  our  financial  performance  is  enhanced  by  disclosing  the  specific  items  that  we  exclude  from  segment 
operating income. However, any measure of operating income excluding any or all of these items is not, and should not be viewed as, a substitute for 
operating income prepared under U.S. GAAP. These items are presented solely to allow investors to more fully understand how we assess financial 
performance.  

(2)  When  assessing  our  financial  performance,  we  use  an  internal  measure  of  earnings  from  continuing  operations,  net  of  non-controlling  interests, 
determined in accordance with U.S. GAAP that includes dividends and accretion on convertible preferred stock and excludes specific items recognized 
in other income/expense, impairment losses on goodwill, long-lived assets and investments, other unusual items that are identified and evaluated on an 
individual basis, which due to their nature or size, we would not expect to occur as part of our normal business on a regular basis.  We believe that the 
identification of these excluded items enhances an analysis of our financial performance of our business when comparing those operating results between 
periods, as we do not consider these items to be reflective of normal business operations.   

The following table presents a reconciliation of adjusted earnings/loss from loss from continuing operations, which we consider to be the most directly 
comparable U.S. GAAP financial measure.  In addition, in recognition of our exit from flexible resealable pouch and nutrition bar product lines and 
operations (as described above under “Value Creation Plan”), we have prepared this table in a columnar format to present the effect of these operations 
on our consolidated results for the current and comparative period.  We believe this presentation assists investors in assessing the results of the operations 
we have exited and the effect of those operations on our financial performance. 

SUNOPTA INC. 

45 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the years ended 
December 30, 2017 
Loss from continuing operations 
Less: earnings attributable to non-controlling interests 
Less: dividends and accretion of Series A Preferred Stock 
Loss from continuing operations available to common 

Excluding flexible 
resealable pouch  
and nutrition bar 
Per Diluted 
Share 
$ 

$ 

Flexible  
resealable pouch   
and nutrition bar 
Per Diluted 
Share 
$ 

$ 

Consolidated 
Per Diluted 
Share 
$ 

$ 

(119,707)  
(752)  
(7,809)  

(14,861)  
-   
-   

(134,568)  
(752)  
(7,809)  

shareholders 

(128,268) 

(1.49) 

(14,861) 

(0.17) 

(143,129) 

(1.66) 

Adjusted for: 
  Goodwill impairment(a) 

Costs related to the Value Creation Plan(b) 
Product withdrawal and recall costs(c) 
Recovery of legal settlement(d) 
Reversal of stock-based compensation(e) 

  Other(f) 
  Net income tax effect(g) 

Change in unrecognized tax benefits(h) 
Impact of change in enacted U.S. corporate tax rates(i) 

115,000   
32,160   
1,142   
(1,024)  
(546)  
442   
(18,332)  
(452)  
(8,437)  

-   
17,752   
-   
-   
-   
-   
(6,923)  
-   
-   

115,000   
49,912   
1,142   
(1,024)  
(546)  
442   
(25,255)  
(452)  
(8,437)  

Adjusted loss 

(8,315) 

(0.10) 

(4,032) 

(0.05) 

(12,347) 

(0.14) 

December 31, 2016 
Loss from continuing operations 
Less: earnings attributable to non-controlling interests 
Less: dividends and accretion of Series A Preferred Stock 
Loss from continuing operations available to common  

shareholders 

Adjusted for: 

(49,288)  
(54)  
(1,812)  

(1,276)  
-   
-   

(50,564)  
(54)  
(1,812)  

(51,154) 

(0.60) 

(1,276) 

(0.01) 

(52,430) 

(0.61) 

Costs related to business acquisitions(j) 
Costs related to the Value Creation Plan(k) 

  Goodwill impairment(l) 

Legal settlement and litigation-related legal fees(m) 
Product withdrawal and recall costs(n) 
Inventory reserves and liquidation sales to de-risk positions(o) 
Plant start-up costs(p) 

  Write-off of debt issuance costs(q) 
  Other(r) 
  Gain on settlement of contingent consideration(s) 
  Net income tax effect(g) 

Change in unrecognized tax benefits(h) 

Adjusted earnings (loss) 

27,802   
18,326   
17,540   
10,850   
5,693   
3,428   
1,565   
215   
1,642   
(1,715)  
(25,825)  
(1,268)  
7,099 

-   
-   
-   
-   
-   
-   
-   
-   
-   
-   
-   
-   
(1,276) 

27,802   
18,326   
17,540   
10,850   
5,693   
3,428   
1,565   
215   
1,642   
(1,715)  
(25,825)  
(1,268)  
5,823 

(0.01) 

0.08 

0.07 

(a)  Reflects the impairment of goodwill associated with the Healthy Fruit reporting unit of the Consumer Products operating segment.   
(b)  Reflects inventory write-downs and facility closure costs of $3.2 million recorded in cost of goods sold; consulting fees, temporary labor, 
employee recruitment, relocation and retention costs, and bad debt reserves of $22.9 million recorded in selling, general and administrative 
(“SG&A”) expenses; and asset impairment charges and employee termination costs of $23.8 million recorded in other expense (as described 
above under “Value Creation Plan”). 

(c)  Reflects costs related to the recall of certain sunflower kernel products, including a $0.7 million adjustment for the estimated lost gross profit 
in the first quarter of 2017 caused by the sunflower recall, which reflected a shortfall in revenues against prior year volumes of approximately 
$3.3 million, less associated cost of goods sold of approximately $2.6 million; and $0.4 million of product withdrawal costs not eligible for 
reimbursement under our insurance policies, which were recorded in other expense. 

(d)  Reflects a recovery  on the early  extinguishment of a rebate obligation that arose from the prior settlement of  a flexible  resealable pouch 

product recall dispute with a customer (see (m) below), which was recorded in other income. 

(e)  Reflects the reversal to SG&A expenses of previously recognized stock-based compensation related to performance share units granted to 

certain employees as the performance conditions were not achieved. 

(f)  Other included fair value adjustments related to contingent consideration arrangements; severance costs unrelated to the Value Creation Plan; 

and gain/loss on the sale of assets, which were recorded in other expense. 

(g)  Reflects the tax effect of the preceding adjustments to earnings and reflects an overall estimated annual effective tax rate of approximately 

30% on adjusted earnings before tax.  

SUNOPTA INC. 

46 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(h)  Reflects the realization of previously unrecognized tax benefits, due to the expiration of the statute of limitations. 
(i)  Reflects the remeasurement of deferred tax balances to reflect new U.S. corporate tax rates enacted in December 2017. 
(j)  Reflects costs related to the Sunrise Acquisition, including an acquisition accounting adjustment related to Sunrise’s inventory sold during 
the year of $15.0 million, which was recorded in cost of goods sold; the amortization and expense of debt issuance costs incurred in connection 
with the initial financing related to the Sunrise Acquisition of $10.4 million, which were recorded in interest expense; and  $2.4 million of 
integration costs related to the closure and consolidation of our frozen fruit processing facilities following the Sunrise Acquisition, which 
were recorded in cost of goods sold and other expense. 

(k)  Reflects legal and other professional advisory costs associated with the strategic review and execution of the Value Creation Plan of $4.0 
million, which were recorded in SG&A expenses; and asset impairment charges and employee termination costs of $14.3 million recorded in 
other expense (as described above under “Value Creation Plan”). 

(l)  Reflects the impairment of goodwill associated with the Sunflower reporting unit of the Raw Material Sourcing and Supply operating segment. 
(m)  Reflects a charge of $9.0 million for the settlement of a flexible resealable pouch product recall dispute with a customer, which was recorded 
in other expense, and associated legal costs, which were recorded in SG&A expenses.  The settlement amount included up to $4.0 million in 
rebates payable to the customer over a four-year period. 

(n)  Reflects costs of $4.0 million for the withdrawal of certain consumer-packaged products for quality-related issues and the sunflower recall, 
of  which $1.2  million  was  recorded  in cost  of  goods  sold  and $2.8  million  was  recorded  in  other  expense.    Also  reflects  a  $1.7  million 
adjustment for the estimated lost gross profit caused by the sunflower recall, which reflects a shortfall in revenues against anticipated volumes 
of approximately $9.8 million, less associated cost of goods sold of approximately $8.1 million. 

(o)  Reflects aging reserves and low margin sales to reduce inventory exposures mainly related to certain grain varieties that we exited, which 

were recorded in cost of goods sold. 

(p)  Plant start-up costs relate to the ramp-up of production at our Allentown, Pennsylvania, facility following the completion of the addition of 
aseptic beverage processing and filling capabilities, which were recorded in cost of goods sold.  These start-up costs reflected the negative 
gross profit reported by the facility as the facility ramped up to break-even production levels. 

(q)  Reflects the write-off to interest expense of $0.2 million of remaining unamortized debt issuance costs related to our former North American 

credit facilities, which were replaced by a global asset-based credit facility in February 2016 (the “Global Credit Facility”). 

(r)  Other  includes  severance  costs  of  $0.9  million  unrelated  to  the  Value  Creation  Plan,  and  fair  value  adjustments  related  to  contingent 

consideration arrangements of $0.6 million, which were recorded in other expense.   

(s)  Reflects a gain on settlement of the contingent consideration obligation related to the acquisition of Niagara Natural, which was recorded in 

other income. 

We believe that investors’ understanding of our financial performance is enhanced by disclosing the specific items that we exclude from earnings/loss 
attributable to SunOpta Inc. to compute adjusted earnings/loss.  However, adjusted earnings/loss is not, and should not be viewed as, a substitute for 
earnings prepared under U.S. GAAP.  Adjusted earnings/loss is presented solely to allow investors to more fully understand how we assess our financial 
performance. 

(3)  We use a measure of adjusted EBITDA when assessing the performance of our operations, which we believe are useful to investors’ understanding of 
our  operating  profitability  by  excluding  non-operating  expenses,  such  as  interest  and  income  taxes,  and  non-cash  expenses,  such  as  depreciation, 
amortization,  stock-based  compensation  and  asset  impairment  charges,  as  well  as  other  unusual  items  that  affect  the  comparability  of  operating 
performance.  We also use these measures to review and assess our progress under the Value Creation Plan (as described above under “Value Creation 
Plan”) and to assess operating performance in connection with our employee incentive programs.  In addition, we are subject to certain debt covenants 
that restrict our ability to incur additional indebtedness unless we meet certain ratios based on pre-established measures of EBITDA.  We define adjusted 
EBITDA as segment operating income/loss plus depreciation, amortization and non-cash stock-based compensation, and excluding other unusual items 
as identified in the determination of adjusted earnings (refer above to footnote (2)).  The following table presents a reconciliation of segment operating 
income/loss and adjusted EBITDA from loss from continuing operations, which we consider to be the most directly comparable U.S. GAAP financial 
measure.  In addition, as described above under footnote (2), we have prepared this table in a columnar format to present the effect of flexible resealable 
pouch and nutrition bar operations on our consolidated results for the current and comparative periods.  We believe this presentation assists investors in 
assessing the results of the operations we have exited and the effect of those operations on our financial performance. 

SUNOPTA INC. 

47 

December 30, 2017 10-K 

 
 
  
 
 
 
For the years ended 
December 30, 2017 
Loss from continuing operations 
Recovery of income taxes 
Interest expense, net 
Other expense, net 
Goodwill impairment 
Total segment operating income (loss) 
  Depreciation and amortization 
Stock-based compensation(a) 

  Costs related to Value Creation Plan(b) 
Product withdrawal and recall costs(c) 

Adjusted EBITDA 

December 31, 2016 
Loss from continuing operations 
Recovery of income taxes 
Interest expense, net 
Other expense, net 
Goodwill impairment 
Total segment operating income (loss) 
  Depreciation and amortization 
Stock-based compensation(a) 
Costs related to business acquisitions(d) 
Costs related to Value Creation Plan(b) 
Inventory reserves and liquidation sales to de-risk positions(e) 
Product withdrawal and recall costs(c) 
Litigation-related legal fees(f) 
Plant start-up costs(g) 

Adjusted EBITDA 

Excluding flexible 
resealable pouch 
and nutrition bar 
$ 

Flexible  
resealable pouch 
and nutrition bar 
$ 

Consolidated 
$ 

(119,707) 
(26,328) 
32,504 
8,847 
115,000 
10,316 
31,994 
6,395 
23,144 
729 
72,578 

(49,288) 
(22,981) 
43,275 
28,292 
17,540 
16,838 
33,320 
3,885 
15,150 
4,041 
3,428 
2,855 
1,850 
1,565 
82,932 

(14,861) 
(9,501) 
- 
14,813 
- 
(9,549) 
830 
- 
2,939 
- 
(5,780) 

(1,276) 
(816) 
- 
- 
- 
(2,092) 
830 
- 
- 
- 
- 
- 
- 
- 
(1,262) 

(134,568) 
(35,829) 
32,504 
23,660 
115,000 
767 
32,824 
6,395 
26,083 
729 
66,798 

(50,564) 
(23,797) 
43,275 
28,292 
17,540 
14,746 
34,150 
3,885 
15,150 
4,041 
3,428 
2,855 
1,850 
1,565 
81,670 

(a)  For  2017,  stock-based  compensation  of  $6.4  million  was  recorded  in  SG&A  expenses,  and  the  reversal  of  $0.7  million  of  previously 
recognized stock-based compensation, related to forfeited awards of employees that were terminated in connection with the Value Creation 
Plan, was recognized in other expense.  For 2016, stock-based compensation of $3.9 million was recorded in SG&A expenses. 

(b)  For  2017,  reflects  inventory  write-downs  and  facility  closure  costs  of  $3.2  million  recorded  in  cost  of  goods  sold,  and  consulting  fees, 
temporary labor, employee recruitment, relocation and retention costs, and bad debt reserves of $22.9 million recorded in SG&A expenses.  
For 2016, reflects legal and other professional advisory costs of $4.0 million recorded in SG&A expenses.   

(c)  For 2017, reflects the estimated lost gross profit caused by the recall of certain sunflower kernel products of $0.7 million, which reflected the 
shortfall in revenues in the first quarter of 2017 against first quarter 2016 volumes of approximately $3.3 million, less associated cost of goods 
sold of approximately $2.6 million.  For 2016, reflects costs of $1.2 million for the withdrawal of certain consumer-packaged products for 
quality-related issues, which was recorded in cost of goods and the estimated lost gross profit caused by the sunflower recall of $1.7 million, 
which  reflected  a  shortfall  in  revenues  against  anticipated  volumes  of  approximately  $9.8  million,  less  associated  cost  of  goods  sold  of 
approximately $8.1 million. 

(d)  Reflects costs related to the acquisition accounting adjustment related to Sunrise’s inventory sold in 2016 of $15.0 million, and the integration 
costs related to the closure and consolidation of our frozen fruit  processing operations following the Sunrise Acquisition of $0.2 million, 
which were recorded in cost of goods sold. 

(e)  Reflects aging reserves and low margin sales to reduce inventory exposures mainly related to certain grain varieties that we  exited, which 

were recorded in cost of goods sold. 

(f)  Reflects legal costs related to the settlement of the flexible resealable pouch product recall dispute with a customer, which were recorded in 

SG&A expenses. 

(g)  Reflects the negative gross profit reported by the Allentown facility as the facility ramped up to break-even production levels. 

Although we use adjusted EBITDA as a measure to assess the performance of our business and for the other purposes set forth above, this measure has 
limitations  as  analytic  tools,  and  should  not  be  considered  in  isolation,  or  as  a  substitute  for  an  analysis  of  our  results  of  operations  as  reported  in 
accordance with U.S. GAAP.  Some of these limitations are:  

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

adjusted EBITDA reflects the interest expense, or the cash requirements necessary to service interest payments on our indebtedness;  

adjusted EBITDA includes the payment of taxes, which is a necessary element of our operations;  

although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the 
future, and adjusted EBITDA does not reflect any cash requirements for such replacements; and 

adjusted EBITDA includes non-cash stock-based compensation, which is an important component of our total compensation program for 
employees and directors. 

SUNOPTA INC. 

48 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Because of these limitations, adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our 
business.  Management compensates for these limitations by not viewing adjusted EBITDA in isolation, and specifically by using other U.S. GAAP and 
non-GAAP measures, such as revenues, gross profit, segment operating income, earnings and adjusted earnings to measure our operating performance.  
Adjusted EBITDA is not a measurement of financial performance under U.S. GAAP and neither should be considered as an alternative to our results of 
operations or cash flows from operations determined in accordance with U.S. GAAP, and our calculation of adjusted EBITDA may not be comparable 
to the calculation of a similarly titled measure reported by other companies. 

(4)   In order to evaluate our results of operations, we use certain non-GAAP measures that we believe enhance an investor’s ability to derive meaningful 
year-over-year comparisons and trends from our results of operations.  In particular, we evaluate our revenues on a basis that excludes the effects of 
fluctuations in commodity pricing and foreign exchange rates.  In addition, we exclude specific items from our reported results that due to their nature 
or size, we do not expect to occur as part of our normal business on a regular basis.  These items are identified above under footnote (2), and in the 
discussion of our results of operations below.  These non-GAAP measures are presented solely to allow investors to more fully assess our results of 
operations and should not considered in isolation of, or as substitutes for an analysis of our results as reported under U.S. GAAP. 

Revenues for the year ended December 30, 2017 decreased by 5.0% to $1,279.6 million from $1,346.7 million for the year 
ended December 31, 2016.  Excluding the impact on revenues for the year ended December 30, 2017 of changes in commodity-
related pricing and foreign exchange rates (a decrease in revenues of $15.0 million), all sales of flexible resealable pouch and 
nutrition bar products (a decrease in revenues of $6.2 million), and estimated impact of the recall of certain sunflower kernel 
products based on shortfall against prior year volumes (a decrease in revenues of $3.3 million), revenues decreased by 3.3% in 
2017, compared with 2016.  This decrease in revenues on an adjusted basis reflected a lower sales of frozen fruit products due 
to lower consumer demand and lost customer volumes; lower raw and roasted sunflower volumes, due to global competition 
and reduced customer demand following the sunflower recall; and lower sales of non-dairy aseptic beverage products related 
to the previously announced loss of a significant customer.  These factors were partially offset by increased volumes of premium 
juice products and custom fruit ingredients. 

Gross profit increased $19.1 million, or 15.2%, to $145.1 million for the year ended December 30, 2017, compared with $126.0 
million for the year ended December 31, 2016.  As a percentage of revenues, gross profit for the year ended December 30, 2017 
was 11.3% compared to 9.4% for the year ended December 31, 2016, an increase of 2.0%.   The gross profit percentage for 
2017 would have been approximately 11.6%, excluding the impact of the write-down of flexible resealable pouch and nutrition 
bar inventories as a result of the plan to exit these product lines ($2.6 million), lost margin caused by the sunflower recall ($0.7 
million), and facility closure costs under the Value Creation Plan ($0.6 million).  For 2016, the gross profit percentage would 
have been 10.9%, excluding the impact of an acquisition accounting adjustment related to Sunrise’s inventory sold in 2016 
($15.0 million), aging reserves and low  margin sales to reduce inventory exposures  mainly on  specialty  grain  varieties  we 
exited ($3.4 million), lost margin caused by the recall of certain sunflower kernel products ($1.7 million), start-up costs related 
to the ramp-up of production at the Allentown aseptic beverage facility ($1.6 million), and an inventory reserve for certain 
consumer-packaged products due to quality-related issues ($1.2 million).  Excluding these items, the gross profit percentage 
increased 0.7% on an adjusted basis in 2017, compared with 2016, which reflected improved operating efficiencies and raw 
material  pricing  within  our  healthy  fruit  operations,  and  operational  savings  following  the  closure  of  the  San  Bernardino 
premium juice facility, as well as a favorable foreign exchange impact on U.S. dollar-denominated raw material sourcing within 
our  international  organic  ingredient  operations.    These  factors  were  partially  offset  by  higher  losses  within  our  flexible 
resealable pouch and nutrition bar operations, partially related to wind-down activities in the fourth quarter of 2017.  In addition, 
we experienced lower production volumes and operating efficiencies within our sunflower and roasting operations following 
the recall.  

Total segment operating income for the year ended December 30, 2017 decreased by $14.0 million, or 94.8%, to $0.8 million, 
compared with $14.7 million for the year ended December 31, 2016.  As a percentage of revenues, segment operating income 
was 0.1% for the year ended December 30, 2017, compared with 1.1% for the year ended December 31, 2016.  The decrease 
in segment operating income reflected a $28.8 million increase in SG&A expenses that more than offset the higher overall 
gross profit as described above.  The increase in SG&A expenses mainly reflected incremental consulting fees and temporary 
labor costs ($12.5 million), employee recruitment, relocation and retention costs ($6.0 million), and bad debt reserves related 
to  exited  operations  ($0.4  million)  associated  with  the Value  Creation  Plan,  partially  offset  by  lower  legal  costs  related  to 
settlement of a product recall dispute in 2016 ($1.9 million).  Excluding these items, as well as those items identified above 
affecting gross profit, segment operating income as a percentage of revenues on an adjusted basis would have been 2.1% in 
2017, compared with 3.2% in 2016, which reflected higher employee compensation-related costs in 2017 related to structural 
investments in new quality, sales, marketing, engineering and accounting resources.  In addition, segment operating income 
reflected  a  foreign  exchange  loss  of  $5.6  million  in  2017,  which  mainly  reflected  the  impact  on  our  international  organic 
ingredient and frozen fruit operations of a weakening of U.S. dollar relative to the euro and Mexican peso, compared with a 
loss of $1.2 million in 2016. 

Further details on revenue, gross profit and segment operating income/loss variances are provided below under “Segmented 
Operations Information”. 

SUNOPTA INC. 

49 

December 30, 2017 10-K 

 
 
 
  
 
Other expense for the year ended December 30, 2017 of $23.7 million mainly reflected the impairment of long-lived assets 
related to the exits from our flexible resealable pouch and nutrition bar product lines and operations, and consolidation of our 
roasted snack operations, as well as the closure of the San Bernardino facility ($18.2 million), and employee termination costs 
($5.6 million) associated with the Value Creation Plan, partially offset by a $1.0 million recovery on the early extinguishment 
of a rebate obligation that arose from the prior settlement of a recall dispute with a customer related to flexible resealable pouch 
products.  Other expense for the year ended December 31, 2016 of $28.3 million reflected the impairment of long-lived assets 
related to the closure of the San Bernardino and Heuvelton facilities ($11.5 million), and employee termination costs ($2.8 
million) associated with the Value Creation Plan, the cost of the settlement of the aforementioned flexible resealable pouch 
product recall dispute with a customer ($9.0 million, which included up to $4.0 million in rebates payable to the customer over 
a four-year period), as well as costs associated with product withdrawals and recalls ($2.8 million), and facility rationalization 
and  severance  costs  primarily  related  to  the  consolidation  of  our  frozen  fruit  processing  facilities  following  the  Sunrise 
Acquisition ($2.2 million).  Other expenses in 2016 were partially offset by the $1.7 million gain on settlement of the contingent 
consideration obligation related to the acquisition of Niagara Natural.  

In 2017, we recognized a non-cash goodwill impairment charge of $115.0 million related to the Healthy Fruit reporting unit of 
the Consumer Products operating segment, as a result of lower-than-expected sales and operating performance for frozen fruit 
since the Sunrise Acquisition, and uncertainty of future sales due to lost customer volumes and declining consumer consumption 
trends in 2017.  In 2016, we  recognized a non-cash  goodwill impairment charge of $17.5 million related to the Sunflower 
reporting unit of the Raw Material Sourcing and Supply operating segment, due to lower anticipated sales demand and higher 
expected production and capital costs as a result of the sunflower recall. 

Interest expense decreased by $10.8 million to $32.5 million for the year ended December 30, 2017, compared with $43.3 
million for the year ended December 31, 2016.  Interest expense included the amortization and expense of debt issuance costs 
of $2.8 million and $11.3 million in 2017 and 2016, respectively.  The year-over-year decrease in interest expense primarily 
reflected the reduction in non-cash amortization following the one-year maturity of the initial second lien loans used to partially 
fund the Sunrise Acquisition, and repayment of $79.0 million of second lien debt with the net proceeds from the Preferred 
Stock offering in October 2016, and further extinguishment of $7.5 million of second lien debt in October 2017.   

We recognized a recovery of income  tax of $35.8 million for the year ended December 30, 2017 (including a $8.4 million 
recovery related to the remeasurement of deferred tax balances to reflect the new corporate tax rates enacted in the U.S. in 
December 2017, and the realization of $0.5 million of previously unrecognized tax benefits), compared with a recovery of 
income tax of $23.8 million for the year ended December 31, 2016 (including the realization of $1.3 million of previously 
unrecognized tax benefits).  Excluding the effects of the change the U.S. corporate tax rate and the realization of unrecognized 
tax benefits, the effective tax rates  for 2017 and 2016 would have been 48.6% and 39.6%, respectively, of the loss  before 
income taxes (excluding the non-deductible goodwill impairment losses).  The effective tax rates reflected the effect of a mix 
of pre-tax losses in the U.S. and pre-tax earnings in certain other jurisdictions.  In fiscal 2017, pre-tax losses in the U.S. mainly 
reflected costs associated with the Value Creation Plan.  In fiscal 2016, pre-tax losses in the U.S. reflected costs associated with 
the Value Creation Plan, as well as the Sunrise Acquisition, settlement of the product recall dispute, and product withdrawal 
and recall costs.  With the effect of the corporate tax law changes in the U.S. beginning in fiscal 2018, we expect our effective 
tax rate will be approximately 24% to 26%, excluding discrete items. 

Loss  from  continuing  operations  attributable  to  SunOpta  Inc.  for  the  year  ended  December  30,  2017  was  $135.3  million, 
compared with a loss of $50.6 million for the year ended December 31, 2016, a decrease of $84.7 million.  Diluted loss per 
share from continuing operations was $1.66 for the year ended December 30, 2017, compared with diluted loss per share from 
continuing operations of $0.61 for the year ended December 31, 2016.   

The loss from discontinued operations of $0.6 million in 2016 was related to our investment in Opta Minerals, which we sold 
in April 2016. 

On a consolidated basis, we realized a loss of $135.3 million (diluted loss per share of $1.66) for the year ended December 30, 
2017, compared with a loss of $51.2 million (diluted loss per share of $0.62) for the year ended December 31, 2016. 

For the year ended December 30, 2017, adjusted loss was $12.3 million, or $0.14 per diluted share, on a consolidated basis, 
compared  with  adjusted  earnings  of  $5.8  million,  or  $0.07  per  diluted  share,  on  a  consolidated  basis  for  the  year  ended 
December 31, 2016.  Excluding flexible resealable pouch and nutrition bar product lines and operations, adjusted loss was $8.3 
million, or $0.10 per diluted share, for the year ended December 30, 2017, compared with adjusted earnings of $7.1 million, or 
$0.08 per diluted share, for the year ended December 31, 2016.  Adjusted EBITDA for the year ended December 30, 2017 was 
$66.8 million on a consolidated basis, compared with $81.7 million on a consolidated basis for the year ended December 31, 
2016.  Excluding flexible resealable pouch and nutrition bar product lines and operations, adjusted EBITDA for the year ended 

SUNOPTA INC. 

50 

December 30, 2017 10-K 

 
 
 
 
 
 
December 30, 2017 was $72.6 million, compared with $82.9 million for the year ended December 31, 2016.  Adjusted earnings 
and adjusted EBITDA are non-GAAP financial measures.  See footnotes (2) and (3) to the table above for a reconciliation of 
adjusted earnings/loss and adjusted EBITDA from loss from continuing operations, which we consider to be the most directly 
comparable U.S. GAAP financial measure.   

Segmented Operations Information 

Global Ingredients 

December 30, 2017  December 31, 2016 

Change 

% Change 

Revenue 
Gross Profit 
Gross Profit % 

Operating Income 
Operating Income % 

550,527 
67,682 
12.3% 

21,951 
4.0% 

574,295 
64,374 
11.2%  

26,787 

4.7%  

(23,768) 
3,308 

(4,836) 

-4.1% 
5.1% 
1.1% 

-18.1% 
-0.7% 

Global Ingredients contributed $550.5 million in revenues for the year ended December 30, 2017, compared to $574.3 million 
for the year ended December 31, 2016, a decrease of $23.8 million, or 4.1%.  Excluding the impact on revenues of changes 
including foreign exchange rates and commodity-related pricing (a decrease  in revenues  of $9.7 million), and the  recall of 
certain sunflower kernel products announced in the second quarter of 2016 (a decrease in revenues of $3.3 million), Global 
Ingredients revenues decreased approximately 1.9%.  The table below explains the decrease in revenue: 

Global Ingredients Revenue Changes 

Revenues for the year ended December 31, 2016 

Lower roasted volumes due to reduced customer demand following the sunflower 
recall, and lower raw sunflower volumes due to competition from global suppliers 

Decreased commodity pricing for domestically-sourced specialty and organic grains 
and seeds 

Decreased commodity pricing for internationally-sourced organic ingredients 

Decreased volumes of internationally-sourced organic ingredients including alternative 
sweeteners, seeds, fruits, vegetables and coffee, offset by increased volumes of nuts, 
dried fruit, animal feed and cocoa 

Favorable foreign exchange impact on euro-denominated sales due to a weaker U.S. 
dollar period-over-period 

Increased volumes of domestically-sourced specialty soy and organic feed, partially 
offset by lower volumes of specialty corn and crop inputs 

Revenues for the year ended December 30, 2017 

$574,295 

(16,642) 

 (10,943) 

 (2,835) 

 (295) 

 4,096  

 2,851  

$550,527 

Gross profit in Global Ingredients increased by $3.3 million to $67.7 million for the year ended December 30, 2017 compared 
to $64.4 million for the year ended December 31, 2016, and the gross profit percentage  increased by 1.1% to 12.3%.  The 
increase in gross profit as a percentage of revenue was primarily due to a favorable foreign exchange impact on U.S. dollar-
denominated raw material sourcing within our international organic ingredient operations, partially offset by an unfavorable 
product mix of, and reduced pricing spreads on, certain organic commodities, and reduced operating efficiencies within our 
sunflower and roasting operations due to lower volumes following the recall.  The table below explains the increase in gross 
profit: 

SUNOPTA INC. 

51 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Global Ingredients Gross Profit Changes 

Gross profit for the year ended December 31, 2016 

Favorable foreign exchange impact on U.S. dollar-denominated raw material sourcing 
within our international organic ingredient operations (partially offset by losses on 
forward currency contracts included below in operating income), partially offset by 
reduced pricing spreads and lower volumes of certain higher-margin internationally-
sourced organic ingredients  

Increased specialty soy volumes and increased contribution for grain ingredients, 
partially offset by reduced corn volumes and pricing spread on domestically-sourced 
organic feed and reduced volumes of higher-margin crop inputs due to a reduction in 
contracted acres 

Lower sales volumes of raw sunflower and roasted products, and reduced operating 
efficiencies due to lower production volumes 

Gross profit for the year ended December 30, 2017 

$64,374 

4,494 

1,789 

(2,975) 

$67,682 

Operating income in Global Ingredients decreased by $4.8 million, or 18.1%, to $22.0 million for the year ended December 
30, 2017, compared to $26.8 million for the year ended December 31, 2016.  The table below explains the decrease in operating 
income: 

Global Ingredients Operating Income Changes 

Operating income for the year ended December 31, 2016 

Increase in gross profit, as explained above 

Increase in foreign exchange losses primarily related to forward currency contracts 

Increase in corporate cost allocations 

Higher employee-related compensation costs due to increased headcount within our 
international organic ingredient operations, partially offset by lower non-compensation-
related costs 

Operating income for the year ended December 30, 2017 

$26,787 

 3,308 

 (5,256) 

 (2,083) 

 (805) 

$21,951 

Looking  forward,  we believe  Global  Ingredients is  well positioned in  growing organic food and non-GMO categories. We 
intend to focus our efforts on (i) growing our organic sourcing and supply capabilities, making certified organic ingredients a 
larger proportion of our overall sales; (ii)  making  strategic investments in  key product categories that drive  higher volume 
ingredient solutions for our customers; and (iii) leveraging our international sourcing and supply capabilities internally, and 
forward and backward integrating where opportunities exist. The statements in this paragraph are forward-looking statements. 
See “Forward-Looking Statements” above. Increased supply pressure in the commodity-based markets in which we operate, 
increased competition, volume decreases or loss of customers, unexpected delays in our ingredient expansion plans, or our 
inability to secure quality inputs or achieve our product mix or cost reduction goals, along with the other factors described 
above under “Forward-Looking Statements”, could adversely impact our ability to meet these forward-looking expectations.  

Consumer Products 

December 30, 2017 

December 31, 2016 

Change 

% Change 

Revenue 
Gross Profit 
Gross Profit % 

Operating Income 
Operating Income % 

729,066 
77,405 
10.6% 

9,905 
1.4% 

772,436 
61,578 

8.0%  

1,206 
0.2%  

(43,370) 
15,827 

8,699 

-5.6% 
25.7% 
2.6% 

721.3% 
1.2% 

Consumer Products contributed $729.1 million in revenues for the year ended December 30, 2017, compared to $772.4 million 
for the year ended December 31, 2016, a $43.4 million, or 5.6% decrease.  Excluding the impact on revenues of changes in raw 

SUNOPTA INC. 

52 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
fruit commodity-related pricing (a decrease in revenues of $5.3 million) and removing all sales of flexible resealable pouch 
and nutrition bar products, Consumer Products revenues decreased approximately 4.5%.  The table below explains the decrease 
in revenues: 

Consumer Products Revenue Changes 

Revenues for the year ended December 31, 2016 

Lower volumes of frozen fruit due to declines in consumer consumption trends and 
lower distribution to certain retail customers, and the impact of lower raw fruit 
commodity-related pricing passed on to customers, partially offset by increased fruit 
ingredient volumes 

Lower volumes of flexible resealable pouch products (including the impact on revenues 
from the closure of west coast pouch operations due to the fire at a third-party facility in 
the third quarter of 2016), partially offset by higher volumes of nutrition bars related to 
new product offerings, prior to the exit from nutrition bar operations 

Higher volumes of premium juice and fruit snack products, as well as non-dairy aseptic 
beverage products into the foodservice channel, offset by lower retail sales of non-dairy 
aseptic beverages related to the previously announced loss of a significant contract 

Revenues for the year ended December 30, 2017  

$772,436 

 (37,446) 

 (6,206) 

 282  

$729,066 

Gross profit in Consumer Products increased by $15.8 million to $77.4 million for the year ended December 30, 2017 compared 
to $61.6 million for the year ended December 31, 2016, and the gross profit percentage increased by 2.6% to 10.6%.  For the 
year ended December 30, 2017, gross profit as a percentage of revenue was impacted by a write-down of flexible resealable 
pouch and nutrition bar inventories as a result of the exit from these operations ($2.6 million), as well as costs associated with 
the closure of the San Bernardino facility ($0.5 million).  For the year ended December 31, 2016, gross profit as a percentage 
of  revenue  was  impacted  by  the  acquisition  accounting  adjustment  related  to  Sunrise  inventory  sold  ($15.0  million),  costs 
associated with the expansion activities at the Allentown aseptic beverage facility ($1.6 million), and an inventory reserve for 
certain  consumer-packaged  products  due  to  quality-related  issues  ($1.2  million).   Excluding  these  costs,  the  gross  profit 
percentage in Consumer Products would have been 11.1% for the year ended December 30, 2017, compared with 10.3% for 
the year ended December 31, 2016.  The increase in gross profit percentage primarily reflected improved operating efficiencies 
and raw material pricing within our healthy fruit operations and operational savings from the closure of the San Bernardino 
facility, partially offset by higher losses within our flexible resealable pouch and nutrition bar operations.  The table below 
explains the increase in gross profit: 

Consumer Products Gross Profit Changes 

Gross profit for the year ended December 31, 2016 

Acquisition accounting adjustment related to Sunrise inventory sold in 2016 

Higher sales volumes of premium juice and fruit snack products, operational savings 
following the closure of the San Bernardino facility, and increased operating efficiency 
and cost reductions in aseptic as a result of the Value Creation Plan during the fourth 
quarter, offset by lower sales volumes of non-dairy aseptic beverages 

Increased contribution on sales of frozen fruit, based on operating efficiencies due to the 
timing of the fruit harvest (which was delayed in fiscal 2016, resulting in higher labor 
costs and reduced supply) and favorable pricing on sourced raw fruit, as well as 
increased volumes of fruit ingredients, and productivity and cost reduction initiatives 
within fruit ingredient operations 

Higher losses within flexible resealable pouch and nutrition bar operations (including 
the write-down of inventories related to exit activities) 

Gross profit for the year ended December 30, 2017 

$61,578 

         15,000  

           4,110  

3,740 

(7,023) 

$77,405 

Operating income in  Consumer Products increased by $8.7 million to $9.9 million for the  year ended December 30, 2017, 
compared to $1.2 million for the year ended December 31, 2016. The table below explains the increase in operating income: 

SUNOPTA INC. 

53 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
Consumer Products Operating Income Changes 

Operating loss for the year ended December 31, 2016 

Increase in gross profit, as explained above 

Lower foreign exchange losses on international operations and lower non-
compensation-related costs, partially offset by higher employee-related compensation 
costs 

Increase in corporate cost allocations 

Operating income for the year ended December 30, 2017 

 $1,206 

 15,827 

1,390 

(8,518) 

 $9,905 

Looking  forward  we  believe  Consumer  Products  remains  well-positioned  in  markets  with  long-term  growth  potential.  
However, a continued decline in consumer consumption of frozen fruit could adversely affect the near-term performance of 
the Consumer Products.  We intend to focus our efforts on (i) leveraging our new sales and marketing resources to create greater 
channel specific focus on retail and foodservice to bolster our pipeline of opportunities to diversify our portfolio and drive 
incremental sales volume; (ii) continuing to invest in our facilities to enhance quality, safety, and manufacturing efficiency to 
drive both incremental sales and cost reduction; (iii) executing procurement and supply chain cost reduction initiatives focused 
on  leveraging  our  buying  power  and  creating  increased  network  efficiency  in  our  planning  and  logistics  efforts;  and  (iv) 
leveraging our innovation capabilities to bring new value-added packaged products and processes to market and to increase 
our  capacity  utilization  across  Consumer  Products.    The  statements  in  this  paragraph  are  forward-looking  statements.  See 
“Forward-Looking Statements” above. Unfavorable shifts in consumer preferences, increased competition, availability of raw 
material supply, volume decreases or loss of customers, unexpected delays in our expansion and integration plans, inefficiencies 
in our manufacturing processes, lack of consumer product acceptance, or our inability to successfully implement the particular 
goals and strategies indicated above, along with the other factors described above under “Forward-Looking Statements”, could 
have an adverse impact on these forward-looking expectations. 

Corporate Services 

December 30, 2017  December 31, 2016 

Change 

% Change 

Operating Loss 

(31,089) 

(13,247) 

(17,842) 

-134.7% 

Operating loss at Corporate Services increased by $17.8 million to $31.1 million for the year ended December 30, 2017, from 
a loss of $13.2 million for the year ended December 31, 2016. The table below explains the increase in operating loss: 

Corporate Services Operating Loss Changes 

Operating loss for the year ended December 31, 2016 

Non-structural third-party consulting costs and employee recruitment, relocation and 
retention costs associated with the Value Creation Plan 

Higher structural employee-related compensation costs due to increased headcount, and 
higher information technology costs, all in support of the Value Creation Plan 

Increased stock-based compensation costs as a result of a change in our long-term 
incentive plan 

Decrease in foreign exchange gains on foreign currency transactions 

Increase in corporate cost allocations to SunOpta reporting segments, mainly related to 
structural investments in new quality, sales, marketing, engineering and accounting 
resources under the Value Creation Plan 

Operating loss for the year ended December 30, 2017 

 $(13,247) 

(18,469) 

(7,134) 

(2,510) 

(330) 

10,601 

 $(31,089) 

Management fees mainly consist of salaries of corporate personnel who perform back office functions for operating segments, 
as well as costs related to the enterprise resource management system. These expenses are allocated to the operating segments 
based on (1) specific identification of allocable costs that represent a service provided to each segment and (2) a proportionate 

SUNOPTA INC. 

54 

December 30, 2017 10-K 

 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
distribution of costs based on a weighting of factors such as revenue contribution and number of people employed within each 
segment.  

Consolidated Results of Operations for Fiscal Years 2016 and 2015 

Revenues 
  Global Ingredients 
  Consumer Products 
Total revenues 

Gross Profit 
  Global Ingredients 
  Consumer Products 
Total gross profit 

Segment operating income (loss)(1) 
  Global Ingredients 
  Consumer Products 
  Corporate Services 
Total segment operating income 

Other expense, net 
Goodwill impairment 
Earnings (loss) from continuing operations before the  

following 

Interest expense, net 
Recovery of income taxes 
Loss from continuing operations(2),(3) 
Earnings (loss) attributable to non-controlling interests 
Loss from discontinued operations 
 attributable to SunOpta Inc. 

December 31, 
2016 
$ 

January 2, 
2016 
$ 

574,295 
772,436 
1,346,731 

610,890 
534,244 
1,145,134 

64,374 
61,578 
125,952 

66,461 
43,901 
110,362 

26,787 
1,206 
(13,247) 
14,746 

28,292 
17,540 

(31,086) 
43,275 
(23,797) 
(50,564) 
54 

28,184 
3,208 
(10,094) 
21,298 

12,151 
- 

9,147 
15,669 
(3,390) 
(3,132) 
(136) 

Change 
$ 

(36,595) 
238,192 
201,597 

(2,087) 
17,677 
15,590 

(1,397) 
(2,002) 
(3,153) 
(6,552) 

16,141 
17,540 

(40,233) 
27,606 
(20,407) 
(47,432) 
190 

Change 
% 

-6.0% 
44.6% 
17.6% 

-3.1% 
40.3% 
14.1% 

-5.0% 
-62.4% 
-31.2% 
-30.8% 

132.8% 
- 

-439.8% 
176.2% 
-602.0% 
-1514.4% 
139.7% 

(570) 

(19,475) 

18,905 

97.1% 

Loss attributable to SunOpta Inc.(4) 

(51,188) 

(22,471) 

(28,717) 

-127.8% 

(1)  The following table presents a reconciliation of segment operating income/loss to earnings (loss) from continuing operations before the following, which 
we consider to be the most directly comparable U.S. GAAP financial measure (refer to footnote (1) to the “Consolidated Results of Operations for Fiscal 
Years 2017 and 2016” table regarding the use of this non-GAAP measure). 

December 31, 2016 
Segment operating income (loss) 
Other expense, net 
Goodwill impairment 
Earnings (loss) from continuing operations before the following 

January 2, 2016 
Segment operating income (loss) 
Other income (expense), net 
Earnings (loss) from continuing operations before the following 

Global 
Ingredients 
$ 

26,787 
(1,753) 
(17,540) 
7,494 

28,184 
(1,317) 
26,867 

Consumer 
Products 
$ 

1,206 
(25,705) 
- 
(24,499) 

3,208 
(939) 
2,269 

Corporate 
Services 
$ 

(13,247) 
(834) 
- 
(14,081) 

(10,094) 
(9,895) 
(19,989) 

Consolidated 
$ 

14,746 
(28,292) 
(17,540) 
(31,086) 

21,298 
(12,151) 
9,147 

(2)  The  following  table  presents  a  reconciliation  of  adjusted  earnings  from  loss  from  continuing  operations,  which  we  consider  to be  the  most directly 
comparable  U.S.  GAAP  financial  measure  (refer  to  footnote  (2)  to  the  “Consolidated  Results  of  Operations  for  Fiscal  Years  2017  and  2016”  table 
regarding  the  use  of  this non-GAAP  measure).    In  addition, in  recognition  of  our  exit  flexible  resealable  pouch  and  nutrition bar product  lines  and 

SUNOPTA INC. 

55 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
operations (as described above under “Value Creation Plan”), we have prepared this table in a columnar format to present the effect of these operations 
on our consolidated results for the current and comparative period.  We believe this presentation assists investors in assessing the results of the operations 
we intend to exit and the effect of those operations on our financial performance. 

For the years ended 
December 31, 2016 
Loss from continuing operations 
Less: earnings attributable to non-controlling interests 
Less: dividends and accretion of Series A Preferred Stock 
Loss from continuing operations available to common 

shareholders 

Adjusted for: 

Excluding flexible 
resealable pouch  
and nutrition bar 
Per Diluted 
Share 
$ 

$ 

Flexible  
resealable pouch   
and nutrition bar 
Per Diluted 
Share 
$ 

$ 

Consolidated 
Per Diluted 
Share 
$ 

$ 

(49,288)  
(54)  
(1,812)  

(1,276)  
-   
-   

(50,564)  
(54)  
(1,812)  

(51,154) 

(0.60) 

(1,276) 

(0.01) 

(52,430) 

(0.61) 

Costs related to business acquisitions(a) 
Costs related to the Value Creation Plan(b) 

  Goodwill impairment(c) 

Legal settlement and litigation-related legal fees(d) 
Product withdrawal and recall costs(e) 
Inventory reserves and liquidation sales to de-risk positions(f) 
Plant start-up costs(g) 

  Write-off of debt issuance costs(h) 
  Other(i) 
  Gain on settlement of contingent consideration(j) 
  Net income tax effect(k) 

Change in unrecognized tax benefits(l) 

27,802   
18,326   
17,540   
10,850   
5,693   
3,428   
1,565   
215   
1,642   
(1,715)  
(25,825)  
(1,268)  

-   
-   
-   
-   
-   
-   
-   
-   
-   
-   
-   
-   

27,802   
18,326   
17,540   
10,850   
5,693   
3,428   
1,565   
215   
1,642   
(1,715)  
(25,825)  
(1,268)  

Adjusted earnings (loss) 

7,099 

0.08 

(1,276) 

(0.01) 

5,823 

0.07 

January 2, 2016 
Loss from continuing operations 
Less: earnings attributable to non-controlling interests 
Loss from continuing operations available to common 

shareholders 

Adjusted for: 

Costs related to business acquisitions(m) 
Plant expansion and start-up costs(n) 
Inventory reserves and liquidation sales to de-risk(o) 

  Downtime, spoilage and other costs due to equipment failure(p) 
  Demurrage, detention and other related expenses(q) 

Litigation-related legal fees(d) 
Reversal of stock-based compensation(r) 

  Other(s) 
  Net income tax effect(l) 

Change in unrecognized tax benefits(m) 

Adjusted earnings (loss) 

(1,417)  
136   

(1,715)  
-   

(3,132)  
136   

(1,281) 

(0.02) 

(1,715) 

(0.02) 

(2,996) 

(0.04) 

17,192   
4,081   
2,367   
676   
2,038   
1,709   
(579)  
4,384   
(9,996)  
(855)  

19,736 

0.27 

-   
-   
-   
1,543   
-   
-   
-   
-   
(602)  
-   
(774) 

17,192   
4,081   
2,367   
2,219   
2,038   
1,709   
(579)  
4,384   
(10,598)  
(855)  

(0.01) 

18,962 

0.26 

(a)  Reflects costs related to the Sunrise Acquisition, including an acquisition accounting adjustment related to Sunrise’s inventory sold during 
the  year  of  $15.0  million,  which  was  recorded  in  cost  of  goods  sold;  the amortization  and  expense  of  debt  issuance  costs incurred in 
connection with the initial financing related to the Sunrise Acquisition of $10.4 million, which were recorded in interest expense; and $2.4 
million  of  integration  costs  related  to  the  closure  and  consolidation  of  our  frozen  fruit  processing  facilities  following  the  Sunrise 
Acquisition, which were recorded in cost of goods sold and other expense. 

(b)  Reflects legal and other professional advisory costs associated with the strategic review and execution of the Value Creation Plan of $4.0 
million, which were recorded in SG&A expenses; and asset impairment charges and employee termination costs of $14.3 million recorded 
in other expense (as described above under “Value Creation Plan”). 

(c)  Reflects the impairment of goodwill  associated with the  Sunflower reporting unit of the Raw Material Sourcing and Supply operating 

segment. 

(d)  Reflects  a  charge  of  $9.0  million  for  the  settlement  of  a  flexible  resealable  pouch  product  recall  dispute  with  a  customer,  which  was 
recorded in other expense, and associated legal costs of $1.9 million (2015 - $1.7 million), which were recorded in SG&A expenses.  The 
settlement amount included up to $4.0 million in rebates payable to the customer over a four-year period. 

SUNOPTA INC. 

56 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(e)  Reflects costs of $4.0 million for the withdrawal of certain consumer-packaged products for quality-related issues and the sunflower recall, 
of which $1.2 million was recorded in cost of goods sold and $2.8 million was recorded in other expense.  Also reflects a $1.7 million 
adjustment  for the  estimated  lost  gross profit  caused by  the  sunflower  recall,  which  reflects  a  shortfall  in  revenues  against  anticipated 
volumes of approximately $9.8 million, less associated cost of goods sold of approximately $8.1 million. 

(f)  Reflects aging reserves and low margin sales to reduce inventory exposures mainly related to certain grain varieties that we exited, which 

were recorded in cost of goods sold. 

(g)  Plant start-up costs relate to the ramp-up of production at the Allentown facility following the completion of the addition of aseptic beverage 
processing and filling capabilities, which were recorded in cost  of goods sold.  These start-up costs reflected the negative gross profit 
reported by the facility as the facility ramped up to break-even production levels. 

(h)  Reflects the write-off to interest expense of $0.2 million of remaining unamortized debt issuance costs related to our former North American 

credit facilities, which were replaced by the Global Credit Facility. 

(i)  Other  includes  severance  costs  of  $0.9  million  unrelated  to  the  Value  Creation  Plan,  and  fair  value  adjustments  related  to  contingent 

consideration arrangements of $0.6 million, which were recorded in other expense.   

(j)  Reflects a gain on settlement of the contingent consideration obligation related to the acquisition of Niagara Natural, which was recorded 

in other income. 

(k)  Reflects the tax effect of the preceding adjustments to earnings and reflects an overall estimated annual effective tax rate of approximately 

30% on adjusted earnings before tax. 

(l)  Reflects the realization of previously unrecognized tax benefits, due to the expiration of the statute of limitations. 
(m)  Reflects  costs  related  to  the  Sunrise  Acquisition,  including  an  acquisition  accounting  adjustment  related  to  Sunrise’s  inventory  sold 
subsequent to the acquisition date of $4.0 million, which was recorded in cost of goods sold; acquisition- and integration-related costs 
incurred  in  connection  with  the  Sunrise  Acquisition  of  $7.8  million,  which  were  recorded  in  other  expense;  and the  amortization  and 
expense of debt issuance costs incurred in connection with the initial financing related to the Sunrise Acquisition of $5.4 million, which 
were recorded in interest expense. 

(n)  Reflects costs related to the retrofit of our San Bernardino, California, juice facility and expansion of the Allentown facility to add aseptic 

beverage processing and filling capabilities, which were recorded in cost of goods sold. 

(o)  Reflects inventory reserves and low  margin sales incurred to reduce inventory exposures in certain organic raw materials, which were 

recorded in cost of goods sold. 

(p)  Reflects downtime and spoilage caused by equipment failures, which were recorded in cost of goods sold. 
(q)  Reflects additional logistics costs stemming from capacity constraints on imports and exports within the Global Ingredients segment, which 

were recorded in cost of goods sold. 

(r)  Reflects the reversal to SG&A expenses of previously recognized stock-based compensation related to performance share units granted to 

certain employees as the performance conditions were not achieved. 

(s)  Other  includes  severance  benefits  of  $2.1  million  for  a  former  CEO;  fair  value  adjustments  related  to  contingent  consideration 

arrangements; and gain/loss on disposal of assets, which were recorded in other expense. 

(3)  The following table presents a reconciliation of segment operating income/loss and adjusted EBITDA from loss from continuing operations, which we 
consider to be the most directly comparable U.S. GAAP financial measure (refer to footnote (3) to the “Consolidated Results of Operations for the Fiscal 
Years 2017 and 2016” table regarding the use of this non-GAAP measure).  In addition, as described above under footnote (2), we have prepared this 
table in a columnar format to present the effect of flexible resealable pouch and nutrition bar operations on our consolidated results for the current and 
comparative  period.    We  believe  this  presentation  assists  investors  in  assessing  the  results  of  the  operations  we  have  exited  and the  effect  of  those 
operations on our financial performance. 

SUNOPTA INC. 

57 

December 30, 2017 10-K 

 
 
  
 
 
For the years ended 
December 31, 2016 
Loss from continuing operations 
Recovery of income taxes 
Interest expense, net 
Other expense, net 
Goodwill impairment 
Total segment operating income (loss) 
  Depreciation and amortization 
Stock-based compensation(a) 
Costs related to business acquisitions(b) 
Costs related to Value Creation Plan(c) 
Inventory reserves and liquidation sales to de-risk positions(d) 
Product withdrawal and recall costs(e) 
Litigation-related legal fees(f) 
Plant start-up costs(g) 

Adjusted EBITDA 

January 2, 2016 
Loss from continuing operations 
Recovery of income taxes 
Interest expense, net 
Other expense, net 
Total segment operating income (loss) 
  Depreciation and amortization 
Stock-based compensation(a) 
Plant expansion and start-up costs(h) 
Costs related to business acquisitions(b) 
Inventory reserves and liquidation sales to de-risk positions(i) 
  Downtime, spoilage and other costs due to equipment failure(j) 
  Demurrage, detention and other related expenses(k) 

Litigation-related legal fees(f) 

Adjusted EBITDA 

Excluding flexible 
resealable pouch 
and nutrition bar 
$ 

Flexible  
resealable pouch 
and nutrition bar 
$ 

Consolidated 
$ 

(49,288) 
(22,981) 
43,275 
28,292 
17,540 
16,838 
33,320 
3,885 
15,150 
4,041 
3,428 
2,855 
1,850 
1,565 
82,932 

(1,417) 
(2,294) 
15,669 
12,151 
24,109 
20,372 
3,512 
4,081 
4,000 
2,367 
480 
2,038 
1,709 
62,668 

(1,276) 
(816) 
- 
- 
- 
(2,092) 
830 
- 
- 
- 
- 
- 
- 
- 
(1,262) 

(1,715) 
(1,096) 
- 
- 
(2,811) 
635 
- 
- 
- 
- 
1,739 
- 
- 
(437) 

(50,564) 
(23,797) 
43,275 
28,292 
17,540 
14,746 
34,150 
3,885 
15,150 
4,041 
3,428 
2,855 
1,850 
1,565 
81,670 

(3,132) 
(3,390) 
15,669 
12,151 
21,298 
21,007 
3,512 
4,081 
4,000 
2,367 
2,219 
2,038 
1,709 
62,231 

(a)  For 2016 and 2015, stock-based compensation of $3.9 million and $3.5 million, respectively, was recorded in SG&A expenses. 
(b)  For 2016, reflects costs related to the acquisition accounting adjustment related to Sunrise’s inventory sold in 2016 of $15.0 million, and the 
integration costs related to the closure and consolidation of our frozen fruit processing operations following the Sunrise Acquisition of $0.2 
million,  which  were  recorded  in  cost  of  goods  sold.    For  2015,  reflects  costs  related  to  the  acquisition  accounting  adjustment  related  to 
Sunrise’s inventory sold subsequent to the acquisition date of $4.0 million. 

(c)  Reflects legal and other professional advisory costs of $4.0 million recorded in SG&A expenses.   
(d)  Reflects aging reserves and low margin sales to reduce inventory exposures mainly related to certain grain varieties that we exited, which 

were recorded in cost of goods sold. 

(e)  Reflects costs of $1.2 million for the withdrawal of certain consumer-packaged products for quality-related issues, which was recorded in 
cost of goods and the estimated lost gross profit caused by the sunflower recall of $1.7 million, which reflected a shortfall in revenues against 
anticipated volumes of approximately $9.8 million, less associated cost of goods sold of approximately $8.1 million. 

(f)  Reflects legal costs related to the settlement of the flexible resealable pouch product recall dispute with a customer, which were recorded in 

SG&A expenses. 

(g)  Reflects the negative gross profit reported by the Allentown facility as the facility ramped up to break-even production levels. 
(h)  Reflects costs related to the retrofit of our San Bernardino, California, juice facility and expansion of the Allentown facility to add aseptic 

beverage processing and filling capabilities, which were recorded in cost of goods sold. 

(i)  Reflects inventory reserves and low margin sales incurred to reduce inventory exposures in certain organic raw materials, which were recorded 

in cost of goods sold. 

(j)  Reflects downtime and spoilage caused by equipment failures, which were recorded in cost of goods sold. 
(k)  Reflects additional logistics costs stemming from capacity constraints on imports and exports within the Global Ingredients segment, which 

were recorded in cost of goods sold. 

(4)   Refer to footnote (4) to the “Consolidated Results of Operations for the Fiscal Years 2017 and 2016” table regarding the use of certain other non-GAAP 

measures in the discussion of our results of operations below. 

Revenues for the year ended December 31, 2016 increased by 17.6% to $1,346.7 million from $1,145.1 million for the year 
ended January 2, 2016.  Excluding the impact on revenues for the year ended December 31, 2016 of business acquisitions and 
associated product rationalizations (an increase in revenues of approximately $230.8 million), changes in commodity-related 
pricing and foreign exchange rates (a decrease in revenues of approximately $28.1 million), estimated impact of the recall of 
certain sunflower kernel products based on shortfall against anticipated volumes (a decrease in revenues of approximately $9.8 
million), and estimated impact on west coast pouch operations as a result of a fire at a third-party facility (a decrease in revenues 

SUNOPTA INC. 

58 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
of  approximately  $5.1  million),  revenues  increased  1.0%  in  2016,  compared  with  2015.   This  increase  in  revenues  on  an 
adjusted basis reflected higher demand for organic ingredients and growth in aseptic beverage volumes with the added output 
from the Allentown facility and new product launches.  These positive factors were mostly offset by lower volumes of specialty 
raw materials driven by a reduction in contracted acres and lower retail market demand for frozen fruit in the fourth quarter of 
the 2016.  

Gross profit increased $15.6 million, or 14.1%, to $126.0 million for the year ended December 31, 2016, compared with $110.4 
million for the year ended January 2, 2016.  As a percentage of revenues, gross profit for the year ended December 31, 2016 
was 9.4% compared to 9.6% for the year ended January 2, 2016, a decrease of 0.2%.  The gross profit percentage for 2016 
would  have  been  approximately  10.9%,  excluding  the  impact  of  an  acquisition  accounting  adjustment  related  to  Sunrise’s 
inventory sold in 2016 ($15.0 million), aging reserves and low margin sales to reduce inventory exposures mainly on specialty 
grain  varieties  we  were  exiting  ($3.4  million),  lost  margin  caused  by  the  recall  of  certain  sunflower  kernel  products  ($1.7 
million), start-up costs related to the ramp-up of production at the Allentown aseptic beverage facility ($1.6 million), and an 
inventory reserve for certain consumer-packaged products due to quality-related issues ($1.2 million).  For 2015, the gross 
profit percentage would also have been approximately 10.9%, excluding the impact of costs related to the retrofit of the San 
Bernardino juice facility and expansion of the Allentown facility to add aseptic beverage production capabilities ($4.1 million), 
an acquisition accounting adjustment related to the Sunrise’s inventory sold subsequent to the acquisition date ($4.0 million), 
aging reserves and low margin sales to reduce inventory exposures on certain organic raw materials ($2.4 million), downtime 
and spoilage caused by equipment failures at the Allentown pouch facility ($2.2 million), and demurrage, detention and other 
related expenses ($2.0 million).  Excluding these items, the year-over-year gross profit percentage on an adjusted basis reflected 
increased efficiency and lower costs at our aseptic beverage operations and improved pricing spreads on organic ingredients.  
These  positive  factors  were  offset  by  increased  raw  material  costs  for  frozen  strawberries  that  could  not  be  passed  on 
immediately to customers, as well as production inefficiencies within our frozen fruit operations in the first half of 2016 caused 
by a late harvest and the resultant shortage of strawberries.  In addition, we experienced lower pricing spreads on specialty corn 
and soy and reduced throughput in our sunflower and roasting operations  with the implementation of  new food safety and 
quality processes.  

Total segment operating income for the year ended December 31, 2016 decreased by $6.6 million, or 30.8%, to $14.7 million, 
compared with $21.3 million for the year ended January 2, 2016.  As a percentage of revenues, segment operating income was 
1.1% for the year ended December 31, 2016, compared with 1.9% for the year ended January 2, 2016.  The decrease in segment 
operating income mainly reflected a $12.9 million increase in SG&A expenses and $6.3 million increase in intangible asset 
amortization, which more than offset the higher overall gross profit as described above. The increase in SG&A expenses in 
2016, compared with 2015, reflected incremental expenses from acquired businesses, and external advisory costs associated 
with the strategic review and Value Creation Plan ($4.0 million).  The year-over-year increase in intangible asset amortization 
of $6.3 million reflected the incremental amortization of identified intangible assets of acquired businesses.  Also contributing 
to the decrease in segment operating income was a foreign exchange loss of $1.2 million in 2016, compared with a foreign 
exchange gain of $1.6 million in 2015, mainly reflecting the negative impact of a strengthening of the U.S. dollar relative to 
the peso on our Mexican frozen fruit operations in 2016, compared with the positive impact of a strengthening of the U.S. 
dollar relative to the euro in 2015. 

Further  details  on  revenue,  gross  profit  and  segment  operating  income  variances  are  provided  below  under  “Segmented 
Operations Information”. 

Other expense for the year ended December 31, 2016 of $28.3 million reflected the impairment of long-lived assets related to 
the closures of the San Bernardino and Heuvelton  facilities ($11.5 million),  and employee termination costs ($2.8  million) 
associated with the Value Creation Plan, the cost of the  settlement of the aforementioned flexible resealable pouch product 
recall dispute with a customer ($9.0 million), as well as costs associated with product withdrawals and recalls ($2.8 million), 
and facility rationalization and severance costs primarily related to the consolidation of our frozen fruit processing facilities 
following the Sunrise Acquisition ($2.2 million).  Other expenses in 2016 were partially offset by the $1.7 million gain  on 
settlement of the contingent consideration obligation related to the acquisition of Niagara Natural.  Other expense for the year 
ended January 2, 2016 of $12.2 million included business development costs of $7.8 million, primarily reflecting acquisition- 
and integration-related costs incurred in connection with the Sunrise Acquisition; as well as severance and other rationalization 
costs of $2.9 million.   

In 2016, we recognized a non-cash goodwill impairment charge of $17.5 million related to the Sunflower reporting unit of the 
Global Ingredients segment, due to lower anticipated sales demand and higher expected production and capital costs as a result 
of the sunflower recall. 

SUNOPTA INC. 

59 

December 30, 2017 10-K 

 
 
  
 
 
 
 
The increase in interest expense of $27.6 million to $43.3 million for the year ended December 31, 2016, compared with $15.7 
million for the year ended January 2, 2016, primarily reflected increased costs associated with borrowings to finance the Sunrise 
Acquisition.  Interest expense for 2016 included $10.5 million of non-cash amortization and expense of the initial second lien 
loans used to partially fund the Sunrise Acquisition, compared with $3.4 million in 2015.     

We recognized a recovery of income tax of $23.8 million for the year ended December 31, 2016 (including the realization of 
$1.3 million of previously unrecognized tax benefits), compared with a recovery of income tax of $3.4 million for the year 
ended January 2, 2016.  Excluding the impact of the change in unrecognized tax benefits, the effective tax rate for 2016 was 
39.6% of the loss before income taxes (excluding the non-deductible goodwill impairment loss), compared with 52.0% of loss 
before income taxes for 2015.  The effective tax rates reflected the impact of changes in the jurisdictional mix of earnings, 
mainly as the result of pre-tax losses in the U.S. in 2016 and 2015, which reflected costs related to the Sunrise Acquisition 
(including financing-related costs and acquisition accounting adjustments to Sunrise inventory sold).  In addition, for 2016, 
pre-tax losses in the U.S. reflected costs associated with the Value Creation Plan, settlement of the product recall dispute, and 
product withdrawal and recall costs. 

Loss from continuing operations, net of non-controlling interests, for the year ended December 31, 2016 was $50.6 million, 
compared with a loss of $3.0 million for the year ended January 2, 2016, an increase of $47.6 million.  Diluted loss per share 
from  continuing  operations  was  $0.61  for  the  year  ended  December  31,  2016,  compared  with  diluted  loss  per  share  from 
continuing operations of $0.04 for the year ended January 2, 2016.   

Loss from discontinued operations of $0.6 million for the year ended December 31, 2016 reflected the loss from operations of 
Opta Minerals of $2.0 million, which included an asset impairment charge of $1.2 million, partially offset by a $0.6 million 
gain on classification as held for sale, net of recovery of income taxes and non-controlling interest of $0.9 million. Loss from 
discontinued operations of $19.5 million for the year ended January 2, 2016 primarily reflected the results of Opta Minerals, 
including an asset impairment charge of $12.4 million and loss on classification as held for sale of $10.5 million, net of non-
controlling interest of $8.8 million. 

On a consolidated basis, we realized a loss of $51.2 million (diluted loss per share of $0.62) for the year ended December 31, 
2016, compared with a loss of $22.5 million (diluted loss per share of $0.31) for the year ended January 2, 2016. 

For the year ended December 31, 2016, adjusted earnings were $5.8 million, or $0.07 per diluted share, on a consolidated basis, 
compared with adjusted earnings of $19.0 million, or $0.26 per diluted share, on a consolidated basis for the year ended January 
2, 2016.  Excluding flexible resealable pouch and nutrition bar product lines and operations, adjusted earnings $7.1 million, or 
$0.08 per diluted share, for the year ended December 31, 2016, compared with adjusted earnings of $19.7 million, or $0.27 per 
diluted share, for the year ended January 2, 2016.  Adjusted EBITDA for the year ended December 31, 2016 was $81.7 million 
on a consolidated basis, compared with $62.2 million on a consolidated basis for the year ended January 2, 2016.  Excluding 
flexible resealable pouch and nutrition bar product lines and operations, adjusted EBITDA for the year ended December 31, 
2016 was $83.0 million, compared with $62.7 million for the year ended January 2, 2016.  Adjusted earnings and adjusted 
EBITDA  are  non-GAAP  financial  measures.    See  footnotes  (2)  and  (3)  to  the  table  above  for  a  reconciliation  of  adjusted 
earnings/loss  and  adjusted  EBITDA  from  loss  from  continuing  operations,  which  we  consider  to  be  the  most  directly 
comparable U.S. GAAP financial measure. 

Segmented Operations Information 

Global Ingredients 

December 31, 2016 

January 2, 2016 

Change 

% Change 

Revenue 
Gross Profit 
Gross Profit % 

Operating Income 
Operating Income % 

574,295 
64,374 
11.2% 

26,787 
4.7% 

610,890 
66,461 
10.9%  

28,184 
4.6%  

(36,595) 
(2,087) 

(1,397) 

-6.0% 
-3.1% 
0.3% 

-5.0% 
0.1% 

Global Ingredients contributed $574.3 million in revenues for the year ended December 31, 2016, compared to $610.9 million 
for the year ended January 2, 2016, a decrease of $36.6 million or 6.0%.  Excluding the estimated impact on revenues of the 
recall of certain sunflower kernel products and the impact of changes including foreign exchange rates and commodity-related 
pricing, Global Ingredients revenues decreased approximately 0.2%. The table below explains the decrease in revenue: 

SUNOPTA INC. 

60 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Global Ingredients Revenue Changes 

Revenues for the year ended January 2, 2016 

Lower volumes of specialty corn and soy driven by a reduction of contracted acres, as 
well as decreased volumes of organic feed, roasted and other ingredient products 

Lower sunflower volumes attributed to downtime due to the impact of the recall in the 
second quarter of 2016, and lower throughput after restarting our roasting operations, 
combined with lower export volumes of in-shell sunflower due primarily to a strong 
U.S. dollar 

Decreased commodity pricing of specialty corn, soy, sunflower and organic feed 

Decreased commodity pricing for organic seeds and nuts, coffee, oils, sugar and quinoa 

Higher volumes of internationally sourced organic ingredients including cocoa, fruit, 
vegetables, coffee, seeds and nuts  

Revenues for the year ended December 31, 2016 

$610,890 

(36,551) 

(17,301) 

(14,651) 

(13,458) 

45,366 

$574,295 

Gross profit in Global Ingredients decreased by $2.1 million to $64.4 million for the year ended December 31, 2016 compared 
to $66.5 million for the year ended January 2, 2016, and the gross profit percentage increased by 0.3% to 11.2%.  The increase 
in gross profit as a percentage of revenue was primarily due to a favorable sales mix driven by higher margin international 
organic raw materials and improved mix in domestic raw materials as a result of a decline in acres contracted of low margin 
seed  and  grain  varieties,  mark-to-market  gains  on  commodity  futures  contracts,  and  improved  transloading  operating 
efficiencies from the prior year, partially offset by the impact of the sunflower recall on operations and lower pricing spreads 
on non-GMO soy, corn and organic feed. The table below explains the decrease in gross profit: 

Global Ingredients Gross Profit Changes 

Gross profit for the year ended January 2, 2016 

Margin loss from downtime associated with the sunflower recall, and as reduced 
throughput following the restart of our roasting operations, as well as lower export 
volumes of in-shell sunflower due primarily to a strong U.S. dollar 

Lower pricing spread on specialty corn and soy, as well as inventory reserves and low 
margin sales recorded against certain grain varieties that we are exiting, partially offset 
by improved recoveries over the prior year related to transloading costs in 2015  

Favorable margin impact of mark-to-market gains related to commodity futures 
contracts 

Favorable impact on gross margins due to improved pricing spreads on internationally 
sourced organic ingredients, partially offset by reduced yield and other operational 
inefficiencies at our European sunflower operations 

Gross profit for the year ended December 31, 2016 

$66,461 

(4,201) 

(2,881) 

2,707 

2,288 

$64,374 

Operating income in Global Ingredients decreased by $1.4 million, or 5.0%, to $26.8 million for the year ended December 31, 
2016,  compared  to  $28.2  million  for  the  year  ended  January  2,  2016.  The  table  below  explains  the  decrease  in  operating 
income: 

SUNOPTA INC. 

61 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Global Ingredients Operating Income Changes 

Operating income for the year ended January 2, 2016 

Decrease in gross profit, as explained above 

Decreased foreign exchange gains on forward currency contracts 

Decrease in corporate cost allocations 

Lower professional fees and employee-related compensation costs 

Operating income for the year ended December 31, 2016 

$28,184 

(2,087) 

(2,590) 

2,573 

707 

$26,787 

Consumer Products 

December 31, 2016 

January 2, 2016 

Change 

% Change 

Revenue 
Gross Profit 
Gross Profit % 

Operating Income 
Operating Income % 

772,436 
61,578 
8.0% 

1,206 
0.2% 

534,244 
43,901 

8.2%  

3,208 
0.6%  

238,192 
17,677 

(2,002) 

44.6% 
40.3% 
-0.2% 

-62.4% 
-0.4% 

Consumer Products contributed $772.4 million in revenues for the year ended December 31, 2016, compared to $534.2 million 
for the year ended January 2, 2016, an increase of $238.2 million or 44.6%. Excluding the impact of business acquisitions and 
associated product rationalizations, as well as the estimated impact on west coast pouch operations as a result of a fire at a 
third-party facility in the third quarter of 2016, Consumer Products revenues  increased 1.6%. The table below explains the 
increase in revenue: 

Consumer Products Revenue Changes 

Revenues for the year ended January 2, 2016 

Acquired revenues as a result of the acquisition of Sunrise, partially offset by the impact 
of customer transition following the closure of the Buena Park processing facility in the 
first quarter of 2016, as well as lower volumes in the foodservice and retail customer 
markets in the latter half of the year  

Higher sales of aseptic beverages including retail almond beverages and non-dairy into 
the foodservice channel, along with stronger sales of shelf-stable juice as a result of new 
product innovation 

Acquired revenues as a result of the acquisition of Niagara Natural and increased 
volumes of flexible resealable pouch offerings as a result of new business contracted, 
partially offset by lower volumes of nutrition bars 

Impact on revenues from closure of west coast pouch operations as a result of a fire at a 
third-party facility in the third quarter on 2016 

Revenues for the year ended December 31, 2016 

$534,244 

209,397 

28,682 

4,303 

(4,190) 

$772,436 

Gross profit in Consumer Products increased by $17.7 million to $61.6 million for the year ended December 31, 2016 compared 
to $43.9 million for the year ended January 2, 2016, and the gross profit percentage decreased by 0.2% to 8.0%. For the year 
ended December 31, 2016, gross profit as  a percentage of revenue was impacted by a $15.0 million acquisition accounting 
adjustment related to Sunrise inventory  sold, as  well as costs associated  with expansion activities at the Allentown aseptic 
beverage facility ($1.6 million), and an inventory reserve for certain consumer-packaged products due to quality-related issues 
($1.2 million). Excluding these costs, the gross profit percentage in Consumer Products would have been 10.3% for the year 
ended December 31, 2016. The increase in gross profit percentage on an adjusted basis reflected the higher margin profile of 
2015 business acquisitions, and increased facility utilization and operating costs within the beverage operations, partially offset 
by higher costs within healthy fruit operations due to a delayed 2016 fruit harvest that led to increased labor costs and higher 
raw material prices that were not immediately built into customer pricing. The table below explains the increase in gross profit: 

SUNOPTA INC. 

62 

December 30, 2017 10-K 

 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consumer Products Gross Profit Changes 

Gross profit for the year ended January 2, 2016 

Margin impact of the Sunrise Acquisition and improved pricing for frozen fruit offerings 
and for fruit bases and toppings 

Increased contribution from sales of aseptic and non-aseptic private label beverages, 
driven by increased production volumes and higher facility utilization 

Margin impact from acquisition accounting adjustment related to Sunrise inventory sold  

Lower volumes of fruit snacks and nutrition bars, partially offset by increased volumes 
of flexible resealable pouch offerings from our east coast pouch facility as a result of 
new business contracted 

Gross profit for the year ended December 31, 2016 

$43,901 

26,551 

4,763 

(11,000) 

(2,637) 

$61,578 

Operating income in Consumer Products decreased by $2.0 million, or 62.4%, to $1.2 million for the year ended December 31, 
2016, compared to $3.2 million for the year ended January 2, 2016. The table below explains the decrease in operating income: 

Consumer Products Operating Income Changes 

Operating income for the year ended January 2, 2016 

Increase in gross profit, as explained above 

Increased SG&A costs due primarily to the acquisitions of Sunrise and Niagara Natural, 
and increased foreign exchange losses on international operations, partially offset by 
lower employee-related compensation costs  

Increase in corporate cost allocations, reflecting additional revenues and headcount 
related to the acquisitions of Sunrise, Citrusource and Niagara Natural 

Operating income for the year ended December 31, 2016 

 $3,208 

17,677 

(14,418) 

(5,261) 

 $1,206 

Corporate Services 

December 31, 2016 

January 2, 2016 

Change 

% Change 

Operating Loss 

(13,247) 

(10,094) 

(3,153) 

-31.2% 

Operating loss at Corporate Services increased by $3.2 million to $13.2 million for the year ended December 31, 2016, from a 
loss of $10.1 million for the year ended January 2, 2016. The table below explains the increase in operating loss: 

Corporate Services Operating Loss Changes 

Operating loss for the year ended January 2, 2016 

Increased costs associated with strategic review and Value Creation Plan 

Higher employee-related compensation costs due to increased headcount, stock-based 
compensation and health benefits 

Increase in non-compensation-related costs, offset by lower foreign exchange losses 

Increase in corporate cost allocations, due in part to centralization of services 

Operating loss for the year ended December 31, 2016 

 $(10,094) 

(4,041) 

(1,603) 

(197) 

2,688 

 $(13,247) 

Management fees mainly consist of salaries of corporate personnel who perform back office functions for operating segments, 
as well as costs related to the enterprise resource management system. These expenses are allocated to the operating segments 
based on (1) specific identification of allocable costs that represent a service provided to each segment and (2) a proportionate 

SUNOPTA INC. 

63 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
distribution of costs based on a weighting of factors such as revenue contribution and number of people employed within each 
segment.  

Liquidity and Capital Resources 

We have the following sources from which we can fund our operating cash requirements: 

(cid:120)  Existing cash and cash equivalents; 

(cid:120)  Available operating lines of credit; 

(cid:120)  Cash flows generated from operating activities, including working capital efficiency efforts; 

(cid:120)  Cash flows generated from the exercise, if any, of stock options during the year; 

(cid:120)  Potential additional long-term financing, including the offer and sale of debt and/or equity securities; and 

(cid:120)  Potential sales of divisions, or assets. 

On  February  11,  2016,  we  entered  a  five-year  credit  agreement  for  the  Global  Credit  Facility  in  the  maximum  aggregate 
principal amount of $350 million, subject to borrowing base capacity.  The Global Credit Facility supports the working capital 
and  general  corporate  needs  of  our  global  operations,  in  addition  to  funding  strategic  initiatives.    In  addition,  subject  to 
customary  borrowing  conditions  and  the  agreement  of  any  such  lenders  to  provide  such  increased  commitments,  we  may 
request to increase the total lending commitments under this facility to a maximum aggregate principal amount not to exceed 
$450 million.  The applicable margin in the Global Credit Facility ranges from 1.25% to 1.75% for loans bearing interest based 
on LIBOR and from 0.25% to 0.75% for loans bearing interest based on the prime rate and, in each case, is set quarterly based 
on average borrowing availability for the preceding fiscal quarter.   

On September 19, 2017, we entered into an amendment to the Global Credit Facility to add an additional U.S. asset-based 
credit subfacility (the “New U.S. Subfacility”) of an aggregate principal amount of $15.0 million.  The principal amount of 
New U.S. Subfacility is repayable in quarterly instalments of $2.5 million, commencing with the fiscal quarter ending March 
31, 2019.  Borrowings repaid under the New U.S. Subfacility may not be borrowed again.  The applicable margin for the New 
U.S. Subfacility ranges from 2.00% to 2.50% with respect to base rate and prime rate borrowings  and from 3.00% to 3.50% 
for eurocurrency rate and bankers’ acceptance rate borrowings. 

As  at  December  30,  2017,  we  had  outstanding  borrowings  of  $230.5  million  and  approximately  $54  million  of  available 
borrowing capacity under the Global Credit Facility.  For more information on the Global Credit Facility, see note 13(1) to the 
consolidated financial statements at Item 15 of this Form 10-K. 

On October 20, 2016, SunOpta Foods issued $231.0 million of 9.5% Senior Secured Second Lien Notes due October 9, 2022 
(the “Notes”).  The issuance of the Notes represented the culmination of the financing arrangements associated with the Sunrise 
Acquisition.    As  at  December  30,  2017,  the  outstanding  principal  amount  of  the  Notes  was  $223.5  million,  following  the 
principal repayment of $7.5 million in October 2017.   For more information on the Notes, see note 13(3) to the  consolidated 
financial statements at Item 15 of this Form 10-K. 

In order to finance significant acquisitions, if any, that may arise in the future, we may need additional sources of cash that we 
could attempt to obtain through a combination of additional bank or subordinated financing, a private or public offering of debt 
or equity securities, or the issuance of common stock as consideration in an acquisition.  There can be no assurance that these 
types of financing would be available at all or, if so, on terms that are acceptable to us. 

In the event that we require additional liquidity due to market conditions, unexpected actions by our lenders, changes to our 
growth strategy, or other factors, our ability to obtain any additional financing on favourable terms, if at all, could be limited. 

SUNOPTA INC. 

64 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash Flows 

Fiscal 2017 Compared to Fiscal 2016 

Net cash and cash equivalents increased $1.9 million to $3.2 million as at December 30, 2017, compared with $1.3 million at 
December 31, 2016, which primarily reflected the following uses of cash: 

(cid:120) 

(cid:120) 

(cid:120) 

capital expenditures of $41.1 million, mainly related to new capabilities within our aseptic beverage operations and 
expansion of our Dutch cocoa and Mexican frozen fruit facilities, as well as food safety and production enhancements 
across our manufacturing base; 

repayment of $7.5 million principal amount of outstanding Notes; and 

payment of cash dividends on preferred stock of $6.7 million. 

These uses of cash were mostly offset by the following sources of cash: 

(cid:120) 

(cid:120) 

cash provided by continuing operating activities of $31.5 million; and 

borrowings of $22.2 million under our line of credit facilities. 

Cash  provided  by  operating  activities  of  continuing  operations  was  $31.5  million  for  the  year  ended  December  30,  2017, 
compared with cash provided of $0.7 million for the year ended December 31, 2016, an increase in cash provided of $30.7 
million.    The  increase  in  cash  provided  by  operating  activities  reflected  cash  generated  through  working  capital  efficiency 
initiatives during 2017, which were focused on lowering inventory positions, maximizing purchasing terms, and augmenting 
collection efforts for accounts receivable.  These positive efforts were partially offset by the cash settlement of $38.6 million 
of costs incurred under the Value Creation Plan in 2017, compared to $3.1 million in 2016. 

Cash used in investing activities of continuing operations was $40.1 million for the year ended December 30, 2017, compared 
with cash used on $21.6 million for the year ended December 31, 2016, an increase in cash used of $18.5 million, which mainly 
reflected an increase in capital expenditures of $18.6 million, partially reflecting the early buyout of equipment leases associated 
with the closure of the San Bernardino facility and exit from flexible resealable pouch operations ($11.9 million). 

Cash  provided  by  financing  activities  of  continuing  operations  was  $10.6  million  for  the  year  ended  December  30,  2017, 
compared with cash provided of $16.8 million for the  year ended December 31, 2016, a decrease in cash provided of $6.2 
million. Net borrowings under our line of credit facilities increased $22.2 million in 2017, compared with an increase of $44.3 
million  in  2016,  a  period-over-period  decrease  in  net  borrowings  under  the  line  of  credit  facilities  of  $22.1  million.    This 
decrease  in  borrowings  reflected  the  year-over-year  reductions  in  working  capital  requirements  ($31.6  million)  and  debt 
issuance costs related to the Notes and Global Credit Facility ($12.6 million), partially offset by the year-over-year increase in 
capital spending of $18.6 million.   

Fiscal 2016 Compared to Fiscal 2015 

Net cash and cash equivalents related to continuing operations decreased $1.0 million to $1.3 million as at December 31, 2016, 
compared with $2.3 million at January 2, 2016, which primarily reflected the following uses of cash: 

(cid:120) 

(cid:120) 

repayment of $320.0 million second lien borrowings used to initially fund the Sunrise Acquisition; 

capital expenditures of $22.6 million, mainly related to the automation of frozen fruit processing and to food safety 
and quality initiatives in connection with the Value Creation Plan; and 

(cid:120) 

payment of $13.0 million of debt issuance costs related to the Notes and Global Credit Facility. 

These uses of cash were mostly offset by the following sources of cash: 

(cid:120) 

proceeds of $231.0 million and $79.0 million on the issuance of the Notes and preferred stock, respectively, used to 
repay the second lien borrowings; and 

SUNOPTA INC. 

65 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(cid:120) 

net borrowings of $44.3 million under our line of credit facilities. 

Cash  provided  by  operating  activities  of  continuing  operations  was  $0.7  million  for  the  year  ended  December  31,  2016, 
compared with $26.4 million for the year ended January 2, 2016, a decrease in cash provided of $25.7 million, which reflected 
lower year-over-year operating performance in the fourth quarter of 2016, resulting in reduced inventory turnover, partially 
offset by the receipt of income tax refunds during 2016 related to 2015. 

Cash used in investing activities of continuing operations was $21.6 million for the year ended December 31, 2016, compared 
with cash used of $521.6 million for the year ended January 2, 2016, a decrease in cash used of $500.0 million, which mainly 
reflected total cash paid of $490.7 million in connection with the Sunrise Acquisition, as well as upfront payments for Niagara 
Natural and Citrusource in 2015.  In addition, capital expenditures declined year-over-year by $8.6 million, reflecting higher 
spending in 2015 related to a retrofit of the San Bernardino juice facility and the expansion of the Allentown aseptic beverage 
facility. Cash provided by investing activities of discontinued operations in 2016 reflected cash proceeds from the sale of Opta 
Minerals of $3.2 million, net of cash sold. 

Cash  provided  by  financing  activities  of  continuing  operations  was  $16.8  million  for  the  year  ended  December  31,  2016, 
compared with cash provided of $490.0 million for the year ended January 2, 2016, a decrease in cash provided of $473.2 
million, which mainly reflected debt and equity issuances in connection with the Sunrise Acquisition in 2015 for proceeds of 
$408.1 million in the aggregate, net of issuance costs.  In addition, net borrowings under our line of credit facilities decreased 
$41.7  million  in  2016,  compared  with  2015,  reflecting  borrowings  of  $79.2  million  to  finance  a  portion  of  the  Sunrise 
Acquisition and upfront payments for Niagara Natural and Citrusource in 2015, partially offset by the payment of $13.0 million 
of debt issuance costs incurred in 2016 in connection with the Notes and Global Credit Facility, and repayment of $10.0 million 
of second line borrowings in 2016.  In addition, we repaid the remaining $310.0 million outstanding under the second lien 
borrowings with gross proceeds of $231.0 million from the issuance of the Notes and net proceeds of $79.0 million from the 
issuance of the preferred stock.  In 2016, we also repaid in full outstanding borrowings of $192.7 million under our former 
North American and European credit facilities with new borrowings under the Global Credit Facility.  

Off – Balance Sheet Arrangements 

There are currently no off-balance sheet arrangements that have or are reasonably likely to have a current or future material 
effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources. 

Contractual Obligations   

The table below sets out our contractual obligations as at December 30, 2017: 

Bank indebtedness(1) 
Long-term debt 
Interest on bank indebtedness and long-term debt(2) 
Purchase commitments 

Operating leases 

Long-term liabilities 

Commodity and foreign exchange contracts 

Total 

$ 

234,090 

235,749 

113,873 

346,500 

71,899 

13,652 

1,001 

Payments due by Period 

2018 

2019-2020 

2021-2022 

Thereafter 

$ 

219,090 

2,228 

29,073 

346,500 

19,048 

5,300 

997 

$ 

15,000 

5,971 

42,720 

- 

29,070 

8,352 

4 

$ 

- 

225,523 

41,502 

- 

15,913 

- 

- 

$ 

- 

2,027 

578 

- 

7,868 

- 

- 

1,016,764 

622,236 

101,117 

282,938 

10,473 

(1) 

(2) 

Includes borrowings of $215.5 million under the revolving facilities of the Global Credit Facility that have terms of six months or less.  Outstanding 
borrowings under these revolving facilities are repayable in full on February 10, 2021.  Also includes borrowings of $15.0 million under the New 
U.S. Subfacility that are repayable in quarterly instalments of $2.5 million beginning March 31, 2019. 
Interest on bank indebtedness is calculated based on scheduled repayments over the periods as indicated, using existing interest rates at December 
30, 2017, as disclosed in note 13 to the consolidated financial statements included in Item 15 of this Form 10-K. 

SUNOPTA INC. 

66 

December 30, 2017 10-K 

 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 7A.  Quantitative and Qualitative Disclosures About Market Risk 

Interest rate risk 

Variable  and  fixed  rate  borrowings  carry  different  types  of  interest  rate  risk.  Variable  rate  debt  gives  less  predictability  to 
earnings and cash flows as interest rates change, while the fair value of fixed rate debt is affected by changes in interest rates.  
As  at  December  30,  2017,  we  had  $234.1  million  and  $228.0  million  principal  amount  of  variable  and  fixed  rate  debt, 
respectively, with weighted-average interest rates of 3.4% and 9.2%, respectively. A 100 basis-point change in interest rates 
would  have  a  pre-tax  effect  of  $2.3  million on  our  earnings  and  cash  flows,  based  on  current  outstanding  borrowings  and 
effective interest rates on our variable rate debt.  While our variable-rate debt may impact earnings and cash flows as interest 
rates change, it is not subject to changes in fair value. 

As at December 30, 2017, most of our fixed rate debt was comprised of the Notes.  If interest rates were to increase or decrease 
by 100 basis-points, the fair value of the Notes would increase or decrease by approximately $8.0 million.  

Foreign currency risk 

All of our U.S. subsidiaries use the U.S. dollar as their functional currency, and the U.S. dollar is also our reporting currency. 
In addition, the functional currency of our Canadian and Mexican operations is the U.S. dollar. The functional currency of our 
operations located in Europe are principally the euro. For these operations, gains or losses on translation of net assets to U.S. 
dollars on consolidation are recorded in accumulated other comprehensive loss within shareholders’ equity.  We are exposed 
to foreign exchange rate fluctuations as the financial results of our European subsidiaries are translated into U.S. dollars on 
consolidation.  A 10% change in the exchange rates for the euro, relative to the U.S. dollar, would affect the carrying value of 
our net assets by approximately $7.1 million, with a corresponding impact to accumulated other comprehensive loss. 

The euro appreciated against the U.S. dollar during 2017, with closing rates moving from $1.0553 at December 31, 2016 to 
$1.1998 at December 30, 2017.   In 2017, the Canadian dollar also appreciated relative to the U.S. dollar, with closing rates 
moving from $0.7448 at December 31, 2016 to $0.7971 at December 30, 2017. 

Our operations based in the U.S. have limited exposure to other currencies since almost all sales and purchases are made in 
U.S.  dollars.  The  European  operations  are  exposed  to  various  currencies  as  they  purchase  product  from  a  wide  variety  of 
countries  in several currencies and primarily  sell into the  European  market.  It is our intention to hold excess  funds in the 
currency  in  which  the  funds  are  likely  to  be  used,  which  will  from  time  to  time  potentially  expose  us  to  exchange  rate 
fluctuations when converted into U.S. dollars.  In addition, we enter into forward foreign exchange contracts to reduce exposure 
to  fluctuations  in  foreign  currency  exchange  rates.  Open  forward  foreign  exchange  contracts  were  marked-to-market  at 
December 30, 2017, resulting in a loss of $2.4 million (December 31, 2016 – gain of $1.0 million), which is included in foreign 
exchange on the consolidated statements of operations, and a loss of $0.4 million included in other comprehensive loss.   

Commodity risk 

We enter into exchange-traded commodity futures and options contracts to hedge its exposure to price fluctuations on grain 
and  certain  other  commodity  transactions  to  the  extent  considered  practicable  for  minimizing  risk  from  market  price 
fluctuations.  Futures contracts used for hedging purposes are purchased and sold through regulated commodity exchanges. 
Inventories,  however,  may  not  be  completely  hedged,  due  in  part  to  our  assessment  of  our  exposure  from  expected  price 
fluctuations. Exchange purchase and sales contracts may expose us to risk in the event that the counterparty to a transaction is 
unable to fulfill its contractual obligation. We manage our risk by entering into purchase contracts with pre-approved growers.  

We have a risk of loss from hedging activities if a grower does not deliver as scheduled. Sales contracts are entered into with 
organizations of acceptable creditworthiness, as internally evaluated. All futures transactions are marked to market. Gains and 
losses on futures transactions related to grain inventories are included in cost of goods sold. As at December 30, 2017, we 
owned 280,558 (December 31, 2016 – 354,699) bushels of corn with a weighted-average price of  $3.55 (December 31, 2016 
– $3.17) and 254,022 (December 31, 2016 – 569,943) bushels of soybeans with a weighted-average price of  $9.68 (December 
31, 2016 – $10.74). As at December 30, 2017, we had a net long position on corn of 10,425 (December 31, 2016 – net short 
position of 10,937) bushels and a net short position on soybeans of 9,354 (December 31, 2016 – net short position of 43,866). 
An increase or decrease in commodity prices of either soy or corn of 10% would not result in a material change in the carrying 
value of these commodities.  

In addition, we enter into forward contracts to hedge our cocoa and coffee positions in an effort to minimize price fluctuations.  
As at December 30, 2017, we had net open forward contracts to sell 299 lots of cocoa (December 31, 2016 – 142 lots) and 3 

SUNOPTA INC. 

67 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
lots of coffee (December 31, 2016 – 21 lots).  A 10% change in the commodity price of cocoa and coffee would impact the fair 
value of these derivative instruments by $0.1 million (December 31, 2016 – $0.3 million). 

Item 8.  Financial Statements and Supplementary Data 

The consolidated financial statements required by this item are set forth immediately following the signature page to this 
Form 10-K beginning on page F-1 and are incorporated herein by reference. 

Item 9.  Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 

None. 

SUNOPTA INC. 

68 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
Item 9A - Controls and Procedures 

Evaluation of Disclosure Controls and Procedures 

Our  management  has  established  disclosure  controls  and  procedures  designed  to  ensure  that  information  required  to  be 
disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended (the 
“Exchange Act”) is recorded, processed, summarized and reported within time periods specified in the Securities and Exchange 
Commission’s rules and forms. Such disclosure controls and procedures include, without limitation, controls and procedures 
designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the 
Exchange Act is accumulated and communicated to its management to allow timely decisions regarding required disclosure. 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial 
Officer, we conducted an evaluation of our disclosure controls and procedures (as such term is defined under Rule 13a-15(e) 
promulgated under the Exchange Act) as of the end of the period covered by this annual report. Based on this evaluation, our 
Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective 
as of December 30, 2017. 

Management’s Annual Report on Internal Control Over Financial Reporting 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined 
in Rule 13a-15(f) under the Exchange Act. 

Our internal control framework and processes are designed to provide reasonable assurance to management and our board of 
directors regarding the reliability of financial reporting and the preparation of our consolidated financial statements for external 
purposes in accordance with accounting principles generally accepted in the United States of America. 

All internal control systems, no matter how well designed, have inherent limitations. Because of these inherent limitations, 
internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to 
be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.  Projections 
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of 
changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

Management assessed the effectiveness of our internal control over financial reporting as of December 30, 2017. In making 
this  assessment,  management  used  the  criteria  set  forth  by  the  Committee  on  Sponsoring  Organizations  of  the  Treadway 
Commission in Internal Control—Integrated Framework (2013). 

Based  on  its  assessment,  our  management  concluded  that  our  internal  control  over  financial  reporting  was  effective  as  of 
December 30, 2017, based on those criteria. 

The effectiveness of our internal control over financial reporting as of December 30, 2017 has been audited by Deloitte LLP, 
Independent Registered Public Accounting Firm, that also audited our  consolidated financial statements for the  year ended 
December 30, 2017, as stated in their reports which appear herein. 

Changes in Internal Control Over Financial Reporting 

There  were  no  changes  in  our  internal  control  over  financial  reporting  during  the  quarter  ended  December  30,  2017  that 
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

SUNOPTA INC. 

69 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

To the Shareholders and the Board of Directors of SunOpta Inc. 

Opinion on Internal Control over Financial Reporting 

We have audited the internal control over financial reporting of SunOpta Inc. and subsidiaries (the “Company”) as of December 
30,  2017,  based  on  criteria  established  in  Internal  Control—Integrated  Framework  (2013)  issued  by  the  Committee  of 
Sponsoring Organizations of  the Treadway Commission (COSO). In our opinion, the  Company  maintained, in all  material 
respects, effective internal control over financial reporting as of December 30, 2017, based on criteria established in Internal 
Control — Integrated Framework (2013) issued by COSO.   

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) 
(PCAOB), the consolidated financial statements as of and for the year ended December 30, 2017, of the Company and our 
report dated February 28, 2018, expressed an unqualified opinion on those financial statements. 

Basis for Opinion 

The  Company’s  management  is  responsible  for  maintaining  effective  internal  control  over  financial  reporting  and  for  its 
assessment  of  the  effectiveness  of  internal  control  over  financial  reporting,  included  in  the  accompanying  Management’s 
Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s 
internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and 
are  required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the 
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.  

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the 
audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all 
material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk 
that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the 
assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit 
provides a reasonable basis for our opinion. 

Definition and Limitations of Internal Control over Financial Reporting 

A  company’s  internal  control  over  financial  reporting  is  a  process  designed  to  provide  reasonable  assurance  regarding  the 
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting 
principles generally accepted in the United States of America. A company’s internal control over financial reporting includes 
those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly 
reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are 
recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted 
in the United States of America, and that receipts and expenditures of the company are being made only in accordance with 
authorizations of  management and directors of the  company; and  (3) provide reasonable assurance regarding prevention or 
timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on 
the financial statements. 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, 
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate 
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

/s/ Deloitte LLP 

Chartered Professional Accountants 
Licensed Public Accountants  
Toronto, Canada 
February 28, 2018 

SUNOPTA INC. 

70 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
Item 9B.  Other Information 

None. 

SUNOPTA INC. 

71 

December 30, 2017 10-K 

 
 
Item 10.  Directors, Executive Officers and Corporate Governance 

PART III 

The information required under this item is incorporated herein by reference to our Definitive Proxy Statement for the Annual 
Meeting of Shareholders to be filed with the Securities and Exchange Commission not later than 120 days after December 30, 
2017 (the “2018 Proxy Statement”).  

Item 11.  Executive Compensation 

The information required under this item is incorporated herein by reference from the 2018 Proxy Statement. 

Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 

The information required under this item is incorporated herein by reference from the 2018 Proxy Statement. 

Item 13.  Certain Relationships and Related Transactions, and Director Independence 

The information required under this item is incorporated herein by reference from the 2018 Proxy Statement. 

Item 14.  Principal Accounting Fees and Services 

The information required under this item is incorporated herein by reference from the 2018 Proxy Statement. 

Item 15.  Exhibits and Financial Statement Schedules 

The following documents are being filed as part of this annual report. 

PART IV 

1.  Financial Statements.  See “Index to Consolidated Financial Statements” set forth on page F1. 

2.  Financial Statement Schedules.  All schedules for which provision is made in the applicable accounting requirements of 
the  Securities  and  Exchange  Commission  are  not  required  or  the  required  information  has  been  included  within  the 
financial statements or the notes thereto. 

3.  Exhibits.  The list of exhibits in the Exhibit Index included in this annual report is incorporated herein by reference. 

Exhibits 

Description 

EXHIBIT INDEX 

2.1+ 

3.1 

3.2 

Asset Purchase Agreement, dated August 11, 2015, among SunOpta Inc., Niagara  Natural Fruit Snack 
Company Inc., John Boot and Guy Armstrong (incorporated by reference to Exhibit 2.1 to the Company’s 
Current Report on Form 8-K filed on August 17, 2015). 

Amalgamation of Stake Technology Ltd. and 3754481 Canada Ltd. (formerly George F. Pettinos (Canada) 
Limited) (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-KSB for 
the year ended December 31, 2000).  

Certificate  of  Amendment,  dated  October  31,  2003,  to  change  the  Company’s  name  from  Stake 
Technology Ltd. to SunOpta Inc. (incorporated by reference to Exhibit 3i(b) to the Company’s Annual 
Report on Form 10-K for the year ended December 31, 2003).  

SUNOPTA INC. 

72 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibits 

Description 

3.3 

3.4 

3.5 

3.6 

3.7 

3.8 

3.9 

Articles of Amalgamation of SunOpta Inc. and Sunrich Valley Inc., Integrated Drying Systems Inc., Kettle 
Valley  Dried  Fruits  Ltd.,  Pro  Organics  Marketing  Inc.,  Pro  Organics  Marketing  (East)  Inc.,  4157648 
Canada Inc. and 4198000 Canada Ltd., dated January 1, 2004 (incorporated by reference to Exhibit 3i(c) 
to the Company’s Annual Report on Form 10-K for the year ended December 31, 2003).  

Articles  of  Amalgamation  of  SunOpta  Inc.  and  6319734  Canada  Inc.,  4157656  Canada  Inc.  Kofman-
Barenholtz  Foods  Limited,  dated  January  1,  2005  (incorporated  by  reference  to  Exhibit  3i(d)  to  the 
Company’s Annual Report on Form 10-K for the year ended December 31, 2004).  

Articles of Amalgamation of SunOpta Inc. and 4307623 Canada Inc., dated January 1, 2006 (incorporated 
by reference to Exhibit 3i(e) to the Company’s Annual Report on Form 10-K for the year ended December 
31, 2005). 

Articles of Amalgamation of SunOpta Inc., 4208862 SunOpta Food Ingredients Canada  Ltd., 4406150 
Canada Inc. and 4406168 Canada Inc., dated January 1, 2007 (incorporated by reference to Exhibit 3i(f) 
to the Company’s Annual Report on Form 10-K for the year ended December 31, 2007).  

Articles of Amalgamation of SunOpta Inc. and 4460596 Canada Inc., dated January 1, 2008 (incorporated 
by reference to Exhibit 3i(g) to the Company’s Annual Report on Form 10-K for the year ended December 
31, 2007). 

Amended and Restated By-law No. 14, dated May 27, 2010 (incorporated by reference to Exhibit 4.4 to 
the Company’s Registration Statement on Form S-3 filed on July 3, 2014). 

Certificate of Amendment, dated July 10, 2013, to authorize the directors to fix the number of directors to 
be elected by the shareholders and to appoint one or more directors (incorporated by reference to Exhibit 
4.3 to the Company’s Registration Statement on Form S-3 filed on July 3, 2014). 

3.10 

By-Law Number 15 of SunOpta Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current 
Report on Form 8-K filed on November 13, 2015). 

4.1 

4.2 

4.3 

4.4 

4.5 

4.6 

Form of Certificate representing Common Shares, no par value (incorporated by reference to Exhibit 4.9 
to the Company’s Registration Statement on Form S-8 filed on September 2, 2011). 

Shareholder  Rights  Plan  Agreement,  dated  November  10,  2015,  between  SunOpta  Inc.  and  American 
Stock Transfer & Trust Company LLC, as rights agent (incorporated by reference to Exhibit 4.1 to the 
Company’s Current Report on Form 8-K filed on November 13, 2015). 

Amended  and  Restated  Shareholder  Rights  Plan  Agreement,  dated  November  10,  2015,  amended  and 
restated as of April 18, 2016, between SunOpta Inc. and American Stock Transfer & Trust Company LLC, 
as rights agent (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K 
filed on April 20, 2016). 

Amended and Restated Certificate of Incorporation of SunOpta Foods Inc., setting forth the terms of its 
Series A Preferred Stock, which is exchangeable for Common Shares of SunOpta Inc. (incorporated by 
reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on October 12, 2016). 

Articles  of  Amendment  of  SunOpta  Inc.,  setting  forth  the  terms  of  its  Special  Shares,  Series  1 
(incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on October 
12, 2016). 

Indenture, dated as of October 20, 2016, among SunOpta Foods, the guarantors named therein and U.S. 
Bank National Association, as trustee and notes collateral agent (incorporated by reference to Exhibit 4.1 
to the Company’s Current Report on Form 8-K filed on October 26, 2016). 

SUNOPTA INC. 

73 

December 30, 2017 10-K 

 
 
Exhibits 

Description 

4.7 

4.8 

4.9 

4.10 

10.1† 

10.2† 

10.3† 

10.4† 

10.5 

10.6† 

10.7† 

10.8† 

10.9† 

10.10† 

10.11 

Form of 9.5% Senior Secured Second Lien Notes due 2022 (incorporated by reference to Exhibit 4.2 to 
the Company’s Current Report on Form 8-K filed on October 26, 2016). 

Second Lien U.S. Security Agreement, dated as of October 20, 2016, among the grantors referred therein 
and the Notes Collateral Agent (incorporated by reference to Exhibit 4.3 to the Company’s Current Report 
on Form 8-K filed on October 26, 2016). 

Second Lien Canadian Security Agreement, dated as of October 20, 2016, among the grantors referred 
therein and the Notes Collateral Agent (incorporated by reference to Exhibit 4.4 to the Company’s Current 
Report on Form 8-K filed on October 26, 2016). 

Amended and Restated Intercreditor Agreement, dated as of October 20, 2016, among Bank of America, 
N.A.  as  first  lien  collateral  agent,  the  Notes  Collateral  Agent  and  the  grantors  referred  therein 
(incorporated by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on October 
26, 2016). 

Employee Stock Purchase Plan amended March 4, 2013 (incorporated by reference to Exhibit 10.1 to the 
Company’s Annual Report on Form 10-K for the year ended December 29, 2012).  

Retiring Allowance Agreement, dated March 8, 2011, between the Company and Jeremy Kendall which 
terminates and supersedes the Employment Agreement dated October 1, 2001 between the Company and 
Mr. Jeremy Kendall, as amended (incorporated by reference to Exhibit 10.3 to the Company’s Annual 
Report on Form 10-K for the year ended December 31, 2010).  

SunOpta Inc. 2002 Stock Option Plan, Amended and Restated May 2011 (incorporated by reference to 
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 24, 2011). 

Letter  Agreement,  dated  October  10,  2011,  by  and  between  SunOpta  Inc.  and  Robert  McKeracher 
(incorporated  by  reference  to  Exhibit  10.1  to  the  Company’s  Quarterly  Report  on  Form  10-Q  for  the 
quarter ended October 1, 2011). 

Stock Deferral Plan for Non-Employee Directors dated August 12, 2014 (incorporated by reference to 
Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended July 5, 2014). 

Letter Agreement re Terms of Employment, dated October 10, 2011, by and between SunOpta Inc. and 
John Ruelle (incorporated by reference to Exhibit 10.13 to the Company’s Annual Report on Form 10-K 
for the year ended January 3, 2015). 

Letter Agreement re Amendment of Terms of Employment, dated April 5, 2013, by and between SunOpta 
Inc. and John Ruelle (incorporated by reference to Exhibit  10.14 to the Company’s  Annual Report on 
Form 10-K for the year ended January 3, 2015). 

Letter Agreement re Amendment of Terms of Employment, dated December 30, 2014, by and between 
SunOpta  Inc.  and  John  Ruelle  (incorporated  by  reference  to  Exhibit  10.15  to  the  Company’s  Annual 
Report on Form 10-K for the year ended January 3, 2015). 

Employment Agreement, dated April 2012, by and between The Organic  Corporation B.V. and G.J.M. 
Versteegh (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K 
for the year ended January 3, 2015). 

Separation Agreement, dated July 6, 2015, between SunOpta Inc. and Steven Bromley (incorporated by 
reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on July 7, 2015). 

Commitment Letter dated July 30, 2015, among SunOpta Inc., SunOpta Foods Inc., Bank of Montreal and 
BMO Capital Corp. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 
8-K filed on August 3, 2015). 

SUNOPTA INC. 

74 

December 30, 2017 10-K 

 
 
 
Exhibits 

Description 

10.12+ 

10.13+ 

10.14 

10.15 

10.16† 

10.17† 

10.18† 

10.19† 

10.20† 

10.21† 

10.22† 

Second Lien Loan Agreement, dated October 9, 2015, among SunOpta Inc., as Holdings, SunOpta Foods 
Inc., as the Borrower, Certain Subsidiaries of SunOpta Inc., as Subsidiary Guarantors and Loan Parties, 
the Several Lenders from Time to Time Parties Hereto, Bank of Montreal, as Administrative Agent and 
Collateral  Agent,  BMO  Capital  Markets  Corp.  and  Coӧperatieve  Centrale  Raiffeisen-Boerenleenbank 
B.A.,  “Rabobank  Nederland”,  New  York  Branch,  as  Joint  Lead  Arrangers  and  Joint  Bookrunners 
(incorporated  by  reference  to  Exhibit  10.5  to  the  Company’s  Quarterly  Report  on  Form  10-Q  for  the 
quarter ended October 3, 2015). 

Credit Agreement, dated as of February 11, 2016, among SunOpta Inc., SunOpta Foods Inc., The Organic 
Corporation B.V., the other borrowers and guarantors party thereto, the lenders party thereto, Bank of 
America, N.A., as U.S. Administrative Agent, Bank of America, N.A. (acting through its Canada Branch), 
as Canadian Administrative Agent, Bank of America, N.A. (acting through its London Branch), as Dutch 
Administrative  Agent,  and  Bank  of  America,  N.A.,  as  Collateral  Agent  (incorporated  by  reference  to 
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 17, 2016). 

Support Agreement dated February 12, 2016, among SunOpta Inc., Wedge Acquisition Inc. and Wedge 
Acquisition Holdings Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on 
Form 8-K filed on February 18, 2016). 

Second  Amending  Agreement,  dated  October  9,  2015,  amending  the  Seventh  Amended  and  Restated 
Credit  Agreement,  among  SunOpta  Inc.  and  SunOpta  Foods,  as  Borrowers,  Each  of  the  Financial 
Institutions and Other Entities from Time to Time Parties Thereto, as Lenders, Certain Affiliates of the 
Borrowers, as Obligors, and Bank of Montreal, as Agent (incorporated by reference to Exhibit 10.19 to 
the Company’s Annual Report on Form 10-K for the year ended January 2, 2016).  

Amended 2013 Stock Incentive Plan (incorporated by reference to Exhibit C to the Company’s Definitive 
Proxy Statement on Schedule 14A filed on March 31, 2016). 

Form  of  Incentive  Stock  Option  Award  Agreement  under  Amended  2013  Stock  Incentive  Plan 
(incorporated  by  reference  to  Exhibit  10.2  to  the  Company’s  Quarterly  Report  on  Form  10-Q  for  the 
quarter ended July 2, 2016). 

Form of Restricted Stock Unit Award Agreement (Non-Employee Directors) under Amended 2013 Stock 
Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-
Q for the quarter ended July 2, 2016). 

Form  of  2016  Performance  Share  Unit  Award  Agreement  under  2013  Amended  Stock  Incentive  Plan 
(incorporated  by  reference  to  Exhibit  10.4  to  the  Company’s  Quarterly  Report  on  Form  10-Q  for  the 
quarter ended July 2, 2016). 

Employment  Agreement,  dated  August  18,  2016,  by  and  between  SunOpta  Inc.  and  Jill  E.  Barnett 
(incorporated  by  reference  to  Exhibit  10.6  to  the  Company’s  Quarterly  Report  on  Form  10-Q  for  the 
quarter ended October 1, 2016). 

Employment  Agreement,  dated  August  18,  2016,  by  and  between  SunOpta  Inc.  and  James  P.  Gratzek 
(incorporated  by  reference  to  Exhibit  10.7  to  the  Company’s  Quarterly  Report  on  Form  10-Q  for  the 
quarter ended October 1, 2016). 

Employment Agreement Amendment, dated August 19, 2016, by and between The Organic Corporation 
B.V. and G.J.M. Versteegh (incorporated by reference to Exhibit 10.9 to the Company’s Quarterly Report 
on Form 10-Q for the quarter ended October 1, 2016). 

SUNOPTA INC. 

75 

December 30, 2017 10-K 

 
Exhibits 

Description 

10.23 

10.24 

10.25 

10.26 

10.27 

10.28 

10.29† 

10.30† 

10.31† 

10.32† 

10.33† 

10.34† 

First Amendment, dated as of October 7, 2016, to the Credit Agreement, dated as of February 11, 2016, 
among SunOpta Inc., SunOpta Foods Inc., The Organic Corporation B.V., each of the other borrowers 
and  guarantors  party  thereto  from  time  to  time,  the  lenders  party  thereto  from  time  to  time,  Bank  of 
America, N.A., as U.S. Administrative Agent, Bank of America, N.A. (acting through its Canada Branch), 
as Canadian Administrative Agent, Bank of America, N.A. (acting through its London Branch), as Dutch 
Administrative Agent under the Dutch, and Bank of America, N.A, as Collateral Agent (incorporated by 
reference to Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the quarter ended October 
1, 2016). 

First Amendment, dated as of October 7, 2016, to the Second Lien Loan Agreement, dated as of October 
9, 2015, among SunOpta Inc., SunOpta Foods Inc., certain subsidiaries of SunOpta Inc., the several banks 
and  other  financial  institutions  or  entities  from  time  to  time  party  thereto,  and  Bank  of  Montreal,  as 
Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.12 to the Company’s 
Quarterly Report on Form 10-Q for the quarter ended October 1, 2016). 

Subscription Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc. and Oaktree 
Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (incorporated by reference to Exhibit 
10.1 to the Company’s Current Report on Form 8-K filed on October 12, 2016). 

Investor  Rights  Agreement,  dated  October  7,  2016,  between  SunOpta  Inc.,  SunOpta  Foods  Inc.  and 
Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (incorporated by reference to 
Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on October 12, 2016). 

Exchange and Support Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc., 
Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. and any person that becomes a 
Holder of Preferred Stock, from time to time (incorporated by reference to Exhibit 10.3 to the Company’s 
Current Report on Form 8-K filed on October 12, 2016). 

Voting Trust Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc., the trustee 
named therein, Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. and any other 
Holder of Preferred Stock, from time to time (incorporated by reference to Exhibit 10.4 to the Company’s 
Current Report on Form 8-K filed on October 12, 2016). 

Letter Agreement, dated November 8, 2016, between Hendrik Jacobs and SunOpta Inc. (incorporated by 
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 15, 2016). 

Letter Agreement, dated November 8, 2016, between Robert McKeracher and SunOpta Inc. (incorporated 
by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on November 15, 2016). 

Letter  Agreement,  dated  November  8,  2016,  between  John  Ruelle  and  SunOpta  Inc.  (incorporated  by 
reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on November 15, 2016). 

Letter Agreement, dated November 8, 2016, between Gerard Versteegh and SunOpta Inc. (incorporated 
by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on November 15, 2016). 

Employment  Agreement,  effective  February  6,  2017,  between  SunOpta  Inc.  and  David  J.  Colo 
(incorporated  by  reference  to  Exhibit  10.1  to  the  Company’s  Current  Report  on  Form  8-K  filed  on 
February 7, 2017). 

Restricted Stock Award Agreement, dated effective February 6, 2017, between SunOpta Inc. and David 
J. Colo (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on 
February 7, 2017). 

SUNOPTA INC. 

76 

December 30, 2017 10-K 

 
Exhibits 

Description 

10.35† 

10.36† 

10.37 

10.38† 

10.39 

10.40 

10.41† 

10.42† 

10.43† 

10.44† 

10.45† 

10.46† 

10.47† 

Stock Option Award Agreement, dated effective February 6, 2017, between SunOpta Inc. and David J. 
Colo (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on 
February 7, 2017). 

Performance Share Unit Award Agreement, dated effective February 6, 2017, between SunOpta Inc. and 
David J. Colo (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K 
filed on February 7, 2017). 

Second Amendment and Joinder, dated September 19, 2017, to the Credit Agreement, dated as of February 
11, 2016, among SunOpta Inc., SunOpta Foods Inc., The Organic Corporation B.V., the other borrowers 
and guarantors party thereto, the lenders party thereto, Bank of America, N.A., as U.S.  Administrative 
Agent, Bank of America, N.A. (acting through its Canada Branch), as Canadian Administrative Agent, 
Bank of America, N.A. (acting through its London Branch), as Dutch Administrative Agent, and Bank of 
America, N.A., as Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s Current 
Report on Form 8-K filed on September 22, 2017). 

Separation Agreement and Full and Final Release between SunOpta Inc. and Edward Haft (incorporated 
by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 28, 2017).   

Consent  to  Purchase  Shares,  dated  May  6,  2017,  between  SunOpta  Inc.  and  Oaktree  Organics,  L.P. 
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (incorporated 
by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 8, 2017). 

Amendment  Agreement,  dated  May  6,  2017,  between  SunOpta  Inc.,  Oaktree  Organics,  L.P.,  Oaktree 
Huntington Investment Fund II, L.P., SunOpta Foods Inc. and OCM SunOpta Trustee, LLC. (incorporated 
by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on May 8, 2017). 

Restricted Stock Award Agreement, dated effective March 9, 2017, between SunOpta Inc. and David J. 
Colo (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on 
March 13, 2017, as amended). 

Separation  Agreement,  dated  March  3,  2017,  by  and  between  SunOpta  Inc.  and  Michelle  Coleman 
(incorporated  by  reference  to  Exhibit  10.3  to  the  Company’s  Quarterly  Report  on  Form  10-Q  for  the 
quarterly period ended April 1, 2017). 

Employment  Agreement,  dated  March  13, 2017,  by  and  between  SunOpta  Inc.  and  Robert  Duchscher 
(incorporated  by  reference  to  Exhibit  10.5  to  the  Company’s  Quarterly  Report  on  Form  10-Q  for  the 
quarterly period ended April 1, 2017). 

Employment  Agreement,  dated  April  1,  2017,  by  and  between  SunOpta  Inc.  and  Jeffrey  Gough 
(incorporated  by  reference  to  Exhibit  10.6  to  the  Company’s  Quarterly  Report  on  Form  10-Q  for  the 
quarterly period ended April 1, 2017). 

Amended 2013 Stock Incentive Plan (incorporated by reference to Exhibit A to the Company’s Definitive 
Proxy Statement on Schedule 14A filed on April 13, 2017). 

Form  of  2017  Incentive  Stock  Option  Award  Agreement  under  Amended  2013  Stock  Incentive  Plan 
(incorporated by reference to Exhibit 10.10 to the Company’s Quarterly Report on Form 10-Q for the 
quarterly period ended July 1, 2017). 

Form  of  2017  Restricted  Stock  Unit  Award  Agreement  under  Amended  2013  Stock  Incentive  Plan 
(incorporated by reference to Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the 
quarterly period ended July 1, 2017). 

SUNOPTA INC. 

77 

December 30, 2017 10-K 

 
Exhibits 

Description 

10.48† 

10.49† 

10.50† 

10.51† 

10.52† 

10.53† 

21 

23.1 

31.1* 

31.2* 

32* 

Form  of  2017  Performance  Share  Unit  Award  Agreement  under  Amended  2013  Stock  Incentive  Plan 
(incorporated by reference to Exhibit 10.12 to the Company’s Quarterly Report on Form 10-Q for the 
quarterly period ended July 1, 2017). 

Employment Agreement, effective January 23, 2017, by and between SunOpta Inc. and Patrick McCoy 
(incorporated by reference to Exhibit 10.49 to the Company’s Annual Report on Form 10-K for the year 
ended December 30, 2017, filed on March 1, 2018). 

Employment Agreement, effective February 21, 2017, by and between SunOpta Inc. and Michael J. Buick 
(incorporated by reference to Exhibit 10.50 to the Company’s Annual Report on Form 10-K for the year 
ended December 30, 2017, filed on March 1, 2018). 

Employment  Agreement,  effective  March  6,  2017,  by  and  between  SunOpta  Inc.  and  Robert  S.  Grant 
(incorporated by reference to Exhibit 10.51 to the Company’s Annual Report on Form 10-K for the year 
ended December 30, 2017, filed on March 1, 2018). 

Employment  Agreement,  effective  April  10,  2017,  by  and  between  SunOpta  Inc.  and  Christopher 
Whitehair (incorporated by reference to Exhibit 10.52 to the Company’s Annual Report on Form 10-K for 
the year ended December 30, 2017, filed on March 1, 2018). 

Employment Agreement, effective November 1, 2017, by and between SunOpta Inc. and George Miketa 
(incorporated by reference to Exhibit 10.53 to the Company’s Annual Report on Form 10-K for the year 
ended December 30, 2017, filed on March 1, 2018). 

List of subsidiaries (incorporated by reference to Exhibit 21 to the Company’s Annual Report on Form 
10-K for the year ended December 30, 2017, filed on March 1, 2018).  

Consent of Deloitte LLP, Independent Registered Public Accounting Firm (incorporated by reference to 
Exhibit 23.1 to the Company’s Annual Report on Form 10-K for the year ended December 30, 2017, filed 
on March 1, 2018).  

Certification by David Colo, President and Chief Executive Officer, pursuant to Rule 13a – 14(a) under 
the Securities Exchange Act of 1934, as amended.  

Certification by Robert McKeracher, Vice President and Chief Financial Officer, pursuant to Rule 13a – 
14(a) under the Securities Exchange Act of 1934, as amended.   

Certifications  by  David  Colo,  President  and  Chief  Executive  Officer,  and  Robert  McKeracher,  Vice 
President and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350.  

101.INS*  XBRL Instance Document 

101.SCH*  XBRL Taxonomy Extension Schema Document 

101.CAL*  XBRL Taxonomy Extension Calculation Linkbase Document 

101.DEF*  XBRL Taxonomy Extension Definition Linkbase Document 

101.LAB*  XBRL Taxonomy Extension Label Linkbase Document 

101.PRE*  XBRL Taxonomy Extension Presentation Linkbase Document 

+   Exhibits and schedules to this exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K.  SunOpta will 

furnish copies of the omitted exhibits and schedules to the Securities and Exchange Commission upon its request. 

SUNOPTA INC. 

78 

December 30, 2017 10-K 

 
 
 
†     Indicates management contract or compensatory plan or arrangement. 

*   Filed herewith.  

SUNOPTA INC. 

79 

December 30, 2017 10-K 

 
 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this 
report to be signed on its behalf by the undersigned, thereunto duly authorized. 

SIGNATURES 

SUNOPTA INC. 

 /s/ Robert McKeracher 
Robert McKeracher 
Vice President and Chief Financial Officer 

Date: March 7, 2018 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons 
on behalf of the registrant and in the capacities and on the dates indicated. 

Signature 
/s/ David Colo 
David Colo 
/s/ Robert McKeracher 
Robert McKeracher 
/s/ Dean Hollis 
Dean Hollis 
/s/ Margaret Shan Atkins 
Margaret Shan Atkins 
/s/ Al Bolles 
Al Bolles 
/s/ Derek Briffett 
Derek Briffett 
/s/ Michael Detlefsen 
Michael Detlefsen 
/s/ Katrina Houde 
Katrina Houde 
/s/ Brendan Springstubb 
Brendan Springstubb 
/s/ Gregg Tanner 
Gregg Tanner 

Item 16. Form 10-K Summary 

Title 
President, Chief Executive Officer and Director 
(Principal Executive Officer) 
Vice President and Chief Financial Officer 
(Principal Financial and Accounting Officer) 
Chair of the Board and Director 

Director 

Director 

Director 

Director 

Director 

Director 

Director 

Date 
March 7, 2018 

March 7, 2018 

March 7, 2018 

March 7, 2018 

March 7, 2018 

March 7, 2018 

March 7, 2018 

March 7, 2018 

March 7, 2018 

March 7, 2018 

The Company has chosen not to include an optional summary of the information required by this Form 10-K.  For a reference 
to information in the Form 10-K, investors should refer to the Table of Contents to this Form 10-K. 

SUNOPTA INC. 

80 

December 30, 2017 10-K 

 
 
  
 
 
 
 
 
 
SunOpta Inc. 

Index to Consolidated Financial Statements 

Report of Independent Registered Public Accounting Firm 
Consolidated Statements of Operations 

For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 

Consolidated Statements of Comprehensive Loss  

For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 

Consolidated Balance Sheets 

As at December 30, 2017 and December 31, 2016  

Consolidated Statements of Shareholders’ Equity 

As at and for the years ended December 30, 2017, December 31, 2016 and January 
2, 2016 

Consolidated Statements of Cash Flows 

For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 

Notes to Consolidated Financial Statements 

For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 

Page 
F2 

F3 

F4 

F5 

F6 

F7 

F9 

SUNOPTA INC.                                                                                             

 -F1- 

December 30, 2017 10-K 

 
 
 
  
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

To the Shareholders and the Board of Directors of SunOpta Inc. 

Opinion on the Financial Statements 

We  have  audited  the  accompanying  consolidated  balance  sheets  of  SunOpta  Inc.  and  subsidiaries  (the  “Company”)  as  of 
December  30,  2017  and  December  31,  2016,  the  related  consolidated  statements  of  operations,  comprehensive  loss, 
shareholders’ equity, and cash flows, for each of the three years in the period ended December 30, 2017, and the related notes 
(collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material 
respects,  the  financial  position  of  the  Company  as  of  December  30,  2017  and  December  31,  2016,  and  the  results  of  its 
operations and its cash flows for each of the three years in the period ended December 30, 2017, in conformity with accounting 
principles generally accepted in the United States of America. 

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) 
(PCAOB), the Company's internal control over financial reporting as of December 30, 2017, based on criteria established in 
Internal  Control  —  Integrated  Framework  (2013)  issued  by  the  Committee  of  Sponsoring  Organizations  of  the  Treadway 
Commission and our report dated February 28, 2018, expressed an unqualified opinion on the Company's internal control over 
financial reporting. 

Basis for Opinion 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on 
the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are 
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable 
rules and regulations of the Securities and Exchange Commission and the PCAOB. 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform 
the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due 
to  error  or  fraud.  Our  audits  included  performing  procedures  to  assess  the  risks  of  material  misstatement  of  the  financial 
statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included 
examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included 
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall 
presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. 

/s/ Deloitte LLP 

Chartered Professional Accountants 
Licensed Public Accountants 
Toronto, Canada 
February 28, 2018 

We have served as the Company’s auditor since 2008. 

SUNOPTA INC.                                                                                             

 -F2- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Consolidated Statements of Operations  
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 

Revenues 

Cost of goods sold  

Gross profit 

Selling, general and administrative expenses 
Intangible asset amortization 
Other expense, net (note 18) 
Goodwill impairment (note 11) 
Foreign exchange loss (gain) 

Earnings (loss) from continuing operations before the following 

Interest expense, net (note 13) 

Loss from continuing operations before income taxes 

Recovery of income taxes (note 19) 

Loss from continuing operations 

Discontinued operations (note 5) 

Loss from discontinued operations 

  Gain (loss) on classification as held for sale 
  Recovery of (provision for) income taxes 

Loss from discontinued operations attributable to non-controlling 

interests 

Loss from discontinued operations attributable to SunOpta Inc. 

December 30, 2017  December 31, 2016 
$ 

$ 

January 2, 2016 
$ 

1,279,593 

1,346,731 

1,145,134 

1,134,506 

1,220,779 

1,034,772 

125,952 

110,362 

145,087 

127,507 
11,195 
23,660 
115,000 
5,618 

(137,893) 

32,504 

(170,397) 

(35,829) 

(134,568) 

- 
- 
- 

- 
- 

98,681 
11,282 
28,292 
17,540 
1,243 

(31,086) 

43,275 

(74,361) 

(23,797) 

(50,564) 

(1,993) 
560 
599 

264 
(570) 

85,754 
4,951 
12,151 
- 
(1,641) 

9,147 

15,669 

(6,522) 

(3,390) 

(3,132) 

(17,377) 
(10,515) 
(402) 

8,819 
(19,475) 

(22,607) 

(136) 

Loss 

(134,568) 

(51,134) 

Earnings (loss) attributable to non-controlling interests 

752 

54 

Loss attributable to SunOpta Inc. 

(135,320) 

(51,188) 

(22,471) 

Loss per share – basic (note 20) 
-from continuing operations 
-from discontinued operations 

Loss per share – diluted (note 20) 
-from continuing operations 
-from discontinued operations 

(1.66) 
- 
(1.66) 

(1.66) 
- 
(1.66) 

(0.61) 
(0.01) 
(0.62) 

(0.61) 
(0.01) 
(0.62) 

(0.04) 
(0.27) 
(0.31) 

(0.04) 
(0.27) 
(0.31) 

(See accompanying notes to consolidated financial statements) 

SUNOPTA INC.                                                                                             

 -F3- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Consolidated Statements of Comprehensive Loss 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All dollar amounts expressed in thousands of U.S. dollars) 

December 30, 2017  December 31, 2016 
$ 

$ 

January 2, 2016 
$ 

Loss from continuing operations 
Loss from discontinued operations attributable to SunOpta Inc. 
Loss 

Other comprehensive earnings (loss), net of income taxes 
  Changes related to cash flow hedges (note 7) 

  Unrealized gain (loss), net 
  Reclassification of loss (gain) to earnings 
  Net changes related to cash flow hedges 

  Currency translation adjustment 
  Other comprehensive earnings (loss), net of income taxes 

(134,568) 
- 
(134,568) 

1,263 
(1,568) 
(305) 
6,184 
5,879 

(50,564) 
(570) 
(51,134) 

- 
- 
- 
(2,042) 
(2,042) 

Comprehensive loss 

(128,689) 

(53,176) 

Comprehensive earnings (loss) attributable to non-controlling interests 

713 

(355) 

Comprehensive loss attributable to SunOpta Inc. 

(129,402) 

(52,821) 

(See accompanying notes to consolidated financial statements) 

(3,132) 
(19,475) 
(22,607) 

(129) 
339 
210 
(5,155) 
(4,945) 

(27,552) 

(9,565) 

(17,987) 

SUNOPTA INC.                                                                                             

 -F4- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Consolidated Balance Sheets 
As at December 30, 2017 and December 31, 2016 
(All dollar amounts expressed in thousands of U.S. dollars) 

December 30, 2017 
$ 

December 31, 2016 
$ 

ASSETS 
Current assets 
  Cash and cash equivalents  
  Accounts receivable (note 8) 

Inventories (note 9) 
Prepaid expenses and other current assets  

  Current income taxes recoverable 
Total current assets 

Property, plant and equipment (note 10) 
Goodwill (note 11) 
Intangible assets (note 11) 
Deferred income taxes (note 19) 
Other assets  

Total assets 

LIABILITIES 
Current liabilities 
  Bank indebtedness (note 13) 
  Accounts payable and accrued liabilities (note 12) 
  Customer and other deposits 

Income taxes payable 
  Other current liabilities  
  Current portion of long-term debt (note 13) 
  Current portion of long-term liabilities 
Total current liabilities 

Long-term debt (note 13) 
Long-term liabilities  
Deferred income taxes (note 19) 
Total liabilities 

Series A Preferred Stock (note 14) 

EQUITY 
SunOpta Inc. shareholders’ equity 
  Common shares, no par value, unlimited shares authorized, 

86,757,334 shares issued (December 31, 2016 - 85,743,958) (note 15) 

  Additional paid-in capital  
  Retained earnings (accumulated deficit) 
  Accumulated other comprehensive loss (note 17) 

Non-controlling interests 
Total equity 

Total equity and liabilities 

Commitments and contingencies (note 23) 

(See accompanying notes to consolidated financial statements) 

3,228 
125,152 
354,978 
33,213 
12,006 
528,577 

163,624 
109,533 
172,059 
363 
8,017 

982,173 

234,090 
161,364 
4,901 
1,351 
818 
2,228 
5,300 
410,052 

225,805 
8,352 
15,850 
660,059 

80,193 

308,899 
28,006 
(89,291) 
(7,268) 
240,346 
1,575 
241,921 

982,173 

1,251 
157,369 
368,482 
19,794 
2,801 
549,697 

162,239 
223,611 
183,524 
1,045 
9,442 

1,129,558 

201,494 
173,745 
2,543 
5,661 
1,016 
2,079 
5,500 
392,038 

229,008 
15,354 
44,561 
680,961 

79,184 

300,426 
25,522 
53,838 
(13,104) 
366,682 
2,731 
369,413 

1,129,558 

SUNOPTA INC.                                                                                             

 -F5- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Consolidated Statements of Shareholders’ Equity 
As at and for the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All dollar amounts expressed in thousands of U.S. dollars) 

Additional 
paid-in 
capital 
$ 

Retained 
earnings 
(accumu-
lated deficit) 
$ 

Accumulated 
other com-
prehensive 
income (loss) 
$ 

Non-
controlling 
interests 
$ 

Total 
$ 

Common shares 
$ 

000s 

Balance at January 3, 2015 

67,074 

190,668 

22,490 

129,309 

(1,778) 

12,639 

353,328 

Issuance of common shares, net (note 15) 
Employee share purchase plan 
Stock incentive plan 
Warrants 
Stock-based compensation 
Loss from continuing operations 
Loss from discontinued operations, 
net of income taxes (note 5) 
Currency translation adjustment 
Change in fair value of interest rate 
swaps, net of income taxes  

Non-controlling interest from acquisition 

of business 

Acquisitions of non-controlling interest  

16,670 
55 
769 
850 
- 
- 

95,654 
590 
5,033 
6,042 
- 
- 

- 
- 

- 

- 
- 

- 
- 

- 

- 
- 

- 
- 
(1,739) 
(2,163) 
4,757 
- 

- 
- 

- 

- 
(1,018) 

- 
- 
- 
- 
- 
(2,996) 

- 
- 
- 
- 
- 
- 

- 
- 
- 
- 
- 
(136) 

95,654 
590 
3,294 
3,879 
4,757 
(3,132) 

(19,475) 
- 

- 
(4,474) 

(8,819) 
(681) 

(28,294) 
(5,155) 

- 

- 
- 

139 

71 

210 

- 
- 

1,781 
285 

1,781 
(733) 

Balance at January 2, 2016 

85,418 

297,987 

22,327 

106,838 

(6,113) 

5,140 

426,179 

Employee share purchase plan 
Stock incentive plan 
Stock-based compensation 
Dividends on Series A Preferred Stock (note 14) 
Accretion on Series A Preferred Stock (note 14) 
Loss from continuing operations 
Loss from discontinued operations, 
net of income taxes (note 5) 

Disposition of discontinued operation (note 5) 
Currency translation adjustment 

83 
243 
- 
- 
- 
- 

- 
- 
- 

391 
2,048 
- 
- 
- 
- 

- 
- 
- 

- 
(953) 
4,148 
- 
- 
- 

- 
- 
- 

- 
- 
- 
(1,590) 
(222) 
(50,618) 

(570) 
- 
- 

- 
- 
- 
- 
- 
- 

- 
- 
- 
- 
- 
54 

- 
(5,094) 
(1,897) 

(264) 
(2,054) 
(145) 

391 
1,095 
4,148 
(1,590) 
(222) 
(50,564) 

(834) 
(7,148) 
(2,042) 

Balance at December 31, 2016 

85,744 

300,426 

25,522 

53,838 

(13,104) 

2,731 

369,413 

Employee share purchase plan 
Stock incentive plan 
Stock-based compensation 
Dividends on Series A Preferred Stock (note 14) 
Accretion on Series A Preferred Stock (note 14) 
Loss 
Currency translation adjustment 
Cash flow hedges, net of income taxes 

of $130 (note 7) 

Acquisition of non-controlling interests (note 3) 

61 
952 
- 
- 
- 
- 
- 

- 
- 

409 
8,064 
- 
- 
- 
- 
- 

- 
- 

- 
(3,439) 
5,709 
- 
- 
- 
- 

- 
214 

- 
- 
- 
(6,800) 
(1,009) 
(135,320) 
- 

- 
- 
- 
- 
- 
- 
6,223 

- 
- 
- 
- 
- 
752 
(39) 

409 
4,625 
5,709 
(6,800) 
(1,009) 
(134,568) 
6,184 

- 
- 

(305) 
(82) 

- 
(1,869) 

(305) 
(1,737) 

Balance at December 30, 2017 

86,757 

308,899 

28,006 

(89,291) 

(7,268) 

1,575 

241,921 

(See accompanying notes to consolidated financial statements) 

SUNOPTA INC.                                                                                             

 -F6- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Consolidated Statements of Cash Flows 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All dollar amounts expressed in thousands of U.S. dollars) 

December 30, 2017  December 31, 2016 
$ 

$ 

January 2, 2016 
$ 

CASH PROVIDED BY (USED IN) 
Operating activities 
Loss 
Loss from discontinued operations attributable to SunOpta Inc. 
Loss from continuing operations 
Items not affecting cash: 
  Depreciation and amortization 
  Amortization and write-off of debt issuance costs (note 13) 
  Deferred income taxes (note 19) 
Stock-based compensation  

  Unrealized loss (gain) on derivative instruments (note 7) 

Fair value of contingent consideration (note 18) 
Impairment of long-lived assets (note 18) 

  Goodwill impairment (note 11) 
  Acquisition accounting adjustment on inventory sold (note 2) 
  Other 
  Changes in non-cash working capital, net of businesses 

acquired (note 21) 

Net cash flows from operating activities - continuing operations 
Net cash flows from operating activities - discontinued operations 

Investing activities 
Purchases of property, plant and equipment 
Acquisition of non-controlling interests (note 3) 
Proceeds from sale of assets 
Acquisition of businesses, net of cash acquired (note 2) 
Other 
Net cash flows from investing activities - continuing operations 
Net cash flows from investing activities - discontinued operations 

Financing activities 
Increase under line of credit facilities (note 13) 
Repayment of line of credit facilities (note 13) 
Borrowings under long-term debt (note 13) 
Repayment of long-term debt (note 13) 
Issuance of Series A Preferred Stock, net (note 14) 
Payment of cash dividends on Series A Preferred Stock (note 14) 
Payment of contingent consideration (note 7) 
Payment of debt issuance costs 
Proceeds from the exercise of stock options and employee 

share purchases 

Proceeds from the issuance of common shares, net 
Proceeds from the exercise of warrants 
Other 
Net cash flows from financing activities - continuing operations 
Net cash flows from financing activities - discontinued operations 

Foreign exchange gain (loss) on cash held in a foreign currency 

Increase (decrease) in cash and cash equivalents during the year 

Discontinued operations cash activity included above: 
  Add:  Balance included at beginning of year 
Less:  Balance included at end of year 

Cash and cash equivalents - beginning of the year 

Cash and cash equivalents - end of the year 

(134,568) 
- 
(134,568) 

32,824 
2,825 
(27,899) 
5,709 
(631) 
371 
18,193 
115,000 
- 
9 

19,630 
31,463 
- 
31,463 

(41,139) 
(1,737) 
2,385 
- 
369 
(40,122) 
- 
(40,122) 

22,170 
- 
5,176 
(9,959) 
- 
(6,691) 
(4,330) 
(442) 

5,034 
- 
- 
(390) 
10,568 
- 
10,568 

68 

1,977 

- 
- 

1,251 

3,228 

(51,134) 
(570) 
(50,564) 

34,150 
11,301 
(29,850) 
4,148 
(547) 
(1,158) 
13,257 
17,540 
15,000 
335 

(12,891) 
721 
758 
1,479 

(22,560) 
- 
254 
- 
700 
(21,606) 
1,754 
(19,852) 

236,976 
(192,677) 
231,430 
(322,004) 
78,963 
- 
(4,554) 
(13,017) 

1,486 
- 
- 
168 
16,771 
(1,180) 
15,591 

52 

(2,730) 

1,707 
- 

2,274 

1,251 

(22,607) 
(19,475) 
(3,132) 

21,007 
5,895 
(4,038) 
4,366 
143 
884 
- 
- 
4,000 
990 

(3,685) 
26,430 
4,814 
31,244 

(31,186) 
(733) 
1,138 
(490,715) 
(89) 
(521,585) 
(1,235) 
(522,820) 

85,968 
- 
330,135 
(11,018) 
- 
- 
(204) 
(15,966) 

3,884 
94,080 
3,879 
(781) 
489,977 
(4,304) 
485,673 

(54) 

(5,957) 

2,170 
(1,707) 

7,768 

2,274 

(See accompanying notes to consolidated financial statements) 

SUNOPTA INC.                                                                                             

 -F7- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Consolidated Statements of Cash Flows (Continued) 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All dollar amounts expressed in thousands of U.S. dollars) 

December 30, 2017  December 31, 2016 
$ 

$ 

January 2, 2016 
$ 

Non-cash investing and financing activities 
Accrued cash dividends on Class A Preferred Stock (note 14) 
Proceeds on disposition of discontinued operation, 

note receivable (note 5) 

Acquisition of business, contingent consideration at fair value (note 2) 
Acquisition of business, working capital adjustment 
Acquisition of business, settlement of pre-existing relationship 

(1,700) 

(1,590) 

- 

- 
- 
- 
- 

1,537 
- 
- 
- 

- 
(20,330) 
82 
(749) 

(See accompanying notes to consolidated financial statements) 

SUNOPTA INC.                                                                                             

 -F8- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

1.   Description of Business and Significant Accounting Policies 

SunOpta  Inc.  (the  “Company”  or  “SunOpta”)  was  incorporated  under  the  laws  of  Canada  on  November  13,  1973.    The 
Company operates businesses focused on a healthy products portfolio that promotes sustainable well-being.  The Company’s 
two reportable segments, Global Ingredients and Consumer Products, operate in the natural, organic and specialty food sectors 
and utilize an integrated business model to bring cost-effective and quality products to market.   

Basis of Presentation 

These consolidated financial statements have been prepared by the Company in United States (“U.S.”) dollars and in accordance 
with  accounting  principles  generally  accepted  in  the  United  States  of  America  (“U.S.  GAAP”).    The  consolidated  financial 
statements  include  the  accounts  of  the  Company  and  those  of  its  wholly-owned  and  majority-owned  subsidiaries.    All 
intercompany accounts and transactions have been eliminated on consolidation. 

Fiscal Year 

The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31.  Fiscal years 
2017,  2016  and  2015  were  each  52-week  periods  ending  on  December  30,  2017,  December  31,  2016  and  January  2,  2016, 
respectively.  Fiscal year 2018 will be a 52-week period ending on December 29, 2018, with quarterly periods ending on March 
31, June 30, and September 29, 2018.   

Use of Estimates 

The preparation of financial statements in conformity with  U.S. GAAP requires management to make certain estimates and 
assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes.  Areas involving 
significant  estimates  and  assumptions  include:  allocation  of  the  purchase  price  of  acquired  businesses;  inventory  valuation 
reserves; income tax liabilities and assets, and related valuation allowances; provisions for loss contingencies related to claims 
and litigation; fair value of contingent consideration liabilities; useful lives of property, plant and equipment and intangible 
assets; expected future cash flows used in evaluating long-lived assets for impairment; and reporting unit fair values in testing 
goodwill for impairment.  The estimates and assumptions made require judgment on the part of management and are based on 
the  Company’s  historical  experience  and  various  other  factors  that  are  believed  to  be  reasonable  in  the  circumstances.  
Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the 
Company and the general business environment changes.   

Business Acquisitions 

Acquired  businesses  are  accounted  for  using  the  acquisition  method  of  accounting,  which  requires  that  assets  acquired  and 
liabilities assumed be recorded at fair value, with limited exceptions.  Any excess of the purchase price over the fair value of the 
net assets acquired is recorded as goodwill.  Acquisition-related transaction costs are accounted for as an expense in the period 
in which the costs are incurred.  Contingent consideration is measured at fair value and recognized as part of the consideration 
transferred in exchange for the acquired businesses.  Contingent consideration liabilities are remeasured to fair value at each 
reporting date with the changes in fair value recognized in other expense/income on the consolidated statements of operations.   

Financial Instruments 

The Company’s financial instruments recognized in the consolidated balance sheets and included in working capital consist of 
cash and cash equivalents, accounts receivable, derivative instruments, accounts payable and accrued liabilities, and customer 
and other deposits.  Cash and cash equivalents, inventories carried at market and derivative instruments are measured at fair 
value each reporting period.  The fair values of the remaining financial instruments approximate their carrying values due to 
their short-term maturities.   

The  Company’s  financial  instruments  exposed  to  credit  risk  include  cash  equivalents,  accounts  receivable  and  derivative 
instruments.  The Company places its cash and cash equivalents with institutions of high creditworthiness. To limit the credit 
risk  associated  with  derivative  instruments,  the  Company  contracts  with  counterparties  that  are  highly-rated  financial 

SUNOPTA INC.                                                                                             

 -F9- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

institutions.  The Company’s trade accounts receivable are not subject to a high concentration of credit risk.  The Company 
routinely assesses the financial strength of its customers and believes that its accounts receivable credit risk exposure is limited.  
The Company maintains an allowance for losses based on the expected collectability of the accounts receivable. 

Fair Value Measurements 

The Company has various financial assets and liabilities that are measured at fair value on a recurring basis, including certain 
inventories  and  derivatives,  as  well  as  contingent  consideration.  The  Company  also  applies  the  provisions  of  fair  value 
measurement to various non-recurring measurements for financial and non-financial assets and liabilities measured at fair value 
on a non-recurring basis. 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction 
between market participants at the measurement date (that is, an exit price). Fair value measurements are estimated based on 
inputs categorized as follows: 

(cid:120)  Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable. 

(cid:120)  Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices  for identical or 
similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the 
asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation 
or other means. 

(cid:120)  Level  3  includes  unobservable  inputs  that  reflect  the  Company’s  own  assumptions  about  what  factors  market 

participants would use in pricing the asset or liability. 

When  measuring  fair  value,  the  Company  maximizes  the  use  of  observable  inputs  and  minimizes  the  use  of  unobservable 
inputs. 

Foreign Currency Translation 

The assets and liabilities of the Company’s operations having a functional currency other than the U.S. dollar are translated 
into U.S. dollars at the exchange rate prevailing at the balance sheet date, and at the average rate for the reporting period for 
revenue and expense items.  The cumulative currency translation adjustment is recorded as a component of accumulated other 
comprehensive  income  in  shareholders’  equity.    Foreign  currency  gains  and  losses  related  to  the  remeasurement  of  the 
Company’s Mexican operation into its U.S. dollar functional currency are recognized in earnings.   

Exchange gains and losses on transactions occurring in a currency other than an operation’s functional currency are recognized 
in earnings. 

Cash and Cash Equivalents   

Cash and cash equivalents consist of cash and short-term deposits with an original maturity of 90 days or less.  

Accounts Receivable 

Accounts receivable includes trade receivables that are recorded at the invoiced amount and do not bear interest.  The allowance 
for doubtful accounts is an estimate of the amount of probable credit losses in existing accounts receivable.  Account balances 
are charged off against the allowance when the Company determines the receivable will not be recovered.  As at December 30, 
2017 and December 31, 2016, no customer’s balance represented 10% or more of the Company’s consolidated trade receivables 
balance. 

SUNOPTA INC.                                                                                             

 -F10- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Inventories 

Inventories (excluding commodity grains) are valued at the lower of cost and net realizable value.  Shipping and handling costs 
are included in cost of goods sold on the consolidated statements of operations. 

Inventories  of  commodity  grains,  which  include  amounts  acquired  under  deferred  pricing  contracts  traded  on  the  Chicago 
Board of Trade (“CBoT”), are valued at market.  Grain inventory quantities at year-end are multiplied by the quoted price on 
the CBoT to reflect the market value of the inventory.  This market value is then adjusted for a basis factor that represents 
differences in local markets, and broker and dealer quotes to arrive at market.  Changes in CBoT prices or the basis factor are 
included in cost of goods sold on the consolidated statements of operations.  

SunOpta economically hedges its commodity grain positions to protect gains and minimize losses due to market fluctuations. 
Futures  contracts  and  purchase  and  sale  contracts  are  adjusted  to  market  price  and  resulting  gains  and  losses  from  these 
transactions are included in cost of goods sold.  As the Company has a risk of loss from hedge activity if the grower does not 
deliver the grain as scheduled, these transactions do not qualify as hedges under U.S. GAAP and, therefore, changes in market 
value are recorded in cost of goods sold on the consolidated statements of operations.  

Property, Plant and Equipment  

Property, plant and equipment are stated at cost, less accumulated depreciation.  Depreciation is provided using the straight-
line basis at rates reflecting the estimated useful lives of the assets.   

Buildings 
Machinery and equipment 
Enterprise software 
Office furniture and equipment 
Vehicles 

Goodwill 

20 - 40 years 
5 - 20 years 
3 - 5 years 
3 - 7 years 
3 - 7 years 

Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable 
net assets acquired.  Goodwill is not amortized but is instead tested for impairment at least annually, or whenever events or 
circumstances  change  between  the  annual  impairment  tests  that  would  indicate  the  carrying  amount  of  goodwill  may  be 
impaired.  The Company performs its annual test for goodwill impairment in the fourth quarter of each fiscal year.  Prior to 
fiscal 2017, the Company performed a quantitative test for goodwill impairment by comparing the carrying amount of each 
reporting unit to its estimated fair value (Step 1).  If the carrying amount exceeded the reporting unit’s fair value, there was a 
potential impairment of goodwill.  Any impairment of goodwill was measured by comparing the implied fair value of goodwill 
with its carrying amount (Step 2).  The implied fair value of goodwill was determined by deducting the fair value of all the 
assets and liabilities of the reporting unit from the reporting unit’s fair value as determined in Step 1.   

Effective with the fiscal 2017 annual impairment test, the Company elected the early adoption of ASU 2017-04, “Simplifying 
the Test for Goodwill Impairment”, which simplifies the accounting for goodwill impairment by eliminating the requirement 
to calculate the implied fair value of goodwill as contemplated by Step 2 of the prior goodwill impairment test model.  Instead, 
impairment charges are recognized based on the excess of a reporting unit’s carrying amount over its fair value as contemplated 
by Step 1 of the goodwill impairment model.  The fair values of the Company’s reporting units are determined using an income 
approach (discounted cash flow method).  The results of the Company annual impairment tests for goodwill are described in 
note 11. 

SUNOPTA INC.                                                                                             

 -F11- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Intangible Assets 

The Company’s finite-lived intangible assets consist of customer and other relationships, patents and trademarks, and other 
intangible assets.  These intangible assets are amortized on a straight-line basis over their estimated useful lives as follows: 

Customer and other relationships 
Patents and trademarks 
Other 

Impairment of Long-Lived Assets 

10 - 25 years 
15 years 
5 - 15 years 

The  Company  reviews  its  long-lived  assets  for  impairment  whenever  events  or  changes  in  circumstances  indicate  that  the 
carrying amounts of the assets may not be recoverable through undiscounted future cash flows.  If impairment exists based on 
expected future undiscounted cash flows, a loss is recognized in earnings.  The amount of the impairment loss is the excess of 
the carrying amount of the impaired asset over the fair value of the asset, typically determined using a discounted cash flow 
analysis (income approach). 

Derivative Instruments 

The Company is exposed to fluctuations in commodity prices and foreign currency exchange.  The Company utilizes certain 
derivative financial instruments to enhance its ability to manage  these risks, including exchange-traded commodity futures, 
commodity forward purchase and sale contracts and forward foreign exchange contracts.  Derivative instruments are entered 
into for periods consistent with related underlying exposures and do not constitute positions independent of those exposures.  
The Company does not enter into contracts for speculative purposes. 

All  derivative  instruments  are  recognized  on  the  consolidated  balance  sheets  at  fair  value.    Changes  in  the  fair  value  of 
derivative instruments are recorded in earnings or other comprehensive earnings, based on whether the instrument is designated 
as part of a hedge transaction. Gains or losses on derivative instruments reported in accumulated other comprehensive income 
are reclassified to earnings in the period in which earnings are affected by the underlying hedged item.  The ineffective portion 
of all hedges is recognized in earnings in the current period.  As at December 30, 2017, the Company utilized the following 
derivative instruments to manage commodity and foreign currency risks: 

(cid:120)  Exchange-traded commodity futures contracts to economically hedge its exposure to price fluctuations on grain and 
cocoa transactions to the extent considered practicable for minimizing risk from market price fluctuations.  Futures 
contracts used for economical hedging purposes are purchased and sold through regulated commodity exchanges in 
the U.S.  However, inventories may not be completely hedged, due in part to the Company’s assessment of its exposure 
from expected price fluctuations. Forward purchase and sale contracts may expose the Company to risk in the event 
that a counterparty to a transaction is unable to fulfill its contractual obligation or if a grower does not deliver grain 
as scheduled.  The Company manages its risk by entering into purchase contracts with pre-approved growers and sale 
contracts are entered into with organizations of acceptable creditworthiness, as internally evaluated.  All futures and 
forward purchase and sale contracts are marked-to-market. Gains and losses on these transactions are included in cost 
of goods sold on the consolidated statements of operations.   

(cid:120)  Forward foreign exchange contracts to minimize exchange rate fluctuations relating to foreign currency denominated 
purchase and sale contracts and accounts payable and receivable.  Forward foreign exchange contracts designated as 
hedges are marked-to-market with the effective portion of the gain or loss recognized in other comprehensive earnings 
and subsequently recognized in earnings in the same period the hedged item affects earnings.  Gains and losses on 
forward  exchange  contracts  not  specifically  designated  as  hedging  instruments  are  included  in  foreign  exchange 
gain/loss on the consolidated statements of operations. 

SUNOPTA INC.                                                                                             

 -F12- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Debt Issuance Costs 

Costs  incurred  in  connection  with  obtaining  debt  financing  are  deferred  and  amortized  over  the  term  of  the  financing 
arrangement using the effective interest method.  Costs incurred to secure revolving lines of credit are recorded in other long-
term assets.  All other debt issuance costs are recorded as a direct deduction from the related debt liability.  

Customer and Other Deposits 

Customer and other deposits include prepayments by customers for merchandise inventory to be purchased at a future date.   

Income Taxes 

The Company follows the asset and liability method of accounting for income taxes whereby deferred income tax assets are 
recognized  for  deductible  temporary  differences  and  operating  loss  carry-forwards,  and  deferred  income  tax  liabilities  are 
recognized for taxable temporary differences.  Temporary differences are the differences between the amounts of assets and 
liabilities recorded for income tax and financial reporting purposes. 

Deferred income tax assets are recognized only to the extent that management determines that it is more likely than not that the 
deferred income tax assets will be realized.  Deferred income tax assets and liabilities are adjusted for the effects of changes in 
tax laws and rates on the date of enactment.  The income tax expense or benefit is the income tax payable or recoverable for 
the year plus or minus the change in deferred income tax assets and liabilities during the year.  

The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions.  Accordingly, the 
Company may incur additional income tax expense based upon the outcomes of such matters.  In addition, when applicable, 
the  Company  adjusts  income  tax  expense  to  reflect  the  Company’s  ongoing  assessments  of  such  matters,  which  requires 
judgment and can materially increase or decrease its effective rate as well as impact operating results.  The evaluation of tax 
positions taken or expected to be taken in a tax return is a two-step process, whereby (1) the Company determines whether it 
is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (2) for those 
tax  positions  that  meet  the  more-likely-than-not  recognition  threshold,  the  Company  recognizes  the  largest  amount  of  tax 
benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority.   

Stock Incentive Plan 

The Company maintains a stock incentive plan under which stock options and other stock-based awards may be granted to 
selected  employees  and  directors.    The  Company  measures  stock-based  awards  at  fair  value  as  of  the  date  of  grant.  
Compensation expense is recognized on a straight-line basis over vesting period of the entire stock-based award based on the 
estimated number of awards that are expected to vest. When exercised, stock-based awards are settled through the issuance of 
common shares and are therefore treated as equity awards. 

Revenue Recognition 

Revenue  is  recognized  when  realized  or  realizable  and  earned,  and  when  all  of  the  following  criteria  are  met:  persuasive 
evidence of an arrangement exists; delivery has occurred; the price to the customer is fixed or determinable; and collection is 
reasonably assured.  Revenue is recognized when title and possession of the product has transferred to the customer.  Possession 
is transferred to the customer at the time of shipment from the  Company’s facility  or at the time of delivery to a specified 
destination depending on the contractual terms of the sale.  Consideration given to customers such as value incentives, rebates, 
early payment discounts and other discounts are recorded as reductions to revenues at the time of sale.  These reductions are 
estimated based on contractual sales terms with customers and historical payment experience. 

Earnings Per Share 

Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number 
of  common  shares  outstanding  during  the  year.    Earnings  available  to  common  shareholders  is  computed  by  deducting 
dividends and accretion on convertible preferred stock from earnings attributable to SunOpta Inc.  The potential diluted effect 

SUNOPTA INC.                                                                                             

 -F13- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

of stock options and other stock-based awards is computed using the treasury stock method whereby the weighted-average 
number of common shares used in the basic earnings per share calculation is increased to include the number of additional 
common shares that would have been outstanding if the potential dilutive common shares had been issued at the beginning of 
the  year.    The  potential  dilutive  effect  of  convertible  preferred  stock  is  computed  using  the  if-converted  method  whereby 
dividends and accretion on the convertible preferred stock are added back to the numerator, and the common shares resulting 
from the assumed conversion of the convertible preferred stock are included in the denominator of the diluted earnings per 
share calculation. 

Contingencies 

In the normal course of business, the Company is subject to loss contingencies, such as accrued but unpaid bonuses; tax-related 
matters; and claims or litigation.  Accruals for loss contingencies are recorded when the Company determines that it is both 
probable that a liability has been incurred and the amount of loss can be reasonably estimated. If the estimate of the amount of 
the loss is a range and some amount within the range appears to be a better estimate than any other amount within the range, 
that amount is accrued as a liability. If no amount within the range is a better estimate than any other amount, the minimum 
amount of the range is accrued as a liability.   

The Company recognizes an asset for insurance recoveries when a loss event has occurred and recovery is considered probable, 
to the extent that the potential recovery does not exceed the loss recognized. 

Recent Accounting Pronouncements 

Adoption of New Accounting Standards 

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, 
“Improvements to Employee Share-Based Payment Accounting”, which is intended to simplify the accounting for share-based 
payment transactions, including income tax consequences, the classification of awards as either equity or liabilities, and the 
classification  on  the  statement  of  cash  flows.  Under  the  new  guidance,  companies  will  record  excess  tax  benefits  and  tax 
deficiencies as income tax expense or benefit in the income statement rather than in additional paid-in capital.  In addition, the 
guidance permits companies to elect to recognize forfeitures of share-based payments as they occur, rather than estimating the 
number of awards expected to be forfeited as is currently required.  This guidance is effective for annual and interim periods 
beginning after December 15, 2016. The Company adopted ASU 2016-09 effective January 1, 2017, and elected upon adoption 
to recognize forfeitures of stock-based awards as they occur versus estimating at the time of grant.  The cumulative effect of 
this change in accounting policy as at January 1, 2017, was not material to the Company’s financial statements.  Commencing 
January  1,  2017,  the  Company  recognizes  excess  tax  benefits  and  deficiencies  in  the  provision  for  income  taxes  on  its 
consolidated statements of operations and as an operating activity on the consolidated statements of cash flows. 

Recently Issued Accounting Standards, Not Adopted as at December 30, 2017 

In  June  2016,  the  FASB  issued  ASU  2016-13,  “Measurement  of  Credit  Losses  on  Financial  Instruments”,  which  requires 
measurement and recognition of expected versus incurred credit losses for most financial assets. ASU 2016-13 is effective for 
interim  and  annual  periods  beginning  after  December  15,  2019.  The  Company  is  currently  assessing  the  impact  that  this 
standard will have on its consolidated financial statements. 

In February 2016, the FASB issued ASU 2016-02, “Leases”, a comprehensive new standard that amends various aspects of 
existing accounting guidance for leases, including the recognition of a right of use asset and a lease liability for leases with a 
duration of greater than one year.  The guidance is effective for fiscal years beginning after December 15, 2018, including 
interim periods within those fiscal years.  Early adoption is permitted.  The Company is currently assessing the impact that this 
standard  will  have  on  its  consolidated  financial  statements;  however,  the  Company  anticipates  that  upon  adoption  of  the 
standard it will recognize additional assets and corresponding liabilities related to leases on its balance sheet. 

In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers”, which supersedes existing revenue 
recognition guidance under U.S. GAAP.  Under the new standard, a company recognizes revenue when it transfers promised 

SUNOPTA INC.                                                                                             

 -F14- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in 
exchange for those goods or services.  ASU 2014-09 defines a five-step process to achieve this principle and, in doing so, it is 
possible more judgment and estimates may be required within the revenue recognition process than are required under existing 
U.S. GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to 
include in the transaction price and allocating the transaction price to each separate performance obligation.  In August 2015, 
the FASB issued ASU 2015-14, which defers by one year the effective date of ASU 2014-09.  During 2016, the FASB issued 
ASU 2016-08, ASU 2016-10, 2016-11, 2016-12 and 2016-20, all of which clarify certain implementation guidance within ASU 
2014-09.  ASU 2014-09, as amended, is effective for annual and interim periods beginning on or after December 15, 2017, and 
is to be applied on either a full retrospective or modified retrospective basis.   

With the assistance of third-party consultants, the Company analyzed its significant customer contracts to determine the effects 
of ASU 2014-09.  In particular, the Company assessed under the new guidance whether its contracts with customers to produce 
certain consumer-packaged goods would permit the Company to recognize revenue over time versus at a point in time, based 
on  whether the given product has an  alternative use or not and  whether there is an enforceable right to payment  under the 
contract for product produced to date.  Based on its assessment, the Company concluded that it does not satisfy the criteria to 
recognize revenue over time.  The Company will continue to recognize revenue at a point in time consistent with its current 
policies and processes, which is typically when title and physical possession of the product has transferred to the customer.  
The Company also transacts with certain customers on a bill-and-hold basis, whereby the Company bills a customer for product 
to be delivered at a later date.  Prior to the adoption of ASU 2014-09, the Company deferred the recognition of revenue related 
to these bill-and-hold arrangements, as the arrangements did not typically include a fixed delivery schedule.  As this criterion 
is no longer a consideration under ASU 2014-09, these arrangements now qualify for revenue recognition at the point in time 
that the customer obtains control of the product and the Company has a present right to payment.  With the exception of bill-
and-hold  arrangements,  the  adoption  of  ASU  2014-09  is  not  expected  to  have  a  significant  impact  on  the  Company’s 
consolidated financial statements and revenue recognition practices, or its internal controls.   

The Company will adopt ASU 2014-09 using the modified retrospective approach, which is expected to result in a cumulative 
effect adjustment to opening accumulated deficit as at December 31, 2017 of $0.2 million, related to the recognition of $4.8 
million of bill-and-hold revenue deferred under existing U.S. GAAP as at December 30, 2017.  The Company is currently in 
the process of reviewing its disclosures for revenue recognition to conform with the disclosure requirements of the standard 
beginning with the first quarter of 2018. 

2.   Business Acquisitions 

Sunrise Holdings (Delaware), Inc. 

On October 9, 2015, the Company completed the acquisition of 100% of the issued and outstanding common shares of Sunrise 
Holdings  (Delaware),  Inc.  (“Sunrise”),  pursuant  to  a  Purchase  and  Sale  Agreement  dated  July  30,  2015  (the  “Sunrise 
Acquisition”).  Sunrise is a processor of conventional and organic frozen fruit in the U.S. and Mexico.  The acquisition of 
Sunrise was accounted for as a business combination under the acquisition method of accounting.  The results of Sunrise have 
been included in the Company’s consolidated financial statements since the date of acquisition and are reported in the Consumer 
Products operating segment. The acquisition of Sunrise is aligned with the Company’s strategic focus on organic and healthy 
foods. 

Total consideration for the Sunrise Acquisition was $472.7 million in cash paid at the acquisition date, which included the 
repayment of all outstanding obligations under Sunrise’s senior credit facility in the amount of $171.5 million.  In addition, the 
total consideration included $23.0 million paid by the Company to the holders of Sunrise stock options.  As all outstanding 
Sunrise stock options vested upon the consummation of the Sunrise Acquisition, pursuant to the terms of Sunrise’s pre-existing 
stock  option  agreements,  the  cash  consideration  paid  to  the  option  holders  was  attributed  to  services  prior  to  the  Sunrise 
Acquisition and included as a component of the purchase price.  The total consideration also included $20.9 million paid by 
the Company to settle acquisition-related transaction costs incurred by Sunrise in connection with the Sunrise Acquisition.  As 
none of these costs were incurred by Sunrise on behalf of the Company, the cash consideration paid to settle these costs was 
included as a component of the purchase price. 

SUNOPTA INC.                                                                                             

 -F15- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The following table summarizes the fair values of the assets acquired and liabilities assumed as at the acquisition date: 

Cash and cash equivalents 
Accounts receivable 
Inventories(1) 
Income taxes recoverable 
Other current assets 
Property, plant and equipment 
Intangible assets(2) 
Accounts payable and accrued liabilities 
Long-term debt, including current portion 
Deferred income taxes, net 
Net identifiable assets acquired 
Goodwill(3) 
Non-controlling interest(4) 
Net assets acquired 

$ 
1,728 
26,090 
124,829 
12,025 
3,982 
46,068 
170,000 
(24,169) 
(7,620) 
(75,193) 
277,740 
196,709 
(1,781) 
472,668 

(1)  Includes an estimated fair value adjustment to inventory of $19.0 million, of which $15.0 million and $4.0 million was 

recognized in costs of goods sold for inventory sold during 2016 and in the fourth quarter of 2015, respectively. 

(2)  The identified intangible assets relate to customer relationships in existence at the acquisition date between Sunrise and 
major  U.S.  retail  and  foodservice  customers.    The  customer  relationships  intangible  assets  will  be  amortized  over  an 
estimated weighted-average useful life of approximately 23 years.  The estimated fair value of the intangible asset was 
determined  using  an  income  approach  (discounted  cash  flow  method),  which  applied  a  risk-adjusted  discount  rate  of 
approximately 12.0%.  

(3)  Goodwill is calculated as the difference between the acquisition-date fair values of the total consideration and the net assets 
acquired.  The total amount of goodwill has been assigned to the Consumer Products operating segment and is not expected 
to be deductible for tax purposes.  The goodwill recognized is attributable to: (i) cost savings, operating synergies, and 
other benefits expected to result from combining the operations of Sunrise with those of the Company; (ii) the value of 
longer-term growth prospects in the private label frozen fruit market; (iii) the value of acquiring the current capabilities 
and low-cost position of the existing Sunrise business (i.e., the higher rate of return on the assembled net assets versus 
acquiring all of the net assets separately); and (iv) the value of Sunrise’s assembled workforce.   

In 2017, the Company recorded a $115.0 million impairment charge related to the goodwill that arose from the Sunrise 
Acquisition (see note 11). 

(4)  Represents  the  estimated  fair  value  of  the  non-controlling  interest  in  Sunrise’s  75%-owned  Mexican  subsidiary,  Opus 
Foods Mexico, S.A. de C.V. (“Opus”).  In 2017, the Company acquired all of the non-controlling interests in Opus (see 
note 3).   

SUNOPTA INC.                                                                                             

 -F16- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Niagara Natural Fruit Snack Company Inc. 

On August 11, 2015, the Company acquired the net operating assets of Niagara Natural Fruit Snack Company Inc. (“Niagara 
Natural”).    Niagara  Natural  is  a  manufacturer  of  all-natural  fruit  snacks  located  in  the  Niagara  Region  of  Ontario.    The 
acquisition of the net operating assets of Niagara Natural was accounted for as a business combination under the acquisition 
method of accounting.  The results of Niagara Natural have been included in the Company’s consolidated financial statements 
since the date of acquisition and are reported in the Consumer Products operating segment.  The transaction included a cash 
purchase price of $6.5 million, subject to certain post-closing adjustments, plus contingent consideration of up to approximately 
$2.8 million based on specific performance targets.  The fair value of the contingent consideration obligation was determined 
to be $2.3 million as at the acquisition date.   

The following table summarizes the fair values of the assets acquired and liabilities assumed as at the acquisition date: 

Current assets 
Machinery and equipment 
Intangible assets(2) 
Current liabilities 
Net identifiable assets acquired 
Goodwill(3) 
Net assets acquired 

Provisional 
Amounts 
Recognized as at 
the Acquisition 
Date 

$ 
2,220 
3,414 
2,459 
(687) 
7,406 
1,636 
9,042 

Measurement 
Period 
Adjustment(1) 
$ 
(292) 
- 
- 
- 
(292) 
- 
(292) 

Final Amounts 
Recognized as at 
the Acquisition 
Date 

$ 
1,928 
3,414 
2,459 
(687) 
7,114 
1,636 
8,750 

(1)  The measurement period adjustment reflected the final determination of net working capital as at the acquisition date. 

(2)  Intangible assets comprise customer relationships and non-competition arrangements,  which will be amortized over an 

estimated weighted-average useful life of approximately 19 years. 

(3)   The total amount of goodwill was assigned to the Consumer Products operating segment.  

On  May  5,  2016,  the  Company  and  the  owners  of  Niagara  Natural  entered  into  an  agreement  to  settle  the  contingent 
consideration obligation in exchange for a one-time cash payment of $0.6 million.  In 2016, the Company recognized a gain of 
$1.7 million in connection with this settlement, based on the difference between the fair value of the contingent consideration 
obligation and the cash payment, which is recorded in other expense on the consolidated statement of operations for the year 
ended December 31, 2016. 

Citrusource, LLC 

On March 2, 2015, the Company acquired 100% of the issued and outstanding units of Citrusource, LLC (“Citrusource”), a 
producer of premium not-from-concentrate private label organic and conventional orange juice and citrus products in the U.S.  
The acquisition of Citrusource was accounted for as a business combination under the acquisition method of accounting.  The 
results of Citrusource have been included in the Company’s consolidated financial statements since the date of acquisition and 
are reported in the Consumer Products operating segment.  The transaction included a cash purchase price of $13.3 million, 
subject to certain post-closing adjustments, plus contingent consideration based on the incremental growth in Citrusource’s 
base business.  The fair value of the contingent consideration obligation was determined to be $18.0 million as at the acquisition 
date.  In 2017 and 2016, the Company paid $4.1 million and $3.9 million, respectively, to the former unitholders of Citrusource 
in partial settlement of the contingent consideration obligation.   

SUNOPTA INC.                                                                                             

 -F17- 

December 30, 2017 10-K 

 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The following table summarizes the fair values of the assets acquired and liabilities assumed as at the acquisition date:   

Accounts receivable 
Inventories 
Machinery and equipment 
Customer relationships intangible asset(1) 
Accounts payable and accrued liabilities 
Net identifiable assets acquired 
Goodwill(2) 
Net assets acquired 

$ 
2,351 
1,745 
164 
14,000 
(1,666) 
16,594 
15,136 
31,730 

(1)  The customer relationships intangible asset was recognized based on contracts in existence at the acquisition date between 
Citrusource  and  major  U.S.  retail  customers.    This  intangible  asset  will  be  amortized  over  an  estimated  useful  life  of 
approximately 12 years.   

(2)  Goodwill is calculated as the difference between the acquisition-date fair values of the consideration transferred and net 
assets  acquired.   The  total  amount  of  goodwill  has  been  assigned  to  the  Consumer  Products  operating  segment  and  is 
expected  to  be  fully  deductible  for  tax  purposes.    The  goodwill  recognized  is  attributable  to:  (i)  operating  synergies 
expected  to  result  from  combining  the  operations  of  Citrusource  with  those  of  the  Company;  and  (ii)  opportunities  to 
leverage  the  business  experience  of  Citrusource’s  management  team  to  grow  the  Company’s  existing  citrus  beverage 
program.   

3.   Acquisition of Non-Controlling Interests in Mexican Subsidiary 

On July 28, 2017, the Company acquired all the capital stock of Opus held by non-controlling interests for $1.7 million, which 
increased the Company’s equity ownership in Opus from 75% to 100%.  The Company acquired its initial 75% interest in Opus 
through  the  Sunrise  Acquisition  (see  note  2).    Opus  owns  and  operates  a  frozen  fruit  processing  facility  located  in  central 
Mexico.   The  increase  in  the  Company’s  ownership  position  in  Opus  was  accounted  for as  an  equity  transaction,  with  the 
difference between the cash consideration paid and the amount of the non-controlling interest related to Opus being recognized 
in additional paid-in capital. 

4.  Value Creation Plan 

Overview 

On October 7, 2016, the Company entered into a strategic partnership with Oaktree Capital Management L.P., a private equity 
investor (together with its affiliates, “Oaktree”).  On October 7, 2016, Oaktree invested $85.0 million through the purchase of 
cumulative, non-participating Series A Preferred Stock (the “Preferred Stock”) of the Company’s wholly-owned subsidiary, 
SunOpta Foods Inc. (“SunOpta Foods”) (see note 14).  Following the strategic partnership, with the assistance of Oaktree, the 
Company conducted a thorough review of its operations, management and governance, with the objective of maximizing the 
Company’s ability to deliver long-term value to its shareholders.  As a product of this review, the Company developed a Value 
Creation  Plan  built  on  four  pillars:    portfolio  optimization,  operational  excellence,  go-to-market  effectiveness  and  process 
sustainability.  The Company engaged third-party management consulting firms to support the design and implementation of 
the Value Creation Plan. 

In 2016, measures taken under the Value Creation Plan included the closure of the Company’s San Bernardino, California, juice 
facility and the Company’s soy extraction facility in Heuvelton, New York.  In addition, effective November 11, 2016, Hendrik 
Jacobs stepped down as the Company’s President and Chief Executive Officer (“CEO”).   

In 2017, further measures were taken under the Value Creation Plan, including the exits from flexible resealable pouch and 
nutrition bar product lines and operations (as described below), as well as the consolidation of grain operations and related 

SUNOPTA INC.                                                                                             

 -F18- 

December 30, 2017 10-K 

 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

closure of a grain-handling facility in Moorhead, Minnesota, and the planned consolidation of roasted snack operations and 
related closure of the Company’s Wahpeton, North Dakota, roasting facility.  In addition, the Company made organizational 
changes within its management and executive teams, including the appointment of David Colo as President and CEO effective 
February 6, 2017, along with new leadership to many corporate, commercial and operational functions.  The Company also 
added new employees in the areas of quality, sales, marketing, operations and engineering, and made capital investments at 
several of its manufacturing facilities to enhance food safety and production efficiencies.   

Exit from Flexible Resealable Pouch and Nutrition Bar Product Lines and Operations 

On July 26, 2017, SunOpta Foods entered an agreement with Skjodt-Barrett Contract Packaging LLC to sell equipment used 
in the production of flexible resealable pouches at the Company’s Allentown, Pennsylvania facility for gross proceeds of $2.0 
million ($1.3 million net of costs to sell).  The transaction closed on November 3, 2017.  The Company continued to produce 
flexible resealable pouch products for existing customers until the closing date.  The Company’s aseptic beverage operations 
were not affected by the sale of assets, and the Company will continue to produce aseptic beverages at its Allentown facility. 

On September 27, 2017, the Company announced its intention to exit its nutrition bar product lines and operations in Carson 
City, Nevada, with final production for customers ending on December 20, 2017.  On November 21, 2017, the Company entered 
into an agreement to sell the nutrition bar equipment for gross proceeds of $0.9 million, of which $0.2 million was received on 
signing and $0.7 million was received at closing on January 3, 2018.  The Company is pursuing potential parties interested 
assuming the facility lease. 

As the flexible resealable pouch and nutrition bar product lines and operations do not qualify for presentation as discontinued 
operations, operating results from these activities  were reported in continuing operations on the consolidated statements of 
operations for the current and comparative periods.  Revenues  from sales of these product lines  were $53.1 million, $59.3 
million  and  $58.1  million  for  the  years  ended  December  30,  2017,  December  31,  2016 and  January  2,  2016,  respectively.  
Losses  before  income  taxes  from  these  operations  were  $24.4  million,  $2.1  million  and  $2.8  million  for  the  years  ended 
December 30, 2017, December 31, 2016 and January 2, 2016, respectively.  For the year ended December 30, 2017, the loss 
before  income  taxes  from  these  operations  included  write-offs  of  accounts  receivable  and  inventory  ($2.9  million)  and 
impairments of long-lived assets ($13.2 million) related to the exit activities, as well as employee termination costs of $1.7 
million.  These operations were included in the Consumer Products operating segment. 

SUNOPTA INC.                                                                                             

 -F19- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Continuity of Costs Incurred Under the Value Creation Plan 

The following table summarizes costs incurred since the inception of the Value Creation Plan to December 30, 2017: 

(a) 

Asset 
impairments 
and facility 
closure costs 
$ 

(b) 
Employee  
recruitment, 
retention and 
termination 
costs 
$ 

(c) 

Consulting 
fees and 
temporary 
labor costs 
$ 

11,522 
- 
(11,522) 
 - 

21,766 
(10,746) 
(11,720) 
 (700) 

2,763 
(694) 
(266) 
1,803 

11,618 
(9,683) 
689 
4,427 

4,041 
(2,384) 
- 
1,657 

16,528 
(18,185) 
- 
- 

Total 
$ 

18,326 
(3,078) 
(11,788) 
3,460 

49,912 
(38,614) 
(11,031) 
3,727 

Fiscal 2016 
Costs incurred and charged to expense 
Cash payments 
Non-cash adjustments 
  Balance payable, December 31, 2016(1) 

Fiscal 2017 
Costs incurred and charged to expense 
Cash payments, net of proceeds on disposal of assets 
Non-cash adjustments 
  Balance payable (receivable), December 30, 2017(1) 

(1)  Balance  payable  was  included  in  accounts  payable  and  accrued  liabilities  and  balance  receivable  was  included  in  accounts  receivable  on  the 

consolidated balance sheets. 

(a)  Asset impairments and facility closure costs 

For 2017, includes an additional asset impairment loss of $3.7 million on the disposal of the San Bernardino assets, and 
facility closure costs of $0.6 million incurred by the Company for rent and maintenance of the San Bernardino facility 
prior to its disposal.  In addition, includes asset impairment losses related to the exits from flexible resealable pouch and 
nutrition bar operations of $16.1 million, and consolidation of the Company’s roasted snack operations of $1.3 million.  
Cash payments in 2017 related to the early buy-outs of the San Bernardino and flexible resealable pouch equipment leases, 
net of proceeds on the disposal of those assets, as well as on the sale of the nutrition bar equipment.  Balance receivable as 
at December 30, 2017, represents remaining proceeds on the sale of the nutrition bar equipment received on January 3, 
2018. 

For 2016, represents asset impairment losses of $11.5 million related to the closures of the San Bernardino and Heuvelton 
facilities. 

 (b)  Employee recruitment, retention and termination costs 

Represents third-party recruiting fees incurred to identify and retain new employees; reimbursement of relocation costs for 
new employees; retention and signing bonuses accrued for certain existing and new employees; and severance benefits, 
net of forfeitures of stock-based awards, and legal costs related to employee terminations.  Some employee termination 
costs will be paid out in periods after termination.  Retention bonuses will be paid out to employees who remain employed 
by the Company through specified retention dates.  Certain employees will be entitled to pro-rata payouts of their retention 
bonuses if their employment terminates earlier than their retention payment date. 

SUNOPTA INC.                                                                                             

 -F20- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

(c)  Consulting fees and temporary labor costs 

Represents the cost for third-party consultants and temporary labor engaged to support the design and implementation of 
the Value Creation Plan.  In addition, consulting fees incurred in the third quarter of 2016 were related to external financial 
and legal advisors engaged to review the Company’s operating plan and evaluate a range of strategic and financial actions 
that the Company could take to maximize shareholder value, which concluded with the strategic partnership with Oaktree. 

For the years ended December 30, 2017 and December 31, 2016, costs incurred and charged to expense were recorded in the 
consolidated statement of operations as follows: 

Cost of goods sold(1) 
Selling, general and administrative expenses(2) 
Other expense(3) 

December 30, 
2017 
$ 
3,189 
22,894 
23,829 
49,912 

December 31, 
2016 
$ 
- 
4,041 
14,285 
18,326 

(1)  Inventory write-downs and facility closure costs recorded in cost of goods sold were allocated to the Consumer Products operating segment. 
(2)  Consulting fees and temporary labor costs, and employee recruitment, relocation and retention costs recorded in selling, general and administrative 

expenses were allocated to Corporate Services. 

(3)  For the year ended December 30, 2017, asset impairment and employee termination costs recorded in other expense were allocated as follows:  Raw 
Material Sourcing and Supply operating segment - $2.1 million; Consumer Products operating segment - $20.6 million; and Corporate Services - 
$1.1 million.  For the year ended December 31, 2016, asset impairment and employee termination costs recorded in other expense were allocated as 
follows:  Raw Material Sourcing and Supply operating segment - $1.6 million; Consumer Products operating segment - $10.6 million; and Corporate 
Services - $2.1 million. 

5.   Discontinued Operation 

On  April  6,  2016,  the  Company  completed  the  sale  of  its  66%  holding  of  common  shares  of  Opta  Minerals  Inc.  (“Opta 
Minerals”) to Speyside Equity Fund I LP for aggregate gross proceeds of $4.8 million (C$6.2 million), of which $3.2 million 
(C$4.2 million) was received in cash, and $1.5 million (C$2.0 million) was received in the form of a subordinated promissory 
note bearing interest at 2.0% per annum that will mature on October 6, 2018.  The sale of Company’s equity interest in Opta 
Minerals was consistent with its objective of divesting its non-core assets in order to become a pure-play organic and healthy 
foods company.  The Company has no continuing involvement with Opta Minerals. 

SUNOPTA INC.                                                                                             

 -F21- 

December 30, 2017 10-K 

 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The following table reconciles the major components of the results of discontinued operations to the amounts reported in the 
consolidated statement of operations: 

Revenues 
Cost of goods sold 
Selling, general and administrative expenses 
Intangible asset amortization 
Other expense, net(1) 
Foreign exchange gain (loss) 
Interest expense 
Loss before income taxes 
Gain (loss) on classification as held for sale before income taxes 
Total pre-tax loss from discontinued operations 
Recovery of (provision for) income taxes 
Loss from discontinued operations 
Loss from discontinued operations attributable to non-controlling interest 
Loss from discontinued operations attributable to SunOpta Inc. 

December 31, 
2016 

January 2, 2016 

$ 
24,896 
(22,133) 
(3,024) 
- 
 (794) 
(454) 
(484) 
(1,993) 
560 
(1,433) 
599 
(834) 
264 
(570) 

$ 
113,805 
(99,256) 
(11,170) 
(1,987) 
(15,097) 
717 
(4,389) 
(17,377) 
(10,515) 
(27,892) 
(402) 
(28,294) 
8,819 
(19,475) 

(1)  For the years ended December 31, 2016 and January 2, 2016, other expense, net includes charges related to the impairment of long-lived assets of 

Opta Minerals of $0.4 million and $12.4 million, respectively. 

6.   Product Recall 

During the second quarter of 2016, the Company announced a voluntary recall of certain roasted sunflower kernel products 
due to potential contamination with Listeria monocytogenes bacteria.  The affected sunflower products were produced between 
May  31,  2015  and  April  21,  2016.    Estimated  losses  related  to  the  recall  totaled  $47.5  million  as  at  December  30,  2017, 
compared to $40.0 million as at December 31, 2016, comprised of estimates for customer losses and direct incremental costs 
incurred  by  the  Company.    The  estimates  for  customer  losses  reflected  the  cost  of  the  affected  sunflower  kernel  products 
returned to or replaced by the Company and the estimated cost to reimburse customers for costs incurred by them related to the 
recall of their retail products that contain the affected sunflower kernels as an ingredient or component.  The incremental costs 
incurred directly by the Company do not include lost earnings associated with the interruption of production at the Company’s 
roasting facilities, or the costs to put into place corrective and preventive actions at those facilities.   

The Company’s estimates for customer losses related to the recall are provisional and were determined based on an assessment 
of the information available up to the date of filing of this report, including a review of customer claims received as of that date 
and consideration of the extent of potential additional claims that have yet to be received.  The Company’s estimates reflect the 
amount of losses that it determined as at December 30, 2017 to be both probable and reasonably estimable.  The Company may 
need to revise its estimates in subsequent periods as the Company continues to work with its customers and insurance providers 
to substantiate the claims received to date and any additional claims that may be received.  These revisions may occur at any 
time and may be material. 

The Company has general liability and product recall insurance policies with aggregate limits of $47.0 million under which it 
expects to recover recall-related costs, less applicable deductibles.  The Company recognizes expected insurance recoveries in 
the period in which the recoveries are determined to be probable of realization. As at December 30, 2017, the Company had 
recognized recoveries up to the limit of the coverage available under its insurance policies.  Consequently, to the extent any 
losses are excluded under the insurance policies or additional losses are recognized related to existing or new claims, these 
excluded or excess losses will be recognized as a charge to future earnings.   

SUNOPTA INC.                                                                                             

 -F22- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

As at December 30, 2017, the Company had settled customer claims and direct costs in the amount of $40.5 million, which 
was fully funded under the Company’s general liability and product recall insurance policies.  As at December 30, 2017, $7.0 
million of the estimated recall-related costs were unsettled and were recorded in accounts payable and accrued liabilities on the 
consolidated balance sheet.  As at December 30, 2017, the Company had received $44.2 million in advances from its insurance 
providers.  The remaining estimated insurance recovery of $2.7 million was included in accounts receivable on the consolidated 
balance sheet as at December 30, 2017.     

7.   Derivative Financial Instruments and Fair Value Measurements 

The following table presents for each of the fair value hierarchies, the assets and liabilities that are measured at fair value on a 
recurring basis as at December 30, 2017 and December 31, 2016: 

Fair value 
asset (liability) 
$ 

Level 1 
$ 

(a)  Commodity futures and forward contracts(1) 
  Unrealized short-term derivative asset 
  Unrealized short-term derivative liability 
  Unrealized long-term derivative liability 
Inventories carried at market(2) 
(b) 
(c)  Forward foreign currency contracts 

  Not designated as hedging instruments(3) 
  Designated as a hedging instruments(4) 

(d)  Contingent consideration(5) 
(e)  Embedded derivative(6) 

(a)  Commodity futures and forward contracts(1) 
  Unrealized short-term derivative asset 
  Unrealized short-term derivative liability 
  Unrealized long-term derivative liability 
Inventories carried at market(2) 
(b) 
(c)  Forward foreign currency contracts 

  Not designated as hedging instruments(3) 

(d)  Contingent consideration(5) 
(e)  Embedded derivative(6) 

738 
(240) 
(4) 
3,838 

(1,060) 
(435) 
(11,320) 
2,690 

Fair value 
asset (liability) 
$ 

787 
(916) 
(8) 
8,231 

1,345 
(15,279) 
2,944 

December 30, 2017 

Level 2 
$ 

738 
(205) 
(4) 
3,838 

(1,060) 
(435) 
- 
- 

Level 3 
$ 

- 
- 
- 
- 

- 
- 
(11,320) 
2,690 

- 
(35) 
- 
- 

- 
- 
- 
- 

December 31, 2016 

Level 1 
$ 

Level 2 
$ 

Level 3 
$ 

43 
- 
- 
- 

- 
- 
- 

744 
(916) 
(8) 
8,231 

1,345 
- 
- 

- 
- 
- 
- 

- 
(15,279) 
2,944 

(1)  Unrealized  short-term  derivative  asset  was  included  in  prepaid  expenses  and  other  current  assets,  unrealized  short-term  derivative  liability  was 
included in other current liabilities and unrealized long-term derivative liability was included in long-term liabilities on the consolidated balance 
sheets. 

(2)  Inventories carried at market were included in inventories on the consolidated balance sheets. 
(3)  Forward foreign currency contracts not designated as a hedge were included in accounts receivable or accounts payable and accrued liabilities on the 

consolidated balance sheets. 

(4)  Forward foreign currency contracts designated as a hedge were included in other assets or other current liabilities on the consolidated balance sheets. 
(5)  Contingent consideration obligations were included in long-term liabilities (including the current portion thereof) on the consolidated balance sheets. 
(6)  The embedded derivative was included in other assets (long-term) on the consolidated balance sheets. 

SUNOPTA INC.                                                                                             

 -F23- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

(a)  Commodity futures and forward contracts 

The  Company’s  derivative  contracts  that  are  measured  at  fair  value  include  exchange-traded  commodity  futures  and 
forward  commodity  purchase  and  sale  contracts.    Exchange-traded  futures  are  valued  based  on  unadjusted  quotes  for 
identical assets priced in active markets and are classified as level 1.  Fair value for forward commodity purchase and sale 
contracts is estimated based on exchange-quoted prices adjusted for differences in local markets.  Local market adjustments 
use observable inputs or market transactions for similar assets or liabilities, and, as a result, are classified as level 2.  Based 
on historical experience with the Company’s suppliers and customers, the Company’s own credit risk, and the Company’s 
knowledge of current market conditions, the Company does not view non-performance risk to be a significant input to fair 
value for the majority of its forward commodity purchase and sale contracts.   

These exchange-traded commodity futures and forward commodity purchase and sale contracts are used as part of the 
Company’s risk management strategy, and represent economic hedges to limit risk related to fluctuations in the price of 
certain commodity grains, as well as the prices of cocoa and coffee.  These derivative instruments are not designated as 
hedges for accounting purposes.  Gains and losses on changes in fair value of these derivative instruments are included in 
cost of  goods sold on the consolidated statement of operations. For the  year ended December 30, 2017, the Company 
recognized a gain of $0.6 million (December 31, 2016 – gain of $0.5 million; January  2, 2016 – loss of $0.1 million) 
related to changes in the fair value of these derivatives. 

As at December 30, 2017, the notional amounts of open commodity futures and forward purchase and sale contracts were 
as follows (in thousands of bushels): 

Forward commodity purchase contracts 
Forward commodity sale contracts 
Commodity futures contracts 

Number of bushels purchased (sold) 
Soybeans 
64 
(837) 
510 

Corn 
(68) 
(447) 
245 

In addition, as at December 30, 2017, the Company had open forward contracts to sell 299 lots of cocoa and 3 lots of 
coffee. 

(b)  Inventories carried at market 

Grains inventory carried at fair value is determined using quoted market prices from the CBoT.   Estimated fair market 
values for grains inventory quantities at period end are valued using the quoted price on the CBoT adjusted for differences 
in local markets, and broker or dealer quotes. These assets are placed in level 2 of the fair value hierarchy, as there are 
observable quoted prices for similar assets in active markets.  Gains and losses on commodity grains inventory are included 
in cost of goods sold on the consolidated statements of operations.  As at December 30, 2017, the Company had 280,558 
bushels of commodity corn and 254,022 bushels of commodity soybeans in inventories carried at market. 

(c)   Foreign forward currency contracts 

As part of its risk management strategy, the Company enters into forward foreign exchange contracts to reduce its exposure 
to fluctuations in foreign currency exchange rates. For any open forward foreign exchange contracts at period end, the 
contract rate is compared to the forward rate, and a gain or loss is recorded. These contracts are placed in level 2 of the fair 
value  hierarchy,  as  the  inputs  used  in  making  the  fair  value  determination  are  derived  from  and  are  corroborated  by 
observable market data.  Certain of these forward foreign exchange contracts may be designated as cash flow hedges for 
accounting  purposes,  while  other  of  these  contracts  represent  economic  hedges  that  are  not  designated  as  hedging 
instruments.  

SUNOPTA INC.                                                                                             

 -F24- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

(i)  Not designated as hedging instruments 

As at December 30, 2017, the Company had open forward foreign exchange contracts to sell euros to buy U.S. dollars with 
a notional value of €33.4 million ($39.2 million), and to sell British pounds to buy euros with a notional value of £0.4 
million (€0.4 million).  As these contracts were not designated as hedging instruments, gains and losses on changes in the 
fair value of the derivative instruments are included in foreign exchange loss or gain on the consolidated statement of 
operations. For the year ended December 30, 2017, the Company recognized a loss of $2.4 million (December 31, 2016 – 
gain of $1.0 million; January 2, 2016 – loss of $0.7 million) related to changes in the fair value of these derivatives.   

(ii)  Designated as hedging instruments 

In  2017,  the  Company  initiated  a  foreign  currency  cash  flow  hedging  program  with  the  objective  of  managing  the 
variability of cash flows associated with a portion of forecasted purchases of raw fruit inventories denominated in Mexican 
pesos.  As at December 30, 2017, the Company had net open forward foreign exchange contracts to sell U.S. dollars to 
buy Mexican pesos with a notional value of $15.0 million (M$292.0 million). As these contracts have been designated as 
hedging instruments, the effective portion of the gains and losses on changes in the fair value of the derivative instruments 
are  included  in  other  comprehensive  earnings  and  reclassified  to  cost  of  goods  sold  in  the  same  period  the  hedged 
transaction affects earnings, which is upon the sale of the inventories.  For the year ended December 30, 2017, the Company 
recognized net unrealized gains in other comprehensive earnings of $1.8 million related to changes in the fair value of 
these derivatives, and the Company reclassified from other comprehensive earnings realized gains on these derivatives of 
$1.4 million to cost of goods sold.  In addition, in 2017, the Company reclassified an unrealized gain of $0.9 million related 
to the ineffective portion of the hedge to foreign exchange loss on the consolidated statements of operations.  The Company 
expects to reclassify the $0.4 million amount of the unrealized loss recorded in accumulated other comprehensive loss as 
at December 30, 2017, to earnings over the next twelve months. 

(d)   Contingent consideration 

The  fair  value  measurement  of  contingent  consideration  arising  from  business  acquisitions  is  determined  using 
unobservable (level 3) inputs.  These inputs include: (i) the estimated amount and timing of the projected cash flows on 
which  the  contingency  is  based;  and  (ii)  the  risk-adjusted  discount  rate  used  to  present  value  those  cash  flows.    The 
following table presents a reconciliation of contingent consideration obligations for the years ended December 30, 2017 
and December 31, 2016: 

Balance, beginning of year 
  Fair value adjustment(1) 
  Payments(2) 
  Foreign exchange 
Balance, end of year 

December 30, 2017  December 31, 2016 
$ 
(21,010) 
1,158 
4,554 
19 
(15,279) 

$ 
(15,279) 
(371) 
4,330 
- 
(11,320) 

(1)  For  all  periods presented,  reflected  the  accretion  for  the  time  value  of  money,  which  was  included  in  other  income/expense  (see  note  18).   In 
addition, for the year ended December 31, 2016, included a gain of $1.7 million on the settlement of the contingent consideration obligation related 
to Niagara Natural (see note 2). 

(2)  For the year ended December 30, 2017, reflected the second payment against the contingent consideration obligation related to Citrusource, and 
payment of the remaining deferred consideration to a former shareholder of Organic Land Corporation OOD, which was acquired by the Company 
in December 2012.  For the year ended December 31, 2016, reflected the first payment related to Citrusource obligation, and cash settlement of the 
remaining obligation related to Niagara Natural. 

(e)   Embedded derivative 

On August 5, 2011 and August 29, 2014, the Company invested $0.5 million and $0.9 million, respectively, in convertible 
subordinated  notes  issued  by  Enchi  Corporation  (“Enchi”),  a  developer  of  advanced  bioconversion  products  for  the 
renewable fuels industry.  The Company’s investment includes the value of an accelerated payment option embedded in 

SUNOPTA INC.                                                                                             

 -F25- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

the notes, which may result in a maximum payout to the Company of $5.1 million.  Due to a lack of level 1 or level 2 
observable market quotes for the notes, the Company used a discounted cash flow analysis (income approach) to estimate 
the original fair value of the embedded derivative based on unobservable level 3 inputs.  The Company assesses changes 
in the fair value of the embedded derivative based on the performance of actual cash flows derived from certain royalty 
rights owned by Enchi, which are expected to be the primary source of funds available to settle the embedded derivative, 
relative to the financial forecasts used in the valuation analysis.  As at December 30, 2017 and December 31, 2016, the 
Company determined that the fair value of this embedded derivative was $2.7 million and $2.9 million, respectively, based 
on distributions received from Enchi on the notes up to those dates and on expectations related to the remaining royalty 
rights. 

8.   Accounts Receivable 

Trade receivables 
Recall-related insurance recoveries (see note 6) 
Allowance for doubtful accounts 

December 30, 2017  December 31, 2016 
$ 
122,916 
37,400 
(2,947) 
157,369 

$ 
125,408 
2,656 
(2,912) 
125,152 

The change in the allowance for doubtful accounts provision for the years ended December 30, 2017 and December 31, 2016 
is comprised as follows: 

Balance, beginning of year 
Net additions to provision 
Accounts receivable written off, net of recoveries 
Effects of foreign exchange rate differences 

Balance, end of year 

9.   Inventories 

Raw materials and work-in-process 
Finished goods 
Company-owned grain 
Inventory reserve 

December 30, 2017  December 31, 2016 
$ 
2,492 
1,013 
(536) 
(22) 

$ 
2,947 
491 
(596) 
70 

2,912 

2,947 

December 30, 2017  December 31, 2016 
$ 
266,072 
101,585 
15,027 
(14,202) 
368,482 

$ 
262,527 
92,489 
9,937 
(9,975) 
354,978 

SUNOPTA INC.                                                                                             

 -F26- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The change in the inventory reserve for the years ended December 30, 2017 and December 31, 2016 is comprised as follows: 

Balance, beginning of year 
Additions to reserve during the year 
Reserves applied and inventories written off during the year 
Effect of foreign exchange rate differences 

Balance, end of year 

10.   Property, Plant and Equipment 

December 30, 2017  December 31, 2016 
$ 
6,774 
14,029 
(6,532) 
(69) 

$ 
14,202 
10,278 
(14,367) 
(138) 

9,975 

14,202 

The major components of property, plant and equipment as at December 30, 2017 and December 31, 2016 were as follows: 

Land 
Buildings 
Machinery and equipment 
Enterprise software 
Office furniture and equipment 
Vehicles 

Land 
Buildings 
Machinery and equipment 
Enterprise software 
Office furniture and equipment 
Vehicles 

Cost 
$ 
7,124 
70,383 
178,760 
14,829 
12,063 
3,609 
286,768 

Cost 

$ 
7,165 
68,014 
168,120 
10,845 
10,191 
3,515 
267,850 

Accumulated 
depreciation 
$ 
- 
21,784 
84,525 
6,651 
7,834 
2,350 
123,144 

December 30, 2017 

Net book value 
$ 
7,124 
48,599 
94,235 
8,178 
4,229 
1,259 
163,624 

Accumulated 
depreciation 

December 31, 2016 

Net book value 

$ 
- 
19,432 
73,914 
4,179 
5,930 
2,156 
105,611 

$ 
7,165 
48,582 
94,206 
6,666 
4,261 
1,359 
162,239 

As at December 30, 2017 property, plant and equipment included construction in process assets of $23.7 million (December 
31, 2016 – $13.7 million), which were not being depreciated as they had not yet reached the stage of commercial viability.  In 
addition, as at December 30, 2017, machinery and equipment included equipment under capital leases with a cost of $11.9 
million (December 31, 2016 – $11.9 million) and a net book value of $5.4 million (December 31, 2016 – $10.7 million), as 
well as $5.0 million (December 31, 2016 – $6.1 million) of spare parts inventory. 

Total depreciation expense included in cost of goods sold and selling, general and administrative expense on the consolidated 
statements of operations related to property, plant and equipment for the year ended December 30, 2017 was $21.7 million 
(December 31, 2016 – $22.9 million; January 2, 2016 – $16.1 million). 

SUNOPTA INC.                                                                                             

 -F27- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

11.   Goodwill and Intangible Assets 

Goodwill 
Intangible assets with a finite life at cost, less accumulated 
amortization of $41,036 (December 31, 2016 - $30,989) 

The following is a summary of changes in goodwill: 

December 30, 2017  December 31, 2016 
$ 
223,611 

$ 
109,533 

172,059 

183,524 

Balance at January 2, 2016 
  Goodwill impairment(1) 
  Foreign exchange 

Balance at December 31, 2016 

  Goodwill impairment(2) 
  Foreign exchange 

Balance at December 30, 2017 

Global Ingredients  Consumer Products 
$ 
215,700 
- 
(344) 
215,356 
(115,000) 
- 
100,356 

$ 
25,990 
(17,540) 
(195) 
8,255 
- 
922 
9,177 

Total 
$ 
241,690 
(17,540) 
(539) 
223,611 
(115,000) 
922 
109,533 

(1)  Based  on  the  results  of  the  annual  impairment  test  performed  for  the  year  ended  December  31,  2016,  the  Company 
determined  that  the  carrying  value  of  the  goodwill  associated  with  the  Sunflower  reporting  unit  of  the  Raw  Material 
Sourcing and Supply operating segment  exceeded its implied fair value, reflecting  lower anticipated sales demand and 
higher expected production and capital costs as a result of the sunflower recall.  As a result, the Company recognized a 
goodwill impairment charge of $17.5 million in 2016.   

(2)  Based  on  the  results  of  the  annual  impairment  test  performed  for  the  year  ended  December  30,  2017,  the  Company 
determined that the carrying value of the Healthy Fruit reporting unit of the Consumer Products reporting unit exceeded 
its fair value, reflecting lower-than-expected sales and operating performance for frozen fruit since the Sunrise Acquisition, 
and uncertainty of future sales due to lost customer volumes and declining consumer consumption trends in 2017.  As a 
result, the Company recognized a goodwill impairment charge of $115.0 million in 2017. 

SUNOPTA INC.                                                                                             

 -F28- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The major components of intangible assets as at December 30, 2017 and December 31, 2016 were as follows:  

Customer relationships 
Patents, trademarks and other 

Customer relationships 
Patents, trademarks and other 

The following is a summary of changes in intangible assets:  

Balance at January 2, 2016 
  Amortization 
  Foreign exchange 
Balance at December 31, 2016 

Impairment(1) 
  Amortization 
  Foreign exchange 
Balance at December 30, 2017 

Cost 
$ 
211,176 
1,919 
213,095 

Cost 
$ 
212,172 
2,341 
214,513 

Accumulated 
amortization 
$ 
39,274 
1,762 
41,036 

Accumulated 
amortization 
$ 
28,914 
2,075 
30,989 

December 30, 2017 

Net book value 
$ 
171,902 
157 
172,059 

December 31, 2016 

Net book value 
$ 
183,258 
266 
183,524 

Customer  Patents, trademarks 
and other 
$ 
375 
(116) 
7 
266 
- 
(109) 
- 
157 

relationships 
$ 
194,633 
(11,166) 
(209) 
183,258 
(456) 
(11,086) 
186 
171,902 

Total 
$ 
195,008 
(11,282) 
(202) 
183,524 
(456) 
(11,195) 
186 
172,059 

(1)  Represents impairment of customer relationship intangible asset related to the exited nutrition bar product lines (see note 4). 

The Company estimates that the aggregate future amortization expense associated with finite-life intangible assets in each of 
the next five fiscal years and thereafter will be as follows:  

2018 
2019 
2020 
2021 
2022 
Thereafter 

$ 
11,135 
11,021 
10,324 
10,112 
10,112 
119,355 
172,059 

SUNOPTA INC.                                                                                             

 -F29- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

12.   Accounts Payable and Accrued Liabilities 

Accounts payable 
Payroll and commissions 
Accrued grain liabilities 
Accrued recall-related costs (see note 6) 
Accrued interest 
Accrued product recall settlement (see note 18(5)) 
Dividends payable on Series A Preferred Stock (see note 14) 
Other accruals 

13.   Bank Indebtedness and Long-Term Debt 

Bank indebtedness: 
  Global Credit Facility(1) 
  Bulgarian credit facility(2) 

Long-term debt: 
  Senior Secured Second Lien Notes, net of unamortized debt issuance costs   

of $7,716 (December 31, 2016 - $8,835)(3) 

  Asset-backed term loan(4) 
  Capital lease obligations(5) 
  Other 

  Less: current portion 

(1)   Global Credit Facility 

December 30, 2017  December 31, 2016 
$ 
89,034 
14,262 
15,254 
39,750 
5,500 
- 
1,590 
8,355 
173,745 

$ 
94,992 
15,161 
15,039 
6,980 
5,496 
2,250 
1,700 
19,746 
161,364 

December 30, 2017  December 31, 2016 
$ 

$ 

230,502 
3,588 
234,090 

215,782 
3,600 
5,651 
3,000 
228,033 
2,228 
225,805 

199,281 
2,213 
201,494 

222,163 
- 
7,454 
1,470 
231,087 
2,079 
229,008 

On February 11, 2016, the Company entered into a five-year credit agreement for a senior secured asset-based revolving 
credit  facility  with  a  syndicate  of  banks  in  the  maximum  aggregate  principal  amount  of  $350.0  million,  subject  to 
borrowing base capacity (the “Global Credit Facility”). The Global Credit Facility is used to support the working capital 
and general corporate needs of the Company’s global operations, in addition to funding future strategic initiatives.  The 
Global Credit Facility also includes borrowing capacity available for letters of credit and provides for borrowings on same-
day notice, including in the form of swingline loans.  Subject to customary borrowing conditions and the agreement of any 
such lenders to provide such increased commitments, the Company may request to increase the total lending commitments 
under the Global Credit Facility to a maximum aggregate principal amount not to exceed $450.0 million.  Outstanding 
principal amounts under the Global Credit Facility are repayable in full on the maturity date of February 10, 2021.    

Individual borrowings under the Global Credit Facility have terms of six months or less and bear interest based on various 
reference rates, including prime rate and LIBOR plus an applicable margin.  The applicable margin in the Global Credit 
Facility ranges from 1.25% to 1.75% for loans bearing interest based on LIBOR and from 0.25% to 0.75% for loans bearing 
interest based on the prime rate and, in each case, is set quarterly based on average borrowing availability for the preceding 
fiscal quarter.  As at December 30, 2017, the weighted-average interest rate on the facilities was 3.45%.  

SUNOPTA INC.                                                                                             

 -F30- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

On September 19, 2017 (the “Effective Date”), the Company entered into an amendment to the Global Credit Facility to 
add an additional U.S. asset-based credit subfacility of an aggregate principal amount of $15.0 million (the “New U.S. 
Subfacility”). 

The  New  U.S.  Subfacility  was  fully  drawn  on  the  Effective  Date.    Amortization  payments  on  the  aggregate  principal 
amount of the New U.S. Subfacility are equal to $2.5 million payable at the end of each fiscal quarter, commencing with 
the fiscal quarter ending March 31, 2019.  Optional prepayment of borrowings under the New U.S. Subfacility are not 
permitted until the first anniversary of the Effective Date and are subject to certain availability conditions.  Borrowings 
repaid under the New U.S. Subfacility may not be borrowed again. 

Borrowings under the New U.S. Subfacility bear interest at a margin over various reference rates.  The applicable margin 
for the New U.S. Subfacility will be set quarterly based on average borrowing availability for the preceding fiscal quarter 
and will range from 2.00% to 2.50% with respect to base rate and prime rate borrowings and from 3.00% to 3.50% for 
eurocurrency rate and bankers’ acceptance rate borrowings.  The initial margin for the New U.S. Subfacility is 2.50% with 
respect to base rate and prime rate borrowings and 3.50% with respect to eurocurrency rate borrowings. 

Obligations under the Global Credit Facility are guaranteed by substantially all of the Company’s subsidiaries and, subject 
to certain exceptions, such obligations are secured by first priority liens on substantially all of the assets of the Company.  

The Global Credit Facility contains a number of covenants that, among other things, restrict, subject to certain exceptions, 
the Company’s ability to create liens on assets; sell assets and enter into sale and leaseback transactions; pay dividends, 
prepay junior lien and unsecured indebtedness and make other restricted payments; incur additional indebtedness and make 
guarantees; make investments, loans or advances, including acquisitions; and engage in mergers or consolidations.  The 
foregoing covenants are subject to certain threshold amounts and exceptions as set forth in the credit agreement. 

(2)  Bulgarian credit facility 

On June 28, 2017, a subsidiary of The Organic Corporation B.V. (“TOC”), a wholly-owned subsidiary of the Company, 
extended its revolving credit facility agreement dated May 22, 2013, to provide up to €4.5 million to cover the working 
capital needs of TOC’s Bulgarian operations.  The facility is secured by the accounts receivable and inventories of the 
Bulgarian operations and is fully guaranteed by TOC.  Interest accrues under the facility based on EURIBOR plus a margin 
of  2.75%,  and  borrowings  under  the  facility  are  repayable  in  full  on  April  30,  2018.    As  at  December  30,  2017,  the 
weighted-average interest rate on the Bulgarian credit facility was 2.75%. 

(3)   Senior Secured Second Lien Notes 

On October 20, 2016, SunOpta Foods issued $231.0 million of 9.5% Senior Secured Second Lien Notes due 2022 (the 
“Notes”).    The  Company  incurred  $9.3  million  of  debt  issuance  costs  related  to  the  Notes,  which  were  recorded  as  a 
reduction against the principal amount of the Notes and are being amortized over the six-year term of the Notes.  Interest 
on the Notes is payable semi-annually in arrears on April 15 and October 15 at a rate of 9.5% per annum, commencing on 
April 15, 2017.  The Notes will mature on October 9, 2022.  Giving effect to the amortization of debt issuance costs, the 
effective interest rate on the Notes is approximately 10.4% per annum. 

Prior to October 9, 2018, SunOpta Foods may redeem some or all of the Notes at any time and from time to time at a 
“make-whole” redemption price set forth in  the indenture  governing the Notes. On or after October  9, 2018, SunOpta 
Foods may redeem the Notes, in whole or in part, at any time at the redemption prices equal to 107.125% through October 
8, 2019, 104.750% from October 9, 2019 through October 8, 2020, 102.375% from October 9, 2020 through October 8, 
2021 and at par thereafter, plus accrued and unpaid interest, if any, to but excluding the date of redemption.  In addition, 
prior to October 9, 2018, SunOpta Foods may, on one or more occasions, redeem up to 35% of the aggregate principal 
amount of the Notes with the proceeds of certain equity offerings at a redemption price equal to 109.500% of the principal 
amount of the Notes redeemed, plus accrued and unpaid interest, if any, to but excluding the date of redemption. At any 
time prior to October 9, 2018, SunOpta Foods may also redeem, during each twelve-month period beginning on October 
20, 2016, up to 10% of the aggregate principal amount of the Notes at a price equal to 103.000% of the aggregate principal 

SUNOPTA INC.                                                                                             

 -F31- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

amount of the Notes being redeemed, plus accrued and unpaid interest, if any, to but excluding the date of redemption.  In 
the event of a change of control, SunOpta Foods will be required to make an offer to repurchase the Notes at 101.000% of 
their principal amount, plus accrued and unpaid interest, if any, to the date of purchase.   

On October 19, 2017, the Company repaid $7.5 million principal amount of the Notes at 103.000%.  The premium paid 
and write-off of a pro-rata portion of debt issuance costs were charged to interest expense on the consolidated statement 
of operations. 

The Notes are secured by second-priority liens on substantially all of the assets that secure the credit facilities provided 
under the Global Credit Facility, subject to certain exceptions and permitted liens.  The Notes are senior secured obligations 
and rank equally in right of payment with SunOpta Foods’ existing and future senior debt and senior in right of payment 
to any future subordinated debt. The Notes are effectively subordinated to debt under the Global Credit Facility and any 
future indebtedness secured on a first priority basis.  The Notes are initially guaranteed on a senior secured second-priority 
basis by the Company and each of its subsidiaries (other than  SunOpta Foods) that  guarantees indebtedness  under the 
Global Credit Facility, subject to certain exceptions. 

The Notes are subject to covenants that, among other things, limit the Company’s ability to (i) incur additional debt or 
issue preferred stock; (ii) pay dividends and make certain types of investments and other restricted payments; (iii) create 
liens;  (iv)  enter  into  transactions  with  affiliates;  (v)  sell  assets;  and  (vi)  create  restrictions  on  the  ability  of  restricted 
subsidiaries to pay dividends, make loans or advances or transfer assets to the Company, SunOpta Foods or any guarantor 
of the Notes.  The foregoing covenants are subject to certain threshold amounts and exceptions as set forth in the indenture 
governing  the  Notes.    In  addition,  the  indenture  provides  for  customary  events  of  default  (subject  in  certain  cases  to 
customary  grace  and  cure  periods),  which  include  nonpayment,  breach  of  covenants  in  the  indenture,  certain  payment 
defaults or acceleration of other indebtedness, a failure to pay certain judgments and certain events  of bankruptcy and 
insolvency.  If an event of default occurs and is continuing, the trustee or holders of at least 25% in principal amount of 
the outstanding Notes may declare the principal of and accrued and unpaid interest on, if any, all the Notes to be due and 
payable. 

As at December 30, 2017, the estimated fair value of the outstanding Notes was approximately $240 million, based on 
quoted prices of recent over-the-counter transactions (Level 2).  

(4)  Asset-backed term loan 

On December 28, 2017, TOC entered into a €3.0 million asset-backed term loan.  The loan is secured by a first priority 
lien on equipment owned by TOC for a second processing line at its cocoa processing facility in the Netherlands.  Interest 
on this loan accrues at an effective rate of 3.06% and the loan matures on December 28, 2027.  Principal and accrued 
interest is repayable in equal monthly installments.  The loan is fully guaranteed by TOC. 

(5)  Capital lease obligations 

The Company leases certain equipment under capital lease agreements.  The cost and accumulated depreciation of assets 
under capital lease are included in machinery and equipment. 

SUNOPTA INC.                                                                                             

 -F32- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
  
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Principal repayments of long-term debt are as follows: 

2018 
2019 
2020 
2021 
2022 
Thereafter 
Total gross repayments 
Unamortized debt issuance costs 

The components of interest expense, net are as follows: 

Interest expense 
Amortization and write-off of debt issuance costs 
Interest income 
Interest expense, net 

14.   Series A Preferred Stock 

$ 
2,228 
2,149 
3,822 
993 
224,530 
2,027 
235,749 
(7,716) 
228,033 

December 30, 2017  December 31, 2016 
$ 
32,090 
11,301 
(116) 
43,275 

$ 
29,771 
2,825 
(92) 
32,504 

January 2, 2016 
$ 
9,853 
5,895 
(79) 
15,669 

On  October  7,  2016  (the  “Closing  Date”),  the  Company  and  SunOpta  Foods  entered  into  a  subscription  agreement  (the 
“Subscription Agreement”) with Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (collectively, the 
“Investors”).  Pursuant to the Subscription Agreement, SunOpta Foods issued an aggregate of 85,000 shares of Preferred Stock 
to the Investors for consideration in the amount of $85.0 million.  In connection with the issuance of the Preferred Stock, the 
Company incurred direct and incremental expenses of $6.0 million, which reduced the carrying value of the Preferred Stock.  
At any time on or after the fifth anniversary of the Closing Date, SunOpta Foods may redeem all of the Preferred Stock for an 
amount, per share of Preferred Stock, equal to the value of the liquidation preference at such time.  The carrying value of the 
Preferred Stock is being accreted to the redemption amount of $85.0 million through charges to retained earnings over the 
period preceding the fifth anniversary of the Closing Date, which accretion amounted to $1.0 million and $0.2 million for the 
year ended December 30, 2017 and period ended December 31, 2016.  

In connection with the Subscription Agreement, the Company agreed to, among other things (i) ensure SunOpta Foods has 
sufficient funds to pay its obligations under the terms of the Preferred Stock and (ii) grant each holder of Preferred Stock (the 
“Holder”) the right to exchange the Preferred Stock for shares of common stock of the Company (the “Common Shares”).  The 
Preferred Stock is non-participating with the Common Shares in dividends and undistributed earnings of the Company. 

The Preferred Stock has a stated value and initial liquidation preference of $1,000 per share.  Cumulative preferred dividends 
accrue daily on the Preferred Stock at an annualized rate of 8.0% prior to October 5, 2025 and 12.5% thereafter, in each case 
of the liquidation preference (subject to an increase of 1.0% per quarter, up to a maximum rate of 5.0% per quarter on the 
occurrence of certain events of non-compliance).  Prior to October 5, 2025, SunOpta Foods may pay dividends in cash or elect, 
in lieu of paying cash, to add the amount that would have been paid to the liquidation preference.  After October 4, 2025, the 
failure to pay dividends in cash will be an event of non-compliance.  The Preferred Stock ranks senior to the shares of common 
stock of SunOpta Foods with respect to dividend rights and rights on the distribution of assets on any liquidation, winding up 
or dissolution of the Company or SunOpta Foods.  For the year ended December 30, 2017, the Company paid cash dividends 
on the Preferred Stock of $6.7 million, and, as at December 30, 2017, the Company had accrued unpaid dividends of $1.7 
million, which were recorded in accounts payable and accrued liabilities on the consolidated balance sheet. 

SUNOPTA INC.                                                                                             

 -F33- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

At any time, the Holders may exchange their shares of Preferred Stock, in whole or in part, into the number of Common Shares 
equal to, per share of Preferred Stock, the quotient of the liquidation preference divided by $7.50 (such price, the “Exchange 
Price” and such quotient, the “Exchange Rate”).  As at December 30, 2017, the aggregate shares of Preferred Stock outstanding 
were  exchangeable  into  11,333,333  Common  Shares.    The  Exchange  Price  is  subject  to  certain  anti-dilution  adjustments, 
including  a  weighted-average  adjustment  for  issuances  of  Common  Shares  below  the  Exchange  Price,  provided  that  the 
Exchange Price may not be lower than $7.00 (subject to adjustment in certain circumstances).  SunOpta Foods may cause the 
Holders to exchange all of the Preferred Stock into a number of Common Shares based on the applicable Exchange Price if (i) 
fewer than 10% of the shares of Preferred Stock issued on the Closing Date remain outstanding or (ii) on or after the third 
anniversary of the Closing Date, the average volume-weighted average price of the Common Shares during the then preceding 
20 trading day period is greater than 200% of the Exchange Price.   

In connection with the Subscription Agreement, the Company issued 11,333,333 Special Shares, Series 1 (the “Special Voting 
Shares”) to the Investors, which entitle the Investors to one vote per Special Voting Share on all matters submitted to a vote of 
the holders of Common Shares, together as a single class, subject to certain exceptions.  Additional Special Voting Shares will 
be issued, or existing Special Voting Shares will be redeemed, as necessary to ensure that the aggregate number of Special 
Voting Shares outstanding is equal to the number of shares of Preferred Stock outstanding from time to time multiplied by the 
Exchange Rate in effect at such time.  As at December 30, 2017, 11,333,333 Special Voting Shares were issued and outstanding, 
which represented an approximate 11.7% voting interest in the Company.  The Special Voting Shares are not transferable and 
the voting rights associated with the Special Voting Shares will terminate upon the transfer of the Preferred Stock to a third 
party, other than a controlled affiliate of the Investors.  The Investors are entitled to designate up to two nominees for election 
to the Board of Directors of the Company (the “Board”) and have the right to designate one individual to attend meetings of 
the Board as a non-voting observer, subject to the Investors maintaining certain levels of beneficial ownership of Common 
Shares on an as-exchanged basis.  For so long as the Investors beneficially own or control at least 50% of the Preferred Stock 
issued on the Closing Date, including any corresponding Common Shares into which such Preferred Stock are exchanged, the 
Investors will be entitled to (i) participation rights with respect to future equity offerings of the Company; and (ii) governance 
rights, including the right to approve certain actions proposed to be taken by the Company and its subsidiaries. 

15.   Common Shares 

The Company is authorized to issue an unlimited number of Common Shares without par value and an unlimited number of 
special shares without par value. 

On September 30, 2015, the Company completed a registered offering of 16,670,000 of Common Shares at a price of $6.00 
per share, for aggregate gross proceeds of $100.0 million.  Underwriting and other issuance costs of $4.4 million incurred in 
connection with the issuance of these new Common Shares were recorded as a reduction to the gross proceeds from the offering, 
net of income taxes of $1.6 million. The net proceeds from the offering were used by the Company to fund a portion of the 
purchase price of the Sunrise Acquisition (see note 2). 

16.   Stock-Based Compensation 

Stock Incentive Plan 

On May 28, 2013, the Company’s shareholders approved the 2013 Stock Incentive Plan (the “2013 Plan”), which permits the 
grant of a variety of stock-based awards, including stock options, restricted stock units (“RSUs”) and performance share units 
(“PSUs”)  to  selected  employees  and  directors  of  the  Company.    As  at  December  30,  2017,  3,674,298  securities  remained 
available for issuance under the 2013 Plan.  

For the years ended December 30, 2017, December 31, 2016 and January 2, 2016, total stock-based compensation expense 
amounted to $5.7 million, $4.1 million and $4.4 million, respectively. 

SUNOPTA INC.                                                                                             

 -F34- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Stock Options 

Stock options granted to selected employees during the year ended December 30, 2017 and December 31, 2016, vest ratably 
on each of the first through third anniversaries of the grant date and expire on the tenth anniversary of the grant date.  Stock 
options granted during the year ended January 2, 2016, vest ratably on each of the first through fifth anniversaries of the grant 
date and expire on the tenth anniversary of the grant date.  Stock options granted by the Company contain an exercise price 
that is equal to the closing market price of the shares on the day prior to the grant date.  Any consideration paid by employees 
or directors on exercise of stock options or purchase of stock is credited to capital stock.   

The following table summarizes stock option activity for the year ended December 30, 2017: 

Outstanding, beginning of year 
Granted 
Exercised 
Forfeited 
Expired 
Outstanding at end of year 
Exercisable, end of year 

Weighted- 
average 
exercise price 
6.47   
9.29   
5.34   
6.74   
7.56   
7.51 
7.16 

Options 
4,579,850  $ 
1,120,406   
(827,272)  
(1,260,767)  
(305,489)  
3,306,728  $ 
1,157,507  $ 

Weighted- 
average 
remaining 
contractual 
term (years) 

Aggregate 
intrinsic value 

6.92  $ 
5.12  $ 

4,145 
1,615 

The following table summarizes non-vested stock option activity during the year ended December 30, 2017: 

Non-vested, beginning of year 
Granted 
Vested 
Forfeited 
Non-vested, end of year 

Stock options 

2,843,676  $ 
1,120,406   
(756,075)  
(1,058,786)  
2,149,221  $ 

Weighted- 
average grant- 
date fair value 
3.06 
4.12 
3.19 
3.05 
3.57 

The weighted-average grant-date fair values of all stock options granted in the years ended December 30, 2017, December 31, 
2016 and January 2, 2016, were $4.12, $1.86 and $4.37, respectively.  The weighted-average assumptions used in the Black-
Scholes option pricing model to determine the fair value of the stock options granted in those years were as follows: 

Grant-date stock price 
Dividend yield(1) 
Expected volatility(2) 
Risk-free interest rate(3) 
Expected life of options (years)(4) 

December 30, 2017  December 31, 2016 
$4.25 
0% 
41.7% 
1.6% 
6.0 

$9.29 
0% 
42.1% 
2.0% 
6.4 

January 2, 2016 
$8.41 
0% 
50.1% 
1.9% 
6.5 

(1)  Determined based on expected annual dividend yield at the time of grant. 
(2)  Determined based on historical volatility of the Company’s Common Shares over the expected life of the option. 
(3)  Determined based on the yield on U.S. Treasury zero-coupon issues with maturity dates equal to the expected life of the option. 

SUNOPTA INC.                                                                                             

 -F35- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

(4)  Determined using simplified method, as the Company changed the vesting period of its stock option grants from five years to three years in 2016, 

and, as a result, historical exercise data may not provide a reasonable basis upon which to estimate expected life.  

The following table summarizes stock options outstanding and exercisable as at December 30, 2017: 

$ 

$ 

Exercise price range 
High 
5.14 
7.28 
9.38 
9.60 
13.86 

Low 
3.27 
5.15 
7.29 
9.39 
9.61 

Outstanding 
options 
664,048 
636,177 
704,499 
706,052 
595,952 
3,306,728 

Weighted- 
average 
remaining 

(years) 

Weighted- 
contractual life  average exercise 
price 
3.41 
6.01 
8.00 
9.50 
10.75 
7.51 

6.43  $ 
6.47   
6.53   
9.40   
5.46   
6.92  $ 

Weighted- 
Exercisable  average exercise 
price 
3.78 
5.74 
7.40 
- 
10.89 
7.16 

options 
184,866  $ 
383,844   
294,900   
-   
293,897   
1,157,507  $ 

Total compensation costs related to non-vested stock option awards not yet recognized as an expense was $5.3 million as at 
December 30, 2017, which will be amortized over a weighted-average remaining vesting period of 2.2 years. 

Restricted Stock Units 

For  the  year  ended  December  30,  2017,  the  Company  granted  762,710  RSUs  to  selected  employees  and  directors.    RSUs 
granted to employees vest ratably on each of the first through third anniversaries of the grant date.  RSUs granted to directors 
vest 100% on the first anniversary of the grant date.  Each vested RSU will entitle the employee or director to receive one 
common share of the Company.  The weighted-average grant-date fair value of the RSUs was estimated to be $9.18, based on 
the stock price of the Common Shares as of the dates of grant.   

The following table summarizes non-vested RSU activity during the year ended December 30, 2017: 

Non-vested, beginning of year 
Granted 
Vested 
Forfeited 
Non-vested, end of year 

Weighted- 

average grant- 

date fair value 
6.10 
9.18 
6.31 
9.50 
8.85 

RSUs 
175,860  $ 
762,710   
(95,724)  
(67,490)  
775,356  $ 

Total compensation costs related to non-vested RSU awards not yet recognized as an expense was $4.9 million as at December 
30, 2017, which will be amortized over a weighted-average remaining vesting period of 2.2 years. 

Performance Share Units 

For the year ended December 30, 2017, the Company granted 1,560,535 PSUs to selected employees.  The vesting of the PSUs 
is subject to the satisfaction of certain stock price performance conditions during a three-year performance period ending May 
24, 2020.  One-third of the PSUs will vest upon achieving a stock price of $11.00, one-third will vest upon achieving a stock 
price of $14.00, and one-third will vest upon achieving a stock price of $18.00, in each case for 20 consecutive trading days 
and subject to the employee’s continued employment throughout the performance period.  Each vested PSU will entitle the 
employee to receive one common share of the Company without payment of additional consideration. 

SUNOPTA INC.                                                                                             

 -F36- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The fair value of the PSUs was estimated using a Monte Carlo valuation model, which simulates the potential outcomes for the 
Company’s stock price performance and determines the payouts that would occur under each scenario.  Fair value is based on 
the average of those results.  The grant-date weighted-average fair value of the PSUs was determined to be $5.64, based on the 
following inputs to the valuation model: 

Grant-date stock price 
Dividend yield 
Expected volatility(1) 
Risk-free interest rate(2) 
Expected life (in years)(3) 

$ 

9.33 
0% 
42.2% 
1.5% 
3.0 

(1)   Determined based on the historical volatility of the Common Shares over 6.5 years, which is consistent with the volatility assumption for stock 

options granted to employees. 

(2)   Determined based on U.S. Treasury yields with a remaining term equal to the expected life of the PSUs. 
(3)   Determined based on vesting for the PSUs.   

The following table summarizes non-vested PSU activity during the year ended December 30, 2017: 

Non-vested, beginning of year 
Granted 
Forfeited or cancelled 
Non-vested, end of year 

Weighted- 

average grant- 

date fair value 
6.75 
5.64 
6.70 
5.68 

PSUs 
454,425  $ 

1,560,535   
(495,208)  
1,519,752  $ 

Total compensation costs related to non-vested PSU awards not yet recognized as an expense was $6.4 million as at December 
30, 2017, which will be amortized over a weighted-average remaining vesting period of 2.4 years. 

CEO Plan 

On February 6, 2017, David Colo was appointed President and CEO of the Company.  In connection with his appointment, the 
Company granted Mr. Colo 473,940 performance-based stock options (the “Special Stock Options”) and 277,780 PSUs.  In 
addition, Mr. Colo was granted 100,000 RSUs, of which 50,000 were contingent on Mr. Colo purchasing Common Shares with 
an aggregate value of $1.0 million in the open market.   

The vesting of the Special Stock Options and PSUs is subject to: (i) Mr. Colo’s continued employment with the Company 
during a three-year performance period ending February 6, 2020; and (ii) the satisfaction of certain stock price performance 
conditions during the performance period.  One-third of the Special Stock Options and PSUs will vest upon achieving a stock 
price of $11.00, one-third will vest upon achieving a stock price of $14.00, and one-third will vest upon achieving a stock price 
of  $18.00,  in  each  case  for  20  consecutive  trading  days  and  subject  to  Mr.  Colo’s  continued  employment  through  the 
performance period.  Each vested Special Stock Option will entitle Mr. Colo to purchase one common share of the Company 
at an exercise price of $7.00, which was equal to the closing price of the Common Shares as at February 6, 2017.  Each vested 
PSU will entitle Mr. Colo to receive one common share of the Company without payment of additional consideration. 

SUNOPTA INC.                                                                                             

 -F37- 

December 30, 2017 10-K 

 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The  grant-date  weighted-average  fair  values  of  the  Special  Stock  Options  and  PSUs  were  estimated  using  a  Monte  Carlo 
valuation model and determined to be $1.84 and $2.79, respectively, based on the following inputs to the valuation model: 

Grant-date stock price 
Exercise price 
Dividend yield 
Expected volatility(1) 
Risk-free interest rate(2) 
Expected life (in years)(3) 

$ 
$ 

Special Stock 
Options 

7.00  $ 
7.00 
0%  
42.0%  
2.2%  
6.5   

PSUs 
7.00 
NA 
0% 
42.0% 
1.5% 
3.0 

(1)  Determined based on the historical volatility of the Common Shares over the expected life of the Special Stock Options. 
(2)   Determined based on U.S. Treasury yields with a remaining term equal to the respective expected lives of the Special Stock Options and PSUs. 
(3)   Determined using the simplified method for the Special Stock Options, based on the mid-point of vesting (three years) and expiration (ten years).  

Determined based on vesting for the PSUs.   

The aggregate grant-date fair value of the Special Stock Options and PSUs awarded to Mr. Colo was $1.6 million, which will 
be recognized on a straight-line basis over the requisite three-year performance period.  

The RSUs granted to Mr. Colo vest in three equal installments beginning on February 6, 2018.  Each vested RSU will entitle 
Mr. Colo to receive one common share of the Company.  The grant-date fair value of the RSUs was estimated to be $7.00 based 
on the stock price of the Common Shares as of the date of grant.  The aggregate grant-date fair value of the RSUs awarded to 
Mr. Colo of $0.7 million will be recognized on a straight-line basis over the three-year vesting period.  

Employee Share Purchase Plan 

The Company maintains an employee share purchase plan whereby employees can purchase common shares through payroll 
deductions.  In the year ended December 30, 2017, the Company’s employees purchased 61,796 common shares (December 
31, 2016 – 82,841; January 2, 2016 – 55,024) for total proceeds of $0.4 million (December 31, 2016 – $0.4 million; January 2, 
2016 – $0.4 million).  As at December 30, 2017, 1,112,073 common shares are remaining to be granted under this plan. 

17.  Accumulated Other Comprehensive Loss 

Net unrealized losses recorded in accumulated other comprehensive loss were as follows: 

Currency translation adjustment 
Cash flow hedges, net of income taxes 

December 30, 
2017 
$ 
(6,963) 
(305) 
(7,268) 

December 31, 
2016 
$ 
(13,104) 
- 
(13,104) 

SUNOPTA INC.                                                                                             

 -F38- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

18.   Other Expense (Income), Net 

The components of other expense (income) are as follows: 

Impairment of long-lived assets(1) 
Employee termination costs(2) 
Product withdrawal and recall costs(3) 
Increase (decrease) in fair value of contingent 

consideration(4) 
Legal settlement(5) 
Business acquisition costs(6) 
Other 

(1)  Impairment of long-lived assets 

December 30, 2017  December 31, 2016 
$ 

$ 

January 2, 2016 
$ 

18,193 
5,636 
413 

371 
(1,024) 
- 
71 
23,660 

13,257 
4,186 
2,838 

(1,158) 
9,000 
233 
(64) 
28,292 

- 
2,936 
- 

884 
- 
7,767 
564 
12,151 

For  the  year  ended  December  30,  2017,  represents  the  impairment  of  assets  associated  with  the  exits  from  flexible 
resealable pouch and nutrition bar products lines and operations, and consolidation of roasted snack operations, as well as 
the early buyout of the San Bernardino equipment leases (see note 4).   

For  the  year  ended  December  31,  2016,  represents  the  impairment  of  assets  associated  with  the  closures  of  the  San 
Bernardino and Heuvelton facilities (see note 4).  In addition, includes the impairment of leasehold improvements at the 
Company’s  Buena  Park,  California,  facility  on  the  consolidation  of  Company’s  frozen  fruit  processing  operations 
following the Sunrise Acquisition.    

(2)  Employee termination costs 

For the year ended December 30, 2017, represents severance benefits, net of forfeitures of stock-based awards, and legal 
costs incurred in connection with the Value Creation Plan (see note 4), including employees affected by the exits from 
flexible resealable pouch and nutrition bar product lines and operations, and consolidation of roasted snack operations. 

For the year ended December 31, 2016, represents contractual severance benefits and previously unrecognized stock-based 
compensation expense recognized in connection  with the departure of Mr. Jacobs as President and CEO in November 
2016, as well as costs for employees affected by the closures of the Company’s San Bernardino, Heuvelton and Buena 
Park facilities.   

(3)  Product withdrawal and recall costs 

For  the  year  ended  December  30,  2017,  represents  product  withdrawal  and  recall  costs  that  were  not  eligible  for 
reimbursement under the Company’s insurance policies, including certain direct costs related to the sunflower recall. 

For the year ended December 31, 2016, represents costs related to the voluntary withdrawal of certain consumer-packaged 
products due to quality-related issues, as well as certain direct costs and insurance deductibles related to the sunflower 
recall. 

SUNOPTA INC.                                                                                             

 -F39- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

(4)   Fair value of contingent consideration 

For all years presented, reflects the accretion of contingent consideration obligations to reflect the time value of money.  
In addition, for the year ended December 31, 2016, includes a gain of $1.7 million on the settlement of the contingent 
consideration obligation related to the acquisition of Niagara Natural (see note 2). 

(5)  Legal settlement 

In 2016, the Company recorded a charge of $9.0 million related to the settlement of a product recall dispute with a customer 
involving  certain  flexible  resealable  pouch  products  manufactured  by  the  Company  in  2013.    The  settlement  amount 
included up to $4.0 million in rebates payable to the customer over a four-year period.  In connection with the exit from 
the  flexible  resealable  pouch  product  lines  and  operations,  the  Company  agreed  to  an  upfront  cash  settlement  of  the 
remaining rebate obligation, resulting in a recovery of $1.0 million recognized in 2017. 

(6)  Business acquisition costs 

Represents transaction costs incurred in connection with the acquisitions of Sunrise, Niagara Natural and Citrusource (see 
note 2). 

 19.   Income Taxes 

The recovery of income taxes differs from the amount that would have resulted from applying the combined Canadian federal 
and provincial statutory income tax rate to loss from continuing operations before income taxes due to the following: 

Loss from continuing operations before income taxes 
Canadian statutory rate 
Income tax recovery at statutory rate 
Impact of changes in enacted tax rates(1) 
Foreign tax rate differential 
Change in unrecognized tax benefits 
Goodwill impairment loss 
Impact of stock-based compensation and other non- 

deductible expenses 

Change in valuation allowance 
Impact of non-deductible acquisition expenses 
Impairment loss on investment 
Other 
Recovery of income taxes 

December 30, 2017  December 31, 2016 
$ 
(74,361) 
26.5% 
(19,706) 
90 
(11,329) 
(1,268) 
6,841 

$ 
(170,397) 
26.5% 
(45,155) 
(8,437) 
(9,324) 
(452) 
30,475 

January 2, 2016 
$ 
(6,522) 
26.5% 
(1,728) 
(208) 
(3,097) 
(855) 
- 

1,590 
72 
- 
- 
(4,598) 
(35,829) 

1,238 
(267) 
- 
- 
604 
(23,797) 

1,470 
4,015 
910 
(4,029) 
132 
(3,390) 

(1)  For the year ended December 30, 2017, the impact of changes in enacted tax rates reflected the remeasurement of deferred tax balances to reflect 

new U.S. corporate tax rates enacted in December 2017. 

SUNOPTA INC.                                                                                             

 -F40- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The components of loss from continuing operations before income taxes are shown below: 

Canada 
U.S. 
Other 

December 30, 2017  December 31, 2016 
$ 
9,811 
(93,941) 
9,769 
(74,361) 

$ 
(3,286) 
(178,033) 
10,922 
(170,397) 

January 2, 2016 
$ 
6,038 
(20,028) 
7,468 
(6,522) 

The components of the provision for (recovery of) income taxes are shown below: 

Current income tax provision (recovery): 
  Canada 
  U.S. 
  Other 

Deferred income tax provision (recovery): 
  Canada 
  U.S. 
  Other 

Recovery of income taxes 

December 30, 2017  December 31, 2016 
$ 

$ 

January 2, 2016 
$ 

(658) 
(10,346) 
3,074 
(7,930) 

642 
(28,606) 
65 
(27,899) 
(35,829) 

3,560 
(1,293) 
3,664 
5,931 

(12) 
(29,463) 
(253) 
(29,728) 
(23,797) 

- 
(1,982) 
2,300 
318 

2,484 
(5,971) 
(221) 
(3,708) 
(3,390) 

Deferred income taxes of the Company are comprised of the following: 

Differences in property, plant and equipment 

and intangible assets 

Capital and non-capital losses 
Tax benefit of scientific research expenditures 
Tax benefit of costs incurred during share issuances 
Inventory basis differences 
Interest expense limitation (163j) 
Other accrued reserves 

Less: valuation allowance 
Net deferred income tax liability 

December 30, 2017  December 31, 2016 
$ 

$ 

(51,093) 
22,144 
1,871 
- 
5,193 
10,311 
5,249 
(6,325) 
9,162 
(15,487) 

(87,833) 
31,494 
1,199 
944 
5,761 
3,356 
10,653 
(34,426) 
9,090 
(43,516) 

SUNOPTA INC.                                                                                             

 -F41- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The components of the deferred income tax asset (liability) are shown below: 

Canada 
U.S. 
Other 

The components of the deferred income tax valuation allowance are as follows: 

Balance, beginning of year 
Increase in valuation allowance 
Foreign exchange 
Balance, end of year 

December 30, 2017  December 31, 2016 
$ 
1,045 
(43,668) 
(893) 
(43,516) 

$ 
362 
(14,892) 
(957) 
(15,487) 

December 30, 2017  December 31, 2016 
$ 
9,347 
(267) 
10 
9,090 

$ 
9,090 
72 
- 
9,162 

As at December 30, 2017, the Company had approximately $0.4 million (December 31, 2016 – $0.4 million) in U.S. federal 
scientific  research  investment  tax  credits  and  $0.9  million  (December  31,  2016  –  $0.8  million)  in  U.S.  State  research  and 
development tax credits, which will expire in varying amounts up to 2029. 

As  at  December  30,  2017,  the  Company  had  U.S.  federal  non-capital  loss  carry-forwards  of  approximately  $46.0  million 
(December 31, 2016 – $51.3 million).  In addition, the Company had state loss carry-forwards of approximately $62.6 million as 
at December 30, 2017 (December 31, 2016 – $64.2 million).  These amounts are available to reduce future federal and state income 
taxes.  

As at December 30, 2017, the Company had Canadian capital losses of approximately $27.7 million (December 31, 2016 – $29.7 
million) for which a full valuation allowance exists.  These amounts are available to reduce future capital gains and do not expire. 

The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized.  In making 
such determinations, the Company considers all available positive and negative evidence, including future reversals of existing 
temporary differences, projected future taxable income, tax planning strategies and recent financial operations.  Based on this 
evaluation, as at December 30, 2017, a valuation allowance of $9.2 million (December 31, 2016 – $9.1 million) had been recorded 
against certain assets to reduce the net benefit recorded in the consolidated financial statements.   

Undistributed  earnings  of  the  Company’s  non-Canadian  affiliates  and  associated  companies  are  considered  to  be  indefinitely 
reinvested; accordingly, no provision for deferred taxes has been provided thereon.     

The Company believes it has adequately examined its tax positions taken or expected to be taken in a tax return; however, amounts 
asserted  by  taxing  authorities  could  differ  from  the  Company’s  positions.    Accordingly,  additional  provisions  on  federal, 
provincial, state and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying 
matters are settled or otherwise resolved.   A reconciliation  of the beginning and ending amount of  unrecognized tax benefits 
(excluding interest and penalties) is presented below: 

Balance, beginning of year 
Reductions in tax positions of prior years 
Balance, end of year 

December 30, 2017  December 31, 2016 
$ 
1,720 
(1,268) 
452 

$ 
452 
(452) 
- 

SUNOPTA INC.                                                                                             

 -F42- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

The Company’s opening unrecognized tax benefits position largely included a possible reduction to prior year losses for U.S. 
exposures relating to the deductibility of certain interest amount accrued.  The amount has become fully statute barred in the 
U.S. and the liability reduced to zero. 

Consistent  with  its  historical  financial  reporting,  the  Company  has  classified  interest  and  penalties  related  to  income  tax 
liabilities, when applicable, as part of interest expense in its consolidated statements of operations, and with the related liability 
on the consolidated balance sheets.  

The number of years with open tax audits varies depending on the tax jurisdiction. The Company’s major taxing jurisdictions 
include Canada (including Ontario), the U.S. (including multiple states), and the Netherlands.  The Company’s 2010 through 
2016 tax years (and any tax year for which available non-capital loss carry-forwards were generated up to the amount of non-
capital loss carry-forward) remain subject to examination by the Internal Revenue Service for U.S. federal tax purposes, and 
the 2010 through 2016 tax years remain subject to examination by the appropriate governmental agencies for Canadian federal 
tax purposes. There are other ongoing audits in various other jurisdictions that are not considered material to the Company’s 
consolidated financial statements. 

SUNOPTA INC.                                                                                             

 -F43- 

December 30, 2017 10-K 

 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

20.   Loss Per Share 

Basic and diluted loss per share were calculated as follows (shares in thousands): 

Numerator for basic loss per share: 
  Loss from continuing operations, less amounts 
attributable to non-controlling interests 

  Less: dividends and accretion on Series A Preferred Stock 
  Loss from continuing operations available to 

common shareholders 

  Loss from discontinued operations attributable to SunOpta Inc. 
  Loss available to common shareholders 

December 30, 
2017 

December 31, 
2016 

January 2, 2016 

$ 

(135,320)  $ 
(7,809) 

(50,618)  $ 
(1,812) 

(143,129) 
- 

$ 

(143,129)  $ 

(52,430) 
(570) 
(53,000)  $ 

(2,996) 
- 

(2,996) 
(19,475) 
(22,471) 

Denominator for basic loss per share: 
  Basic weighted-average number of shares outstanding 

86,355 

85,569 

72,408 

$ 

$ 

$ 

Basic loss per share: 

 - from continuing operations 
 - from discontinued operations 

Numerator for diluted loss per share: 
  Loss from continuing operations, less amounts 
attributable to non-controlling interests 

  Less: dividends and accretion on Series A Preferred Stock (1) 
  Loss from continuing operations available to 

common shareholders 

  Loss from discontinued operations attributable to SunOpta Inc. 
  Loss available to common shareholders 

Denominator for diluted loss per share: 
  Basic weighted-average number of shares outstanding 
  Dilutive effect of the following: 
  Series A Preferred Stock (1) 
  Stock options (2) 

  Diluted weighted-average number of shares outstanding 

Diluted loss per share: 

 - from continuing operations 
 - from discontinued operations 

(1.66)  $ 
- 
(1.66)  $ 

(0.61)  $ 
(0.01) 
(0.62)  $ 

(0.04) 
(0.27) 
(0.31) 

(135,320)  $ 
(7,809) 

(50,618)  $ 
(1,812) 

(143,129) 
- 

$ 

(143,129)  $ 

(52,430) 
(570) 
(53,000)  $ 

(2,996) 
- 

(2,996) 
(19,475) 
(22,471) 

86,355 

85,569 

72,408 

- 
- 
86,355 

- 
- 
85,569 

$ 

$ 

(1.66)  $ 
- 

(1.66)  $ 

(0.61)  $ 
(0.01) 

(0.62)  $ 

- 
- 
72,408 

(0.04) 
(0.27) 

(0.31) 

(1)     For the years ended December 30, 2017 and December 31, 2016, it was more dilutive to assume the Preferred Stock was 
not converted into Common Shares, and, therefore, the numerator of the diluted loss per share calculation was not adjusted 
to  add  back  the  dividends  and  accretion  on  the  Preferred  Stock  and  the  denominator  was  not  adjusted  to  include 
11,333,333 and 2,670,320 Common Shares issuable on an if-converted basis for the years ended December 30, 2017 and 
December 31, 2016, respectively. 

SUNOPTA INC.                                                                                             

 -F44- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

(2)  For the years ended December 30, 2017, December 31, 2016, and January 2, 2016, stock options to purchase 815,952, 
66,166 and 54,316 Common Shares, respectively, were excluded from the calculation of diluted loss per share due to 
their anti-dilutive effect of reducing the loss per share.  In addition, for the years ended December 30, 2017, December 
31, 2016 and January 2, 2016, options to purchase 2,540,189, 2,321,448 and 856,492 Common Shares were anti-dilutive 
because the exercise prices of these options were greater than the average market price. 

21.   Supplemental Cash Flow Information 

Changes in non-cash working capital, net of 

businesses acquired: 

Accounts receivable 
Inventories 
Income tax recoverable/payable 
Prepaid expenses and other current assets 
Accounts payable and accrued liabilities 
Customer and other deposits 

Cash paid for: 
Interest 
Income taxes 

22.   Related Party Transactions 

December 30, 2017  December 31, 2016 
$ 

$ 

January 2, 2016 
$ 

35,773 
27,475 
(13,515) 
(11,994) 
(20,437) 
2,328 
19,630 

29,683 
4,150 

(39,857) 
(16,107) 
22,868 
(242) 
23,221 
(2,774) 
(12,891) 

28,651 
1,781 

17,404 
(25,732) 
(9,782) 
(2,044) 
15,242 
1,227 
(3,685) 

10,496 
10,526 

The following table summarizes transactions between the Company and related parties: 

Sales of agronomy products(1) 
Purchases of fruits, grains and seeds(2) 
Sales of coffee beans(3) 
Rent paid and other(4) 

December 30, 2017  December 31, 2016 
$ 
488 
14,867 
1,896 
976 

$ 
1,141 
18,487 
1,954 
220 

January 2, 2016 
$ 
906 
2,340 
1,395 
1,002 

(1)  Represents sales of agronomy products to employees at market prices, which are included in revenues on the consolidated 

statements of operations. 

(2)  Represents  purchases  of  raw  fruit  and  fruit  processing  services  at  market  prices  from  former  shareholders  of  Opus  who 
remain employed by the Company, as well as purchases of grains and seeds at market prices from employees of the Company, 
which are included in cost of goods sold on the consolidated statements of operations. 

(3)  Represents the sale of coffee beans at market prices from TOC to a company that is owned by the non-controlling shareholder 
of Trabocca B.V., a less-than-wholly-owned subsidiary of TOC.  These sales are included in revenues on the consolidated 
statement of operations. 

(4)  Includes rental payments at market rates for the lease of production, warehouse and/or office facilities from former owners 
of acquired businesses who remain or were employed by the Company.  These payments are included in cost of goods sold 
or selling, general and administrative expenses on the consolidated statements of operations. 

SUNOPTA INC.                                                                                             

 -F45- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

23.   Commitments and Contingencies    

Employment Matter 

On April 19, 2013, a class-action complaint, in the case titled De Jesus, et al. v. Frozsun, Inc. d/b/a Frozsun Foods, was filed 
against Sunrise Growers, Inc. (then named Frozsun, Inc.) in California Superior Court, Santa Barbara County seeking damages, 
equitable relief and reasonable attorneys’ fees for alleged wage and hour violations.  This case includes claims for failure to 
pay all hours worked, failure to pay overtime wages, meal and rest period violations, waiting-time penalties, improper wage 
statements and unfair business practices. The putative class includes approximately 10,000 non-exempt hourly employees from 
Sunrise’s production facilities in Santa Maria and Oxnard, California. The parties attended mediation on October 12, 2017 and 
reached a general agreement to resolve the matter on a class-wide basis.  The parties are negotiating the remaining details of 
the  settlement  which  is  subject  to  court  approval.    It  is  anticipated  that  the  parties  will  seek  preliminary  approval  of  the 
settlement  from  the  court  in  March  2018.    The  Company  expects  to  recover  the  full  amount  payable  under  the  settlement 
through insurance coverage and an escrow account established in connection with the Sunrise Acquisition. 

Product Recall 

On November 20, 2017, Treehouse Foods, Inc., several of its related entities, and its insurer filed a lawsuit against the Company 
in  the  Circuit  Court  of  Cook  County,  Illinois  titled  Treehouse  Foods,  Inc.  et  al.  v.  SunOpta  Grains  and  Food,  Inc.      The 
Company was served with the Summons and Complaint on January 24, 2018.   The plaintiffs allege economic damages resulting 
from  the  Company’s  2016  voluntary  recall  of  certain  roasted  sunflower  kernel  products  due  to  the  potential  for  Listeria 
monocytogenes contamination.  The case includes claims for breach of express and implied warranty, negligence, strict liability, 
and  indemnity  seeking  $16.2  million  in  damages.    There  are  no  allegations  of  personal  injury.    The  Company  intends  to 
vigorously defend itself against these claims.  The Company cannot reasonably predict the outcome of this claim, nor can it 
estimate the amount of loss, or range of loss, if any, that may result from this claim. 

Other Claims 

In addition, various claims and potential claims arising in the normal course of business are pending against the Company. It 
is the opinion of management that these claims or potential claims are without merit and the amount of potential liability, if 
any, to the Company is not determinable. Management believes the final determination of these claims or potential claims will 
not materially affect the financial position or results of the Company. 

Environmental Laws 

The Company believes that,  with respect to both its operations  and real property, it is in  material compliance  with current 
environmental  laws.    Based  on  known  existing  conditions  and  the  Company’s  experience  in  complying  with  emerging 
environmental issues, the Company is of the view that future costs relating to environmental compliance will not have a material 
adverse  effect  on  its  consolidated  financial  position,  but  there  can  be  no  assurance  that  unforeseen  changes  in  the  laws  or 
enforcement policies of relevant governmental bodies, the discovery of changed conditions on the Company’s real property or 
in its operations, or changes in the use of such properties and any related site restoration requirements, will not result in the 
incurrence of significant costs. 

Grain Held for Others  

As at December 30, 2017, the Company held grain for the benefit of others in the amount of $0.4 million (December 31, 2016 
– $0.5 million).  The Company is liable for any deficiencies of grade or shortage of quantity that may arise in connection with 
such grain.   

Letters of Credit 

The Company has outstanding letters of credit at December 30, 2017 totaling $9.4 million (December 31, 2016 – $4.3 million). 

SUNOPTA INC.                                                                                             

 -F46- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Real Property Lease Commitments 

The Company has entered into various leasing arrangements, which have fixed monthly rents that are adjusted annually each 
year for inflation. 

Minimum commitments under operating leases, principally for processing facilities, warehouse and distribution facilities, and 
equipment for the next five fiscal years and thereafter are as follows: 

2018 
2019 
2020 
2021 
2022 
Thereafter 

$ 
19,048 
15,820 
13,250 
8,902 
7,011 
7,868 
71,899  

In the years ended December 30, 2017, December 31, 2016 and January 2, 2016, net minimum rents, including contingent rents 
and sublease rental income, were $28.0 million, $27.9 million and $21.6 million, respectively. 

24.   Segmented Information 

The composition of the Company’s reportable segments is as follows:  

(cid:120)  Global Ingredients aggregates our North American-based Raw  Material Sourcing and Supply and European-based 
International Sourcing and Supply operating segments focused on the procurement and sale of specialty and organic 
grains and seeds, raw material ingredients, value-added grain- and cocoa-based ingredients, and organic commodities. 

(cid:120)  Consumer  Products  consists  of  three  main  commercial  platforms:  Healthy  Beverages,  Healthy  Fruit  and  Healthy 
Snacks.    Healthy  Beverages  includes  aseptic  packaged  products  including  non-dairy  beverages,  broths  and  teas; 
refrigerated premium juices; and shelf-stable juices and functional waters.  Healthy Fruit includes individually quick 
frozen (“IQF”) fruits for retail; IQF and bulk frozen fruit for foodservice; and custom fruit preparations for industrial 
use.    Healthy  Snacks  is  focused  on  fruit  snack  offerings,  and  included  flexible  resealable  pouch  and  nutrition  bar 
product lines, which were exited in 2017.   

In  addition,  Corporate  Services  provides  a  variety  of  management,  financial,  information  technology,  treasury  and 
administration  services  to  each  of  the  Company’s  operating  segments  from  the  Company’s  headquarters  in  Mississauga, 
Ontario and administrative office in Edina, Minnesota. 

When reviewing the operating results of the Company’s operating segments, management uses segment revenues from external 
customers and segment operating income/loss to assess performance and allocate resources.  Segment operating income/loss 
excludes other income/expense items and goodwill impairment losses.  In addition, interest expense and income amounts, and 
provisions for income taxes are not allocated to the operating segments. 

SUNOPTA INC.                                                                                             

 -F47- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Segment Revenues and Operating Income 

Reportable segment operating results for the years ended December 30, 2017, December 31, 2016 and January 2, 2016 were 
as follows: 

Segment revenues from external customers 
Segment operating income 
Corporate Services 
Other expense, net (see note 18) 
Goodwill impairment (see note 11) 
Interest expense, net 
Loss from continuing operations before income taxes 

Segment revenues from external customers 
Segment operating income 
Corporate Services 
Other expense, net (see note 18) 
Goodwill impairment (see note 11) 
Interest expense, net 
Loss from continuing operations before income taxes 

Segment revenues from external customers 
Segment operating income 
Corporate Services 
Other expense, net (see note 18) 
Interest expense, net 
Loss from continuing operations before income taxes 

December 30, 2017 

Global 
Ingredients 
$ 
550,527 
21,951 

Consumer 
Products 
$ 
729,066 
9,905 

Consolidated 
$ 
1,279,593 
31,856 
(31,089) 
(23,660) 
(115,000) 
(32,504) 
(170,397) 

December 31, 2016 

Global 
Ingredients 
$ 
574,295 
26,787 

Consumer 
Products 
$ 
772,436 
1,206 

Global 
Ingredients 
$ 
610,890 
28,184 

Consumer 
Products 
$ 
534,244 
3,208 

Consolidated 
$ 
1,346,731 
27,993 
(13,247) 
(28,292) 
(17,540) 
(43,275) 
(74,361) 

January 2, 2016 

Consolidated 
$ 
1,145,134 
31,392 
(10,094) 
(12,151) 
(15,669) 
(6,522) 

SUNOPTA INC.                                                                                             

 -F48- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Segment Assets 

Total assets and goodwill by reportable segment as at December 30, 2017 and December 31, 2016 were as follows: 

Segment assets: 
  Global Ingredients 
  Consumer Products 

  Total segment assets 

  Corporate Services 
  Total assets 

Segment goodwill: 
  Global Ingredients 
  Consumer Products 

  Total segment goodwill 

  December 30, 2017  December 31, 2016 
$ 
$ 

347,971 
588,542 
936,513 
45,660 
982,173 

9,177 
100,356 
109,533 

304,149 
776,405 
1,080,554 
49,004 
1,129,558 

8,255 
215,356 
223,611 

Segment Capital Expenditures, Depreciation and Amortization 

Capital expenditures, depreciation and amortization by reportable segment for the years ended December 30, 2017, December 
31, 2016 and January 2, 2016 were as follows: 

  December 30, 2017  December 31, 2016 
$ 
$ 

January 2, 2016 
$ 

Segment capital expenditures: 

  Global Ingredients 
  Consumer Products 

  Total segment capital expenditures 

  Corporate Services 

  Total capital expenditures 

Segment depreciation and amortization: 
  Global Ingredients 
  Consumer Products 

  Total segment depreciation and amortization 

  Corporate Services 

  Total depreciation and amortization 

9,060 
27,054 
36,114 
5,025 
41,139 

6,464 
23,666 
30,130 
2,694 
32,824 

4,767 
14,586 
19,353 
3,207 
22,560 

6,406 
25,532 
31,938 
2,212 
34,150 

5,872 
21,529 
27,401 
3,785 
31,186 

6,352 
12,814 
19,166 
1,841 
21,007 

SUNOPTA INC.                                                                                             

 -F49- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SunOpta Inc. 
Notes to Consolidated Financial Statements 
For the years ended December 30, 2017, December 31, 2016 and January 2, 2016 
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts) 
____________________________________________________________________________________________________ 

Geographic Information 

The Company’s assets, operations and employees are principally located in the U.S., Canada, Europe, Mexico and Ethiopia.  
Revenues from external customers are attributed to countries based on the location of the customer.  Revenues from external 
customers by geographic area for the years ended December 30, 2017, December 31, 2016 and January 2, 2016 were as follows: 

Revenues from external customers: 
  U.S. 
  Canada 
  Europe and other 

  Total revenues from external customers 

  December 30, 2017  December 31, 2016 
$ 
$ 

January 2, 2016 
$ 

1,001,417 
27,929 
250,247 
1,279,593 

1,084,199 
30,959 
231,573 
1,346,731 

893,637 
33,291 
218,206 
1,145,134 

Long-lived assets consist of property, plant and equipment, net of accumulated depreciation, which are attributed to countries 
based on the physical location of the assets.  Long-lived assets by geographic area as at December 30, 2017 and December 31, 
2016 were as follows: 

Long-lived assets: 
  U.S. 
  Canada 
  Europe and other 

  Total long-lived assets 

Major Customers 

  December 30, 2017  December 31, 2016 
$ 
$ 

128,367 
3,094 
32,163 
163,624 

133,335 
3,346 
25,558 
162,239 

For the years ended December 30, 2017 and December 31, 2016, Costco Wholesale (“Costco”) accounted for approximately 
10% and 11%, respectively, of consolidated revenues.  Revenues from Costco are included in the Consumer Products operating 
segment. The Company did not have any customers that exceeded 10% of total revenues for the year ended January 2, 2016. 

SUNOPTA INC.                                                                                             

 -F50- 

December 30, 2017 10-K 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental financial information (unaudited) 

Summarized below is the Consolidated Statement of Operations for the quarters ended December 30, 2017, September 30, 
2017, July 1, 2017 and April 1, 2017, as well as the fiscal 2016 quarterly comparatives. 

December 30, 2017 
$ 

Quarter ended 
December 31, 2016 
$ 

Revenues(1) 
Cost of goods sold 
Gross profit 

Selling, general and administrative expenses 
Intangible asset amortization 
Other expense, net(2) 
Goodwill impairment(3) 
Foreign exchange loss (gain) 

Loss before the following 

Interest expense, net 

Loss before income taxes 

Recovery of income taxes 

Loss 

Earnings attributable to non-controlling interests 

Loss attributable to SunOpta Inc. 

Loss per share - basic 

 -from continuing operations 
 -from discontinued operations 

Loss per share - diluted 

 -from continuing operations 
 -from discontinued operations 

 292,395  
264,124 
28,271 

28,094 
2,766 
 11,638  
 115,000  
1,268 

(130,495) 

8,684 

(139,179) 

(21,780) 

(117,399) 

88 

(117,487) 

(1.38) 
- 
(1.38) 

(1.38) 
- 
(1.38) 

297,539 
280,496 
17,043 

26,005 
2,810 
5,569 
17,540 
(1,817) 

(33,064) 

8,527 

(41,591) 

(8,165) 

(33,426) 

50 

(33,476) 

(0.41) 
- 
(0.41) 

(0.41) 
- 
(0.41) 

(1)  Fourth quarters of 2017 and 2016 included revenues from exited flexible resealable pouch and nutrition bar product lines of $9.1 million and $14.4 

million, respectively (see note 4 to the consolidated financial statements). 

(2)  Fourth quarters of 2017 and 2016 included asset impairment charges of $10.0 million and $1.2 million, respectively, associated with the Value Creation 

Plan (see note 4 to the consolidated financial statements). 

(3)  Fourth quarters of 2017 and 2016 reflected the impairment of goodwill associated with the Frozen Fruit and Sunflower reporting units, respectively (see 

note 11 to the consolidated financial statements). 

SUNOPTA INC.                                                                                             

 -F51- 

December 30, 2017 10-K 

     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental financial information (unaudited) continued 

Revenues(1) 
Cost of goods sold 
Gross profit 

Selling, general and administrative expenses 
Intangible asset amortization 
Other expense, net(2) 
Foreign exchange loss 

Earnings (loss) before the following 

Interest expense, net 

Loss before income taxes 

Recovery of income taxes 

Loss 

Earnings (loss) attributable to non-controlling interests 

Loss attributable to SunOpta Inc. 

Loss per share - basic 

 -from continuing operations 
 -from discontinued operations 

Loss per share - diluted 

 -from continuing operations 
 -from discontinued operations 

September 30, 2017 
$ 

 320,713  
284,258 
36,455 

Quarter ended 
October 1, 2016 
$ 

348,732 
307,702 
41,030 

26,102 
2,817 
 5,972  
2,575 

(1,011) 

8,371 

(9,382) 

(3,499) 

(5,883) 

144 

(6,027) 

(0.09) 
- 
(0.09) 

(0.09) 
- 
(0.09) 

23,915 
2,826 
10,312 
1,068 

2,909 

12,178 

(9,269) 

(5,411) 

(3,858) 

(503) 

(3,355) 

(0.04) 
- 
(0.04) 

(0.04) 
- 
(0.04) 

(1)  Third quarters of 2017 and 2016 included revenues from exited flexible resealable pouch and nutrition bar product lines of $13.5 million and $14.3 

million, respectively (see note 4 to the consolidated financial statements). 

(2)  Third quarters of 2017 and 2016 included asset impairment charges of $4.5 million and $10.3 million, respectively, associated with the Value Creation 

Plan (see note 4 to the consolidated financial statements). 

SUNOPTA INC.                                                                                             

 -F52- 

December 30, 2017 10-K 

     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Supplemental financial information (unaudited) continued 

Revenues(1) 
Cost of goods sold 
Gross profit 

Selling, general and administrative expenses 
Intangible asset amortization 
Other expense, net 
Foreign exchange loss (gain) 

Earnings before the following 

Interest expense, net 

Loss before income taxes 

Recovery of income taxes 

Loss 

Earnings attributable to non-controlling interests 

Loss attributable to SunOpta Inc. 

Loss per share - basic 

 -from continuing operations 
 -from discontinued operations 

Loss per share - diluted 

 -from continuing operations 
 -from discontinued operations 

July 1, 2017 
$ 

 336,454  
294,792 
41,662 

35,039 
2,809 
607 
1,195 

2,012 

7,695 

(5,683) 

(5,581) 

(102) 

306 

(408) 

(0.03) 
- 
(0.03) 

(0.03) 
- 
(0.03) 

Quarter ended 
July 2, 2016 
$ 

348,146 
312,168 
35,978 

24,489 
2,824 
8,433 
(180) 

412 

11,548 

(11,136) 

(7,135) 

(4,001) 

123 

(4,124) 

(0.05) 
- 
(0.05) 

(0.05) 
- 
(0.05) 

(1)  Second quarters of 2017 and 2016 included revenues from exited flexible resealable pouch and nutrition bar product lines of $15.2 million and $15.0 

million, respectively (see note 4 to the consolidated financial statements). 

SUNOPTA INC.                                                                                             

 -F53- 

December 30, 2017 10-K 

     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental financial information (unaudited) continued 

Revenues(1) 
Cost of goods sold 
Gross profit 

Selling, general and administrative expenses 
Intangible asset amortization 
Other expense, net(2) 
Foreign exchange loss 

Loss from continuing operations before the following 

Interest expense, net 

Loss from continuing operations before income taxes 

Recovery of income taxes 

Loss from continuing operations 

Loss from discontinued operations, net of income taxes and non- 

controlling interest 

Loss 

Earnings attributable to non-controlling interests 

Loss attributable to SunOpta Inc. 

Loss per share - basic 

 -from continuing operations 
 -from discontinued operations 

Loss per share - diluted 

 -from continuing operations 
 -from discontinued operations 

April 1, 2017 
$ 

 330,031  
291,332 
38,699 

38,272 
2,803 
 5,443  
580 

(8,399) 

7,754 

(16,153) 

(4,969) 

(11,184) 

- 

(11,184) 

214 

(11,398) 

(0.16) 
- 
(0.16) 

(0.16) 
- 
(0.16) 

Quarter ended 
April 2, 2016 
$ 

352,314 
320,413 
31,901 

24,272 
2,822 
3,978 
2,172 

(1,343) 

11,022 

(12,365) 

(3,086) 

(9,279) 

(570) 

(9,849) 

384 

(10,233) 

(0.11) 
(0.01) 
(0.12) 

(0.11) 
(0.01) 
(0.12) 

(1)  First quarters of 2017 and 2016 included revenues from exited flexible resealable pouch and nutrition bar product lines of $15.4 million and $15.7 million, 

respectively (see note 4 to the consolidated financial statements). 

(2)  First quarter of 2017 included an asset impairment charge of $3.7 million associated the Value Creation Plan (see note 4 to the consolidated financial 
statements).  First quarter of 2016 included asset impairment charge of $1.7 million associated with the consolidation of the Company’s frozen fruit 
processing operations (see note 18 to the consolidated financial statements). 

SUNOPTA INC.                                                                                             

 -F54- 

December 30, 2017 10-K 

     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER 
PURSUANT TO RULE 13a-14(a)  
AS ADOPTED PURSUANT TO  
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 

Exhibit 31.1 

I, David Colo, certify that: 

(1) 

(2) 

(3) 

(4) 

I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of SunOpta Inc.  

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a 
material fact necessary to make the statements made, in light of the circumstances under which such statements 
were made, not misleading with respect to the period covered by this report; 

Based on my knowledge, the financial statements, and other financial information included in this report, fairly 
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, 
and for, the periods presented in this report; 

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls 
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial 
reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have: 

a. 

b. 

c. 

d. 

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be 
designed under our supervision, to ensure that material information relating to the registrant, including its 
consolidated  subsidiaries,  is  made  known  to  us  by  others  within  those  entities,  particularly  during  the 
period in which this report is being prepared; 

Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial 
reporting to be designed under our supervision, to provide reasonable assurance regarding the  reliability 
of financial reporting and the preparation of financial statements for external purposes in accordance with 
generally accepted accounting principles; 

Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this 
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of 
the period covered by this report based on such evaluation; and 

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred 
during the registrant’s  most recent  fiscal quarter (the registrant’s fourth  fiscal quarter in the case of an 
annual  report)  that  has  materially  affected,  or  is  reasonably  likely  to  materially  affect,  the  registrant’s 
internal control over financial reporting; and 

(5) 

The  registrant’s  other  certifying  officer  and  I  have  disclosed,  based  on  our  most  recent  evaluation  of  internal 
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of 
directors (or persons performing the equivalent functions): 

a. 

b. 

All significant deficiencies and  material  weaknesses in the  design or operation of internal control over 
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, 
summarize and report financial information; and 

Any fraud, whether or not material, that involves management or other employees who have a significant 
role in the registrant’s internal control over financial reporting. 

/s/ David Colo 

David Colo 
President and Chief Executive Officer 
SunOpta Inc. 
Date: March 7, 2018 

     
 
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
 
 
  
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER 
PURSUANT TO RULE 13a-14(a)  
AS ADOPTED PURSUANT TO  
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 

Exhibit 31.2 

I, Robert McKeracher, certify that: 

(1) 

(2) 

(3) 

(4) 

I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of SunOpta Inc.  

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a 
material fact necessary to make the statements made, in light of the circumstances under which such statements 
were made, not misleading with respect to the period covered by this report; 

Based on my knowledge, the financial statements, and other financial information included in this report, fairly 
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, 
and for, the periods presented in this report; 

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls 
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial 
reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have: 

a. 

b. 

c. 

d. 

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be 
designed under our supervision, to ensure that material information relating to the registrant, including its 
consolidated  subsidiaries,  is  made  known  to  us  by  others  within  those  entities,  particularly  during  the 
period in which this report is being prepared; 

Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial 
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability 
of financial reporting and the preparation of financial statements for external purposes in accordance with 
generally accepted accounting principles; 

Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this 
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of 
the period covered by this report based on such evaluation; and 

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred 
during the registrant’s  most recent  fiscal quarter (the registrant’s fourth  fiscal quarter in the case of an 
annual  report)  that  has  materially  affected,  or  is  reasonably  likely  to  materially  affect,  the  registrant’s 
internal control over financial reporting; and 

(5) 

The  registrant’s  other  certifying  officer  and  I  have  disclosed,  based  on  our  most  recent  evaluation  of  internal 
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of 
directors (or persons performing the equivalent functions): 

a. 

b. 

All significant deficiencies and  material  weaknesses in the  design or operation of internal control over 
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, 
summarize and report financial information; and 

Any fraud, whether or not material, that involves management or other employees who have a significant 
role in the registrant’s internal control over financial reporting. 

/s/ Robert McKeracher 

Robert McKeracher 
Vice President and Chief Financial Officer 
SunOpta Inc. 
Date: March 7, 2018 

     
 
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
 
CERTIFICATION  
PURSUANT TO 18 U.S.C. SECTION 1350 
AS ADOPTED PURSUANT TO  
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

 Exhibit 32 

In connection with Amendment No. 1 to the Annual Report on Form 10-K/A of SunOpta Inc. (the “Company”) for the year 
ended December 30, 2017, as filed with the Securities and Exchange Commission (the “Report”), I, David Colo, President and 
Chief  Executive  Officer  of  the  Company,  and  I,  Robert  McKeracher,  Vice  President  and  Chief  Financial  Officer  of  the 
Company, certify pursuant to 18 U.S.C. Section 1350, that to our knowledge: 

1.  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

2.  The  information  contained  in  the  Report  fairly  presents,  in  all  material  respects,  the  financial  condition  and  results  of 

operations of the Company. 

A  signed  original  of  this  written  statement,  or  other  document  authenticating,  acknowledging,  or  otherwise  adopting  the 
signature that appears in typed form within the electronic version of this written statement, has been provided to the Company 
and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. 

Date:  March 7, 2018 

/s/ David Colo 
David Colo 
President and Chief Executive Officer 
SunOpta Inc. 

/s/ Robert McKeracher 
Robert McKeracher 
Vice President and Chief Financial Officer 
SunOpta Inc. 

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and should not 
be deemed to be filed under the Exchange Act by the Company or the certifying officers. 

     
 
 
[This page intentionally left blank] 

SUSTAINABILITY IS 
AN INTEGRAL PART 
OF SUNOPTA’S 
BUSINESS

SunOpta’s passion for bringing well-
being to life drives everything we do. 
Sustainability plays a vital role in fulfilling 
this purpose. Our approach is built on 
five platforms that are integrated into 
our overall business strategy: workplace, 
community, partnerships, environment 
and marketplace. These platforms 
address each dimension of sustainability 
in a way that serves our customers’ best-
interests, improves the communities in 
which we operate, maximizes value for 
our shareholders and guides our efforts 
to become an increasingly sustainable 
organization.

Download our latest Corporate Sustainability Report at www.sunopta.com.

EXTENSIVE GLOBAL CAPABILITIES

Publicly Held

Employees

Headquarters

Locations

Geography

NASDAQ - STKL
TSX - SOY

Approximately 1,800

Mississauga, Ontario, Canada

Processing and Packaging:  22
Other: 22

Americas:  33 locations
Europe:  6 locations
Africa:  3 locations
Asia:  2 locations

Currently doing business in
approximately 65 countries

2017 Annual ReportDIRECTORS AND LEADERSHIP TEAM 

Directors

Leadership Team 

Shareholder Information

Margaret Shân Atkins (4)(5)
Independent Director

David J. Colo
President and Chief Executive Officer

Dr. Albert Bolles (2)(4)
Independent Director

Derek Briffett (2)
Independent Director

David J. Colo
President and Chief Executive 
Officer and Director

Michael Detlefsen (1)(6)
Independent Director

Dean Hollis (4)(6)
Chair

Kathy Houde (2)(3)
Independent Director

Brendan Springstubb (2)(6)
Independent Director

Gregg Tanner (2)(4)
Independent Director 

(1) Chair of Audit Committee
(2) Member of Audit Committee
(3) Chair of Corporate Governance  
Committee
(4) Member of Corporate Governance 
Committtee
(5) Chair of Compensation Committee
(6) Member of Compensation 
Committee

Corporate Head Office
2233 Argentia Road
Suite 401, West Tower
Mississauga, ON, Canada
L5N 2X7
T:  (905) 821-9669
F:  (905) 819-7971

www.sunopta.com 

Rob McKeracher
Vice President and Chief Financial 
Officer

John Ruelle
Senior Vice President, 
Corporate Development and RMSS

Gerard Versteegh
Senior Vice President, Global 
Ingredients

Jill Barnett
General Counsel and Corporate 
Secretary

Michael  Buick
Senior Vice President and General 
Manager, Beverage & Snack

Rob Duchscher
Chief Information Officer

Jeff Gough
Chief Human Resource Officer

Rob Grant
Senior Vice President, Supply Chain

James Gratzek
Senior Vice President, Research & 
Development and Quality

John Lindell
Senior Vice President and General 
Manager, Fruit

George Miketa
Chief Customer Officer

Susanne Schuster
Vice President, Internal Audit

Chris Whitehair
Senior Vice President, Operations

TRANSFER AGENTS
TSX Trust Company
100 Adelaide Street West, Suite 301
Toronto, ON, Canada M5H 4H1
T:  (416) 361-0930

American Stock Transfer & Trust Company, 
LLP
6201 15th Ave.
Brooklyn, NY, USA 11219
T:  (800) 937-5449

CORPORATE LEGAL COUNSEL
Stoel Rives, LLP
Minneapolis, MN

Wildeboer Dellelce LLP
Toronto, ON, Canada

AUDITORS 
Deloitte LLP
Toronto, ON, Canada

ANNUAL MEETING
May 31, 2018 at 4:00 pm Eastern
SunOpta Inc.
2233 Argentia Road
Suite 401, West Tower
Mississauga, ON, Canada L5N 2X7

Listed on NASDAQ: STKL and TSX:  SOY

SHAREHOLDER COMMUNICATIONS
Copies of SunOpta’s Annual Report, 
Form 10K (Annual Information Form) and 
other regulatory filings are available on 
the Company website www.sunopta.com.  
Additional financial information has been 
filed electronically with various securities 
commissions in Canada through SEDAR 
(www.sedar.com) and in the USA through 
EDGAR (www.sec.gov).  Paper copies are 
available without charge.

Please Contact:
Beth McGillivary, Senior Executive Assistant 
SunOpta Inc.
2233 Argentia Road
Suite 401, West Tower
Mississauga, ON, Canada L5N 2X7
T: (905) 819-7924
F: (905) 819-7971
Email:  beth.mcgillivary@sunopta.com 

www.sunopta.com

2017 Annual Report